Sentence,class,file
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/70/9e/bmjqir-u201125-w713.PMC4949623.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/8c/8b/bmjqir-u202228-w1114.PMC4949624.pdf
Available from:  http://www.nice.org.uk/nicemedia/live/13060/49909/49909.p df 2.,Non-OADS,/arxiv_data1/oa_pdf/f1/6e/bmjqir-u205217-w2159.PMC4949634.pdf
"See http://creativecommons.org/licenses/by-nc/2.0, http://creativecommons.org/licenses/by-nc/2.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/f1/6e/bmjqir-u205217-w2159.PMC4949634.pdf
"Keywords: Contraction; Ischemia; Urinary bladder; Urination This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Rapid Communication - Basic and Translational Research Received: 23 June, 2016  •  Accepted: 28 June, 2016 Corresponding Author: Kazem M. Azadzoi Department of Urology, VA Boston Healthcare System and Boston University School of Medicine, 150 South Huntington Avenue, Boston, MA 02130, USATEL: +1-857-364-5602, FAX: +1-857-364-4540, E-mail: kazadzoi@bu.edu ⓒ The Korean Urological Association, 2016 [1-3] .",Non-OADS,/arxiv_data1/oa_pdf/ac/f5/icu-57-249.PMC4949689.pdf
"It is thought that aging-related  comorbidities influencing neurotransmission, sensation, and  smooth muscle tension may hamper the bladder contractile  www.icurology.orgInvestig Clin Urol 2016;57:249-259.http://dx.doi.org/10.4111/icu.2016.57.4.249pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/ac/f5/icu-57-249.PMC4949689.pdf
250 www.icurology.orgZhao  et al http://dx.doi.org/10.4111/icu.2016.57.4.249 function and impair its ability to empty [1-3] .,OADS,/arxiv_data1/oa_pdf/ac/f5/icu-57-249.PMC4949689.pdf
252 www.icurology.orgZhao  et al http://dx.doi.org/10.4111/icu.2016.57.4.249 3.,Non-OADS,/arxiv_data1/oa_pdf/ac/f5/icu-57-249.PMC4949689.pdf
254 www.icurology.orgZhao  et al http://dx.doi.org/10.4111/icu.2016.57.4.249 DISCUSSION Detrusor underactivity represents a challenging clinical  entity contributing to voiding dysfunction in both men  and women.,Non-OADS,/arxiv_data1/oa_pdf/ac/f5/icu-57-249.PMC4949689.pdf
"256 www.icurology.orgZhao  et al http://dx.doi.org/10.4111/icu.2016.57.4.249 and receptors to enhance smooth muscle contractility to  maintain function [4,6, 13] .",OADS,/arxiv_data1/oa_pdf/ac/f5/icu-57-249.PMC4949689.pdf
258 www.icurology.orgZhao  et al http://dx.doi.org/10.4111/icu.2016.57.4.249 CONCLUSIONS Multiple etiologies are implicated in voiding dysfunction  due to detrusor underactivity but their causality and  underlying mechanisms remain unproven.,OADS,/arxiv_data1/oa_pdf/ac/f5/icu-57-249.PMC4949689.pdf
It should be noted that the  final goal of stone surgery is to remove the stone burden as  much as possible and to reduce the risk of recurrence and  www.icurology.orgInvestig Clin Urol 2016;57:229-230. http://dx.doi.org/10.4111/icu.2016.57.4.229pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/ca/93/icu-57-229.PMC4949690.pdf
230 www.icurology.orgHan and Jeon http://dx.doi.org/10.4111/icu.2016.57.4.229 stone ­related complications.,Non-OADS,/arxiv_data1/oa_pdf/ca/93/icu-57-229.PMC4949690.pdf
"Keywords: Kidney calculi; Lasers; Lithotripsy; Ureteroscopy This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Endourology/Urolithiasis Received: 20 May, 2016  •  Accepted: 20 June, 2016 Corresponding Author: Bum Soo Kim Department of Urology, Kyungpook National University Hospital, Kyungpook National University School of Medicine,  130 Dongdeok-ro, Jung-gu, Daegu 41944, KoreaTEL: +82-53-200-5855, FAX: +82-53-421-9618, E-mail: urokbs@knu.ac.kr ⓒ The Korean Urological Association, 2016 surgery.",Non-OADS,/arxiv_data1/oa_pdf/cc/48/icu-57-274.PMC4949691.pdf
Since the first flexible ureteroscopic procedures were  www.icurology.orgInvestig Clin Urol 2016;57:274-279.http://dx.doi.org/10.4111/icu.2016.57.4.274pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/cc/48/icu-57-274.PMC4949691.pdf
276 www.icurology.orgLee et al http://dx.doi.org/10.4111/icu.2016.57.4.274 laser lithotripsy without being actively removed ( Fig.,Non-OADS,/arxiv_data1/oa_pdf/cc/48/icu-57-274.PMC4949691.pdf
278 www.icurology.orgLee et al http://dx.doi.org/10.4111/icu.2016.57.4.274 small when performing the active stone removal technique.,Non-OADS,/arxiv_data1/oa_pdf/cc/48/icu-57-274.PMC4949691.pdf
"It is well known way to be recognized internationally  that guideline was made with the method of GRADE The authors reply: Korean clinical practice  guideline for benign prostatic hyperplasia Jeong Kyun Yeo1, Hyung Jee Kim2 1Department of Urology, Inje University College of Medicine, Seoul, 2Department of Urology, Dankook University College of Medicine, Cheonan, Korea This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Letter Received: 10 June, 2016  •  Accepted: 17 June, 2016 Corresponding Author: Hyung Jee Kim Department of Urology, Dankook University College of Medicine, 119 Dandae-ro, Dongnam-gu, Cheonan 31116, KoreaTEL: +82-41-550-7114, FAX: +82-41-556-0524, E-mail: killtumor@dankook.ac.kr ⓒ The Korean Urological Association, 2016 (Grading of Recommendations Assessment, Development  and Evaluation) Working Group.",Non-OADS,/arxiv_data1/oa_pdf/70/76/icu-57-305.PMC4949692.pdf
Available from: http://training.cochrane.org/ko/resource/ grade-handbook.,Non-OADS,/arxiv_data1/oa_pdf/70/76/icu-57-305.PMC4949692.pdf
Eur Urol 2015;67:1099-109. www.icurology.orgInvestig Clin Urol 2016;57:305. http://dx.doi.org/10.4111/icu.2016.57.4.305pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/70/76/icu-57-305.PMC4949692.pdf
"Keywords: Complications; Cystectomy; Robotic surgical procedures; Urinary bladder neoplasms This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Urological Oncology Received: 11 April, 2016  •  Accepted: 31 May, 2016 Corresponding Author: Tae Gyun Kwon Department of Urology, Kyungpook National University School of Medicine, 680 Gukchaebosang-ro, Jung-gu, Daegu 41944, KoreaTEL: +82-53-420-5841, FAX: +82-53-421-9618, E-mail: tgkwon@knu.ac.kr ⓒ The Korean Urological Association, 2016 invasive disease, including carcinoma in situ  (CIS) [1].",Non-OADS,/arxiv_data1/oa_pdf/36/58/icu-57-260.PMC4949693.pdf
www.icurology.orgInvestig Clin Urol 2016;57:260-267.http://dx.doi.org/10.4111/icu.2016.57.4.260pISSN 2466-0493  •  eISSN 2466-054X,OADS,/arxiv_data1/oa_pdf/36/58/icu-57-260.PMC4949693.pdf
262 www.icurology.orgBak et al http://dx.doi.org/10.4111/icu.2016.57.4.260 performed intracorporeally after redocking the robotic  system.,OADS,/arxiv_data1/oa_pdf/36/58/icu-57-260.PMC4949693.pdf
"264 www.icurology.orgBak et al http://dx.doi.org/10.4111/icu.2016.57.4.260 12 of 42 patients (28.6%) and 12 of 70 patients (17.1%) for the  RARC and ORC groups, respectively (p=0.",OADS,/arxiv_data1/oa_pdf/36/58/icu-57-260.PMC4949693.pdf
266 www.icurology.orgBak et al http://dx.doi.org/10.4111/icu.2016.57.4.260 multiple complications than RARC group.,Non-OADS,/arxiv_data1/oa_pdf/36/58/icu-57-260.PMC4949693.pdf
"Keywords: Ablation techniques; Aged; Kidney neoplasms; Nephrectomy; Watchful waiting This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Review Article Received: 3 May, 2016  •  Accepted: 31 May, 2016 Corresponding Author: Felix K.-H. Chun Department of Urology, University Medical Center Hamburg-Eppendorf, Martinistr.",Non-OADS,/arxiv_data1/oa_pdf/74/32/icu-57-231.PMC4949694.pdf
Given this discordance of aggressive  approaches towards early stage lesions without a decline  www.icurology.orgInvestig Clin Urol 2016;57:231-239.http://dx.doi.org/10.4111/icu.2016.57.4.231pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/74/32/icu-57-231.PMC4949694.pdf
"232 www.icurology.orgVetterlein et al http://dx.doi.org/10.4111/icu.2016.57.4.231 in mortality, questions have risen regarding appropriate  paradigms of treatment management.",Non-OADS,/arxiv_data1/oa_pdf/74/32/icu-57-231.PMC4949694.pdf
"234 www.icurology.orgVetterlein et al http://dx.doi.org/10.4111/icu.2016.57.4.231 only in a small subgroup of patients and that, specifically  in older patients with severe competing health risks, active  surveillance may be a reasonable treatment approach,  considering the later option of delayed intervention in this  population.",Non-OADS,/arxiv_data1/oa_pdf/74/32/icu-57-231.PMC4949694.pdf
"236 www.icurology.orgVetterlein et al http://dx.doi.org/10.4111/icu.2016.57.4.231 relative to their counterparts undergoing surgery, which  translated into a decreased overall survival in the former  subgroup.",Non-OADS,/arxiv_data1/oa_pdf/74/32/icu-57-231.PMC4949694.pdf
238 www.icurology.orgVetterlein et al http://dx.doi.org/10.4111/icu.2016.57.4.231 660-73.,Non-OADS,/arxiv_data1/oa_pdf/74/32/icu-57-231.PMC4949694.pdf
http://dx.doi.org/10.1111/iju.13001.,Non-OADS,/arxiv_data1/oa_pdf/74/32/icu-57-231.PMC4949694.pdf
"Keywords: Abdominal hernia; Cystectomy; Postoperative complication; Urinary diversion This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Review Article Received: 5 April, 2016  •  Accepted: 13 May, 2016 Corresponding Author: Bernard H. Bochner Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USATEL: +1-646-422-4387, FAX: +1-212-988-0759, E-mail: bochnerb@mskcc.org ⓒ The Korean Urological Association, 2016 high recurrence rates have prompted surgeons to attempt  to prevent their formation from the time of the initial  surgery.",Non-OADS,/arxiv_data1/oa_pdf/d2/0c/icu-57-240.PMC4949695.pdf
www.icurology.orgInvestig Clin Urol 2016;57:240-248.http://dx.doi.org/10.4111/icu.2016.57.4.240pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/d2/0c/icu-57-240.PMC4949695.pdf
242 www.icurology.orgDonahue and Bochner http://dx.doi.org/10.4111/icu.2016.57.4.240 forming the stoma [16] ( Fig.,Non-OADS,/arxiv_data1/oa_pdf/d2/0c/icu-57-240.PMC4949695.pdf
"244 www.icurology.orgDonahue and Bochner http://dx.doi.org/10.4111/icu.2016.57.4.240 27.5% of whom developed a cPH after 2.6 years of median  follow ­up; median BMI for this cohort was 21.4 kg/m2 (range,  15.0–32.8 kg /m2).",OADS,/arxiv_data1/oa_pdf/d2/0c/icu-57-240.PMC4949695.pdf
"246 www.icurology.orgDonahue and Bochner http://dx.doi.org/10.4111/icu.2016.57.4.240 for those having mesh placed and those having standard  surgery (80% vs. 61%, p=0.155).",Non-OADS,/arxiv_data1/oa_pdf/d2/0c/icu-57-240.PMC4949695.pdf
248 www.icurology.orgDonahue and Bochner http://dx.doi.org/10.4111/icu.2016.57.4.240 raphy classification for parastomal hernia.,Non-OADS,/arxiv_data1/oa_pdf/d2/0c/icu-57-240.PMC4949695.pdf
"Keywords: Buccal mucosa; Female; Reconstructive surgical procedures; Urethral stricture This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Innovative Surgical Techniques Received: 17 May, 2016  •  Accepted: 2 June, 2016 Corresponding Author: Nathan Hoag Department of Urology, Austin Hospital, University of Melbourne, 145 Studley Rd, Heidelberg, Victoria, 3084, AustraliaTEL: +61-3-9496-5000, FAX: +61-3-9428-2234, E-mail: nathanhoag2@gmail.com ⓒ The Korean Urological Association, 2016 injury, trauma, and malignancy [1].",Non-OADS,/arxiv_data1/oa_pdf/66/e7/icu-57-298.PMC4949696.pdf
Because of overlapping symptoms with other urologic  www.icurology.orgInvestig Clin Urol 2016;57:298-302.http://dx.doi.org/10.4111/icu.2016.57.4.298pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/66/e7/icu-57-298.PMC4949696.pdf
"300 www.icurology.orgHoag et al http://dx.doi.org/10.4111/icu.2016.57.4.298 graft, and parachuted into position ( Fig.",Non-OADS,/arxiv_data1/oa_pdf/66/e7/icu-57-298.PMC4949696.pdf
"Scan this QR code to see the accompanying video, or visit  www.icurology.org or https://youtu.be/9s1AzELqJEE.",Non-OADS,/arxiv_data1/oa_pdf/66/e7/icu-57-298.PMC4949696.pdf
"4 of this article, or be  available on YouTube (https://youtu.be/9s1AzELqJEE).",Non-OADS,/arxiv_data1/oa_pdf/66/e7/icu-57-298.PMC4949696.pdf
302 www.icurology.orgHoag et al http://dx.doi.org/10.4111/icu.2016.57.4.298 to the bladder flap neourethra.,Non-OADS,/arxiv_data1/oa_pdf/66/e7/icu-57-298.PMC4949696.pdf
"Keywords: Kidney calculi; Percutaneous nephrostomy; Prone position; Supine position; Treatment outcomes This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Endourology/Urolithiasis Received: 14 March, 2016  •  Accepted: 7 June, 2016 Corresponding Author: Weranja Ranasinghe Department of Urology, Casey Hospital, 62-70 Kangan Drive, Victoria 3806, AustraliaTEL: +61-3-8768-1200, FAX: +61-3-8768-1982, E-mail: weranja@gmail.com ⓒ The Korean Urological Association, 2016 more direct approach to the kidney [3] .",Non-OADS,/arxiv_data1/oa_pdf/fe/e4/icu-57-268.PMC4949697.pdf
"As a  result, several alternative positions are increasingly being  utilised including complete supine, modified supine, or  flank positioning [4-9] as they offer advantages including  reduced ventilation and circulation difficulties, less radiation  www.icurology.orgInvestig Clin Urol 2016;57:268-273.http://dx.doi.org/10.4111/icu.2016.57.4.268pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/fe/e4/icu-57-268.PMC4949697.pdf
"270 www.icurology.orgJones et al http://dx.doi.org/10.4111/icu.2016.57.4.268 higher for the modified supine cohort than for the prone  cohort (70% vs. 50%, p=0.005) with a significantly shorter  mean length of stay in hospital (p=0.005).",Non-OADS,/arxiv_data1/oa_pdf/fe/e4/icu-57-268.PMC4949697.pdf
"272 www.icurology.orgJones et al http://dx.doi.org/10.4111/icu.2016.57.4.268 PCNLs were done with no nephrostomies or completely  tubeless, while the traditional prone PCNLs all had  nephrostomies, which delayed discharge from hospital.",Non-OADS,/arxiv_data1/oa_pdf/fe/e4/icu-57-268.PMC4949697.pdf
Available from: http://uroweb.org/wp-content/uploads/22- Urolithiasis_LR_full.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fe/e4/icu-57-268.PMC4949697.pdf
"Second, wording of  recommendations appears inconsistent within the same level  of recommendation; terminology for strong recommendation Letter to the editor: Korean clinical practice  guideline for benign prostatic hyperplasia Jae Hung Jung1, Philipp Dahm2,3 1Department of Urology, Yonsei University Wonju College of Medicine, Wonju, Korea, 2Minneapolis Veterans Healthcare System and University of Minnesota, Department  of Urology, Minneapolis, MN, USA, 3Cochrane Urology Review Group, Minneapolis Veterans Healthcare System, University of Minnesota, Minneapolis, MN, USA This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Letter Received: 18 May, 2016  •  Accepted: 17 June, 2016 Corresponding Author: Philipp Dahm Minneapolis Veterans Healthcare System, Urology Section 112D, 1 Veterans Drive, Minneapolis, MN 55417, USATEL: +1-612-467-3532, FAX: +1-612-467-2232, E-mail: pdahm@umn.edu ⓒ The Korean Urological Association, 2016 varies between “should be offered”, “is recommended,”  “might be considered” to “should be advised” which may  distract the guideline user from the fact that all of these  recommendation are intended to be similarly actionable.",Non-OADS,/arxiv_data1/oa_pdf/24/fa/icu-57-303.PMC4949698.pdf
"While a guideline  that specifically addresses the disease characteristics of  lower urinary tract symptoms in Korean men, addresses  potentially different values and preferences, and considers  local practice patters is of critical importance, it appears a  wasteful use of resources to have organizations such as the  American Urological Association, European Association of  www.icurology.orgInvestig Clin Urol 2016;57:303-304. http://dx.doi.org/10.4111/icu.2016.57.4.303pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/24/fa/icu-57-303.PMC4949698.pdf
"304 www.icurology.orgJung and Dahm http://dx.doi.org/10.4111/icu.2016.57.4.303 Urology, National Institute for Health and Care Excellence,  and the Korean Urological Association to duplicate efforts  in the production of evidence profiles.",Non-OADS,/arxiv_data1/oa_pdf/24/fa/icu-57-303.PMC4949698.pdf
"Keywords: Erectile dysfunction; Gene expression; Microarray analysis; Peripheral nerve injuries This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Basic and Translational Research Received: 26 April, 2016  •  Accepted: 9 June, 2016 Corresponding Author: Sung Won Lee Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, KoreaTEL: +82-2-3410-3559, FAX: +82-2-3410-3027, E-mail: drswlee@skku.edu ⓒ The Korean Urological Association, 2016 leading cause of male cancer death [1].",Non-OADS,/arxiv_data1/oa_pdf/11/2a/icu-57-286.PMC4949699.pdf
ED means that  www.icurology.orgInvestig Clin Urol 2016;57:286-297.http://dx.doi.org/10.4111/icu.2016.57.4.286pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/11/2a/icu-57-286.PMC4949699.pdf
288 www.icurology.orgKam et al http://dx.doi.org/10.4111/icu.2016.57.4.286 intensities for each gene were generated using the Robust  Multi ­Array Average algorithm.,OADS,/arxiv_data1/oa_pdf/11/2a/icu-57-286.PMC4949699.pdf
Our microarray raw  data are available at the Gene Expression Omnibus database  (http://www.ncbi.nlm.nih.gov/geo) under accession number  GSE31247.,OADS,/arxiv_data1/oa_pdf/11/2a/icu-57-286.PMC4949699.pdf
The quality of microarray data was  assessed through the pipeline at http://www.arrayanalysis.,OADS,/arxiv_data1/oa_pdf/11/2a/icu-57-286.PMC4949699.pdf
"290 www.icurology.orgKam et al http://dx.doi.org/10.4111/icu.2016.57.4.286 ED samples could be separated to different clusters, showing  distinct gene expression profiles in the heat map (Fig.",OADS,/arxiv_data1/oa_pdf/11/2a/icu-57-286.PMC4949699.pdf
292 www.icurology.orgKam et al http://dx.doi.org/10.4111/icu.2016.57.4.286 diabetes ­induced ED models (Fig.,Non-OADS,/arxiv_data1/oa_pdf/11/2a/icu-57-286.PMC4949699.pdf
294 www.icurology.orgKam et al http://dx.doi.org/10.4111/icu.2016.57.4.286 Table 4.,Non-OADS,/arxiv_data1/oa_pdf/11/2a/icu-57-286.PMC4949699.pdf
296 www.icurology.orgKam et al http://dx.doi.org/10.4111/icu.2016.57.4.286 models may provide hints for targets for ED treatment and  for biomarkers to predict the effects of drug treatment.,Non-OADS,/arxiv_data1/oa_pdf/11/2a/icu-57-286.PMC4949699.pdf
"Keywords: Multidetector computed tomography; Ureterolithiasis; Ureteroscopes This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article - Endourology/Urolithiasis Received: 3 May, 2016  •  Accepted: 30 May, 2016 Corresponding Author: Jin Kyu Oh Department of Urology, Gachon University Gil Medical Center, 21 Namdong-daero 774beon-gil, Namdong-gu, Incheon 21565, KoreaTEL: +82-32-460-3334, FAX: +82-32-460-8340, E-mail: shaq21@empas.com ⓒ The Korean Urological Association, 2016 is still controversy with regard to determining which  treatment option should be considered the first-line therapy.",Non-OADS,/arxiv_data1/oa_pdf/08/20/icu-57-280.PMC4949700.pdf
Some tiny calculi can be managed with medical expulsive  www.icurology.orgInvestig Clin Urol 2016;57:280-285.http://dx.doi.org/10.4111/icu.2016.57.4.280pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/08/20/icu-57-280.PMC4949700.pdf
"282 www.icurology.orgLee et al http://dx.doi.org/10.4111/icu.2016.57.4.280 finally assessed by using a bootstrap resampling technique  with 1,000 samples [7,8].",Non-OADS,/arxiv_data1/oa_pdf/08/20/icu-57-280.PMC4949700.pdf
"284 www.icurology.orgLee et al http://dx.doi.org/10.4111/icu.2016.57.4.280 Actually, in our study, of a total of 83 patients, 49 patients  should have undergone concomitant ureteral balloon dilation  in order to access targeted stones.",Non-OADS,/arxiv_data1/oa_pdf/08/20/icu-57-280.PMC4949700.pdf
Our proposed test and our high-speed simulator are freelyavailable from the web at: http://www.mathmed.org/wclstewart/ HOME/SOFT/soft.html.,Non-OADS,/arxiv_data1/oa_pdf/b5/37/hdy201633a.PMC4949729.pdf
DATA ARCHIVING Data available from the Dryad Digital Repository: http://dx.doi.org/ 10.5061/dryad.7tb57.,OADS,/arxiv_data1/oa_pdf/b5/37/hdy201633a.PMC4949729.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/A test of independent assortment WCL Stewart and VR Hager 113 Heredity",Non-OADS,/arxiv_data1/oa_pdf/b5/37/hdy201633a.PMC4949729.pdf
http://dx.doi.org/10.1016/j.nicl.2016.07.001 2213-1582/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/a1/77/main.PMC4949734.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/77/main.PMC4949734.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/52/3d/main.PMC4949736.pdf
E-mail address: j.burrell@neura.edu.au http://dx.doi.org/10.1016/j.dadm.2016.03.006 2352-8729/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/52/3d/main.PMC4949736.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/52/3d/main.PMC4949736.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2016.03.006 .,OADS,/arxiv_data1/oa_pdf/52/3d/main.PMC4949736.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/82/c8/main.PMC4949737.pdf
Available from: http://www.alz.co.uk/research/World AlzheimerREPORT2011.pdf .,Non-OADS,/arxiv_data1/oa_pdf/82/c8/main.PMC4949737.pdf
http://dx.doi.org/10.1016/j.dadm.2016.03.010C.,OADS,/arxiv_data1/oa_pdf/82/c8/main.PMC4949737.pdf
"Production and hosting by ElsevierJournal of Advanced Research (2016) 7, 615–623 Cairo University Journal of Advanced Research http://dx.doi.org/10.1016/j.jare.2016.06.005 2090-1232 /C2112016 Production and hosting by Elsevier B.V. on behalf of Cairo University.",Non-OADS,/arxiv_data1/oa_pdf/63/2f/main.PMC4949740.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/63/2f/main.PMC4949740.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/63/2f/main.PMC4949740.pdf
"DNA sequences were aligned using Sechuencher software V.5.0 (Gene CodesCorporation, http://www.genecodes.com ).",OADS,/arxiv_data1/oa_pdf/63/2f/main.PMC4949740.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/63/2f/main.PMC4949740.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/63/2f/main.PMC4949740.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/33/main.PMC4949773.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.07.006 2049-0801/ ©2016 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/1a/33/main.PMC4949773.pdf
http://www.asia-spinalinjury.org/elearning/ASIA_ISCOS_high.pdf .,Non-OADS,/arxiv_data1/oa_pdf/1a/33/main.PMC4949773.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/48/31/main.PMC4949807.pdf
"We  deter- mined  that  the  POEM  would  provide  additional  beneﬁt  over  the gold  standard  LHM  in  our  patient  with  achalasia,  particularly  when http://dx.doi.org/10.1016/j.ijscr.2016.06.046 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/48/31/main.PMC4949807.pdf
"54  (8)  (2009)  1680–1685,  http://dx.doi.org/10.1007/s10620- 009-0863-8 .",Non-OADS,/arxiv_data1/oa_pdf/48/31/main.PMC4949807.pdf
"18  (1)  (2014) 106–111,  http://dx.doi.org/10.1007/s11605-013-2334-y ,  discussion  112.",Non-OADS,/arxiv_data1/oa_pdf/48/31/main.PMC4949807.pdf
This  is  an  open access article under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e8/ed/main.PMC4949808.pdf
He  was  sent  to  our  Clinic  because  of  multiple  perianal  ﬁstulas that  began  at  12  years  of  age  requiring  several  surgical  procedures http://dx.doi.org/10.1016/j.ijscr.2016.06.039 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/ed/main.PMC4949808.pdf
The  case  has  been  reported  in  line  with  the  CARE criteria (http://www.care-statement.org/ ).,Non-OADS,/arxiv_data1/oa_pdf/e8/ed/main.PMC4949808.pdf
This  is  an  open  access  article  under the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/28/14/main.PMC4949809.pdf
The  lesion  appears  to  have  a  solid  and  cystic  component  with http://dx.doi.org/10.1016/j.ijscr.2016.07.002 2210-2612/Published by  Elsevier  Ltd  on  behalf  of  IJS  Publishing  Group  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/28/14/main.PMC4949809.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/28/14/main.PMC4949809.pdf
"Maher,  VHL  mutation analysis  in  patients  with  isolated  central  nervous  system haemangioblastoma, Brain: a journal  of  neurology  130  (2007)  836–842, http://dx.doi.org/10.1093/brain/awl362  (published  online  EubMar).",Non-OADS,/arxiv_data1/oa_pdf/28/14/main.PMC4949809.pdf
"127  (2003)  e382–e384,  http://dx.doi.org/10.1043/1543- 2165(2003)127<e382:SHACRA>2.0.Co;2 (published  online  EpubSep).",OADS,/arxiv_data1/oa_pdf/28/14/main.PMC4949809.pdf
"17  (1960)  751–761, http://dx.doi.org/10.3171/jns.1960.17.4.0751  (published  online  EubJul).",Non-OADS,/arxiv_data1/oa_pdf/28/14/main.PMC4949809.pdf
"70 (1989)  24–30,  http://dx.doi.org/10.3171/jns.1989.70.1.0024  (published  online EubJan).",Non-OADS,/arxiv_data1/oa_pdf/28/14/main.PMC4949809.pdf
"82  (2014)  632–633,  http://dx.doi.org/ 10.1016/j.wneu.2014.08.026 (published  online  EubNov).",OADS,/arxiv_data1/oa_pdf/28/14/main.PMC4949809.pdf
"82  (2014)  629–631,  http://dx.doi.org/10.1016/j.wneu.2014.",Non-OADS,/arxiv_data1/oa_pdf/28/14/main.PMC4949809.pdf
"82  (2014)  836–847,  http://dx.doi.org/10.1016/j.wneu.2014.05.024 (pulished online EubNov).",Non-OADS,/arxiv_data1/oa_pdf/28/14/main.PMC4949809.pdf
"52  (2012)  221–227, http://dx.doi.org/10.3340/jkns.2012.52.3.221  (published  online  EubSe).",Non-OADS,/arxiv_data1/oa_pdf/28/14/main.PMC4949809.pdf
"17  (2008)  882–886, http://dx.doi.org/10.1007/s00586-008-0658-1  (published  online  EpubJun).",Non-OADS,/arxiv_data1/oa_pdf/28/14/main.PMC4949809.pdf
"[22]  S.  Yang,  X.  Yang,  G.  Hong,  Surgical  treatment  of  one  hundred  seventy-four intramedullary  spinal  cord  tumors,  Spine  34  (2009)  2705–2710,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/28/14/main.PMC4949809.pdf
"39  (2010)  160–185,  http://dx.doi.org/10.1067/j.",Non-OADS,/arxiv_data1/oa_pdf/28/14/main.PMC4949809.pdf
"131  (2007)  641–645,  http://dx.doi.org/10.1043/1543- 2165(2007)131[641:MRCCTH]2.0.CO;2  (published  online  EpubApr).",Non-OADS,/arxiv_data1/oa_pdf/28/14/main.PMC4949809.pdf
"3  (2012)  73,  http://dx.doi.org/10.4103/ 2152-7806.98386 .",Non-OADS,/arxiv_data1/oa_pdf/28/14/main.PMC4949809.pdf
"101  (2011)  91–99,  http://dx.doi.org/10.1007/ s11060-010-0231-8 (published  online  EpubJan).",Non-OADS,/arxiv_data1/oa_pdf/28/14/main.PMC4949809.pdf
"Chang,  Stereotactic radiosurgical treatment of  cranial  and  spinal  hemangioblastomas, Neurosurgery 65  (2009)  79–85,  http://dx.doi.org/10.1227/01.neu.",Non-OADS,/arxiv_data1/oa_pdf/28/14/main.PMC4949809.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/dibData in Brief http://dx.doi.org/10.1016/j.dib.2016.06.036 2352-3409/ &2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/d1/main.PMC4949811.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).DOI of original article: http://dx.doi.org/10.1016/j.foodchem.2016.05.093 nCorresponding author.,Non-OADS,/arxiv_data1/oa_pdf/d7/d1/main.PMC4949811.pdf
Supplementary material Transparency data associated with this article can be found in the online version at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/d1/main.PMC4949811.pdf
http://apps.searo.who.int/PDS_DOCS/B0404.pdf 4.,OADS,/arxiv_data1/oa_pdf/72/0d/nihms742415.PMC4949948.pdf
http://www.doctorswithoutborders.org/article/innovating-fight-tuberculosis-papua-new-guinea 5.,Non-OADS,/arxiv_data1/oa_pdf/72/0d/nihms742415.PMC4949948.pdf
2014 published online Nov 3. http://dx.doi.org/10.4102/ajlm.v3i2.239 .,OADS,/arxiv_data1/oa_pdf/72/0d/nihms742415.PMC4949948.pdf
2014 published  online Nov 3. http://dx.doi.org/10.4102/ajlm.v3i2.262 .,OADS,/arxiv_data1/oa_pdf/72/0d/nihms742415.PMC4949948.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/11/ea/ircmj-18-05-22267.PMC4950032.pdf
Avail- able from: http://www.saglik.gov.tr/TR/dosya/1-73168/h/ulusal- ruh-sagligi-eylem-plani.pdf .,Non-OADS,/arxiv_data1/oa_pdf/11/ea/ircmj-18-05-22267.PMC4950032.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/a2/main.PMC4950118.pdf
"Production and hosting by ElsevierJournal of Advanced Research (2016) 7, 611–613 Cairo University Journal of Advanced Research http://dx.doi.org/10.1016/j.jare.2016.06.004 2090-1232 /C2112016 Production and hosting by Elsevier B.V. on behalf of Cairo University.",Non-OADS,/arxiv_data1/oa_pdf/8a/a2/main.PMC4950118.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8a/a2/main.PMC4950118.pdf
"Production and hosting by ElsevierJournal of Advanced Research (2016) 7, 643–649 Cairo University Journal of Advanced Research http://dx.doi.org/10.1016/j.jare.2016.06.008 2090-1232 /C2112016 Production and hosting by Elsevier B.V. on behalf of Cairo University.",Non-OADS,/arxiv_data1/oa_pdf/52/dc/main.PMC4950119.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/52/dc/main.PMC4950119.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/dc/main.PMC4950119.pdf
"Production and hosting by ElsevierJournal of Advanced Research (2016) 7, 651–660 Cairo University Journal of Advanced Research http://dx.doi.org/10.1016/j.jare.2016.06.006 2090-1232 /C2112016 Production and hosting by Elsevier B.V. on behalf of Cairo University.",Non-OADS,/arxiv_data1/oa_pdf/7f/1f/main.PMC4950121.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7f/1f/main.PMC4950121.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/7f/1f/main.PMC4950121.pdf
http://globocan.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/d4/b6/mco-05-02-0257.PMC4950151.pdf
"Production and hosting by ElsevierJournal of Advanced Research (2016) 7, 625–634 Cairo University Journal of Advanced Research http://dx.doi.org/10.1016/j.jare.2016.06.003 2090-1232 /C2112016 Production and hosting by Elsevier B.V. on behalf of Cairo University.",Non-OADS,/arxiv_data1/oa_pdf/46/5b/main.PMC4950162.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/5b/main.PMC4950162.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/46/5b/main.PMC4950162.pdf
"Production and hosting by ElsevierJournal of Advanced Research (2016) 7, 635–641 Cairo University Journal of Advanced Research http://dx.doi.org/10.1016/j.jare.2016.06.009 2090-1232 /C2112016 Production and hosting by Elsevier B.V. on behalf of Cairo University.",Non-OADS,/arxiv_data1/oa_pdf/20/0a/main.PMC4950164.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/0a/main.PMC4950164.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/0a/main.PMC4950164.pdf
"Supplementary material Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.jare.2016.",OADS,/arxiv_data1/oa_pdf/20/0a/main.PMC4950164.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Older adultsPrimary health carePublic healthSenior centers Socioeconomic status Health promotionDiabetes 1.,Non-OADS,/arxiv_data1/oa_pdf/55/9f/main.PMC4950171.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.06.0232211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/55/9f/main.PMC4950171.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/55/9f/main.PMC4950171.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/55/9f/main.PMC4950171.pdf
"ContempClin Trials 37 (1), 1 –9.http://dx.doi.org/10.1016/j.cct.2013.10.003 .",OADS,/arxiv_data1/oa_pdf/55/9f/main.PMC4950171.pdf
American Recovery and Reinvestment Act Communities Putting Prevention to Work: Chronic Disease Self-Management Program Accessedathttp://www.aoa.gov/AoARoot/AoA_Programs/HPW/ARRA/ on October 10 .,Non-OADS,/arxiv_data1/oa_pdf/55/9f/main.PMC4950171.pdf
http://dx.doi.org/10.1093/ije/dyr029 .287 P.H.,OADS,/arxiv_data1/oa_pdf/55/9f/main.PMC4950171.pdf
http://dx.doi.org/10.1186/1477-7525- 3-51.,Non-OADS,/arxiv_data1/oa_pdf/55/9f/main.PMC4950171.pdf
http://dx.doi.org/10.2337/dc13-1161 .,Non-OADS,/arxiv_data1/oa_pdf/55/9f/main.PMC4950171.pdf
http://dx.doi.org/10.2337/dc13-0570 .,Non-OADS,/arxiv_data1/oa_pdf/55/9f/main.PMC4950171.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/55/9f/main.PMC4950171.pdf
http://dx.doi.org/10.1056/NEJMp1500445 .,OADS,/arxiv_data1/oa_pdf/55/9f/main.PMC4950171.pdf
"U.S. DHHS, Atlanta,GA Accessed on 10/1/2014 at http://www.cdc.gov/diabetes/pubs/statsreport14/ national-diabetes-report-web.pdf .",Non-OADS,/arxiv_data1/oa_pdf/55/9f/main.PMC4950171.pdf
http://dx.doi.org/10.1016/j.cct.2010.10.002 .,OADS,/arxiv_data1/oa_pdf/55/9f/main.PMC4950171.pdf
http://dx.doi.org/10.2337/dc08-1296 .,Non-OADS,/arxiv_data1/oa_pdf/55/9f/main.PMC4950171.pdf
http://dx.doi.org/10.1111/j.1532- 5415.2011.03882.x .,Non-OADS,/arxiv_data1/oa_pdf/55/9f/main.PMC4950171.pdf
"58(8), 1496 –15 03. http://dx.doi.org/10.1111/j.1532-5415.2010.02980.x .",Non-OADS,/arxiv_data1/oa_pdf/55/9f/main.PMC4950171.pdf
http://dx.doi.org/10.2337/db14-0020 .,Non-OADS,/arxiv_data1/oa_pdf/55/9f/main.PMC4950171.pdf
http://dx.doi.org/10.1080/ 01639360802060249 .,Non-OADS,/arxiv_data1/oa_pdf/55/9f/main.PMC4950171.pdf
http://dx.doi.org/10.1111/j.1475-6773.,Non-OADS,/arxiv_data1/oa_pdf/55/9f/main.PMC4950171.pdf
"National Academy of Sciences, Washington DC.http://dx.doi.org/10.1016/j.amepre.2011.06.041 (March).",OADS,/arxiv_data1/oa_pdf/55/9f/main.PMC4950171.pdf
http://dx.doi.org/10.2105/AJPH.2007.120402 .,Non-OADS,/arxiv_data1/oa_pdf/55/9f/main.PMC4950171.pdf
http://dx.doi.org/ 10.1177/0145721709335006 .,Non-OADS,/arxiv_data1/oa_pdf/55/9f/main.PMC4950171.pdf
"31, 52. http://dx.doi.org/10.1177/0733464810380545 .",Non-OADS,/arxiv_data1/oa_pdf/55/9f/main.PMC4950171.pdf
http://dx.doi.org/10.1097/JAC.0b013e3181ffc342 .,Non-OADS,/arxiv_data1/oa_pdf/55/9f/main.PMC4950171.pdf
http://dx.doi.org/10.1016/j.amepre.,OADS,/arxiv_data1/oa_pdf/55/9f/main.PMC4950171.pdf
http://dx.doi.org/10.1111/j.1532-5415.2007.01427.x .,Non-OADS,/arxiv_data1/oa_pdf/55/9f/main.PMC4950171.pdf
http://dx.doi.org/10.1001/jama.288.4.475 .,Non-OADS,/arxiv_data1/oa_pdf/55/9f/main.PMC4950171.pdf
http://dx.doi.org/10.2337/dc11-1627 .,Non-OADS,/arxiv_data1/oa_pdf/55/9f/main.PMC4950171.pdf
http://dx.doi.org/10.1080/01639360802060298 .,Non-OADS,/arxiv_data1/oa_pdf/55/9f/main.PMC4950171.pdf
http://dx.doi.org/10.1016/j.amepre.2011.06.041 .,OADS,/arxiv_data1/oa_pdf/55/9f/main.PMC4950171.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: PsychometricsSurveyFood insecurityHunger-coping 1.,Non-OADS,/arxiv_data1/oa_pdf/0c/5b/main.PMC4950172.pdf
Although some hunger coping items were tested in the 1995Preventive Medicine Reports 4 (2016) 289 –295 http://dx.doi.org/10.1016/j.pmedr.2016.06.021 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0c/5b/main.PMC4950172.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0c/5b/main.PMC4950172.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/0c/5b/main.PMC4950172.pdf
"Demographics and household characteristics Table 1 shows the demographic and household characteristics of the sample population, with a large percentage of very low-income participants (e.g., 73% earning less than $20,000 a year; 2015 federalpoverty line for a family of four = $24,250 http://aspe.hhs.gov/2015- poverty-guidelines ) and close to 60% participating in the Supple- mental Nutrition Assistance Program.",Non-OADS,/arxiv_data1/oa_pdf/0c/5b/main.PMC4950172.pdf
http://dx.doi.org/10.1016/S0022-3182(99)70463-2 .,OADS,/arxiv_data1/oa_pdf/0c/5b/main.PMC4950172.pdf
"6 (1), 27 –44.http://dx.doi.org/ 10.1080/19320248.2011.549368 .",Non-OADS,/arxiv_data1/oa_pdf/0c/5b/main.PMC4950172.pdf
Guide to measuring household food security 2000 (June) http://www.fns.usda.gov/fsec/FILES/FSGuide.pdfID (450).,Non-OADS,/arxiv_data1/oa_pdf/0c/5b/main.PMC4950172.pdf
http://dx.doi.org/10.1177/0002764205283807 .,Non-OADS,/arxiv_data1/oa_pdf/0c/5b/main.PMC4950172.pdf
"Household food security in the United States in 2013. http://www.ers.usda.gov/publications/err-economic-research- report/err173.aspx (accessed February 5, 2015).",Non-OADS,/arxiv_data1/oa_pdf/0c/5b/main.PMC4950172.pdf
http://dx.doi.org/10.1016/j.amepre.,OADS,/arxiv_data1/oa_pdf/0c/5b/main.PMC4950172.pdf
"Feeding America, d. http://feedingamerica.org/ .294 C. Pinard et al.",Non-OADS,/arxiv_data1/oa_pdf/0c/5b/main.PMC4950172.pdf
http://dx.doi.org/10.1080/ 19320248.2010.527275 .,Non-OADS,/arxiv_data1/oa_pdf/0c/5b/main.PMC4950172.pdf
"Grist (August) http://grist.org/food/2011-08-08-cheap-twix-more-calories-for-your-cash-in-the-junk-food-aisle/ (accessed January 26, 2015).",Non-OADS,/arxiv_data1/oa_pdf/0c/5b/main.PMC4950172.pdf
http://dx.doi.org/10.1002/nur.,Non-OADS,/arxiv_data1/oa_pdf/0c/5b/main.PMC4950172.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/5b/main.PMC4950172.pdf
http://dx.doi.org/10.1017/S1368980012000857 .,Non-OADS,/arxiv_data1/oa_pdf/0c/5b/main.PMC4950172.pdf
http://dx.doi.org/10.1037/0033-2909.133.4.673 .,Non-OADS,/arxiv_data1/oa_pdf/0c/5b/main.PMC4950172.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/5b/main.PMC4950172.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/5b/main.PMC4950172.pdf
http://dx.doi.org/10.1146/annurev.publhealth.29.020907.090926 .,Non-OADS,/arxiv_data1/oa_pdf/0c/5b/main.PMC4950172.pdf
"Food secu- rity in the U.S. http://www.ers.usda.gov/topics/food-nutrition-assistance/food- security-in-the-us/measurement.aspx#.U9LiZ0C5LaY Published April 30, (accessed July 25, 2014).",Non-OADS,/arxiv_data1/oa_pdf/0c/5b/main.PMC4950172.pdf
"1 (3), 45 –68.http://dx.doi.org/10.1300/J477v01n03_04 .",Non-OADS,/arxiv_data1/oa_pdf/0c/5b/main.PMC4950172.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/0c/5b/main.PMC4950172.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Pattern recognitionGaussian process classi ﬁcation fMRIResponse inhibition Attention-de ﬁcit/hyperactivity disorder Unaffected siblings 1.,Non-OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
http://dx.doi.org/10.1016/j.nicl.2016.06.020 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
1http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/MELODIC .Table 1 Demographic and clinical characteristics of complete sample.,OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
http://dx.doi.org/10.1002/(SICI)1098- 2779(1999)5:3 b177::AID-MRDD3 N3.0.CO;2-G .,OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
http://dx.doi.org/10.1097/00004583-199007000- 00004 .,Non-OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
http://dx.doi.org/10.1016/j.jpsychires.2008.10.003.,OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
http://dx.doi.org/10.1023/A:1022602400621 .,Non-OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
http://dx.doi.org/10.1198/016214504000000089 .,Non-OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
http://dx.doi.org/10.1198/ 016214501753382129 .,Non-OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
"Psychiatry 63, 118– 124. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
"1, 15020. http://dx.doi.or g/10.1038/nrdp.2015.20 .",Non-OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
http://dx.doi.org/10.1002/hbm.22386 .,Non-OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
http://dx.doi.org/10.1016/j.jaac.2013.12.024 .,OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
Springer http://dx.doi.org/10.1007/b94608 .,Non-OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
http://dx.doi.org/10.1016/j.neuroimage.2013.10.,OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
http://dx.doi.org/ 10.1016/j.compmedimag.2012.08.002 .,OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
"Neuroimaging 233, 1–7.http://dx.doi.org/10.1016/j.pscychresns.2015.07.007 .",OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.09.015 .,OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
http://dx.doi.org/10.1007/s13398-014- 0173-7.2 .,Non-OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
"14, 26. http://dx.doi.org/10.1186/1471-2288-14-26 .",Non-OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
Neuroimaging http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
",2 0 1 5 a .S i m i l a rs u b g r o u p s based on cognitive performance parse heterogeneity in adults with ADHD and healthy c o n t r o l s .J .A t t e n .D i s o r d .1 –12.http://dx.doi.org/10.1177/1087054715602332 .",Non-OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
http://dx.doi.org/10.1016/j.euroneuro.2015.08.010 .,OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
PLoS One 8 http://dx.doi.org/10.1371/ journal.pone.0079476 .,Non-OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
http://dx.doi.org/10.1176/appi.ajp.164.6.942 .,Non-OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
"NeuroImage 112, 278 –28  7.http://dx.doi.org/10.1016/j.neuroimage.2015.02.063 .",OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
http://dx.doi.org/10.1016/j.neuroimage.2015.,OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
"Neuroinformatics 13, 31 –46.http://dx.doi.org/10.1007/ s12021-014-9238-1 .",Non-OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
http://dx.doi.org/10.1007/s12021-013- 9178-1 .,Non-OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
"8, 1 –8.http://dx.doi.org/10.3389/fncom.",Non-OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
http://dx.doi.org/10.1192/bjp.bp.107.048827 .,Non-OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
http://dx.doi.org/10.1097/00004583- 200310000-00016 .,Non-OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
http://dx.doi.org/10.1016/j.neuroimage.2004.07.051 .,OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
6.http://dx.doi.org/10.3389/fnsys.2012.00062 .,Non-OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
http://dx.doi.org/10.1136/jamia.2001.0080443 .,Non-OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
1 –11http://dx.doi.org/10.1017/S0033291714001792 .,Non-OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
http://dx.doi.org/10.1016/j.psychres.2006.05.011 .,OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
J. Psychiatry http://dx.doi.org/10.1176/appi.ajp.2014.,Non-OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
Psychiatry http://dx.doi.org/10.1007/s00787-014-0573-4 .,Non-OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
1938 –1941 http://dx.doi.org/10.1109/FSKD.,Non-OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
http://dx.doi.org/10.1016/j.ejrad.2013.04.009 .,OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
http://dx.doi.org/10.1016/j.neubiorev.2015.08.001 .,OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
http://dx.doi.org/10.1016/j.neuroimage.2008.10.055 .,OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
Online 12 http://dx.doi.org/10.1186/1475-925X-12-10 .,Non-OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/12/bd/main.PMC4950173.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/23/2f/main.PMC4950175.pdf
A complete listing of ADNI inves-tigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/ how_to_apply/ADNI_Acknowledgement_List.pdf .,OADS,/arxiv_data1/oa_pdf/23/2f/main.PMC4950175.pdf
E-mail address: bkandel@seas.upenn.edu http://dx.doi.org/10.1016/j.dadm.2016.03.001 2352-8729/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/23/2f/main.PMC4950175.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/23/2f/main.PMC4950175.pdf
Cortical ﬂorbetapir uptake of /C211.11 was considered “positive” for cortical A b[32].APOE genotyping was performed as described on the ADNI website ( http://adni.loni.usc.,Non-OADS,/arxiv_data1/oa_pdf/23/2f/main.PMC4950175.pdf
"The molecular  weight and isoelectric point of TMEM35 are 18,440.23 Da  and 10.09, respectively (http://www.genecards.org/) .",Non-OADS,/arxiv_data1/oa_pdf/db/6f/etm-12-02-0581.PMC4950176.pdf
http://www.irbbarcelona.org/en/news/more -than-50-of-drugs - target -membrane -proteins (In Italian).,Non-OADS,/arxiv_data1/oa_pdf/db/6f/etm-12-02-0581.PMC4950176.pdf
"http://www.nccn.org/professionals/ physician_gls/pdf/ovarian.pdf. Accessed May 5, 2016.",Non-OADS,/arxiv_data1/oa_pdf/f0/7d/ol-12-02-1361.PMC4950178.pdf
"The spectrum of involuntary movements in the autosomal dominant spinocerebellar ataxias has also been described previously.4The focus of this review is to describe the spectrum and, where possible, the frequency of involuntary movements associated with selected childhood-onset autosomal recessive ataxia syndromes in which involuntary movements are very common, or are under-recognized as a presenting feature of the disease: ataxia–telangiectasia (A-T), ataxia withFreely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/d8/09/tre-06-368-7522-1.PMC4950223.pdf
"Abbreviations: AFP, Alphafetoprotein; AOA, Ataxia with Oculomotor Apraxia; AVED, Ataxia with Vitamin E Deficiency; CEA, Carcinoembryonic Antigen; CK, Creatine Kinase; LDL, Low-density Lipoprotein; OMA, Oculomotor Apraxia; SSEP, Somatosensory Evoked Potentia l. Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2Pearson TS Involuntary Movements in Autosomal Recessive Ataxias",Non-OADS,/arxiv_data1/oa_pdf/d8/09/tre-06-368-7522-1.PMC4950223.pdf
"In rare cases, myoclonus may become the predominantmotor finding, several years after initial onset of ataxia (Myoclonus inA-T: http://dx.doi.org/10.1016/j.braindev.2014.06.001; http://dx.doi.org/10.7916/D88P5Z9X).",Non-OADS,/arxiv_data1/oa_pdf/d8/09/tre-06-368-7522-1.PMC4950223.pdf
22 Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3Involuntary Movements in Autosomal Recessive Ataxias Pearson TS,Non-OADS,/arxiv_data1/oa_pdf/d8/09/tre-06-368-7522-1.PMC4950223.pdf
"The neck and upper limbs were the most frequent initial sites of dystonia.14,24–28 In two patients, dystonia was later accompanied by myoclonus of the head, trunk, or upper limbs, mimicking myoclonus–dystonia (Dystonia and dystonia with myoclonus in A-T: http://dx.doi.org/ 10.1016/j.parkreldis.2013.08.013; http://dx.doi.org/10.1212/WNL.",Non-OADS,/arxiv_data1/oa_pdf/d8/09/tre-06-368-7522-1.PMC4950223.pdf
"A specific homozygous founder missense mutation in the Canadian Mennonite population (c.6200 C .A) is associated with a pure dystonia or myoclonus–dystonia-like phenotype with predominant cervical and upper limb involvement (Dystonia and dystonia with myoclonus in A-T: http://dx.doi.org/10.1016/j.parkreldis.2013.08.013; http:// dx.doi.org/10.1212/WNL.0b013e3182494d51).16,23In this popula- tion, the 12 reported patients experienced onset of dystonia betweenages 1 and 20 years.",Non-OADS,/arxiv_data1/oa_pdf/d8/09/tre-06-368-7522-1.PMC4950223.pdf
"32,33 Chorea and dystonia both occur commonly in AOA1 (Dystonia and chorea in AOA1; http://dx.doi.org/10.1056/NEJMra1006610)2.",Non-OADS,/arxiv_data1/oa_pdf/d8/09/tre-06-368-7522-1.PMC4950223.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4Pearson TS Involuntary Movements in Autosomal Recessive Ataxias,Non-OADS,/arxiv_data1/oa_pdf/d8/09/tre-06-368-7522-1.PMC4950223.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services5Involuntary Movements in Autosomal Recessive Ataxias Pearson TS,Non-OADS,/arxiv_data1/oa_pdf/d8/09/tre-06-368-7522-1.PMC4950223.pdf
"57,62In all three cases, the dystonia was cervical and associated with irregular head tremor (Dystonia in AVED; http://dx.doi.org/10.7916/D8B85820)62.",Non-OADS,/arxiv_data1/oa_pdf/d8/09/tre-06-368-7522-1.PMC4950223.pdf
doi: 10.1074/jbc.M103160200 Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services6Pearson TS Involuntary Movements in Autosomal Recessive Ataxias,Non-OADS,/arxiv_data1/oa_pdf/d8/09/tre-06-368-7522-1.PMC4950223.pdf
doi: 10.1212/01.wnl.0000208402.10512.4a Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services7Involuntary Movements in Autosomal Recessive Ataxias Pearson TS,Non-OADS,/arxiv_data1/oa_pdf/d8/09/tre-06-368-7522-1.PMC4950223.pdf
doi: 10.1016/ j.neuroscience.2013.11.062 Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services8Pearson TS Involuntary Movements in Autosomal Recessive Ataxias,Non-OADS,/arxiv_data1/oa_pdf/d8/09/tre-06-368-7522-1.PMC4950223.pdf
"The two cases  were diagnosed with THS by three occupational dermatolo - gists of the hospital, based on the Chinese National Diagnostic  Criteria of Occupational Disease (GBZ  185-2006; Ministry  of Health, China, 2006; appendix A; http://www.moh.gov.",Non-OADS,/arxiv_data1/oa_pdf/45/6b/etm-12-02-0895.PMC4950263.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/73/jjm-09-05-19955.PMC4950267.pdf
"This is an Open Access article distributed under the terms of th e Creative Commons Attribution- NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribu tion, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/ijpc-20-204.PMC4950405.pdf
"3, 204–208http://dx.doi.org/10.1080/13651501.2016.1197275",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/ijpc-20-204.PMC4950405.pdf
"Availablefrom: http://psychiatryonline.org/guidelines .Baldwin DS, Anderson IM, Nutt DJ, Allgulander C, Bandelow B, den Boer JA, Christmas DM, Davies S, Fineberg N, Lidbetter N, et al.",OADS,/arxiv_data1/oa_pdf/c7/d8/ijpc-20-204.PMC4950405.pdf
"Published by Acta Oncologica Foundation This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/Licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.ACTA ONCOLOGICA, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/6c/62/ionc-55-976.PMC4950423.pdf
"8, 976–982http://dx.doi.org/10.3109/0284186X.2016.1146826",Non-OADS,/arxiv_data1/oa_pdf/6c/62/ionc-55-976.PMC4950423.pdf
Available from: http://www.swebcg.se/Files/Docs/NatVP_ Brostcancer_2014-11-11_final[1].pdf .,Non-OADS,/arxiv_data1/oa_pdf/6c/62/ionc-55-976.PMC4950423.pdf
"3, 295 –305, http://dx.doi.org/10.1080/00071668.2016.1156648 © 2016 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/48/db/cbps-57-295.PMC4950446.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any med- ium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/48/db/cbps-57-295.PMC4950446.pdf
"This is an Open Access article distributed under the terms of th e Creative Commons Attribution- NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribu tion, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/b0/40/ijpc-20-126.PMC4950448.pdf
"3, 126–132http://dx.doi.org/10.1080/13651501.2016.1179765",Non-OADS,/arxiv_data1/oa_pdf/b0/40/ijpc-20-126.PMC4950448.pdf
Available from: http://www.who.int/mental_health/management/depression/who_paper_depression_wfmh_ 2012.pdf .,Non-OADS,/arxiv_data1/oa_pdf/b0/40/ijpc-20-126.PMC4950448.pdf
Available from: http://www.bsecho.org.uk / media/40492/echo-pocket_a6_2011__3_.pdf .,Non-OADS,/arxiv_data1/oa_pdf/85/46/yhem-21-272.PMC4950454.pdf
Available from: http://www.nice.org.uk /Guidance /CG43 .,Non-OADS,/arxiv_data1/oa_pdf/85/46/yhem-21-272.PMC4950454.pdf
Available from: http://www.renal.org/docs/default-source/guide lines-resources/Module_1_-_Chronic_Kidney_Disease_CKD_-_ 4th_Edition .,Non-OADS,/arxiv_data1/oa_pdf/85/46/yhem-21-272.PMC4950454.pdf
Available from: http://www.dh.gov.uk /prod_consum_dh /groups /dh_digi talassets /@dh/@en/documents /digitalasset /dh_075219.pdf .,OADS,/arxiv_data1/oa_pdf/85/46/yhem-21-272.PMC4950454.pdf
Available from: http://www.nice.org.uk /guidance /cg127 .,Non-OADS,/arxiv_data1/oa_pdf/85/46/yhem-21-272.PMC4950454.pdf
Available from: http://www.who.int/ diabetes /publications / Definition%20and%20diagnosis%20of%20diabetes_new.pdf .,Non-OADS,/arxiv_data1/oa_pdf/85/46/yhem-21-272.PMC4950454.pdf
Available from: http://www.nice.org.uk /gui dance/cg108 .,Non-OADS,/arxiv_data1/oa_pdf/85/46/yhem-21-272.PMC4950454.pdf
"5, 257–267 http://dx.doi.org/10.3109/14764172.2016.1157368 ORIGINAL RESEARCH REPORT  CONTACT  diane i rvine d uncan  momsurg@aol.com  plastic surgery, p lastic surgical a ssociates of f ort Collins, p .C., 1701 e p rospect r d., f ort Collins, C o 80525, usa.",Non-OADS,/arxiv_data1/oa_pdf/f8/75/ijcl-18-257.PMC4950457.pdf
Available at: http://www.surgery.org/media/ statistics.,Non-OADS,/arxiv_data1/oa_pdf/f8/75/ijcl-18-257.PMC4950457.pdf
Available at:  http://www.surgery.org/media/statistics.,Non-OADS,/arxiv_data1/oa_pdf/f8/75/ijcl-18-257.PMC4950457.pdf
13. http://www.surgery.org/sites/default/files/Stats2013_4.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f8/75/ijcl-18-257.PMC4950457.pdf
"8, 1755–1765http://dx.doi.org/10.3109/10428194.2016.1160082",Non-OADS,/arxiv_data1/oa_pdf/2f/25/ilal-57-1755.PMC4950458.pdf
Potential conflict of interest: Disclosure forms provided by the authors are available with the full text of this article at http: http://dx.doi.org/10.3109/10428194.2016.1160082.,Non-OADS,/arxiv_data1/oa_pdf/2f/25/ilal-57-1755.PMC4950458.pdf
Available from: http://www.istodax.com/wp-content/ uploads/ISTODAX_PackageInsert.pdf .,Non-OADS,/arxiv_data1/oa_pdf/2f/25/ilal-57-1755.PMC4950458.pdf
Available from: https://www.merck.com/product/ usa/pi_circulars/z/zolinza/zolinza_pi.pdf .,Non-OADS,/arxiv_data1/oa_pdf/2f/25/ilal-57-1755.PMC4950458.pdf
Available from: http://www.sppirx.com/downloads/ 140703_final-beleodaq-pi-pt-info.pdf .,Non-OADS,/arxiv_data1/oa_pdf/2f/25/ilal-57-1755.PMC4950458.pdf
Available from: http://www.nccn.org/professionals/ physician_gls/f_guidelines.asp .,Non-OADS,/arxiv_data1/oa_pdf/2f/25/ilal-57-1755.PMC4950458.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/17286158 .,Non-OADS,/arxiv_data1/oa_pdf/2f/25/ilal-57-1755.PMC4950458.pdf
Available from: http://jhoonline.biomedcentral.com/articles/10.,Non-OADS,/arxiv_data1/oa_pdf/2f/25/ilal-57-1755.PMC4950458.pdf
Available from: http://www.folotyn.,Non-OADS,/arxiv_data1/oa_pdf/2f/25/ilal-57-1755.PMC4950458.pdf
Available from: http://www.revlimid.com/wp-content/ uploads/full-prescribing-information.pdf .,Non-OADS,/arxiv_data1/oa_pdf/2f/25/ilal-57-1755.PMC4950458.pdf
Available from: http://otsuka-us.com/products/ Documents/DACOGEN.PI.pdf .,OADS,/arxiv_data1/oa_pdf/2f/25/ilal-57-1755.PMC4950458.pdf
Available from: http://www.velcade.,Non-OADS,/arxiv_data1/oa_pdf/2f/25/ilal-57-1755.PMC4950458.pdf
[cited 2016 Apr 15].Available from: http://pi.lilly.com/us/gemzar.pdf .,OADS,/arxiv_data1/oa_pdf/2f/25/ilal-57-1755.PMC4950458.pdf
[cited 2016 Apr 15].Available from: http://www.abraxane.com/wp-con-tent/uploads/Abraxane_Prescribing_Information.pdf .,Non-OADS,/arxiv_data1/oa_pdf/2f/25/ilal-57-1755.PMC4950458.pdf
Accessed 3 April 2012 from: http://www.iom.edu/Reports/2009/ComparativeEffectivenessResearchPriorities.aspx       American College of Obstetricians and Gynecologists .,Non-OADS,/arxiv_data1/oa_pdf/ce/91/iejc-17-340.PMC4950459.pdf
"Accessed  April 2011 from:  http://www.un.org/esa/population/ publications/contraceptive2011/contraceptive2011.htm        Finer LB ,  Zolner    MR  .",Non-OADS,/arxiv_data1/oa_pdf/ce/91/iejc-17-340.PMC4950459.pdf
"Accessed 12 April 2012 from: http://www.who.int/reproductive health/publications/mec.pdf        MacIsaac   L ,  Espey   E  .",Non-OADS,/arxiv_data1/oa_pdf/ce/91/iejc-17-340.PMC4950459.pdf
Accessed 3 April 2012 from: http://www.kvwl.de/ arzt/recht/kbv/richtlinien/richtl_empfaengnis.pdf       Long-acting reversible contraception  –  the effective and 65.  appropriate use of long-acting reversible contraception .,Non-OADS,/arxiv_data1/oa_pdf/ce/91/iejc-17-340.PMC4950459.pdf
Accessed 12 April 2012 from: http://www.nice.,Non-OADS,/arxiv_data1/oa_pdf/ce/91/iejc-17-340.PMC4950459.pdf
http://www.fda.gov/Drugs/Information - OnDrugs/ApprovedDrugs/ucm436566.htm.,Non-OADS,/arxiv_data1/oa_pdf/39/6e/ol-12-02-0944.PMC4950473.pdf
31. http://www.onclive.com/web -exclusives/fda -grants -priority -rev iew-to-pembrolizumab -in-lung-cancer.,Non-OADS,/arxiv_data1/oa_pdf/39/6e/ol-12-02-0944.PMC4950473.pdf
9; http://www.cdc.gov/nchs/icd/icd9.htm)  were  provided by the cancer registry.,Non-OADS,/arxiv_data1/oa_pdf/e3/58/ol-12-02-1337.PMC4950488.pdf
The source of the interaction  network databases were the Human Protein Reference Data - base (HPRD) ( 24) (http://www.hprd.org /) and the Biological  General Repository for Interaction Datasets (BioGRID) ( 25)  (http: //thebiogrid.org /) database.,OADS,/arxiv_data1/oa_pdf/76/4d/ol-12-02-1279.PMC4950495.pdf
"5, 743 –749 http://dx.doi.org/10.1080/01635581.2016.1180412",Non-OADS,/arxiv_data1/oa_pdf/59/37/hnuc-68-743.PMC4950520.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/59/f0/oaem-8-047.PMC4950546.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/59/f0/oaem-8-047.PMC4950546.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Emergency Medicine 2016:8 47–55Open Access Emergency Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 47 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAEM.S69973 Asthma-related emergency department use:  current perspectives Laurie H Johnson1 Patricia Chambers1 Judith W Dexheimer1,2 1Division of Emergency Medicine,   2Division of Biomedical Informatics,   Cincinnati Children’s Hospital Medical  Center, Cincinnati, OH, USAAbstract:  Asthma is one of the most common chronic pediatric diseases.",Non-OADS,/arxiv_data1/oa_pdf/59/f0/oaem-8-047.PMC4950546.pdf
"In the US, asthma is the third-leading cause of hospitalizations Correspondence: Judith W Dexheimer Division of Emergency Medicine, Cincinnati Children’s Hospital Medical Center, MLC 2008, 3333 Burnet Avenue, Cincinnati, OH 45229-3039, USATel +1 513 803 2962Fax +1 513 803 2581Email Judith.Dexheimer@cchmc.orgJournal name: Open Access Emergency Medicine Article Designation: REVIEWY ear: 2016V olume: 8Running head verso: Johnson et alRunning head recto: Asthma ED useDOI: http://dx.doi.org/10.2147/OAEM.S69973",Non-OADS,/arxiv_data1/oa_pdf/59/f0/oaem-8-047.PMC4950546.pdf
Available from: http://www.cdc.gov/nchs/fastats/asthma.htm.,Non-OADS,/arxiv_data1/oa_pdf/59/f0/oaem-8-047.PMC4950546.pdf
Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5416a5.htm.,OADS,/arxiv_data1/oa_pdf/59/f0/oaem-8-047.PMC4950546.pdf
Available from: http://www.cdc.gov/asthma/pdfs/asthma_facts_program_grantees.pdf.,Non-OADS,/arxiv_data1/oa_pdf/59/f0/oaem-8-047.PMC4950546.pdf
Available from: http://www.cdc.gov/asthma/default.htm.,Non-OADS,/arxiv_data1/oa_pdf/59/f0/oaem-8-047.PMC4950546.pdf
Available from: http://www.cdc.gov/nchs/data/ahcd/nhamcs_emer - gency/2011_ed_web_tables.pdf.,OADS,/arxiv_data1/oa_pdf/59/f0/oaem-8-047.PMC4950546.pdf
Available from: http://www.nhlbi.nih.gov/health-pro/guidelines/archive/asthma-expert-panel-report.,Non-OADS,/arxiv_data1/oa_pdf/59/f0/oaem-8-047.PMC4950546.pdf
Available from: http://ginasthma.org/2016-gina-report-global-strategy-for-asthma-management-and-prevention/.,Non-OADS,/arxiv_data1/oa_pdf/59/f0/oaem-8-047.PMC4950546.pdf
Avail-able from: http://www.nhlbi.nih.gov/files/docs/guidelines/asthgdln.pdf.,Non-OADS,/arxiv_data1/oa_pdf/59/f0/oaem-8-047.PMC4950546.pdf
Available from: http://www.aafa.org/page/pollen-allergy.aspx.,Non-OADS,/arxiv_data1/oa_pdf/59/f0/oaem-8-047.PMC4950546.pdf
"Open Access Emergency Medicine 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Emergency Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/open-access-emergency-medicine-journalThe Open Access Emergency Medicine is an international, peer- reviewed, open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of emergency medicine.",Non-OADS,/arxiv_data1/oa_pdf/59/f0/oaem-8-047.PMC4950546.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 55 Asthma ED use 70.,Non-OADS,/arxiv_data1/oa_pdf/59/f0/oaem-8-047.PMC4950546.pdf
Available from: https://www.ebmedicine.net/topics.php?paction=showTopic&topic_id=159.,Non-OADS,/arxiv_data1/oa_pdf/59/f0/oaem-8-047.PMC4950546.pdf
Available from: http://www.who.int/chp/knowledge/publications/adherence_introduc   tion.pdf.,Non-OADS,/arxiv_data1/oa_pdf/59/f0/oaem-8-047.PMC4950546.pdf
Available from: http://www.commonwealth - fund.org/~ /media/Files/Publications/Case%20Study/2013/Jan/1660_ McCarthy_care_transitions_Cincinnati_case_study_v2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/59/f0/oaem-8-047.PMC4950546.pdf
"Trial  registration, ChiCTR-TRC-12002189 (http://www.chictr.",Non-OADS,/arxiv_data1/oa_pdf/92/f2/etm-12-02-0739.PMC4950571.pdf
ChiCTR-TRC-12002189 http://www.chictr.org/).,Non-OADS,/arxiv_data1/oa_pdf/92/f2/etm-12-02-0739.PMC4950571.pdf
Chinese Health Statistical Digest: http://www.moh.gov.cn/ publicfiles/business/htmlfiles/mohwsbwstjxxzx/s9092/201206/  55044.htm.2012 .,Non-OADS,/arxiv_data1/oa_pdf/92/f2/etm-12-02-0739.PMC4950571.pdf
"The resting -state fMRI data were  processed using the Regional Saturation Technique  (REST; ( http://restfmri.net/forum/REST_V  1.8)  (22) , Data  Processing Assistant for Resting‑state fMRI (DPARSF) (23)  and Statistical Parameter Mapping 8 (SPM8) (24).",OADS,/arxiv_data1/oa_pdf/95/30/etm-12-02-0619.PMC4950574.pdf
"The  preprocessing steps with the DPARSF toolkit ( DPARSF  (http://www.restfmri.net/forum/DPARSF ) were performed as  previously described ( 25), and included slice timing, realign - ment and normalization.",OADS,/arxiv_data1/oa_pdf/95/30/etm-12-02-0619.PMC4950574.pdf
The effects of the processing maps were investigated using  SPM8 ( http://www.fil.ion.ucl.ac.uk/spm/software/spm8/)  (26).,OADS,/arxiv_data1/oa_pdf/95/30/etm-12-02-0619.PMC4950574.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Parkinson's diseaseAtypical parkinsonismSingle photon emission computed tomography(SPECT) Multi vector pattern analysis (MVPA) 1.,Non-OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
http://dx.doi.org/10.1016/j.nicl.2016.07.0042213-1582/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
"Statistical analyses FSL (FMRIB Software Library version 5.0 http://fsl.fmrib.ox.ac.uk/fsl/ fslwiki ), Graphpad Prim (version 6.0, www.graphpad.com ), and Matlab (version R2014a) were used for statistical analyses and classi ﬁcation.",OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
http://dx.doi.org/10.1007/s10072-003-0103-5 .,Non-OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
http://dx.doi.org/10.1007/s00259-015-3176-5 .,Non-OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
http://dx.doi.org/10.1002/(SICI)1098-2396(199711)27:3 b183::AID- SYN4 N3.0.CO;2-9 .,Non-OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
"24, 68 –71.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
http://dx.doi.org/10.2217/bmm.10.86 .,Non-OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
"27, 3 –5.http://dx.doi.org/10.1002/mds.24046 .",Non-OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
http://dx.doi.org/10.1002/ana.410280412 .,Non-OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
http://dx.doi.org/10.1093/brain/awr177 .,Non-OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
http://dx.doi.org/10.2214/ajr.149.2.351 .,Non-OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
http://dx.doi.org/10.1016/j.neuroimage.2012.04.018 .,OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
http://dx.doi.org/10.1002/mds.21062 .,Non-OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
http://dx.doi.org/10.1097/RLU.0b013e318279b991 .,Non-OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
670 –676http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
"23, 12 –19.http://dx.doi.org/10.1007/s00330-012- 2579-y .",Non-OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
http://dx.doi.org/ 10.2967/jnumed.115.153734 .,Non-OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
http://dx.doi.org/10.1007/s00415-013-6886-2 .,Non-OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
"Psychiatry 81, 5 –12.http://dx.doi.org/10.1136/jnnp.2008.",Non-OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
http://dx.doi.org/10.1002/mds.21004 .,Non-OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
http://dx.doi.org/ 10.1007/s00259-014-2785-8 .,Non-OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
http://dx.doi.org/10.1111/j.1369-1600.,Non-OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
"http://dx.doi.org/ 10.1007/s11307-015-0889-6 .Nocker, M., Seppi, K., Donnemiller, E., Virgolini, I., Wenning, G.K., Poewe, W., Scher ﬂer, C., 2012.",Non-OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
http://dx.doi.org/10.1007/s00259-012- 2100-5 .,Non-OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
http://dx.doi.org/10.1093/brain/awh485 .,Non-OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
http://dx.doi.org/10.1118/1.4730289 .,Non-OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
http://dx.doi.org/10.1001/archneur.63.,Non-OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
"Threshold-free cluster enhancement: addressing prob- lems of smoothing, threshold dependence and localisation in cluster inference.NeuroImage 44, 83 –98.http://dx.doi.org/10.1016/j.neuroimage.2008.03.061 .",OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/8f/main.PMC4950578.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b6/db/main.PMC4950581.pdf
E-mail address: rst36@georgetown.edu http://dx.doi.org/10.1016/j.dadm.2016.03.009 2352-8729/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b6/db/main.PMC4950581.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b6/db/main.PMC4950581.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Computer Aided DetectionCerebral MicrobleedsTraumatic Brain InjurySusceptibility Weighted Imaging 1.,Non-OADS,/arxiv_data1/oa_pdf/e2/5f/main.PMC4950582.pdf
http://dx.doi.org/10.1016/j.nicl.2016.07.002 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e2/5f/main.PMC4950582.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/5f/main.PMC4950582.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/40/main.PMC4950584.pdf
"Eighteen days later the patient was admitted to a department of neurology with convulsions and fever, being suspected of an attack of MS. Clini- cally a pneumonia was suspected, and a chest x-ray revealedContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/lrrLeukemia Research Reports http://dx.doi.org/10.1016/j.lrr.2016.06.004 2213-0489/ &2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/03/40/main.PMC4950584.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/40/main.PMC4950584.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e6/cd/main.PMC4950592.pdf
http://dx.doi.org/10.1016/j.nicl.2016.07.0032213-1582/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/e6/cd/main.PMC4950592.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e6/cd/main.PMC4950592.pdf
Lesion identi ﬁcation and analysis Whole brain T2 lesions were identi ﬁed on the co-registered T2 FLAIR images and segmented semi-automatically using ITK-SNAP 3 software(http://www.itksnap.org ) by a trained analyst.,OADS,/arxiv_data1/oa_pdf/e6/cd/main.PMC4950592.pdf
http://dx.doi.org/10.1167/iovs.14-14571 .,Non-OADS,/arxiv_data1/oa_pdf/e6/cd/main.PMC4950592.pdf
http://dx.doi.org/10.2217/iim.13.49.,Non-OADS,/arxiv_data1/oa_pdf/e6/cd/main.PMC4950592.pdf
http://dx.doi.org/10.1002/1522-2594(200010)44: 4b583::AID-MRM12 N3.0.CO;2-O .,OADS,/arxiv_data1/oa_pdf/e6/cd/main.PMC4950592.pdf
"http://dx.doi.org/10.1098/rstb.1999.0511 .Barnes, D., Munro, P.M., Youl, B.D., Prineas, J.W., McDonald, W.I., 1991.",Non-OADS,/arxiv_data1/oa_pdf/e6/cd/main.PMC4950592.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e6/cd/main.PMC4950592.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e6/cd/main.PMC4950592.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/e6/cd/main.PMC4950592.pdf
http://dx.doi.org/10.1177/1352458512436593 .,Non-OADS,/arxiv_data1/oa_pdf/e6/cd/main.PMC4950592.pdf
http://dx.doi.org/10.1177/1352458510371408 .,Non-OADS,/arxiv_data1/oa_pdf/e6/cd/main.PMC4950592.pdf
http://dx.doi.org/10.1212/WNL.0000000000000522 .,Non-OADS,/arxiv_data1/oa_pdf/e6/cd/main.PMC4950592.pdf
http://dx.doi.org/10.1371/journal.pone.0122114 .,Non-OADS,/arxiv_data1/oa_pdf/e6/cd/main.PMC4950592.pdf
http://dx.doi.org/10.1093/brain/aws242 .,Non-OADS,/arxiv_data1/oa_pdf/e6/cd/main.PMC4950592.pdf
http://dx.doi.org/10.1016/j.mri.2008.01.047 .,OADS,/arxiv_data1/oa_pdf/e6/cd/main.PMC4950592.pdf
"9, 1 –13.http://dx.doi.org/10.3389/ fnins.2015.00441 .",Non-OADS,/arxiv_data1/oa_pdf/e6/cd/main.PMC4950592.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e6/cd/main.PMC4950592.pdf
http://dx.doi.org/10.2214/ajr.175.3.1750821 .,Non-OADS,/arxiv_data1/oa_pdf/e6/cd/main.PMC4950592.pdf
http://dx.doi.org/10.1002/ana.22366 .,Non-OADS,/arxiv_data1/oa_pdf/e6/cd/main.PMC4950592.pdf
"2013,671730. http://dx.doi.org/10.1155/2013/671730 .",Non-OADS,/arxiv_data1/oa_pdf/e6/cd/main.PMC4950592.pdf
http://dx.doi.org/10.1002/mrm.21487 .,Non-OADS,/arxiv_data1/oa_pdf/e6/cd/main.PMC4950592.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/e6/cd/main.PMC4950592.pdf
http://dx.doi.org/10.1016/j.neuroimage.2005.01.028 .,OADS,/arxiv_data1/oa_pdf/e6/cd/main.PMC4950592.pdf
http://dx.doi.org/10.1093/ brain/awv046 .,Non-OADS,/arxiv_data1/oa_pdf/e6/cd/main.PMC4950592.pdf
http://dx.doi.org/10.1093/brain/awr307 .,Non-OADS,/arxiv_data1/oa_pdf/e6/cd/main.PMC4950592.pdf
"Neurol-ogy 52, 1626. http://dx.doi.org/10.1212/WNL.52.8.1626 .",OADS,/arxiv_data1/oa_pdf/e6/cd/main.PMC4950592.pdf
http://dx.doi.org/10.3978/ j.issn.2223-4292.2012.12.05 .,Non-OADS,/arxiv_data1/oa_pdf/e6/cd/main.PMC4950592.pdf
http://dx.doi.org/10.1371/journal.pone.0049790 .226 A. Klistorner et al.,OADS,/arxiv_data1/oa_pdf/e6/cd/main.PMC4950592.pdf
"Available from : http://globocan.iarc.fr , accessed on 01 /July/2015 .",Non-OADS,/arxiv_data1/oa_pdf/86/c1/mco-05-02-0241.PMC4950606.pdf
Main results of ‘Hope  Plan’ 2014. http://www.inen.sld.pe/portal/documentos/pdf/insti - tucional/Memoria/19052015_PRINCIPALES%20RESUL%20%  20DEL%20INEN%20%20PARA%20PLAN%20ESPERANZA%  20Diciembre%202014%2020012015.pdf.,Non-OADS,/arxiv_data1/oa_pdf/86/c1/mco-05-02-0241.PMC4950606.pdf
The MRI findings of the  healthy controls showed normal intervertebral disc tissue  (http: //http://www.uscspine.com /conditions /back-degenerative -disc.,Non-OADS,/arxiv_data1/oa_pdf/e9/58/etm-12-02-0702.PMC4950610.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/34/main.PMC4950613.pdf
E-mail address: profzhong@sina.com.cn http://dx.doi.org/10.1016/j.dadm.2016.03.004 2352-8729/ /C2112016 Published by Elsevier Inc. on behalf of the Alzheimer’s Association.,Non-OADS,/arxiv_data1/oa_pdf/b8/34/main.PMC4950613.pdf
Available at: http://www.newsgd.com/news/2015-06/15/content_126401545.htm ; 2015.,Non-OADS,/arxiv_data1/oa_pdf/b8/34/main.PMC4950613.pdf
Avail- able at: http://usa.chinadaily.com.cn/china/2012-03/06/content_ 14763044.htm ; 2012.,Non-OADS,/arxiv_data1/oa_pdf/b8/34/main.PMC4950613.pdf
Availableat: http://www.stats.gov.cn/tjsj/ndsj/2011/html/D0310e.htm .,OADS,/arxiv_data1/oa_pdf/b8/34/main.PMC4950613.pdf
This is an open access articleunder the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2a/38/main.PMC4950614.pdf
E-mail address: dane.cook@wisc.edu http://dx.doi.org/10.1016/j.dadm.2016.03.005 2352-8729/Published by Elsevier Inc. on behalf of the Alzheimer’s Association.,Non-OADS,/arxiv_data1/oa_pdf/2a/38/main.PMC4950614.pdf
"These were derived from the T1 images using the Freesur-fer image analysis suite, version 5.1.0 ( http://surfer.nmr.mgh.",OADS,/arxiv_data1/oa_pdf/2a/38/main.PMC4950614.pdf
"Using a scanning densitometer (KS400v 3.0) (Beijing Maisiqi  High-tech Co., Ltd., Beijing, China; http://www.msdyq.cn/),  the ratio of electrophoresis strips and expression of gray level  of internal control β-actin strip were estimated.",OADS,/arxiv_data1/oa_pdf/d3/25/etm-12-02-1055.PMC4950624.pdf
A systematic search of the (http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/dc/eb/ol-12-02-1301.PMC4950629.pdf
"nih.gov/pubmed), OVID (http://ovidsp.ovid.com/autologin.",Non-OADS,/arxiv_data1/oa_pdf/dc/eb/ol-12-02-1301.PMC4950629.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/02/main.PMC4950647.pdf
"In multivariate analysis, low albumin level ( o3.5 g/dl) was an independent predictor of shorter OS, although lactate dehy-drogenase (LDH), hemoglobin (Hb), C-reactive protein (CRP),Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/lrrLeukemia Research Reports http://dx.doi.org/10.1016/j.lrr.2016.06.003 2213-0489/ &2016 The Authors.",OADS,/arxiv_data1/oa_pdf/a6/02/main.PMC4950647.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/02/main.PMC4950647.pdf
"(2015) , http://dx.doi.org/10.1002/hon.2233 .",Non-OADS,/arxiv_data1/oa_pdf/a6/02/main.PMC4950647.pdf
"USH1C  encodes multipostsynaptic density, disc large, zonula  occludens (PDZ) domain-containing protein harmonin [ 13],  known as the central organizer of the sub-membranous UTLI Molecular Vision  2016; 22:827-835 <http://www.molvis.org/molvis/v 22/827> Received 30 December 2015 | Accepted 16 July 2016 | Published 19 July 2016© 2016 Molecular Vision 827Genetic analysis of Tunisian families with Usher syndrome type 1:  toward improving early molecular diagnosis Imen Ben-Rebeh,1 Mhamed Grati,2 Crystel Bonnet,3 Walid Bouassida,4 Imen Hadjamor,1 Hammadi Ayadi,1  Abdelmonem Ghorbel,5 Christine Petit,2,3,6 Saber Masmoudi1 1Laboratoire de Procédés de criblage moléculaire et cellulaire, Centre de Biotechnologie de Sfax, Université de Sfax, Tunisie;  2Unité de Génétique et Physiologie de l’Audition, INSERM UMRS 1120, Institut Pasteur, Paris, France; 3INSERM UMRS 1120,  Institut de la Vision, Paris, France; 4Service d’Ophtalmologie, C.H.U.",Non-OADS,/arxiv_data1/oa_pdf/16/5f/mv-v22-827.PMC4950652.pdf
Molecular Vision  2016; 22:827-835 <http://www.molvis.org/molvis/v 22/827> © 2016 Molecular Vision  828complex.,Non-OADS,/arxiv_data1/oa_pdf/16/5f/mv-v22-827.PMC4950652.pdf
Molecular Vision  2016; 22:827-835 <http://www.molvis.org/molvis/v 22/827> © 2016 Molecular Vision  829Mutation screening:  Screening of known North African  mutations associated with USH was performed with a cost- effective NADf chip using multiplex-PCR coupled with  dual-color arrayed primer extension as described by Chak - chouk et al.,Non-OADS,/arxiv_data1/oa_pdf/16/5f/mv-v22-827.PMC4950652.pdf
Molecular Vision  2016; 22:827-835 <http://www.molvis.org/molvis/v 22/827> © 2016 Molecular Vision  830DNA Analyzer (Applied Biosystems).,Non-OADS,/arxiv_data1/oa_pdf/16/5f/mv-v22-827.PMC4950652.pdf
Molecular Vision  2016; 22:827-835 <http://www.molvis.org/molvis/v 22/827> © 2016 Molecular Vision  831 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/16/5f/mv-v22-827.PMC4950652.pdf
"Molecular Vision  2016; 22:827-835 <http://www.molvis.org/molvis/v 22/827> © 2016 Molecular Vision  832DISCUSSION Here, we report the results of genomic DNA linkage and  mutation analyses of four Tunisian families with USH1  according to the audiologic and ophthalmologic evaluations.",Non-OADS,/arxiv_data1/oa_pdf/16/5f/mv-v22-827.PMC4950652.pdf
"Molecular Vision  2016; 22:827-835 <http://www.molvis.org/molvis/v 22/827> © 2016 Molecular Vision  833NADf chip analysis and Sanger sequencing of MYO7A   resulted in the identification of two pathological muta - tions, c.470+1G>A and p.Lys615Asnfs*6, causing USH1B.",Non-OADS,/arxiv_data1/oa_pdf/16/5f/mv-v22-827.PMC4950652.pdf
Molecular Vision  2016; 22:827-835 <http://www.molvis.org/molvis/v 22/827> © 2016 Molecular Vision  8342.,Non-OADS,/arxiv_data1/oa_pdf/16/5f/mv-v22-827.PMC4950652.pdf
Molecular Vision  2016; 22:827-835 <http://www.molvis.org/molvis/v 22/827> © 2016 Molecular Vision  83523.,Non-OADS,/arxiv_data1/oa_pdf/16/5f/mv-v22-827.PMC4950652.pdf
2013. http://www.nccn.org/professionals/physician_gls/pdf/pain.,Non-OADS,/arxiv_data1/oa_pdf/7f/ab/ol-12-02-1323.PMC4950721.pdf
"The  PCR product was sequenced using an ABI 3500xL Sequencer  (Guangzhou Golden Mile Medical Testing Center Co., Ltd.,  Guangzhou, China; http://www.kingmed.com.cn).",Non-OADS,/arxiv_data1/oa_pdf/90/3d/etm-12-02-0661.PMC4950735.pdf
"All algorithms were processed on a desktop computer with an  Intel Core ™ i3 Processor  and 4  GB random -access memory, and scripted in Matlab 2013a ( http://uk.mathworks.com /prod- ucts/new_products /release2013a.html) .",OADS,/arxiv_data1/oa_pdf/87/68/etm-12-02-0653.PMC4950751.pdf
"The common miRNAs in Gene set  B, as predicted by the  databases of miRecords ( http: //c1.accurascience.com /miRe - cords /), TarBase ( http://diana.imis.athena- innovation.gr /Diana   Tools /index.php?",OADS,/arxiv_data1/oa_pdf/fd/d9/etm-12-02-0925.PMC4950782.pdf
"targetscan.org /), were selected using WEB‑based GEne SeT  AnaLysis Toolkit software  (update  2013; http://bioinfo.vander - bilt.edu /webgestalt /), and P<0.05 was used as the cut -off  criterion.",OADS,/arxiv_data1/oa_pdf/fd/d9/etm-12-02-0925.PMC4950782.pdf
"The band densities were quantified using  β-actin as a loading control, and analyzed using Image J  (https://imagej.nih.gov/ij/ ).",OADS,/arxiv_data1/oa_pdf/95/fd/ol-12-02-1380.PMC4950784.pdf
The pre - and intraoperative rate and BP were  recorded according to the National Institute of Health Stroke  Scale (https://www.ninds.nih.gov/doctors/NIH_Stroke_Scale.,OADS,/arxiv_data1/oa_pdf/90/78/etm-12-02-1039.PMC4950788.pdf
Putative  transcription factor binding sites were identified with the  Transcription Element Search System (TESS) algorithm  (http://www.cbil.upenn.edu/downloads/ ).,OADS,/arxiv_data1/oa_pdf/00/06/ol-12-02-0933.PMC4950837.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/99/8f/main.PMC4950871.pdf
"These include lack of awareness of and access to such goods and services as appropriate contraceptives, family planning services, and abortion procedures ( SACIM, 2016 ;David & Collins, 2014 ;Finer &Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/ssmphSSM -Population Health http://dx.doi.org/10.1016/j.ssmph.2016.03.007 2352-8273/ &2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/99/8f/main.PMC4950871.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/99/8f/main.PMC4950871.pdf
"BMC Women 's Health ,13, 29. http://dx.doi.org/10.1186/ 1472 –6874-13 –29.",Non-OADS,/arxiv_data1/oa_pdf/99/8f/main.PMC4950871.pdf
〈http://www.guttmacher.org/presentations/trends.pdf 〉.,Non-OADS,/arxiv_data1/oa_pdf/99/8f/main.PMC4950871.pdf
Available at: 〈http://www.guttmacher.org/ datacenter/trend.jsp #〉(accessed 17.03.16).,OADS,/arxiv_data1/oa_pdf/99/8f/main.PMC4950871.pdf
〈http://www.guttmacher.org/pubs/ 2008/09/23/TrendsWomenAbortions-wTables.pdf 〉(accessed 17.03.16).,Non-OADS,/arxiv_data1/oa_pdf/99/8f/main.PMC4950871.pdf
〈http://www.guttmacher.,Non-OADS,/arxiv_data1/oa_pdf/99/8f/main.PMC4950871.pdf
http://dx.doi.org/10.1371/journal.pmed.0050046 .N.,Non-OADS,/arxiv_data1/oa_pdf/99/8f/main.PMC4950871.pdf
http://dx.doi.org/ 10.4172/2167-0420.1000206 .,Non-OADS,/arxiv_data1/oa_pdf/99/8f/main.PMC4950871.pdf
〈http://wonder.cdc.gov/wonder/help/cmf.html 〉.,OADS,/arxiv_data1/oa_pdf/99/8f/main.PMC4950871.pdf
〈http://www.cdc.gov/nchs/linked.htm 〉.,OADS,/arxiv_data1/oa_pdf/99/8f/main.PMC4950871.pdf
〈http://www.cdc.gov/nchs/ VitalStats.htm 〉(accessed 17.03.16).,Non-OADS,/arxiv_data1/oa_pdf/99/8f/main.PMC4950871.pdf
〈http://www.academyhealth.org/ ﬁles/RabarisonMCH.pdf 〉.,Non-OADS,/arxiv_data1/oa_pdf/99/8f/main.PMC4950871.pdf
〈http://www.hrsa.,Non-OADS,/arxiv_data1/oa_pdf/99/8f/main.PMC4950871.pdf
"Geneva, Switzerland: UNAIDS Available at 〈http://www.unaids.org/sites/default/ ﬁles/en/media/unaids/con tentassets/documents/document/2010/10_4-Intro-to-triangulation-MEF.pdf 〉 (accessed 17.04.16).",Non-OADS,/arxiv_data1/oa_pdf/99/8f/main.PMC4950871.pdf
〈http://www2.census.gov/ pub/outgoing/govs/special60/ 〉〉.,OADS,/arxiv_data1/oa_pdf/99/8f/main.PMC4950871.pdf
〈https://www.census.,Non-OADS,/arxiv_data1/oa_pdf/99/8f/main.PMC4950871.pdf
〈http://www.bls.gov/cpi/cpiursai1978_2010.pdf 〉.,Non-OADS,/arxiv_data1/oa_pdf/99/8f/main.PMC4950871.pdf
"The gene test was supported by Beijing Genomics Institute  (http://www.genomics.cn/; Beijing, China ) and the sample  number was LA13001‑220.",OADS,/arxiv_data1/oa_pdf/e6/fa/etm-12-02-0690.PMC4950898.pdf
http://dx.doi.org/10.1016/j.adro.2016.01.003 2452-1094/Copyright /C2112016 the Authors.,Non-OADS,/arxiv_data1/oa_pdf/a5/fa/main.PMC4950982.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Advances in Radiation Oncology (2016) 1, 10-16 www.advancesradonc.org",Non-OADS,/arxiv_data1/oa_pdf/a5/fa/main.PMC4950982.pdf
"2, e1173168 (12 pages)http://dx.doi.org/10.1080/21597081.2016.1173168",Non-OADS,/arxiv_data1/oa_pdf/ba/18/kbac-06-02-1173168.PMC4951002.pdf
"Grete embraced thisidea with passion and dedication, and in pursuing it,rapidly achieved scienti ﬁc independence and creativity, as seen in her correspondence with Weigle, stored atCaltech (http://archives.caltech.edu).",Non-OADS,/arxiv_data1/oa_pdf/ba/18/kbac-06-02-1173168.PMC4951002.pdf
Grete continued to share her ideas with andsuggest experiments to him and his PhD studentDaisy Dussoix (https://fr.wikipedia.org/wiki/Daisy_Dussoix).,Non-OADS,/arxiv_data1/oa_pdf/ba/18/kbac-06-02-1173168.PMC4951002.pdf
"life to this day; and ﬁnally to the late Claire M. Berg, DB ’s sib- ling and research collaborator, discussions with whomincreased his sensitivity to some of the issues discussed here.The research into Grete ’s life and work would not have been possible without the initiative of the Equal Opportunity Of ﬁce of the University of Geneva and the Emilie Gourd Foundation,who sponsored the establishment of a project “Biography of women in Switzerland ”to address the Wikimedia Gender Gap (https://fr.wikipedia.org/wiki/Projet:Suisse/Biographies_des_femmes_en_Suisse): SC thanks Brigitte Mantilleri for encour-agement, Natacha Rault, Gabrielle Marie and Marie PierreVidonne for guidance in the Wikipedia project, and LorenaParini for comments on gender issues.",Non-OADS,/arxiv_data1/oa_pdf/ba/18/kbac-06-02-1173168.PMC4951002.pdf
Accessible athttps://www.nobelprize.org/n obel_prizes/medicine/lau- reates/1978/arber-bio.html.,Non-OADS,/arxiv_data1/oa_pdf/ba/18/kbac-06-02-1173168.PMC4951002.pdf
PLOS Genetics 2014;10(12): http://dx.doi.org/ 10.1371/journal.pgen.1004879.,Non-OADS,/arxiv_data1/oa_pdf/ba/18/kbac-06-02-1173168.PMC4951002.pdf
"[6] Albright M. Madeleine Albright: My undiplomatic moment (NYT Editorial February 13, 2016) (http://www.nytimes.com/2016/02/13/opinion/madel eine-albright-my-undiplom atic-moment.html).",Non-OADS,/arxiv_data1/oa_pdf/ba/18/kbac-06-02-1173168.PMC4951002.pdf
Experientia1952; 8:99-101; PMID:14945418; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ba/18/kbac-06-02-1173168.PMC4951002.pdf
Virology 1957; 3:275-85; PMID:13434011;http://dx.doi.org/10.1016/0042-6822(57)90093-4 [13] Kellenberger G. Interview with Bruno Strasser.,Non-OADS,/arxiv_data1/oa_pdf/ba/18/kbac-06-02-1173168.PMC4951002.pdf
"Experientia 1951; 7:216-7; PMID:14840446;http://dx.doi.org/10.1007/BF02138997 [19] Rouiller C, Huber L, Kellenberger E, Rutishauser E. [The lamellar structure of the osteon].",OADS,/arxiv_data1/oa_pdf/ba/18/kbac-06-02-1173168.PMC4951002.pdf
"Acta Anat (Basel) 1952;14:9-22; PMID:14932625; http://dx.doi.org/10.1159/0001 40589 [20] Arber W, Kellenberger G, Weigle J.",Non-OADS,/arxiv_data1/oa_pdf/ba/18/kbac-06-02-1173168.PMC4951002.pdf
"Biochim Biophys Acta 1958; 30:112-24;PMID:13584403; http://dx.doi.org/10.1016/0006-3002 (58)90247-6 [22] Arber W, Kellenberger G, Weigle J.",OADS,/arxiv_data1/oa_pdf/ba/18/kbac-06-02-1173168.PMC4951002.pdf
"Nature 1960; 187:161-2; http://dx.doi.org/10.1038/187161a0 [24] Kellenberger G, Zichichi ML, Weigle J.",Non-OADS,/arxiv_data1/oa_pdf/ba/18/kbac-06-02-1173168.PMC4951002.pdf
"J Mol Biol 1961; 3:399-408;PMID:13752286; http://dx.doi.org/10.1016/S0022-2836(61)80053-3 [25] Kellenberger G, Zichichi ML, Weigle JJ.",OADS,/arxiv_data1/oa_pdf/ba/18/kbac-06-02-1173168.PMC4951002.pdf
"Virology 1958; 5:458-75; PMID:13557731; http://dx.doi.org/10.1016/0042-6822(58)90039-4 [31] Kellenberger G, Zichichi ML, Epstein HT.",Non-OADS,/arxiv_data1/oa_pdf/ba/18/kbac-06-02-1173168.PMC4951002.pdf
"Heterozygosis and recombination of bacteriophage λ. Virology 1962; 17:44-55; PMID:14454932; http://dx.doi.org/10.1016/0042-6822(62)90080-6 [32] Zichichi ML, Kellenberger G. Two distinct functions in the lysogenization process: the repression of phage multi- plication and incorporation of the prophage in the bacte- rial genome.",OADS,/arxiv_data1/oa_pdf/ba/18/kbac-06-02-1173168.PMC4951002.pdf
"Virology 1963; 19:450-60; PMID:14003601;http://dx.doi.org/10.1016/0042-6822(63)90038-2 [33] Kellenberger G. Letter to Werner Arber, 27.12.60.",Non-OADS,/arxiv_data1/oa_pdf/ba/18/kbac-06-02-1173168.PMC4951002.pdf
Annu Rev Microbiol 1965; 19:365-78;PMID:5318444; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/ba/18/kbac-06-02-1173168.PMC4951002.pdf
"J Mol Biol 1962; 5:37-49;PMID:13888713; http://dx.doi.org/10.1016/S0022-2836(62)80059-X [36] Arber W, Dussoix D. Host speci ﬁcity of DNA produced by Escherichia coli.",OADS,/arxiv_data1/oa_pdf/ba/18/kbac-06-02-1173168.PMC4951002.pdf
"J Mol Biol 1962; 5:18-36; PMID:13862047; http://dx.doi.org/10.1016/S0022-2836(62)80058-8 [37] Laemmli UK, Beguin F, Gujer-Kellenberger G. A factor preventing the major head protein of bacteriophage T4from random aggregation.",OADS,/arxiv_data1/oa_pdf/ba/18/kbac-06-02-1173168.PMC4951002.pdf
J Mol Biol 1970; 47:69-85;PMID:5413343; http://dx.doi.org/10.1016/0022-2836(70)90402-X [38] Laemmli U.,OADS,/arxiv_data1/oa_pdf/ba/18/kbac-06-02-1173168.PMC4951002.pdf
"Virology 1974; 62:234-41; PMID:4608877; http://dx.doi.org/10.1016/0042-6822(74)90318-3 [42] Kellenberger-Gujer G, Boy de la Tour E, Berg DE.",Non-OADS,/arxiv_data1/oa_pdf/ba/18/kbac-06-02-1173168.PMC4951002.pdf
"Trans- fer of the lambda dv plasmid to new bacterial hosts.Virology 1974; 58:576-85; PMID:4595156; http://dx.doi.org/10.1016/0042-6822(74)90091-9 [43] Berg DE, Davies J, Allet B, JD R. Transposition of R factor genes to bacteriophage lambda.",OADS,/arxiv_data1/oa_pdf/ba/18/kbac-06-02-1173168.PMC4951002.pdf
Proc Natl Acad SciU S A 1975; 72:3628-32; PMID:1059152; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ba/18/kbac-06-02-1173168.PMC4951002.pdf
"Mol Gen Genet1978; 162:9-16; PMID:353526; http://dx.doi.org/10.1007/BF00333845 [45] Kellenberger-Gujer G, Podhajska AJ.",OADS,/arxiv_data1/oa_pdf/ba/18/kbac-06-02-1173168.PMC4951002.pdf
"Mol Gen Genetics 1978; 162:17-22; http://dx.doi.org/10.1007/BF00333846 [46] Kellenberger G, Arber W, Kellenberger E. Eigenschaften UV- bestrahlter λ-Phagen.",OADS,/arxiv_data1/oa_pdf/ba/18/kbac-06-02-1173168.PMC4951002.pdf
"Psychol Rev 1995;102:4-27; PMID:7878162; http://dx.doi.org/10.1037/0033-295X.102.1.4 [54] Nosek BA, Smyth FL, Sriram N, Lindner NM, Devos T, Ayala A, Bar-Anan Y, Bergh R, Cai H, Gonsalkorale K, et al.",OADS,/arxiv_data1/oa_pdf/ba/18/kbac-06-02-1173168.PMC4951002.pdf
"Psychol Sci 2015; 26:641-5; PMID:25749702; http://dx.doi.org/10.1177/0956797615569354 [56] Reuben E, Sapienza P, Zingales L. How stereotypes impair women ’s careers in science.",Non-OADS,/arxiv_data1/oa_pdf/ba/18/kbac-06-02-1173168.PMC4951002.pdf
"Addition - ally, fasudil has a therapeutic potential for ocular angiogenic  diseases via blockade Rho-kinase signaling and extracellular Molecular Vision  2016; 22:836-846 <http://www.molvis.org/molvis/v 22/836> Received 30 October 2015 | Accepted 16 July 2016 | Published 19 July 2016© 2016 Molecular Vision 836Fasudil inhibits LPS-induced migration of retinal microglial cells  via regulating p38-MAPK signaling pathway Fan Xu, Yue Xu, Liqiong Zhu, Pinhong Rao, Jiamin Wen, Yunyun Sang, Fu Shang, Yizhi Liu State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong  Province, People’ s Republic of China Purpose:  To investigate the effect and possible molecular mechanisms of fasudil on retinal microglial (RMG) cell  migration.",Non-OADS,/arxiv_data1/oa_pdf/66/5d/mv-v22-836.PMC4951004.pdf
Molecular Vision  2016; 22:836-846 <http://www.molvis.org/molvis/v 22/836> © 2016 Molecular Vision  837signal-related kinase and Akt signaling [ 18].,Non-OADS,/arxiv_data1/oa_pdf/66/5d/mv-v22-836.PMC4951004.pdf
Molecular Vision  2016; 22:836-846 <http://www.molvis.org/molvis/v 22/836> © 2016 Molecular Vision  838Institute of Biotechnology) protein assay kit (Sigma) [ 24].,Non-OADS,/arxiv_data1/oa_pdf/66/5d/mv-v22-836.PMC4951004.pdf
Molecular Vision  2016; 22:836-846 <http://www.molvis.org/molvis/v 22/836> © 2016 Molecular Vision  839indicated that LPS enhanced the migratory potential of the  RMG cells compared to the control.,Non-OADS,/arxiv_data1/oa_pdf/66/5d/mv-v22-836.PMC4951004.pdf
Molecular Vision  2016; 22:836-846 <http://www.molvis.org/molvis/v 22/836> © 2016 Molecular Vision  840inhibitor SB203580 and fasudil together further reduced LPS- stimulated RMG cell migration (Figure 6).,Non-OADS,/arxiv_data1/oa_pdf/66/5d/mv-v22-836.PMC4951004.pdf
Molecular Vision  2016; 22:836-846 <http://www.molvis.org/molvis/v 22/836> © 2016 Molecular Vision  841 Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/66/5d/mv-v22-836.PMC4951004.pdf
Molecular Vision  2016; 22:836-846 <http://www.molvis.org/molvis/v 22/836> © 2016 Molecular Vision  842severe injury or neurodegenerative diseases.,Non-OADS,/arxiv_data1/oa_pdf/66/5d/mv-v22-836.PMC4951004.pdf
"Molecular Vision  2016; 22:836-846 <http://www.molvis.org/molvis/v 22/836> © 2016 Molecular Vision  843induce cellular morphologic changes that promote increased  motility [ 25,32,33].",Non-OADS,/arxiv_data1/oa_pdf/66/5d/mv-v22-836.PMC4951004.pdf
Molecular Vision  2016; 22:836-846 <http://www.molvis.org/molvis/v 22/836> © 2016 Molecular Vision  844that p38-MAPK is involved in cell migration and actin cyto - skeleton reorganization.,OADS,/arxiv_data1/oa_pdf/66/5d/mv-v22-836.PMC4951004.pdf
Molecular Vision  2016; 22:836-846 <http://www.molvis.org/molvis/v 22/836> © 2016 Molecular Vision  84526.,Non-OADS,/arxiv_data1/oa_pdf/66/5d/mv-v22-836.PMC4951004.pdf
Molecular Vision  2016; 22:836-846 <http://www.molvis.org/molvis/v 22/836> © 2016 Molecular Vision  846a role of a p38gamma-dependent signaling pathway.,Non-OADS,/arxiv_data1/oa_pdf/66/5d/mv-v22-836.PMC4951004.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/87/27/cia-11-933.PMC4951051.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 933–940Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  933ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S10496 1 The imaging assessment and specific endograft  design for the endovascular repair of ascending  aortic dissection Yepeng Zhang1 Hanfei Tang1 JianPing Zhou2 Zhao Liu1 Changjian Liu1 T ong Qiao1 Min Zhou1 1Department of Vascular Surgery,   The Affiliated Hospital of Nanjing  University Medical School, Nanjing,   2Department of General Surgery,   Yixin People’s Hospital, Yixin, People’s  Republic of ChinaBackground:  Endovascular option has been proposed for a very limited and selected number  of Stanford type A aortic dissection (TAAD) patients.",Non-OADS,/arxiv_data1/oa_pdf/87/27/cia-11-933.PMC4951051.pdf
"Therefore, owing to the significant  mortality and morbidity of open surgery, patients of high risks are not considered  for this procedure.2 Previous reports have described that, in a small selected subset Correspondence: Min Zhou Department of Vascular Surgery, The  Affiliated Hospital of Nanjing University  Medical School, Zhongshan Road  No 321, Nanjing 210008, People’s  Republic of China Tel +86 139 5193 7586 Email zhouminnjuseu@sina.co m Journal name: Clinical Interventions in Aging Article Designation: ORIGINAL RESEARCH Y ear: 2016 Volume: 11 Running head verso: Zhang et al Running head recto: Endovascular repair of ascending aortic dissection DOI: http://dx.doi.org/10.2147/CIA.S104961",Non-OADS,/arxiv_data1/oa_pdf/87/27/cia-11-933.PMC4951051.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/87/27/cia-11-933.PMC4951051.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/87/27/cia-11-933.PMC4951051.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/05/4e/ndt-12-1739.PMC4951052.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1739–1746Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1739OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10841 1 ESSENCE-Q – a first clinical validation study of a  new screening questionnaire for young children  with suspected neurodevelopmental problems in  south Japan Yuhei hatakenaka1,2 elisabeth Fernell2 Masahiko sakaguchi3 hitoshi Ninomiya3 ichiro Fukunaga1 christopher gillberg2 1Kochi gillberg Neuropsychiatry  Centre, Kochi Prefectural Medical and  Welfare Centre, Kochi, Japan; 2gillberg  Neuropsychiatry centre, sahlgrenska  Academy, University of Gothenburg,   Gothenburg, Sweden; 3integrated  Centre for Advanced Medical  Technologies, Kochi University  Medical school, Kochi, JapanBackground:  Early identification of autism spectrum disorder, intellectual developmental  disorder, attention-deficit/hyperactivity disorder, and other neurodevelopmental disorders/ problems is crucial, yet diagnosis is often delayed for years under the often misguided  “wait-and-see” paradigm.",Non-OADS,/arxiv_data1/oa_pdf/05/4e/ndt-12-1739.PMC4951052.pdf
"Some of the most common disorders subsumed  under ESSENCE are autism spectrum disorder (ASD), attention-deficit/hyperactivity  disorder (ADHD), oppositional defiant disorder (ODD), tic disorder, developmental correspondence: Yuhei hatakenaka email yuhei.hatakenaka@gnc.gu.s eJournal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Hatakenaka et al Running head recto: The ESSENCE-Q – a first clinical validation study DOI: http://dx.doi.org/10.2147/NDT.S108411 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/05/4e/ndt-12-1739.PMC4951052.pdf
Or use: http://youtu.be/TUbYx2Afiw 4Video abstract,Non-OADS,/arxiv_data1/oa_pdf/05/4e/ndt-12-1739.PMC4951052.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/05/4e/ndt-12-1739.PMC4951052.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/05/4e/ndt-12-1739.PMC4951052.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/55/a6/ppa-10-1243.PMC4951054.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1243–1249Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1243OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10972 0 The role of adjunctive dexamethasone in the  treatment of bacterial meningitis: an updated  systematic meta-analysis Mei shao1 Peng Xu2 Jun liu3 Wenyun liu1 Xiujie Wu1 1Department of neurosurgery, linyi  People’s hospital, 2Department of  neurosurgery, linyi Yishui central  hospital, linyi, 3Department of  neurosurgery, Binzhou Medical  college, Yantai, shandong, People’s  republic of chinaBackground:  Bacterial meningitis is a serious infection in children and adults worldwide, with  considerable morbidity, mortality, and severe neurological sequelae.",Non-OADS,/arxiv_data1/oa_pdf/55/a6/ppa-10-1243.PMC4951054.pdf
"Keywords:  bacterial meningitis, dexamethasone, treatment, meta­analysis Introduction Bacterial meningitis is a serious life ­threatening disease with severe neurological  emergency such as hearing loss, developmental disorders, and neuropsychological  impairment, occurring in up to 50% of survivors of the disease.1 The clinical signs of  bacterial meningitis include fever, headache, meningismus, an altered level of con ­ sciousness, and so on.2 It is ranked fourth as a cause of disability, and the estimated  incidence is 1–2 million cases per year worldwide.3 Streptococcus pneumoniae , Hae- mophilus influenzae , and Neisseria meningitidis  are the leading causes, still resulting  in unacceptably high levels of human mortality and morbidity.4 Although routine vac ­ cination against the common pathogens has decreased the burden of disease, improved  the outcomes, and had a notable effect on the prevalence of bacterial meningitis,5,6 correspondence: Xiujie Wu Department of neurosurgery, linyi  People’s hospital, 27 Jiefang road, linyi  276000, People’s republic of china Tel +86 539 812 9102 Fax +86 539 812 9909 email xiujiewuxjw@163.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Shao et al Running head recto: Adjunctive dexamethasone in the treatment of bacterial meningitis DOI: http://dx.doi.org/10.2147/PPA.S109720",Non-OADS,/arxiv_data1/oa_pdf/55/a6/ppa-10-1243.PMC4951054.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer ­reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/55/a6/ppa-10-1243.PMC4951054.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/46/58/copd-11-1597.PMC4951055.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1597–1605International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1597OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10951 0 Phenotypic assessment of pulmonary hypertension  using high-resolution echocardiography is  feasible in neonatal mice with experimental  bronchopulmonary dysplasia and pulmonary  hypertension: a step toward preventing chronic  obstructive pulmonary disease Corey l reynolds1 shaojie Zhang2 amrit Kumar shrestha2 roberto Barrios3 Binoy shivanna2 1Mouse Phenotyping Core, 2section  of neonatology, Department of  Pediatrics, Baylor College of Medicine,   houston, TX, Usa; 3Department of  Pathology and genomic Medicine,   houston Methodist hospital,   houston, TX, UsaAbstract:  Bronchopulmonary dysplasia (BPD) and chronic obstructive pulmonary disease  (COPD) are chronic lung diseases of human infants and adults, respectively, that are character - ized by alveolar simplification.",Non-OADS,/arxiv_data1/oa_pdf/46/58/copd-11-1597.PMC4951055.pdf
"Keywords:  hyperoxia, oxidative stress, malondialdehyde adducts, inflammation, inducible  nitric oxide synthase Introduction Bronchopulmonary dysplasia (BPD) is a chronic lung disease of infancy that  results from interrupted lung alveolar and vascular growth.1,2 The pathogenesis and  pathophysiology of BPD is identical to chronic obstructive pulmonary disease (COPD), Correspondence: Binoy shivanna section of neonatology, Baylor College  of Medicine, 1102 Bates avenue, MC:  FC530.01, houston, TX 77030, Usa Tel +1 832 824 6474 Fax +1 832 825 3204 email shivanna@bcm.ed u Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Reynolds et al Running head recto: Phenotypic assessment of pulmonary hypertension DOI: http://dx.doi.org/10.2147/COPD.S109510",Non-OADS,/arxiv_data1/oa_pdf/46/58/copd-11-1597.PMC4951055.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/46/58/copd-11-1597.PMC4951055.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/46/58/copd-11-1597.PMC4951055.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c7/99/copd-11-1587.PMC4951056.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1587–1596International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1587RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S10757 1 Involvement of informal caregivers in supporting  patients with COPD: a review of intervention  studies Jamie Bryant1,2 elise Mansfield1,2 Allison w Boyes1,2 Amy waller1,2 Rob Sanson-Fisher1,2 Timothy Regan1,2 1Health Behaviour Research Group,   Priority Research Centre for Health  Behaviour, 2Hunter Medical Research  Institute, University of Newcastle,   Callaghan, NSw , AustraliaAbstract:  Caregivers of individuals with COPD have a key role in maintaining patient adherence  and optimizing patient function.",Non-OADS,/arxiv_data1/oa_pdf/c7/99/copd-11-1587.PMC4951056.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/c7/99/copd-11-1587.PMC4951056.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c7/99/copd-11-1587.PMC4951056.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5e/aa/ott-9-4255.PMC4951057.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/5e/aa/ott-9-4255.PMC4951057.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/aa/ott-9-4255.PMC4951057.pdf
“We realize that some of the results referenced in this paper  are preliminary analyses and may not reflect the final data  and conclusions of the clinical trials cited”.Journal name: OncoTargets and Therapy Article Designation: Retraction Y ear: 2016 Volume: 9 Running head verso: Tao et al Running head recto: Comparison of tumor markers using different detection devices DOI: http://dx.doi.org/10.2147/OTT.S115633,Non-OADS,/arxiv_data1/oa_pdf/5e/aa/ott-9-4255.PMC4951057.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5a/01/opth-10-1245.PMC4951058.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1245–1256Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1245Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10200 8 Femtosecond laser-assisted in situ keratomileusis  multifocal ablation profile using a mini-monovision  approach for presbyopic patients with hyperopia iraklis Vastardis1 Brigitte Pajic-eggspühler1 Jörg Müller1,2 Zeljka Cvejic2 Bojan Pajic1–4 1swiss eye research Foundation,   Orasis eye Clinic, aargau,   reinach, switzerland; 2Faculty of  Physics, University of novi sad,   novi sad, serbia; 3Department of  Ophthalmology, geneva University  hospitals, geneva, switzerland;   4Medical Faculty, Military Medical  academy, University of Defence,   Belgrade, serbiaPurpose:  To report the visual outcomes of the femtosecond laser-assisted multifocal aspheric  corneal ablation profile using a mini-monovision approach and to evaluate if corneal multifocality  was effective, and to report the relative benefits of this approach.",Non-OADS,/arxiv_data1/oa_pdf/5a/01/opth-10-1245.PMC4951058.pdf
"Two major surgical approaches exist today, Correspondence: iraklis Vastardis swiss eye research Foundation,  Orasis eye Clinic, Titlisstrasse 44,  Ch-5734 reinach, switzerland Tel +41 62 765 6080 Fax +41 62 765 6081 email vastardis.iraklis@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Vastardis et al Running head recto: PresbyLasik correction for hyperopic patients DOI: http://dx.doi.org/10.2147/OPTH.S102008",Non-OADS,/arxiv_data1/oa_pdf/5a/01/opth-10-1245.PMC4951058.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/5a/01/opth-10-1245.PMC4951058.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/01/opth-10-1245.PMC4951058.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a6/84/ijn-11-3215.PMC4951059.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3215–3223International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3215OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10488 5 sol–gel dip coating of yttria-stabilized tetragonal  zirconia dental ceramic by aluminosilicate  nanocomposite as a novel technique to improve  the bonding of veneering porcelain azamsadat Madani1 Mohammadreza Nakhaei2 Parisa Karami3 ghadir rajabzadeh4 sahar salehi4,5 hossein Bagheri6 1Dental research center, Department  of Prosthodontics, Faculty of  Dentistry, Mashhad University  of Medical sciences, 2Dental Materials  research center, Department of  Prosthodontics, Faculty of Dentistry,   Mashhad University of Medical  sciences, Mashhad, 3Department  of Prosthodontics, Faculty of  Dentistry, Zanjan University of  Medical sciences, Zanjan, 4Department  of Nanotechnology, research Institute  of Food science and T echnology,   Mashhad, 5Department of Material and  Metallurgical engineering, University  of semnan, semnan, 6Dental Materials  research center, Department  of Operative Dentistry, Mashhad  University of Medical sciences,   Mashhad, IranAbstract:  The aim of this in vitro study was to evaluate the effect of silica and aluminosilicate  nanocomposite coating of zirconia-based dental ceramic by a sol–gel dip-coating technique on  the bond strength of veneering porcelain to the yttria-stabilized tetragonal zirconia polycrystal  (Y-TZP) in vitro.",Non-OADS,/arxiv_data1/oa_pdf/a6/84/ijn-11-3215.PMC4951059.pdf
"However, chipping  and debonding of the feldspathic porcelain veneer have been one of the most common correspondence: hossein Bagheri Department of Operative Dentistry,  Faculty of Dentistry, Dental Materials  research center, Mashhad University  of Medical sciences, Ferdowsi campus,  Vakilabad highway, 9177948959  Mashhad, Iran Tel +98 915 313 2180 Fax +98 513 882 9500 email bagherih@mums.ac.i r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Madani et al Running head recto: Sol–gel dip coating of Y-TZP ceramic by aluminosilicate nanocomposite DOI: http://dx.doi.org/10.2147/IJN.S104885",Non-OADS,/arxiv_data1/oa_pdf/a6/84/ijn-11-3215.PMC4951059.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/a6/84/ijn-11-3215.PMC4951059.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a6/84/ijn-11-3215.PMC4951059.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6b/f3/ndt-12-1747.PMC4951060.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1747–1760Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1747Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S11303 7 Zika virus challenges for neuropsychiatry Ana Cristina Simões e Silva1,2 Janaina Matos Moreira1,2 Roberta Maia Castro  Romanelli2 Antonio Lucio T eixeira1,3 1interdisciplinary Laboratory of  Medical investigation, 2Department  of Pediatrics, Faculty of Medicine,   Federal University of Minas Gerais  (UFMG), Belo Horizonte,  Brazil;   3Neuropsychiatry Program,   Department of Psychiatry and  Behavioral Sciences, McGovern  Medical School, University of Texas  Health Science Center at Houston,   Houston, TX, USAAbstract:  Before 2007, Zika virus (ZIKV) was generally considered as an arbovirus of low  clinical relevance, causing a mild self-limiting febrile illness in tropical Africa and Southeast  Asia.",Non-OADS,/arxiv_data1/oa_pdf/6b/f3/ndt-12-1747.PMC4951060.pdf
"Accordingly, it has been proposed  that the Asian cluster was phylogenetically derived from the African ZIKV strain.2,8,9  The first cases of ZIKV infection reported in Brazil were from a strain genetically  related to the Asian lineage.10–12 The introduction of ZIKV in Brazil probably occurred  in 2014 due to the arrival of foreign tourists and athletes during the Soccer World Correspondence: Antonio Lucio Teixeira Neuropsychiatry Program, Department  of Psychiatry and Behavioral Sciences,  McGovern Medical School, University  of Texas Health Science Center at  Houston, 1941 east Road, Houston,  TX 77054, USA Tel +1 713 486 2555 email antonio.l.teixeira@uth.tmc.ed u Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Simões e Silva et al Running head recto: Zika virus challenges DOI: http://dx.doi.org/10.2147/NDT.S113037",Non-OADS,/arxiv_data1/oa_pdf/6b/f3/ndt-12-1747.PMC4951060.pdf
"Available from: http://www.hygiene-publique.gov.pf/IMG/pdf/ no13_-_mai_2015_-_zika.pd f. Accessed January 14, 2016.",Non-OADS,/arxiv_data1/oa_pdf/6b/f3/ndt-12-1747.PMC4951060.pdf
"Available from:  http://portalsaude.saude.gov.br/images/pdf/2015/novembro/26/2015- dengue-SE45.pd f. Accessed April 29, 2016.Table 3  Unanswered questions regarding ZiKv infection and  neuropsychiatric complications what are the mechanisms underlying ZiKv-induced neuronal damage?",Non-OADS,/arxiv_data1/oa_pdf/6b/f3/ndt-12-1747.PMC4951060.pdf
Available from:  http://www.paho.org/hq/index.php?option =com_docman&task =doc_v iew&Itemid =270&gid=32405&lang =en.,OADS,/arxiv_data1/oa_pdf/6b/f3/ndt-12-1747.PMC4951060.pdf
"Available  from: http://portalsaude.saude.gov.br/images/pdf/2016/abril/27/ COES- Microcefalias ---Informe-Epidemiol--gico-23--SE-16-2016-- 25abril2016-20h07.pd f. Accessed May 2, 2016.",Non-OADS,/arxiv_data1/oa_pdf/6b/f3/ndt-12-1747.PMC4951060.pdf
Available from: http://portalsaude.saude.,Non-OADS,/arxiv_data1/oa_pdf/6b/f3/ndt-12-1747.PMC4951060.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/6b/f3/ndt-12-1747.PMC4951060.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6b/f3/ndt-12-1747.PMC4951060.pdf
Available from:  http://apps.who.int/iris/bitstream/10665/204475/1/WHO_ZIKV_ MOC_16.3_eng.pdf?ua =1.,OADS,/arxiv_data1/oa_pdf/6b/f3/ndt-12-1747.PMC4951060.pdf
Available from: http://www.who.int/ childgrowth/standards/second_set/technical_report_2/en /.,Non-OADS,/arxiv_data1/oa_pdf/6b/f3/ndt-12-1747.PMC4951060.pdf
"Available from:  http://www.eclamc.org/eng/index.ph p. Accessed May 2, 2016.",OADS,/arxiv_data1/oa_pdf/6b/f3/ndt-12-1747.PMC4951060.pdf
"Available from: http://www.cdc.gov/zika/pregnancy/ question-answers.htm l. Accessed April 29, 2016.",Non-OADS,/arxiv_data1/oa_pdf/6b/f3/ndt-12-1747.PMC4951060.pdf
Available from: http://www.who.int/iris/handle/10665/20568 6.,OADS,/arxiv_data1/oa_pdf/6b/f3/ndt-12-1747.PMC4951060.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/af/e9/ijn-11-3205.PMC4951061.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3205–3214International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3205OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10409 0 silencing tumor necrosis factor-alpha in vitro  from small interfering rNa-decorated titanium  nanotube array can facilitate osteogenic  differentiation of mesenchymal stem cells Zhenlin Wang1,* Zhiqiang hu2,* Dawei Zhang3 Mengchuan Zhuo1 Jiwei cheng1 Xingping Xu1 Y ongming Xing1 Jie Fan2 1Department of Orthopaedics,   2Department of Otorhinolaryngology,   No 113 hospital of P la, Ningbo,   3Department of Orthopaedics, Xijing  hospital of P la, Xi’an, People’s  republic of china *These authors contributed equally  to this workAbstract:  Titanium implants are known for their bone bonding ability.",Non-OADS,/arxiv_data1/oa_pdf/af/e9/ijn-11-3205.PMC4951061.pdf
"The most validated inflammatory  cytokine is the tumor necrosis factor alpha (TNF- α), which is involved in the focal  loss of cartilage in osteoarthritis.3 Aktas et al even suggested that the serum TNF- α correspondence: Dawei Zhang Department of Orthopaedics, Xijing  hospital of Pla, No 127 changle West  road, Xi’an 710032, People’s republic  of china email daweiz56@126.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Wang et al Running head recto: Silencing TNF- α for osteogenesis on titanium surface DOI: http://dx.doi.org/10.2147/IJN.S104090",Non-OADS,/arxiv_data1/oa_pdf/af/e9/ijn-11-3205.PMC4951061.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/af/e9/ijn-11-3205.PMC4951061.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/af/e9/ijn-11-3205.PMC4951061.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/68/39/ott-9-4289.PMC4951062.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4289–4293OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4289Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9919 5 Upregulation of M agea 4 correlates with poor  prognosis in patients with early stage of esophageal  squamous cell carcinoma Wei-Wei Tang1 Zi-hao liu2 T ong-Xin Yang2 han-Jin Wang1 Xiu-Feng cao2 1Department of general surgery,   2Department of surgical Oncology,   nanjing First hospital, nanjing  Medical University, nanjing, Jiangsu,   People’s republic of chinaAbstract:  Esophageal cancer is a common type of cancer in the People’s Republic of China.",Non-OADS,/arxiv_data1/oa_pdf/68/39/ott-9-4289.PMC4951062.pdf
"Upregulation of MAGEA4   has been found in several types of tumors, for example, oral squamous cell carcinoma,9  non-small-cell lung cancer,10 pancreatic cancer,11 and breast cancer.12 In the present  study, we examined the expression of MAGEA4  in ESCC tissues and investigated the  significance and prognostic value of MAGEA  expression in patients with ESCC.correspondence: Xiu-Feng cao Department of surgical Oncology,  nanjing First hospital, nanjing Medical  University, 68 changle road, nanjing  210006, Jiangsu, People’s republic of  china Tel +86 25 5227 1023 Fax +86 25 5226 9924 email cxf551101@sina.co m  han-Jin Wang Department of general surgery, nanjing  First hospital, nanjing Medical University,  68 changle road, nanjing 210006,  Jiangsu, People’s republic of china Tel +86 25 5227 1023 Fax +86 25 5226 9924 email whj_888@sohu.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Tang et al Running head recto: MAGE-A4 and ESCC DOI: http://dx.doi.org/10.2147/OTT.S99195",Non-OADS,/arxiv_data1/oa_pdf/68/39/ott-9-4289.PMC4951062.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/68/39/ott-9-4289.PMC4951062.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/68/39/ott-9-4289.PMC4951062.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/db/e4/cia-11-941.PMC4951063.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 941–946Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  941OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S10536 0 ChADs2 score has a better predictive value than  ChA2Ds2-VAsc score in elderly patients with  atrial fibrillation Yunli Xing Qing Ma Xiaoying Ma Cuiying Wang Dai Zhang Ying sun Department of geriatrics and  gerontology, Beijing Friendship  hospital, Capital Medical University,   Beijing, People’s republic of ChinaAim:  The study aims to compare the ability of CHA2DS2-VASc (defined as congestive heart fail - ure, hypertension, age $75 years [two scores], type 2 diabetes mellitus, previous stroke, transient  ischemic attack, or thromboembolism [TE] [doubled], vascular disease, age 65–74 years, and  sex category) and CHADS2 (defined as congestive heart failure, hypertension, age $75 years,  type 2 diabetes mellitus, previous stroke [doubled]) scores to predict the risk of ischemic stroke  (IS) or TE among patients with nonvalvular atrial fibrillation (NVAF).",Non-OADS,/arxiv_data1/oa_pdf/db/e4/cia-11-941.PMC4951063.pdf
"However, various studies have reported the underuse  of oral anticoagulation (OAC) among elderly patients with NVAF,2–4 and the situation  is more grim in the People’s Republic of China.5 Both CHADS2 (defined as congestive heart failure, hypertension, age $75 years,  type 2 diabetes mellitus [DM], previous stroke [doubled]) and CHA2DS2-VASc (defined  as congestive heart fail ure, hypertension, age $75 years [two scores], type 2 diabetes  mellitus, previous stroke, transient ischemic attack [TIA], or TE [doubled], vascular  disease, age 65–74 years, and sex category) scores are well-validated tools for the Correspondence: Ying sun Department of geriatrics and  gerontology, Beijing Friendship  hospital, Capital Medical University,  no 95 Yongan road, Xicheng District  100050, Beijing, People’s republic of  China Tel +86 138 1162 6312 Fax +86 10 6313 8040 email ysun15@163.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Xing et al Running head recto: CHADS2 better than CHA2DS2-VASc for NVAF in the elderly DOI: http://dx.doi.org/10.2147/CIA.S105360",Non-OADS,/arxiv_data1/oa_pdf/db/e4/cia-11-941.PMC4951063.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/db/e4/cia-11-941.PMC4951063.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/db/e4/cia-11-941.PMC4951063.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b5/66/ott-9-4265.PMC4951064.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4265–4275OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4265Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10285 8 Theaflavins suppress tumor growth and metastasis  via the blockage of the sT aT3 pathway in  hepatocellular carcinoma Jianping shao1,* Qingyan Meng2,* Y ongyuan li1 1Department of general surgery,   2Outpatient Department, The Fifth  central hospital of Tianjin, Tianjin,   People’s republic of china *These authors contributed equally  to this workAbstract:  Theaflavins, the major black tea polyphenols, have been reported to exhibit promising  antitumor activities in several human cancers.",Non-OADS,/arxiv_data1/oa_pdf/b5/66/ott-9-4265.PMC4951064.pdf
"Although the development of synthetic chemistry has led to the produc - tion of novel drugs, treatments for cancer cannot totally replace the potent biological  activities and great structural diversity of natural products.5 Theaflavins, derived from  black tea, are thought to possess antioxidant properties, the ability to scavenge or  inhibit free radicals, and the ability to treat blood vessel and heart diseases.6–9 Recent  studies have reported that theaflavins exhibit antitumor activities on different tumor  cells, including breast carcinoma, prostate carcinoma, and melanoma.10–15 Theaflavins  also exert their protective effect against dimethylnitrosamine-induced liver fibrosis, correspondence: Jianping shao Department of general surgery,  The Fifth central hospital of Tianjin,  no 41 Tangguzhejiang road, Binhai  new District, 300450 Tianjin,  People’s republic of china Tel/fax +86 22 6566 5302 email shaojianping@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Shao et al Running head recto: Theaflavins suppress tumor growth and metastasis of HCC DOI: http://dx.doi.org/10.2147/OTT.S102858",Non-OADS,/arxiv_data1/oa_pdf/b5/66/ott-9-4265.PMC4951064.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/b5/66/ott-9-4265.PMC4951064.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b5/66/ott-9-4265.PMC4951064.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ad/c7/ott-9-4277.PMC4951066.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 4277–4288OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4277Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10650 8 Pyruvate kinase M2 overexpression and poor  prognosis in solid tumors of digestive system:  evidence from 16 cohort studies Jiayuan Wu1,* liren hu2,* Manyu chen3 Wenjun cao4 haicong chen5 Taiping he4 1nutritional Department, the  affiliated hospital of guangdong  Medical University, 2Department of  epidemiology and health statistics,   school of Public health, guangdong  Medical University, 3Department of  Oncology, the affiliated hospital  of guangdong Medical University,   4school of Public health, guangdong  Medical University, 5Department of  Orthopedics, the affiliated hospital  of guangdong Medical University,   Zhanjiang, guangdong, People’s  republic of china *These authors contributed equally  to this workPurpose:  The expression of pyruvate kinase M2 (PKM2) has been linked to tumor formation  and invasion.",Non-OADS,/arxiv_data1/oa_pdf/ad/c7/ott-9-4277.PMC4951066.pdf
"According the data published by  the International Agency for Research on Cancer in 2013, approximately 14 million  new cancer cases were diagnosed and 8.2 million people died of tumors worldwide in  2012, with DSN contributing to at least 30% of the total morbidity and 40% of the total  mortality.1 On the basis of the latest report of the Global Burden of Disease Cancer  Collaboration, given its increasing incidence rate worldwide, DSN has posed a major  threat to public health since 1990, especially in developing countries where the health  systems that are ill-equipped to deal with complex and expensive cancer treatments.2correspondence: Jiayuan Wu Nutritional Department, the Affiliated  hospital of guangdong Medical  University, no 57, south of People’s  avenue, Zhanjiang, guangdong 524001,  People’s republic of china Tel +86 759 238 7489 Fax +86 759 238 7612 email 87537665@qq.co m  Taiping he school of Public health, guangdong  Medical University, no 2, Wenmin road,  Zhanjiang, guangdong 524023, People’s  republic of china email taipinghe@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Wu et al Running head recto: PKM2 in solid tumors of digestive system DOI: http://dx.doi.org/10.2147/OTT.S106508",Non-OADS,/arxiv_data1/oa_pdf/ad/c7/ott-9-4277.PMC4951066.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ad/c7/ott-9-4277.PMC4951066.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/c7/ott-9-4277.PMC4951066.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f2/76/copd-11-1607.PMC4951067.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1607–1614International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1607OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10605 4 Inhaled corticosteroids can reduce osteoporosis  in female patients with COPD shih-Feng liu1–3 ho-Chang Kuo1,2,4 guan-heng liu5 shu-Chen ho4 huang-Chih Chang1,3 hung-T u huang6 Yu-Mu Chen1 Kuo-T ung huang1,3 Kuan-Yi Chen2 Wen-Feng Fang1–3 Meng-Chih lin1–3 1Department of Internal Medicine,   Division of Pulmonary and Critical  Care Medicine, 2Department of  respiratory Therapy, Kaohsiung Chang  gung Memorial hospital, 3Chang  gung University College of Medicine,   4Department of Pediatrics, Kaohsiung  Chang gung Memorial hospital,   5li-Chih Valuable school, 6Department  of anatomy, school of Medicine,   College of Medicine, Kaohsiung  Medical University, Kaohsiung, Taiwan,   republic of ChinaBackground:  Whether the use of inhaled corticosteroids (ICSs) in patients with COPD can  protect from osteoporosis remains undetermined.",Non-OADS,/arxiv_data1/oa_pdf/f2/76/copd-11-1607.PMC4951067.pdf
"In addition, older age, menopause, and female sex are the other risk factors  for osteoporosis.9–11Correspondence: Meng-Chih lin Department of Internal Medicine,  Division of Pulmonary and Critical  Care Medicine, Kaohsiung Chang gung  Memorial hospital, no 123, Ta-Pei  road, niaosong District, Kaohsiung 833,  Taiwan, republic of China Tel +886 7 731 7123 ext 8199 Fax +886 7 732 24942 email mengchih@adm.cgmh.org.t w  ho-Chang Kuo Department of Pediatrics, Kaohsiung  Chang gung Memorial hospital, no 123,   Ta-Pei road, niaosong District,  Kaohsiung 833, Taiwan, republic of China Tel +886 7 731 7123 ext 8802 Fax +886 7 733 8009 email erickuo48@yahoo.com.t w Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Liu et al Running head recto: ICSs reduce osteoporosis in COPD DOI: http://dx.doi.org/10.2147/COPD.S106054",Non-OADS,/arxiv_data1/oa_pdf/f2/76/copd-11-1607.PMC4951067.pdf
"Available from: http://www.goldcopd.co m.  Accessed May 4, 2016.",Non-OADS,/arxiv_data1/oa_pdf/f2/76/copd-11-1607.PMC4951067.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/f2/76/copd-11-1607.PMC4951067.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/76/copd-11-1607.PMC4951067.pdf
Available from:  http://www.mayoclinic.org/diseases-conditions/osteoporosis/basics/ risk-factors/con-2001992 4.,Non-OADS,/arxiv_data1/oa_pdf/f2/76/copd-11-1607.PMC4951067.pdf
In  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b4/89/nihms-796650.PMC4951091.pdf
Available from: http://kff.org/health-reform/state-indicator/state- activity-around-expanding-medicaid-under-the-affordable-care-act/  [2015 Aug 6] 3.,Non-OADS,/arxiv_data1/oa_pdf/b4/89/nihms-796650.PMC4951091.pdf
Available  from: http://www.medicaid.gov/medicaid-chip-program-information/program-information/ downloads/may-2015-enrollment-report.pdf 8.,OADS,/arxiv_data1/oa_pdf/b4/89/nihms-796650.PMC4951091.pdf
Available  from: http://www.aspe.hhs.gov/health/reports/2015/uninsured_change/ ib_uninsured_change.pdf 12.,Non-OADS,/arxiv_data1/oa_pdf/b4/89/nihms-796650.PMC4951091.pdf
BMC Plant Biology 201 5; 15:295; PMID:26690932; http://dx.doi.org/10.1186/s12870-015-0670-7 © 2016 Allan M. Showalter and Debarati Basu.,Non-OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
"0, e1177687 (6 pages)http://dx.doi.org/10.1080/19420889.2016.1177687",Non-OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
The glycosyltransferase sequences were retrieved from the Carbohydrate-Active enZYmes (CAZY) database (http://www.cazy.org/GT1_eu- karyota.html) and NCBI database.,OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
cbs.dtu.dk/services/TMHMM/) was used to predict the transmembrane domain (T); Pfam domain predictions: Pf01762 identi ﬁed the Gal- actosyltransferase (GALT) domain (http://www.sanger.ac.uk/Software/Pfam/) and Pf00337 identi ﬁed the Galactose-binding lectin (GALECTIN) domain.COMMUNICATIVE & INTEGRATIVE BIOLOGY e1177687-3,OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
"Plant J 2002; 32:105-13; PMID:12366804; http://dx.doi.org/10.1046/j.1365-313X.2002.01406.x [2] Marzec M, Szarejko I, Melzer M. Arabinogalactan pro- teins are involved in root hair development in barley.",OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
"J Exp Bot 2015; 66:1245-57; PMID:25465033; http://dx.doi.org/10.1093/jxb/eru475 [3] Gao M, Showalter AM.",OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
"Plant J1999; 19:321-31; PMID:10476079; http://dx.doi.org/ 10.1046/j.1365-313X.1999.00544.x [4] Chaves I, Regalado AP, Chen M, Ricardo CP, Showalter AM.",OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
"Physiol Plant 2002; 116:548-53; http://dx.doi.org/10.1034/j.1399-3054.2002.1160414.x [5] Levitin B, Richter D, Markovich I, Zik M. Arabinoga- lactan proteins 6 and 11 are required for stamen andpollen function in Arabidopsis.",OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
"Plant Cell 2013; 25:1274-87; PMID:23572547; http://dx.doi.org/10.1105/tpc.112.106237 [7] Coimbra S, Costa M, Mendes MA, Pereira AM, Pinto J, Pereira LG.",OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
"Sex Plant Reprod 2010; 23:199-205; PMID:20162305; http://dx.doi.org/10.1007/s00497-010- 0136-x [8] Qin Y, Zhao J. Localization of arabinogalactan-proteins in different stages of embryos and their role in cotyledon for- mation of Nicotiana tabacum L. Sex Plant Reprod 2007; 20:213-24; http://dx.doi.org/10.1007/s00497-007-0058-4 [9] Shi H, Kim Y, Guo Y, Stevenson B, Zhu JK.",Non-OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
The Arabi- dopsis SOS5 locus encodes a putative cell surface adhe- sion protein and is required for normal cell expansion.Plant Cell 2003; 15:19-32; PMID:12509519; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
"Nature 2004; 429:873-8; PMID:15215864; http://dx.doi.org/10.1038/nature02613 [11] Gens JS, Fujiki M, Pickard BG.",OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
"Protoplasma 2000; 212:115-34; PMID:11543565; http://dx.doi.org/10.1007/BF01279353 [12] Basu D, Tian L, Wang W, Bobbs S, Herock H, Travers A, Showalter AM.",OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
"BMC Plant Biology 2015; 15:295;PMID:26690932; http://dx.doi.org/10.1186/s12870-015-0670-7 [13] Lamport DTA, V /C19arnai P. Periplasmic arabinogalactan glycoproteins act as a calcium capacitor that regulates Figure 2.",Non-OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
"New Phytologist 2013; 197:58-64; http://dx.doi.org/10.1111/nph.12005 [14] Fu H, Yadav MP, Nothnagel EA.",Non-OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
"Planta 2007; 226:1511-24; PMID:17653569;http://dx.doi.org/10.1007/s00425-007-0587-y [15] Costa M, Pereira AM, Rudall PJ, Coimbra S. Immu- nolocalization of arabinogalactan proteins (AGPs) inreproductive structures of an early-divergent angio-sperm, Trithuria (Hydatellaceae).",OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
"Ann Bot 2013; 111:183-90; PMID:23186834; http://dx.doi.org/ 10.1093/aob/mcs256 [16] Popper ZA, Michel G, Herve C, Domozych D S, Willats W G T, Tuohy M G, Kloareg B, Stengel D B. Evolution and diversity of plant cell walls: from algae to ﬂowering plants.",OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
"Annu Rev Plant Biol 2011; 62:567-90; PMID:21351878; http://dx.doi.org/10.1146/annurev- arplant-042110-103809 [17] Classen B, Thude S, Blaschek W, Wack M, Bodinet C. Immunomodulatory effects of arabinogalactan –proteins from Baptisia and Echinacea.",OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
Phytomedicine 2006; 13:688-94; PMID:17085292; http://dx.doi.org/10.1016/j.phymed.2005.10.004 [18] Kieliszewski MJ.,OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
"Phytochemistry 2001; 57:319-23; PMID:11393510;http://dx.doi.org/10.1016/S0031-9422(01)00029-2 [19] Schultz CJ, Ferguson KL, Lahnstein J, Bacic A. Post- translational modi ﬁcations of arabinogalactan-peptides of Arabidopsis thaliana.",OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
2004; 279:45503- 11; PMID:15322080; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
"Plant Physiol 2010; 153:485-513; PMID:20395450;http://dx.doi.org/10.1104/pp.110.156554 [21] Tan L, Showalter AM, Egelund J, Hernandez-Sanchez A, Doblin MS, Bacic A. Arabinogalactan-proteins and theresearch challenges for these enigmatic plant cell surface pro- teoglycans.",OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
"Front Plant Sci 2012; 3:1-10; PMID:22645563; http://dx.doi.org/10.3389/fpls.2012.00140 [22] Tan L, Varnai P, Lamport DTA, Yuan C, Xu J, Qiu F, Kieliszewski MJ.",OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
"2010;285:24575-83; PMID:20489210; http://dx.doi.org/ 10.1074/jbc.M109.100149 [23] Haque MA, Kotake T, Tsumuraya Y. Mode of action of beta-glucuronidase from Aspergillus niger on the sugar chains of arabinogalactan-protein.",OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
"Biosci Biotechnol Bio- chem 2005; 69:2170-7; PMID:16306699; http://dx.doi.org/10.1271/bbb.69.2170 [24] Tryfona T, Liang HC, Kotake T, Kaneko S, Marsh J, Ichi- nose H, Lovegrove A, Tsumuraya Y, Shewry PR, Ste-phens E, et al.",OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
"Carbohydr Res 2010; 345:2648-56; PMID:20971454; http://dx.doi.org/10.1016/ j.carres.2010.09.018 [25] Tryfona T, Liang HC, Kotake T, Tsumuraya Y, Stephens E, Dupree P. Structural characterization of Arabidopsis leaf arabinogalactan polysaccharides.",OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
"2012;160:653-66; PMID:22891237; http://dx.doi.org/10.1104/ pp.112.202309 [26] Knoch E, Dilokpimol A, Geshi N. Arabinogalactan pro- teins: focus on carbohydrate active enzymes.",Non-OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
"Plant J 2015; 81:736-46; PMID:25600942; http://dx.doi.org/10.1111/tpj.12764 [28] Basu D, Liang Y, Liu X, Himmeldirk K, Faik A, Kielis- zewski M, Held M, Showalter AM.",OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
"PLoS One2015; 10:e0125624; PMID:25974423; http://dx.doi.org/ 10.1371/journal.pone.0125624 [30] Qu Y, Egelund J, Gilson PR, Houghton F, Gleeson PA, Schultz CJ, Bacic A. Identi ﬁcation of a novel group of putative Arabidopsis thaliana b-(1,3)-galactosyl transfer- ases.",OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
"Plant Mol Biol 2008; 68:43-59; PMID:18548197;http://dx.doi.org/10.1007/s11103-008-9351-3 [31] Geshi N, Johansen JN, Dilokpimol A, Rolland A, Bel- cram K, Verger S, Kotake T, Tsumuraya Y, Kaneko S,Tryfona T. A galactosyltransferase acting on arabino- galactan protein glycans is essential for embryo devel- opment in Arabidopsis.",Non-OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
"2014; 14:90; PMID:24693939; http://dx.doi.org/ 10.1186/1471-2229-14-90 [33] Knoch E, Dilokpimol A, Tryfona T, Poulsen C P, Xiong G, Harholt J, Petersen BL, Ulvskov P, Hadi MZ, Kotake T. A b-glucuronosyltransferase from Arabidopsis thali- ana involved in biosynthesis of type II arabinogalactanhas a role in cell elongation during seedling growth.",OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
"Plant J 2013; 76:1016-29; PMID:24128328; http://dx.doi.org/ 10.1111/tpj.12353 [34] Dilokpimol A, Geshi N. Arabidopsis thaliana glucurono- syltransferase in family GT14.",OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
"2014; 9:e28891; PMID:24739253; http://dx.doi.org/10.4161/psb.28891 [35] Wu Y, Williams M, Bernard S, Driouich A, Showalter AM, Faik A. Functional identi ﬁcation of two nonredun- dant Arabidopsis alpha (1,2) fucosyltransferases speci ﬁc to arabinogalactan proteins.",OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
"2010; 285:13638-45; PMID:20194500; http://dx.doi.org/10.1074/jbc.M110.102715 [36] Liang Y, Basu D, Pattathil S, Xu W-L, Venetos A, Martin SL, Faik A, Hahn MG, Showalter AM.",OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
2013; 64:5537-51; PMID:24127514; http://dx.doi.org/10.1093/jxb/ert321COMMUNICATIVE & INTEGRATIVE BIOLOGY e1177687-5,Non-OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
"Mol Plant2013; 6:1369-72; PMID:23396039; http://dx.doi.org/10.1093/mp/sst029 [39] Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: Molecular Evolutionary Genetics AnalysisVersion 6.0.",OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
"Mol Biol Evol 2013; 30:2725-9; PMID:24132122; http://dx.doi.org/10.1093/molbev/ mst197 [40] Schultz CJ, Johnson KL, Currie G, Bacic A.",OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
"Plant Cell 2000; 12:1751-67; PMID:11006345; http://dx.doi.org/10.1105/tpc.12.9.1751 [41] Gao M, Kieliszewski MJ, Lamport DT, Showalter AM.",OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
Plant J 1999; 18:43-55; PMID:10341442; http://dx.doi.org/10.1046/j.1365-313X.,OADS,/arxiv_data1/oa_pdf/ed/b2/kcib-09-03-1177687.PMC4951162.pdf
"3, e1172159 (13 pages)http://dx.doi.org/10.1080/19420889.2016.1172159",Non-OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
Phys Life Rev 2013; 8:249-52; http://dx.doi.org/ 10.1016/j.plrev.2011.07.003 [4] Bejan A.,OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
Int J Heat Mass Transf 1997; 40:799-816 (published on 1 November 1996); http://dx.doi.org/10.1016/0017-9310(96)00175-5 [6] Bejan A.,OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
Phys Life Rev 2011; 8:209-40; PMID:21683663; http://dx.doi.org/10.1016/j.plrev.2011.05.010 [8] Kov /C19a/C20c L. Bioenergetics.,OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
"Commun Integr Biol 2008; 1:114- 22; http://dx.doi.org/10.4161/cib.1.1.6670 [9] Balu /C20ska F, Mancuso S. Deep evolutionary origins of neu- robiology.",OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
Life Excit Biol 2015; 3:153-87; http://dx.doi.org/10.9784/LEB3(3)DeLoof.01 [11] Balu /C20ska F. Evolution in Revolution.,OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
J Exp Biol 2015; 218:7-13;PMID:25568446; http://dx.doi.org/10.1242/jeb.106310 [14] Noble D. Physiology is rocking the foundations of evolution- ary biology.,Non-OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
Exp Physiol 2013; 98:1235-43; PMID:23585325; http://dx.doi.org/10.1113/expphysiol.2012.071134 [15] Pigliucci M. Do we need an extended evolutionary the- ory?,Non-OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
Progr Biophys Mol Biol 2012; 111:92-6; http://dx.doi.org/10.1016/j.pbiomolbio.2012.08.016 [19] Kauffman SA.,OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
Med Hypoth 2015; 85:49-57; http://dx.doi.org/10.1016/j.mehy.2015.03.019 [29] Lewins J. Bejan ’s constructal theory of equal potential distribution.,Non-OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
"Int J Heat Mass Transfer 2003; 46:1541-3;http://dx.doi.org/10.1016/S0017-9310(02)00441-6 [30] Mazur S. The Origin of Life Circus: A How to Make Life Extravaganza, New York: Caswell Books, 2014; 2016.",Non-OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
J Physiol 2014; 592:2245-9; PMID:24882809; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
Sci China Technol Sci 2012; 55:802-20; http://dx.doi.org/10.1007/s11431-011-4701-9 [37] Miguel AF.,Non-OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
"The physics principle of the generation of ﬂow conﬁguration, Phys Life Rev 2011; 8:243-4; PMID:21795127; http://dx.doi.org/10.101 6/j.plrev.2011.07.006 [38] Miguel AF.",Non-OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
"J Appl Phys 2006; 100:041301; http://dx.doi.org/10.1063/1.2221896 [40] Bejan A, Lorente S. The constructal law of design and evolution in nature.",Non-OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
"Phil Transact Royal Soc B 2010;365:1335-1347; http://dx.doi.org/10.1098/rstb.2009.0302 [41] Bejan A, Lorente S. Constructal law of design and evolution: Physics, biology, technology, and society.",Non-OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
J Appl Phys 2013;113:151301; http://dx.doi.org/10.1063/1.4798429 [42] Reis AH.,Non-OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
Appl Mech Rev 2006; 59:269-82; http://dx.doi.org/ 10.1115/1.2204075 [43] Green S. Revisiting generality in biology: systems biol- ogy and the quest for design principles.,Non-OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
Interf Foc 2015; 5:20150078; http://dx.doi.org/10.1098/rsfs.2015.0078 [45] Bejan A. Maxwell ’s demons everywhere: evolving design as the arrow of time.,Non-OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
"Int J Heat Mass Transf 2012; 55:802-7; http://dx.doi.org/ 10.1016/j.ijheatmasstransfer.2011.10.029 [51] Bejan A, Lorente S, Yilbas BS, Sahin AZ.",OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
Sci Rep 2013; 3:1711; http://dx.doi.org/10.1038/srep01711 [52] Miguel AF.,Non-OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
"J Fluids Struct 2010; 26:330-5; http://dx.doi.org/10.1016/j.j ﬂuidstructs.2009.11.004 [53] Kacimov AR, Klammler H, Il ’y i n s k i iH ,H a t ﬁeld K. Con- structal design of permeable reactive barriers: groundwater - hydraulics criteria.",OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
"Geomorphology 2010; 114:276-83; http://dx.doi.org/10.1016/j.geomorph.2009.07.008 [55] Reis AH, Bejan A. Constructal theory of global circulation and climate.",Non-OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
"Int J Heat Mass Transf 2006; 49:1857-75; http://dx.doi.org/10.1016/j.ijheatmasstransfer.2005.10.037 [56] Clausse M, Meunier F, Reis AH, Bejan A.",OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
"Int JGlobal Warm 2012; 4:242-60; http://dx.doi.org/10.1504/IJGW.2012.049449 [57] Band LE, McDonnell JJ, Duncan JM, Barros A, Bejan A, Burt T, Dietrich WE, Emanuel RE, Hwang T, Katul G,et al.",OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
"J Exp Biol 2005; 208:1573-769; PMID:15855388; http://dx.doi.org/10.1242/jeb.01630 [59] Bejan A, Morega A, West GB, Brown JH.",OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
Phys Today 2005; 58:20;http://dx.doi.org/10.1063/1.2012444 [60] Miguel AF.,Non-OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
"J Theor Biol 2006; 242:954-61; PMID:16839570; http://dx.doi.org/10.1016/j.jtbi.2006.05.010 [61] Reis AH, Miguel AF, Aydin M. Constructal theory of ﬂow architecture of the lungs.",Non-OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
Med Phys 2004; 31:1135- 40; PMID:15191302; http://dx.doi.org/10.1118/1.1705443 [62] Kasimova R. Optimal shape of anthill dome: Bejan ’s con- structal law revisited.,Non-OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
Ecol Model 2013; 250:384-90; http://dx.doi.org/10.1016/j.ecolmodel.2012.11.021 [63] Bejan A.,OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
Sci Rep 2012;2:594; PMID:22924107; http://dx.doi.org/10.1038/ srep00594 [64] Bejan A.,OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
"Sci Rep 2016; 6:21445; PMID:26883787; http://dx.doi.org/10.1038/srep21445 [65] Lorente S, Bejan A.",OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
"Int J Des Nat Ecodyn 2010; 5:254-67; http://dx.doi.org/10.2495/DNE-V5-N3-254-267 [66] Charles JD, Bejan A.",OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
"J Exp Biol 2009; 212:2419-25;PMID:19617435; http://dx.doi.org/10.1242/jeb.031161 [67] Bejan A, Jones EC, Charles JD.",OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
"Int J Des Nat Ecodyn 2013; 8:17-28; http://dx.doi.org/10.2495/DNE-V8-N1-17-28 [69] Majumder PP, Choudhury SR. Reasons for success in competitive swimming among various human races.",Non-OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
J Sport Phys Educ 2014; 1:24-30; http://dx.doi.org/ 10.9790/6737-0132430[70] Bejan A.,Non-OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
Am J Phys 2010; 78:692-9; http://dx.doi.org/10.1119/1.3431988 [71] Bejan A.,Non-OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
"Int J Des Nat Ecodyn 2009; 4:97-104; http://dx.doi.org/10.2495/DNE-V4-N2-97-104 [72] Hadjistassou C, Bejan A, Ventikos V. Cerebral oxygen- ation and optimal vascular brain organization.",Non-OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
"J Appl Phys 2008; 103:123511; http://dx.doi.org/10.1063/1.2936919 [74] Cetkin E, Lorente S, Bejan A.",OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
J Appl Phys 2010; 107:114901; http://dx.doi.org/10.1063/1.3430941 [75] Bejan A.,Non-OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
Sci Rep 2015; 5:11270; PMID:26053318; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
"Eur Rev 2015; 23:481-8; http://dx.doi.org/10.1017/S1062798715000216 [77] Bejan A, Charles JD, Lorente S. The evolution of air- planes.",Non-OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
"J Appl Phys 2014; 116:044901; http://dx.doi.org/ 10.1063/1.4886855 [78] Bejan A, Merkx GW, eds.",OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
"Int J Design Nat Ecodyn, 2010; 5:268-76; http://dx.doi.org/ 10.2495/DNE-V5-N3-268-276 [83] Lorenzini G, Biserni C, Garcia FL, Rocha LAO.",OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
Int J Heat Mass Transfer 2012; 55:6951- 6958; http://dx.doi.org/10.1016/j.ijheatmasstransfer.,OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
"J Electronic Packaging2003; 125:475-479; http://dx.doi.org/10.1115/1.1615796 [85] Ellis G, Silk J.",Non-OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
Nature 2014; 516:321-3; PMID:25519115; http://dx.doi.org/10.1038/516321a [86] Metzner R. Private communication.,Non-OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
"J Exp Biol 2006; 209:238-48; PMID:16391346; http://dx.doi.org/ 10.1242/jeb.01974 [88] Bejan A, Wagstaff RW.",OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
J Appl Phys 2016; 119:094901; http://dx.doi.org/10.1063/1.4941986COMMUNICATIVE & INTEGRATIVE BIOLOGY e1172159-13,Non-OADS,/arxiv_data1/oa_pdf/af/33/kcib-09-03-1172159.PMC4951165.pdf
"3, e1155010 (19 pages)http://dx.doi.org/10.1080/19420889.2016.1155010",Non-OADS,/arxiv_data1/oa_pdf/fb/a6/kcib-09-03-1155010.PMC4951167.pdf
Found of Phys 2001; 31:1465-99; http://dx.doi.org/ 10.1023/A:1012682413597 [4] Stapp H. Mindful universe: quantum mechanics and the participating observer.,Non-OADS,/arxiv_data1/oa_pdf/fb/a6/kcib-09-03-1155010.PMC4951167.pdf
"Science 1996; 272:1131; PMID:8662445; http://dx.doi.org/ 10.1126/science.272.5265.1131 [10] Einstein A, Podolsky B, Rosen N. Can quantum-mechan- ical description of physical reality be considered com- plete?",Non-OADS,/arxiv_data1/oa_pdf/fb/a6/kcib-09-03-1155010.PMC4951167.pdf
"Phys Rev 1935; 47:777; http://dx.doi.org/10.1103/PhysRev.47.777 [11] Ringbauer M, Duffus B, Branciard C, Cavalcanti EG, White AG, Fedrizzi A. Nat Phy 2015; 11:249-54; http:// dx.doi.org/10.1038/nphys3233 [12] Ma XS, Zotter S, Ko ﬂer J, Ursin R, Jennewein T, Brukner /C20C, Zeilinger A.",OADS,/arxiv_data1/oa_pdf/fb/a6/kcib-09-03-1155010.PMC4951167.pdf
"Physical Rev Letters 2013;110:210403; http://dx.doi.org/10.1103/PhysRevLett.110.210403 [14] Lemos GB, Borish V, Cole GD, Ramelow S, Lapkiewicz R, Zeilinger A. Quantum imaging with undetected photons.Nature 2014; 512:409-12; PMID:25164751; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/fb/a6/kcib-09-03-1155010.PMC4951167.pdf
Science 2011; 334:1253-6; PMID:22144620;http://dx.doi.org/10.1126/science.1211914 [16] Bell JS.,OADS,/arxiv_data1/oa_pdf/fb/a6/kcib-09-03-1155010.PMC4951167.pdf
"Phys Rev 1957; 108:1070-1076; http://dx.doi.org/10.1103/PhysRev.108.1070 [18] Aspect A, Grangier P, Roger G. Experimental realization of Einstein-Podolsky-Rosen-Bohm gedankenexperiment:a new violation of Bell ’s inequalities.",Non-OADS,/arxiv_data1/oa_pdf/fb/a6/kcib-09-03-1155010.PMC4951167.pdf
"Phys Rev Lett 1982; 49:91-4; http://dx.doi.org/10.1103/PhysRevLett.49.91 [19] Tittel W, Brendel J, Zbinden H, Gisin N. Violation of Bell inequalities by photons more than 10 km apart.",OADS,/arxiv_data1/oa_pdf/fb/a6/kcib-09-03-1155010.PMC4951167.pdf
PhysicalReview Letters 1998; 81:3563-6; http://dx.doi.org/ 10.1103/PhysRevLett.81.3563 [20] Friedman M. Reconsidering logical positivism.,Non-OADS,/arxiv_data1/oa_pdf/fb/a6/kcib-09-03-1155010.PMC4951167.pdf
Dev Genes Evol 2005; 215:46-52; PMID:15645318; http://dx.doi.org/ 10.1007/s00427-004-0448-7 [23] Kurakin A. Self-organization versus Watchmaker: sto- chastic dynamics of cellular organization.,OADS,/arxiv_data1/oa_pdf/fb/a6/kcib-09-03-1155010.PMC4951167.pdf
Biol Chem 2005; 386:247-254; PMID:15843170; http://dx.doi.org/ 10.1515/BC.2005.030 [24] Kurakin A. Self-organization versus Watchmaker: molec- ular motors and protein translocation.,OADS,/arxiv_data1/oa_pdf/fb/a6/kcib-09-03-1155010.PMC4951167.pdf
Theor Biol Med Model 2009; 6:6; PMID:19416527; http://dx.doi.org/10.1186/1742-4682-6-6 [26] Kurakin A.,OADS,/arxiv_data1/oa_pdf/fb/a6/kcib-09-03-1155010.PMC4951167.pdf
Nature 2005; 435:1165; PMID:15988502; http://dx.doi.org/10.1038/4351165a [28] Theise ND.,OADS,/arxiv_data1/oa_pdf/fb/a6/kcib-09-03-1155010.PMC4951167.pdf
"Lab Invest 2006; 86:335-44;PMID:16482099; http://dx.doi.or g/10.1038/labinvest.3700401 [29] Theise ND, Harris R. Postmodern biology: (adult) (stem) cells are plastic, stochastic, complex, and uncertain.Handb Exp Pharmacol 2006; 174:389-408; PMID:16370336.",Non-OADS,/arxiv_data1/oa_pdf/fb/a6/kcib-09-03-1155010.PMC4951167.pdf
Complexity 2013; 18:11-20; http://dx.doi.org/ 10.1002/cplx.21453 [37] Bohm D. Wholeness and the implicate order.,Non-OADS,/arxiv_data1/oa_pdf/fb/a6/kcib-09-03-1155010.PMC4951167.pdf
"Philosophy Sci- ence 1937; 4:289-98; http://dx.doi.org/10.1086/286465 [39] Varela FJ, Shear J. First-person methodologies: what, why, how?",Non-OADS,/arxiv_data1/oa_pdf/fb/a6/kcib-09-03-1155010.PMC4951167.pdf
"Source (March 6, 2008): http://www.berzinarchives.com/web/en/about/glos sary/glossary.html_80737397.html[48] Kafatos M. Complementary and cosmology, in: Kafatos M, editor.",Non-OADS,/arxiv_data1/oa_pdf/fb/a6/kcib-09-03-1155010.PMC4951167.pdf
"Phenom- enol Cognitive Sci 2004; 3:381-98; http://dx.doi.org/ 10.1023/B:PHEN.0000048936.73339.dd [55] Margulis L, Sagan D. “Sentient symphony, ”in The nature of life: classical and contemporary perspectives from philosophy and science.",Non-OADS,/arxiv_data1/oa_pdf/fb/a6/kcib-09-03-1155010.PMC4951167.pdf
J Mathematical Physics 1995; 36:6377-96; http://dx.doi.org/10.1063/ 1.531249 [59] Bousso R. The holographic principle.,Non-OADS,/arxiv_data1/oa_pdf/fb/a6/kcib-09-03-1155010.PMC4951167.pdf
"3, e1156278 (14 pages)http://dx.doi.org/10.1080/19420889.2016.1156278",Non-OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"J Biophys Biochem Cytol 1957; 3:269-300; PMID:13438910; http://dx.doi.org/10.1083/jcb.3.2.269 [2] Phillips MJ, Voeltz GK.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Bioessays 2015; 37:1298-302; PMID:26440125; http://dx.doi.org/ 10.1002/bies.201500095 [5] Stefan CJ, Manford AG, Emr SD.",Non-OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Curr Opin Cell Biol 2013;25:434-42; PMID:23522446; http://dx.doi.org/10.1016/j.ceb.2013.02.020 [6] Pan X, Roberts P, Chen Y, Kvam E, Shulga N, Huang K, Lemmon S, Goldfarb DS.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"2000; 11:2445-57; PMID:10888680; http://dx.doi.org/10.1091/mbc.11.7.2445 [7] Toulmay A, Prinz WA.",Non-OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"J CellSci 2012; 125:49-58; PMID:22250200; http://dx.doi.org/10.1242/jcs.085118 [8] Kvam E, Goldfarb DS.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"J Cell Sci 2004; 117:4959-68; PMID:15367582; http://dx.doi.org/ 10.1242/jcs.01372 [9] Peng Y, Tang F, Weisman LS.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Nature 2014; 510:552-5; PMID:24847877; http://dx.doi.org/10.1038/nature13269 [11] Manford AG, Stefan CJ, Yuan HL, Macgurn JA, Emr SD.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"ER-to-plasma membrane tethering proteins regu- late cell signaling and ER morphology Dev Cell 2012; 23:1129-40; PMID:23237950; http://dx.doi.org/10.1016/j.devcel.2012.11.004 [12] Giordano F, Saheki Y, Idevall-Hagren O, Colombo SF, Pirruccello M, Milosevic I, Gracheva EO,Bagriantsev SN, Borgese N, De Camilli P. PI(4,5)P(2)-dependent and Ca(2 C)-regulated ER-PM interac- tions mediated by the extended synaptotagmins.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Cell 2013; 153:1494-509; PMID:23791178; http://dx.doi.org/10.1016/j.cell.2013.05.026 [13] Tavassoli S, Chao JT, Young BP, Cox RC, Prinz WA, de Kroon AI, Loewen CJ.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"EMBO Rep 2013; 14:434- 40; PMID:23519169; http://dx.doi.org/10.1038/embor.2013.36 [14] Nishimura AL, Mitne-Neto M, Silva HCA, Richieri- Costa A, Middleton S, Cascio D, Kok F, Oliveira JR, Gil-lingwater T, Webb J, et al.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Am J Hum Genet 2004; 75:822-31; PMID:15372378; http://dx.doi.org/10.1086/425287 [15] Abe K, Ohno Y, Sassa T, Taguchi R, ¸Cal ı¸skan M, Ober C, Kihara A. Mutation for nonsyndromicCOMMUNICATIVE & INTEGRATIVE BIOLOGY e1156278-9",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"J Biol Chem 2013; 288:36741-9; PMID:24220030; http://dx.doi.org/ 10.1074/jbc.M113.493221 [16] Kvam E, Gable K, Dunn TM, Goldfarb DS.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Targeting of Tsc13p to nucleus-vacuole junctions: a role for very- long-chain fatty acids in the biogenesis of microauto-phagic vesicles Mol Biol Cell 2005; 16:3987-98;PMID:15958487; http://dx.doi.org/10.1091/mbc.E05- 04-0290 [17] Olkkonen VM, B /C19easlas O, Nissil €aE ,O x y s t e r o l sa n d their cellular effectors.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Biomolecules 2012; 2:76- 103; PMID:24970128; http://dx.doi.org/10.3390/ biom2010076 [18] Henne WM, Zhu L, Balogi Z, Stefan C, Pleiss JA, Emr SD.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Mdm1/Snx13 is a novel ER –endolysosomal interorganelle tethering protein, J Cell Biol 2015;210:541-51; PMID:26283797; http://dx.doi.org/10.1083/jcb.201503088 [19] Akizu N, Cantagrel V, Zaki MS, Al-Gazali L, Wang X, Rosti RO, Dikoglu E, Gelot AB, Rosti B, Vaux KK, et al.,Biallelic mutations in SNX14 cause a syndromic form of cerebellar atrophy and lysosome-autophagosome dys- function.",Non-OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Nat Genet 2015; 47:528-34; PMID:25848753;http://dx.doi.org/10.1038/ng.3256 [20] Thomas AC, Williams H, Set /C19o-Salvia N, Bacchelli C, Jenkins D, O ’Sullivan M, Mengrelis K, Ishida M, Ocaka L, Chanudet E, et al., Mutations in SNX14 cause a dis- tinctive autosomal-recessive cerebellar ataxia and intel- lectual disability syndrome.",Non-OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Am J Hum Genet 2014;95:611-21; PMID:25439728; http://dx.doi.org/10.1016/j.ajhg.2014.10.007 [21] Suh JM, Stenesen D, Peters JM, Inoue A, Cade A, Graff JM.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
PLoS One 2008; 3:e2152; PMID:18478054; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"pone.0002152 [22] Murley A, Sarsam RD, Toulmay A, Yamada J, Prinz WA, Nunnari J. Ltc1 is an ER-localized ste- rol transporter and a component of ER-mitochon-dria and ER-vacuole contacts, J Cell Biol 2015;209:539-48; PMID:25987606; http://dx.doi.org/ 10.1083/jcb.201502033 [23] Gatta AT, Wong LH, Sere YY, Calder /C19on-Nore ~na DM, Cockcroft S, Menon AK, Levine TP.",Non-OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"A new family of StART domain proteins at membrane contact sites has a role in ER-PM sterol transport Elife 2015; 4;PMID:26001273; http://dx.doi.org/10.7554/eLife.07253 [24] Elbaz-Alon Y, Eisenberg-Bord M, Shinder V, Stiller SB, Shimoni E, Wiedemann N, Geiger T, Schuldiner M.Lam6 Regulates the Extent of Contacts between Organ- elles.",Non-OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"J Cell Biol 2015; 210:883-90; PMID:26370498; http://dx.doi.org/10.1083/jcb.201502105 [26] Velayos-Baeza A, Vettori A, Copley RR, Dobson-Stone C, Monaco AP.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
Genomics 2004; 84:536-49; PMID:15498460; http://dx.doi.org/10.1016/j.ygeno.2004.04.012 [27] Bharucha KN.,OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Pediatr Res 2009; 65:132-7; PMID:18978647; http://dx.doi.org/10.1203/ PDR.0b013e318191fc68 [28] Owusu-Ansah E, Perrimon N. Modeling metabolic homeostasis and nutrient sensing in Drosophila: impli- cations for aging and metabolic diseases.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Dis ModelMech 2014; 7:343-50; PMID:24609035; http://dx.doi.org/10.1242/dmm.012989 [29] Schlegel A, Stainier DYR.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"PLoS Genet 2007; 3: e199; PMID:18081423; http://dx.doi.org/10.1371/ journal.pgen.0030199 [30] Ratnaparkhi A, Lawless GM, Schweizer FE, Golshani P, Jackson GR.",Non-OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
PLoS One 2008; 3:e2334;PMID:18523548; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Cell Biol 2003; 5:261-3; PMID:12646877; http://dx.doi.org/10.1038/ncb944 [32] Eid JP, Arias A, Robertson H, Hime GR, Dziadek M. The Drosophila STIM1 orthologue, dSTIM, has roles in cell fate speci ﬁcation and tissue patterning.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"BMC Dev Biol 2008; 8:104; PMID:18950512; http://dx.doi.org/ 10.1186/1471-213X-8-104 [33] Liou J, Fivaz M, Inoue T, Meyer T. Live-cell imaging reveals sequential oligomerization and local plasma membrane targeting of stromal interaction molecule 1 after Ca2 Cstore depletion.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Proc Natl Acad Sci USA 2007; 104:9301-6; PMID:17517596; http://dx.doi.org/ 10.1073/pnas.0702866104 [34] Fernandez-Funez P, Nino-Rosales ML, de Gouyon B, She WC, Luchak JM, Martinez P, Turiegano E, Benito J, Capovilla M, Skinner PJ, et al.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Identi ﬁcation of genes that modify ataxin-1-induced neurodegeneration.Nature 2000; 408:101-6; PMID:11081516; http://dx.doi.org/10.1038/35040584 [35] Dorman JB, Albinder B, Shroyer T, Kenyon C. The age- 1 and daf-2 genes function in a common pathway tocontrol the lifespan of Caenorhabditis elegans.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"PLoS One 2008; 3: e3721; PMID:19005568; http://dx.doi.org/10.1371/ journal.pone.0003721 [37] Kannan K, Fridell YWC.",Non-OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
Metab 2009; 10:199-207; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"PLoS Genet 2010; 6:e1000857; PMID:20195512; http://dx.doi.org/10.1371/journal.pgen.1000857 [40] Baker KD, Thummel CS.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Diabetic larvae and obese ﬂies- emerging studies of metabolism in Drosophila CellMetab 2007; 6:257-66; PMID:17908555; http://dx.doi.org/10.1016/j.cmet.2007.09.002 [41] Kim SK, Rulifson EJ.",Non-OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Nat Commun 2015;6:7102; PMID:25994086; http://dx.doi.org/10.1038/ncomms8102 [43] Leopold P, Perrimon N. Drosophila and the genetics of the internal milieu.",Non-OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Nature 2007; 450:186-8;PMID:17994083; http://dx.doi.org/10.1038/nature 06286 [44] Gr €onke S, Mildner A, Fellert S, Tennagels N, Petry S, M€uller G, J €ackle H, K €uhnlein RP.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Cell Metab 2005; 1:323-30; PMID:16054079;http://dx.doi.org/10.1016/j.cmet.2005.04.003 [45] Teixeira L, Rabouille C, Rørth P, Ephrussi A, Vanzo NF.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
Mech Dev 2003; 120:1071-81;PMID:14550535; http://dx.doi.org/10.1016/S0925-4773 (03)00158-8 [46] K €uhnlein RP.,OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"J Lipid Res 2012; 53:1430-6; PMID:22566574; http://dx.doi.org/ 10.1194/jlr.R024299 [47] Singh R, Cuervo AM, Singh R, Cuervo AM, Lipophagy: connecting autophagy and lipid metabolism.",Non-OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Trends Endocrinol Metab 2014; 25:509-17; PMID:24685228; http://dx.doi.org/ 10.1016/j.tem.2014.02.006 [49] Stenesen D, Suh JM, Seo J, Yu K, Lee KS, Kim JS, Min KJ, Graff JM.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
Cell Metab 2013; 17:101-12; PMID:23312286; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Diabe- tes 2012; 61:1315-22; PMID:22618766; http://dx.doi.org/10.2337/db11-1300 [51] Ravikumar B, Sarkar S, Davies JE, Futter M, Garcia-Are- ncibia M, Green-Thompson ZW, Jimenez-Sanchez M, Korolchuk VI, Lichtenberg M, Luo S, et al.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Physiol Rev 2010; 90:1383-435; PMID:20959619; http://dx.doi.org/10.1152/physrev.00030.2009[52] Rubinsztein DC, Mari ~no G, Kroemer G, Autophagy and aging.",Non-OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Gerontology 2013; 59:340-8; PMID:23594965;http://dx.doi.org/10.1159/000348599 [55] Madeo F, Zimmermann A, Maiuri MC, Kroemer G. Essential role for autophagy in life span extension.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"J Clin Invest 2015; 125:85-93; PMID:25654554; http://dx.doi.org/10.1172/JCI73946 [56] Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, Komatsu M, Tanaka K, Cuervo AM, Czaja MJ.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Nature 2009; 458:1131- 5; PMID:19339967; http://dx.doi.org/10.1038/ nature07976 [57] Folick A, Oakley HD, Yu Y, Armstrong EH, Kumari M, Sanor L, Moore DD, Ortlund EA, Zechner R, Wang MC.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Science 2015; 347:83-6; PMID:25554789; http://dx.doi.org/10.1126/ science.1258857 [58] Gems D, Partridge L. Genetics of longevity in model organisms: debates and paradigm shifts.",Non-OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
Annu Rev Physiol 2013; 75:621-44; PMID:23190075; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"FASEB J 2008; 22:807- 18; PMID:17928362; http://dx.doi.org/10.1096/fj.07-9261com [61] Picard F, Kurtev M, Chung N, Topark-Ngarm A, Sena- wong T, Machado De Oliveira R, Leid M, McBurneyMW, Guarente L. Sirt1 promotes fat mobilization inwhite adipocytes by repressing PPAR-gamma.",Non-OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Nature 2004; 429:771-6; PMID:15175761; http://dx.doi.org/ 10.1038/nature02583 [62] Whitaker R, Faulkner S, Miyokawa R, Burhenn L, Hen- riksen M, Wood JG, Helfand SL.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Ageing Res Rev 2015; 24:218-31; PMID:26318059; http://dx.doi.org/10.1016/j.arr.2015.08.005 [64] Friedman JR, Dibenedetto JR, West M, Rowland AA, Voeltz GK.",Non-OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
Mol Biol Cell 2013; 24:1030-40; PMID:23389631; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"CritRev Biochem Mol Biol 2014; 49:262-8; PMID:24382115; http://dx.doi.org/10.3109/10409238.2013.875512 [66] van der Kant R, Neefjes J.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"J Cell Sci 2014; 127:929-38; PMID:24554437; http://dx.doi.org/10.1242/jcs.137539 [67] Rowland AA, Chitwood PJ, Phillips MJ, Voeltz GK.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Cell 2014; 159:1027-41; PMID:25416943; http://dx.doi.org/10.1016/j.cell.2014.10.023 [68] Raiborg C, Wenzel EM, Pedersen NM, Olsvik H, Schink KO, Schultz SW, Vietri M, Nisi V, Bucci C, Brech A, et al.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Nature 2015; 520:234-8; PMID:25855459; http://dx.doi.org/ 10.1038/nature14359 [69] Hashimoto Y, Shirane M, Matsuzaki F, Saita S, Ohnishi T, Nakayama KI.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Science 1999; 283:1544-8; PMID:10066179; http://dx.doi.org/ 10.1126/science.283.5407.1544 [73] Alpy F, Stoeckel ME, Dierich A, Escola JM, Wen- dling C, Chenard MP, Vanier MT, Gruenberg J, Tomasetto C, Rio MC.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"J Biol Chem 2001; 276:4261-9; PMID:11053434; http://dx.doi.org/ 10.1074/jbc.M006279200 [74] Alpy F, Wendling C, Rio MC, Tomasetto C, MENTHO, a MLN64 homologue devoid of the START domain J Biol Chem 2002; 277:50780-7; PMID:12393907; http://dx.doi.org/10.1074/jbc.M208290200 [75] Alpy F, Rousseau A, Schwab Y, Legueux F, Stoll I, Wen- dling C, Spiegelhalter C, Kessler P, Mathelin C, Rio MC,et al.",Non-OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Clin Cancer Res 2005; 11:8348-57; PMID:16322295;http://dx.doi.org/10.1158/1078-0432.CCR-05-0841 [78] Stigliano A, Gandini O, Cerquetti L, Gazzaniga P, Misiti S, Monti S, Gradilone A, Falasca P, Poggi M, Brunetti E,et al.",Non-OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"J Endocrinol 2007; 194:55-61; PMID:17592021;http://dx.doi.org/10.1677/JOE-07-0131 [79] Rivadeneira F, Styrk /C19arsdottir U, Estrada K, Halld /C19orsson BV, Hsu YH, Richards JB, Zillikens MC, Kavvoura FK,Amin N, Aulchenko YS, et al.",Non-OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Twenty bone-mineral-density loci identi ﬁed by large-scale meta-analysis of genome-wide association studies Nat Genet 2009; 41:1199-206; PMID:19801982; http://dx.doi.org/10.1038/ng.446 [80] Toulmay A, Prinz WA.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Bridging the gap: Membrane contact sites in signaling, metabolism, and organelle dynamics J Cell Biol 2014; 205:759-69; PMID:24958771; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Biochimica Et Biophysica Acta (BBA) - Mol Cell Res 2013; 1833:2526-41; http://dx.doi.org/10.1016/j.bbamcr.2013.01.028 [83] English AR, Voeltz GK.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
ColdSpring Harb Perspect Biol 2013; 5:a013227; PMID:23545422; http://dx.doi.org/10.1101/cshperspect.,OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Cold Spring Harb Perspect Biol 2012; 4: a013300; PMID:23028121; http://dx.doi.org/10.1101/ cshperspect.a013300 [85] D ’Angelo G, Vicinanza M, De Matteis MA, Lipid-trans- fer proteins in biosynthetic pathways.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
Curr Opin Cell Biol 2008; 20:360-70; http://dx.doi.org/10.1016/j.ceb.2008.03.013 [86] Lev S. Non-vesicular lipid transport by lipid-transfer proteins and beyond.,OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Nat Rev Mol Cell Biol 2010;11:739-50; PMID:20823909; http://dx.doi.org/10.1038/ nrm2971 [87] Holthuis JCM, Levine TP.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Nat Rev Mol Cell Biol 2005; 6:209-20; PMID:15738987; http://dx.doi.org/10.1038/nrm1591 [88] Wirtz KWA, Schouten A, Gros P. Phosphatidylinosi- tol transfer proteins: from closed for transport toopen for exchange.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
Adv Enzyme Regul 2006; 46:301- 11; PMID:16854452; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Nature 2005; 437:154-8;PMID:16136145; http://dx.doi.org/10.1038/nature03923 [90] Wirtz KW, Zilversmit DB.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
Meth Enzymol 1983; 98:565-73;PMID:6669064; http://dx.doi.org/10.1016/0076-6879(83)98183-1 [92] Levine TP.,OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"J Cell Biol 2007; 179:11-3; PMID:17923527; http://dx.doi.org/10.1083/jcb.200709055 [93] Kawano M, Kumagai K, Nishijima M, Hanada K. Ef ﬁ- cient traf ﬁcking of ceramide from the endoplasmic reticulum to the Golgi apparatus requires a VAMP- associated protein-interacting FFAT motif of CERT.",Non-OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"J Biol Chem 2006; 281:30279-88; PMID:16895911; http://dx.doi.org/10.1074/jbc.M605032200 [94] Hanada K, Kumagai K, Tomishige N, Kawano M. CERT and intracellular traf ﬁcking of ceramide.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Biochim Bio- phys Acta 2007; 1771:644-53; PMID:17314061; http://dx.doi.org/10.1016/j.bbalip.2007.01.009 [95] Kumagai K, Yasuda S, Okemoto K, Nishijima M, K o b a y a s h iS ,H a n a d aK .C E R Tm e d i a t e si n t e r -membrane transfer of various molecular species of ceramides J Biol Chem 2005; 280:6488-95; PMID:15596449; http://dx.doi.org/10.1074/jbc.M409290200 [96] Loewen CJR, Roy A, Levine TP.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"EMBO J 2003;22:2025-35; PMID:12727870; http://dx.doi.org/ 10.1093/emboj/cdg201 [97] Hanada K, Kumagai K, Yasuda S, Miura Y, Kawano M, Fukasawa M, Nishijima M. Molecular machinery for non-vesicular traf ﬁcking of ceramide Nature 2003; 426:803-9; PMID:14685229; http://dx.doi.org/10.1038/nature02188 [98] Kudo N, Kumagai K, Tomishige N, Yamaji T, Wakat- suki S, Nishijima M, Hanada K, Kato R. Structural basisfor speci ﬁc lipid recognition by CERT responsible for nonvesicular traf ﬁcking of ceramide.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
Proc Natl Acad Sci USA 2008; 105:488-93; PMID:18184806; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
EMBO J 2004;23:33-44; PMID:14685263; http://dx.doi.org/ 10.1038/sj.emboj.7600034 [100] Hanada K. Discovery of the molecular machinery CERT for endoplasmic reticulum-to-Golgi traf ﬁcking of cer- amide.,OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Mol Cell Biochem 2006; 286:23-31; PMID:16601923; http://dx.doi.org/10.1007/s11010-005-9044-z [101] Lev S, Halevy DB, Peretti D, Dahan N. The VAP protein family: from cellular functions to motor neuron disease.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Trends Cell Biol 2008; 18:282-90; PMID:18468439;http://dx.doi.org/10.1016/j.tcb.2008.03.006 [102] D ’Angelo G, Polishchuk E, Di Tullio G, Santoro M, Di Campli A, Godi A, West G, Bielawski J, Chuang CC,van der Spoel AC, et al.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Nature 2007; 449:62-7; http://dx.doi.org/10.1038/nature06097 [103] Malinina L, Malakhova ML, Teplov A, Brown RE, Patel DJ.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Structural basis for glycosphingolipid transfer speci- ﬁcity, Nature 2004; 430:1048-53; PMID:15329726; http://dx.doi.org/10.1038/nature02856 [104] Halter D, Neumann S, van Dijk SM, Wolthoorn J, de Mazi /C18ere AM, Vieira OV, Mattjus P, Klumperman J, van Meer G, Sprong H. Pre- and post-Golgi translocation ofglucosylceramide in glycosphingolipid synthesis.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
J Cell Biol 2007; 179:101-15; PMID:17923531; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Phospholipid transfer proteins: mecha- nism of action J Bioenerg Biomembr 1986; 18:71-91; PMID:3522562; http://dx.doi.org/10.1007/BF00743477 [106] Hardie RC, Raghu P, Moore S, Juusola M, Baines RA, Sweeney ST. Calcium in ﬂux via TRP channels is required to maintain PtdIns(4,5) P2 levels in Drosophila photoreceptors.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Neuron 2001; 30:149-59;PMID:11343651; http://dx.doi.org/10.1016/S0896-6273 (01)00269-0 [107] Milligan SC, Alb JG, Elagina RB, Bankaitis VA, Hyde DR.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"J Cell Biol 1997; 139:351- 63; PMID:9334340; http://dx.doi.org/10.1083/ jcb.139.2.351 [108] Tilley SJ, Skippen A, Murray-Rust J, Swigart PM, Stew- art A, Morgan CP, Cockcroft S, McDonald NQ.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Biochem 2005; 44:14760-71; http://dx.doi.org/10.1021/bi051191r [110] Sha B, Phillips SE, Bankaitis VA, Luo M. Crystal struc- ture of the Saccharomyces cerevisiae phosphatidylinosi-tol- transfer protein.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Nature 1998; 391:506-10;PMID:9461221; http://dx.doi.org/10.1038/35179 [111] Ryan MM, Temple BRS, Phillips SE, Bankaitis VA. Con- formational Dynamics of the Major Yeast Phosphatidy-linositol Transfer Protein Sec14p: Insight into the Mechanisms of Phospholipid Exchange and Diseases of Sec14p-Like Protein De ﬁciencies.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"Mol Biol Cell 2007; 18:1928-42; PMID:17344474; http://dx.doi.org/10.1091/ mbc.E06-11-1024 [112] Schaaf G, Ortlund EA, Tyeryar KR, Mousley CJ, Ile KE, Garrett TA, Ren J, Woolls MJ, Raetz CR, Redinbo MR, et al.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
Mol Cell 2008; 29:191-206; PMID:18243114; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"2006; 173:107-19; PMID:16585271; http://dx.doi.org/ 10.1083/jcb.200510084 [114] Teuling E, Ahmed S, Haasdijk E, Demmers J, Stein- metz MO, Akhmanova A, Jaarsma D, Hoogenraad CC.",OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
J Neurosci2007; 27:9801-15; PMID:17804640; http://dx.doi.org/ 10.1523/JNEUROSCI.2661-07.2007e1156278-14 H. HARIRI ET AL.,OADS,/arxiv_data1/oa_pdf/7e/03/kcib-09-03-1156278.PMC4951168.pdf
"3, e1175696 (4 pages)http://dx.doi.org/10.1080/19420889.2016.1175696",Non-OADS,/arxiv_data1/oa_pdf/78/06/kcib-09-03-1175696.PMC4951169.pdf
"Cell 2010; 141:1117-34; PMID:20602996; http://dx.doi.org/10.1016/j.cell.2010.06.011 [2] Delos Santos RC, Garay C, Antonescu CN.",OADS,/arxiv_data1/oa_pdf/78/06/kcib-09-03-1175696.PMC4951169.pdf
"Cell Signal 2015; 27:1963-76; PMID:26163824;http://dx.doi.org/10.1016/j.cellsig.2015.07.004 [3] McMahon HT, Boucrot E. Molecular mechanism and physiological functions of clathrin-mediated endocytosis.",OADS,/arxiv_data1/oa_pdf/78/06/kcib-09-03-1175696.PMC4951169.pdf
"Nat Rev Mol Cell Biol 2011; 12:517-33; PMID:21779028;http://dx.doi.org/10.1038/nrm3151 [4] Aguet F, Antonescu CN, Mettlen M, Schmid SL, Danuser G. Advances in analysis of low signal-to-noise imageslink dynamin and AP2 to the functions of an endocytic checkpoint.",OADS,/arxiv_data1/oa_pdf/78/06/kcib-09-03-1175696.PMC4951169.pdf
"Dev Cell 2013; 26:279-91; PMID:23891661; http://dx.doi.org/10.1016/j.devcel.2013.06.019 [ 5 ] G a r a yC ,J u d g eG ,L u c a r e l l iS ,B a u t i s t aS ,P a n d e yR ,S i n g hT , Antonescu CN.",OADS,/arxiv_data1/oa_pdf/78/06/kcib-09-03-1175696.PMC4951169.pdf
"Mol Biol Cell 2015; 26:3504-19; PMID:26246598; http://dx.doi.org/10.1091/mbc.E14-09-1412 [6] Marcotte R, Zhou L, Kim H, Roskelly CD, Muller WJ.",OADS,/arxiv_data1/oa_pdf/78/06/kcib-09-03-1175696.PMC4951169.pdf
"Mol Cell Biol 2009; 29:5858-71; PMID: 19704002; http://dx.doi.org/10.1128/MCB.01731-08 [7] Muthuswamy SK, Gilman M, Brugge JS.",OADS,/arxiv_data1/oa_pdf/78/06/kcib-09-03-1175696.PMC4951169.pdf
Mol CellBiol 1999; 19:6845-57; PMID:10490623; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/78/06/kcib-09-03-1175696.PMC4951169.pdf
"Ther Adv Med Oncol 2011; 3:S7-S19; PMID:22128289; http://dx.doi.org/10.1177/1758834011422556 [9] Lock LS, Royal I, Naujokas MA, Park M. Identi ﬁcation of an atypical Grb2 carboxyl-terminal SH3 domain bindingsite in Gab docking proteins reveals Grb2-dependent and -independent recruitment of Gab1 to receptor tyrosinekinases.",Non-OADS,/arxiv_data1/oa_pdf/78/06/kcib-09-03-1175696.PMC4951169.pdf
"J Biol Chem 2000; 275:31536-45; PMID:10913131; http://dx.doi.org/10.1074/jbc.M003597200 [10] Lock LS, Frigault MM, Saucier C, Park M. Grb2-indepen- dent recruitment of Gab1 requires the C-terminal lobe and structural integrity of the Met receptor kinase domain.",Non-OADS,/arxiv_data1/oa_pdf/78/06/kcib-09-03-1175696.PMC4951169.pdf
"J Biol Chem 2003; 278:30083-90; PMID:12766170; http://dx.doi.org/10.1074/jbc.M302675200 [11] Li N, Lorinczi M, Ireton K, Elferink LA.",OADS,/arxiv_data1/oa_pdf/78/06/kcib-09-03-1175696.PMC4951169.pdf
"J Biol Chem 2007; 282:16764-75;PMID:17449471; http://dx.doi.org/10.1074/jbc.M610835200 [12] Petrelli A, Gilestro GF, Lanzardo S, Comoglio PM, Migone N, Giordano S. The endophilin-CIN85-Cbl com-plex mediates ligand-dependent downregulation of c- Met.",Non-OADS,/arxiv_data1/oa_pdf/78/06/kcib-09-03-1175696.PMC4951169.pdf
"J Biol Chem 2010;285:24956-67; PMID:20529867; http://dx.doi.org/ 10.1074/jbc.M110.127985 [15] Orth JD, Krueger EW, Weller SG, McNiven MA.",OADS,/arxiv_data1/oa_pdf/78/06/kcib-09-03-1175696.PMC4951169.pdf
"Cancer Res 2006; 66:3603-10; PMID:16585185; http://dx.doi.org/10.1158/0008-5472.CAN-05-2916 [16] Rajadurai CV, Havrylov S, Zaoui K, Vaillancourt R, Stui- ble M, Naujokas M, Zuo D, Tremblay ML, Park M. Metreceptor tyrosine kinase signals through a cortactin-Gab1scaffold complex, to mediate invadopodia.",Non-OADS,/arxiv_data1/oa_pdf/78/06/kcib-09-03-1175696.PMC4951169.pdf
"J Cell Sci 2012; 125:2940-53; PMID:22366451; http://dx.doi.org/ 10.1242/jcs.100834 [17] Williams KC, Coppolino MG. SNARE-dependent inter- action of Src, EGFR and b1 integrin regulates invadopo- dia formation and tumor cell invasion.",OADS,/arxiv_data1/oa_pdf/78/06/kcib-09-03-1175696.PMC4951169.pdf
J Cell Sci 2014;127:1712-25; PMID:24496451; http://dx.doi.org/10.1242/ jcs.134734e1175696-4 S. LUCARELLI ET AL.,OADS,/arxiv_data1/oa_pdf/78/06/kcib-09-03-1175696.PMC4951169.pdf
Dev Cell 2015; 33:644 –59; PMID:26051541; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
"3, e1125053 (5 pages)http://dx.doi.org/10.1080/19420889.2015.1125053",Non-OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
"J Cell Biol 2010;189:619-29; PMID:20457765; http://dx.doi.org/10.1083/ jcb.201003008 [2] Svitkina T, Lin WH, Webb DJ, Yasuda R, Wayman GA, Van Aelst L, Soderling SH.",OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
"J Neurosci 2010; 30:14937-42; PMID:21068295; http://dx.doi.org/10.1523/JNEUROSCI.4276-10.2010 [3] Saarikangas J, Kourdougli N, Senju Y, Chazal G, Segerstra /C14le M, Minkeviciene R, Kuurne J, Mattila PK, Garrett L, H €olter SM, et al.",OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
"Dev Cell 2015; 33:644-59; PMID:26051541; http://dx.doi.org/10.1016/j.devcel.2015.04.014 [4] Carlson BR, Lloyd KE, Kruszewski A, Kim IH, Rodriguiz RM, Heindel C, Faytell M, Dudek SM, Wetsel WC,Soderling SH.",OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
"J Neurosci 2011;31:2447-60; PMID:21325512; http://dx.doi.org/10.1523/JNEUROSCI.4433-10.2011 [5] Coutinho-Budd J, Ghukasyan V, Zylka MJ, Polleux F. The F-BAR domains from srGAP1, srGAP2 and srGAP3regulate membrane deformation differently.",OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
"J Cell Sci 2012; 125:3390-401; PMID:22467852; http://dx.doi.org/ 10.1242/jcs.098962 [6] Kessels MM, Qualmann B.",OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
"J Cell Sci 2015; 128:3177-85;PMID:26285709; http://dx.doi.org/10.1242/jcs.174193 [7] Carlson B, Soderling SH.",OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
"Dev Cell 2009; 17:307-9; PMID: 19758555; http://dx.doi.org/10.1016/j.devcel.2009.08.015 [8] Mattila PK, Pyk €al€ainen A, Saarikangas J, Paavilainen VO, Vihinen H, Jokitalo E, Lappalainen P. Missing-in-metas- tasis and IRSp53 deform PI(4,5)P2-rich membranes byan inverse BAR domain-like mechanism.",OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
"J Cell Biol 2007; 176:953-64; PMID:17371834; http://dx.doi.org/ 10.1083/jcb.200609176 [9] Saarikangas J, Zhao H, Pyk €al€ainen A, Laurinm €aki P, Mat- tila PK, Kinnunen PK, Butcher SJ, Lappalainen P.Molecular mechanisms of membrane deformation by I- BAR domain proteins.",OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
"Curr Biol 2009; 19:95-107; PMID:19150238; http://dx.doi.org/10.1016/j.cub.2008.12.029 [10] Galic M, Tsai FC, Collins SR, Matis M, Bandara S, Meyer T. Dynamic recruitment of the curvature-sensitive pro-tein ArhGAP44 to nanoscale membrane deformations limits exploratory ﬁlopodia initiation in neurons.",OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
"eLife 2014; 3:e03116; PMID:25498153; http://dx.doi.org/10.7554/eLife.03116 [11] Lohmann C, Bonhoeffer T. A role for local calcium sig- naling in rapid synaptic partner selection by dendritic ﬁlopodia.",OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
"Neuron 2008; 59:253-60; PMID:18667153; http://dx.doi.org/10.1016/j.neuron.2008.05.025 [12] Marrs GS, Green SH, Dailey ME.",OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
"Nat Neurosci 2001; 4:1006-13; PMID:11574832; http://dx.doi.org/10.1038/nn717 [13] Ziv NE, Smith SJ.",OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
"Neuron 1996;17:91-102; PMID:8755481; http://dx.doi.org/10.1016/ S0896-6273(00)80283-4 [14] Ketschek A, Gallo G. Nerve growth factor induces axonal ﬁlopodia through localized microdomains of phosphoi- nositide 3-kinase activity that drive the formation of cytoskeletal precursors to ﬁlopodia.",OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
"J Neurosci 2010; 30:12185-97; PMID:20826681; http://dx.doi.org/10.1523/ JNEUROSCI.1740-10.2010 [15] Menna E, Disanza A, Cagnoli C, Schenk U, Gelsomino G, Frittoli E, Hertzog M, Offenhauser N, Sawallisch C, Kreienkamp HJ, et al.",OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
PLoS Biol 2009; 7:e1000138;PMID:19564905; http://dx.doi.org/10.1371/journal.pbio.,Non-OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
"Mol Biol Cell 2010; 21:165-76; PMID:19889835; http://dx.doi.org/10.1091/mbc.E09-07-0596 [17] Portera-Cailliau C, Pan DT, Yuste R. Activity-regulated dynamic behavior of early dendritic protrusions: evi-dence for different types of dendritic ﬁlopodia.",OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
"Nat Neurosci 2005; 8:164-72; PMID:15665879; http://dx.doi.org/ 10.1038/nn1381 [19] Ueda Y, Hayashi Y. PIP(3) regulates spinule formation in dendritic spines during structural long-term potentiation.",OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
"J Neurosci 2013; 33:11040-7; PMID:23825409; http://dx.doi.org/10.1523/JNEUROSCI.3122-12.2013 [20] Luikart BW, Zhang W, Wayman GA, Kwon CH, West- brook GL, Parada LF.",Non-OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
Physiol Rev 2013; 93:1019-137; PMID:23899561; http://dx.doi.org/10.1152/physrev.00- 028.2012e1125053-4 P. HOTULAINEN AND J. SAARIKANGAS,OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
"Nature 2005; 438:605-11; PMID:16319880; http://dx.doi.org/10.1038/nature04398 [23] Dotti CG, Esteban JA, Ledesma MD.",OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
Front Neuroanatomy 2014; 8:76;PMID:25152717; http://dx.doi.org/10.3389/fnana.2014.,Non-OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
"Science 2010; 329:1341-5; PMID:20829485; http://dx.doi.org/10.1126/science.1191710 [25] Saarikangas J, Zhao H, Lappalainen P. Regulation of the actin cytoskeleton-plasma membrane interplay by phos- phoinositides.",OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
"Physiol Rev 2010; 90:259-89; PMID: 20086078; http://dx.doi.org/10.1152/physrev.000-36.2009 [26] Papayannopoulos V, Co C, Prehoda KE, Snapper S, Taunton J, Lim WA.",Non-OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
"Mol Cell 2005;17:181-91; PMID:15664188; http://dx.doi.org/10.1016/j.molcel.2004.11.054 [27] Zhao H, Hakala M, Lappalainen P. ADF/co ﬁlin binds phosphoinositides in a multivalent manner to act as aPIP(2)-density sensor.",OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
Biophys J 2010; 98:2327-36; PMID:20483342; http://dx.doi.org/10.1016/j.bpj.2010.,OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
Biophys J2011; 100:1261-70; PMID:21354399; http://dx.doi.org/ 10.1016/j.bpj.2011.01.025 [29] Brown DA.,OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
"Science 2006; 314:1458-61; PMID:17095657; http://dx.doi.org/10.1126/science.1134389[32] Zhao H, Michelot A, Koskela EV, Tkach V, Stamou D, Drubin DG, Lappalainen P. Membrane-sculpting BAR domains generate stable lipid microdomains.",OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
"Cell Rep2013; 4:1213-23; PMID:24055060; http://dx.doi.org/ 10.1016/j.celrep.2013.08.024 [33] Picas L, Viaud J, Schauer K, Vanni S, Hnia K, Fraisier V, Roux A, Bassereau P, Gaits-Iacovoni F, Payrastre B, et al.",OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
"NatCommun 2014; 5:5647; PMID:25487648; http://dx.doi.org/10.1038/ncomms6647 [34] Ramalingam N, Franke C, Jaschinski E, Winterhoff M, Lu Y, Br €uhmann S, Junemann A, Meier H, Noegel AA, Weber I, et al.",OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
"Nat Commun 2015; 6:8496; PMID:26415699; http://dx.doi.org/10.1038/ncomms9496 [35] Banjade S, Rosen MK.",Non-OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
"Phase transitions of multivalent proteins can promote clustering of membrane receptors.eLife 2014; 3:e04123; PMID:25321392; http://dx.doi.org/10.7554/eLife.04123 [36] Li P, Banjade S, Cheng HC, Kim S, Chen B, Guo L, Lla- guno M, Hollingsworth JV, King DS, Banani SF, et al.Phase transitions in the assembly of multivalent signal- ling proteins.",OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
Nature 2012; 483:336-40; PMID:22398450; http://dx.doi.org/10.1038/nature10879 [37] Lemmon MA.,Non-OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
"Small GTPases 2015; 6:49-70; PMID:25961466; http://dx.doi.org/10.4161/21541248.2014.973770 [39] Takano K, Toyooka K, Suetsugu S. EFC/F-BAR proteins and the N-WASP-WIP complex induce membrane cur- vature-dependent actin polymerization.",OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
"EMBO J 2008; 27:2817-28; PMID:18923421; http://dx.doi.org/10.1038/emboj.2008.216 [40] Gallop JL, Walrant A, Cantley LC, Kirschner MW.",OADS,/arxiv_data1/oa_pdf/97/a2/kcib-09-03-1125053.PMC4951170.pdf
"3, e1174799 (3 pages)http://dx.doi.org/10.1080/19420889.2016.1174799",Non-OADS,/arxiv_data1/oa_pdf/8a/9e/kcib-09-03-1174799.PMC4951172.pdf
"Behav Brain Res 2010; 208:282-5; PMID:19962405; http://dx.doi.org/10.1 016/j.bbr.2009.11.045 [2] Serruya D, Eilam D. Stereotypies, compulsions, and nor- mal behavior in the context of motor routines in the rock hyrax ( Procavia capensis ).",Non-OADS,/arxiv_data1/oa_pdf/8a/9e/kcib-09-03-1174799.PMC4951172.pdf
"ReligionBrain Behav 2011; 1:18-30; http://dx.doi.org/10.1080/2153599X.2010.550722 [4] Keren H, Boyer P, Mort J, Eilam D. Pragmatic and idio- syncratic acts in human everyday routines: The counter-part of compulsive rituals.",Non-OADS,/arxiv_data1/oa_pdf/8a/9e/kcib-09-03-1174799.PMC4951172.pdf
Behav Brain Res 2010; 212:90- 5; PMID:20363260; http://dx.doi.org/10.1016/j.bbr.2010.,OADS,/arxiv_data1/oa_pdf/8a/9e/kcib-09-03-1174799.PMC4951172.pdf
"Psychol Bull 1992; 112:218-38; PMID: 1454893; http://dx.doi.org/10.1037/0033-2909.112.2.218 [8] Zor R, Keren H, Hermesh H, Szechtman H, Mort J, Eilam D. Obsessive –compulsive disorder: a disorder of pessimal (non-functional) motor behavior.",Non-OADS,/arxiv_data1/oa_pdf/8a/9e/kcib-09-03-1174799.PMC4951172.pdf
Am Anthropol 2011; 113:40-55; http://dx.doi.org/10.1111/j.1548-1433.2010.01305.x [10] Malinowski B. Argonauts of the Western Paci ﬁc.,Non-OADS,/arxiv_data1/oa_pdf/8a/9e/kcib-09-03-1174799.PMC4951172.pdf
Behav Brain Sci 2006; 29:22- 3; http://dx.doi.org/10.1017/S0140525X0600937X [13] Fentress JC.,Non-OADS,/arxiv_data1/oa_pdf/8a/9e/kcib-09-03-1174799.PMC4951172.pdf
"Curr Biol 2015; 25:1892-7; PMID:26096971; http://dx.doi.org/10.1016/j.cub.2015.05.049 [15] Feldman PJ, Cohen S, Hamrick N, Lepore SJ.",OADS,/arxiv_data1/oa_pdf/8a/9e/kcib-09-03-1174799.PMC4951172.pdf
"Psychol Health 2004; 19:353-68; http://dx.doi.org/10.1080/0887044042000193497[16] HirshJB,MarRA,PetersonJB.Psychologicalentropy:aframe- work for understanding uncertainty-related anxiety.",Non-OADS,/arxiv_data1/oa_pdf/8a/9e/kcib-09-03-1174799.PMC4951172.pdf
Psychol Rev 2012; 119:304-20; PMID:22250757; http://dx.doi.org/10.1037/a0026767 [17] Friston K. The free-energy principle: a rough guide to the brain?,Non-OADS,/arxiv_data1/oa_pdf/8a/9e/kcib-09-03-1174799.PMC4951172.pdf
Trends Cogn Sci 2009; 13:293-301; PMID:19559644;http://dx.doi.org/10.1016/j.tics.2009.04.005 [18] Clark A.,OADS,/arxiv_data1/oa_pdf/8a/9e/kcib-09-03-1174799.PMC4951172.pdf
"Behav BrainSci 2013; 36:181-204; PMID:23663408; http://dx.doi.org/10.1017/S0140525X12000477 [19] Eysenck MW, Derakshan N, Santos R, Calvo MG. Anxi- ety and cognitive performance: Attentional control the-ory.",Non-OADS,/arxiv_data1/oa_pdf/8a/9e/kcib-09-03-1174799.PMC4951172.pdf
Annu Rev Psychol 2000; 51:59-91; PMID:10751965; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8a/9e/kcib-09-03-1174799.PMC4951172.pdf
"Psychology 2014; 5:1035-43; http://dx.doi.org/10.4236/psych.2014.59116 [22] Kass SJ, Cole KS, Stanny CJ.",Non-OADS,/arxiv_data1/oa_pdf/8a/9e/kcib-09-03-1174799.PMC4951172.pdf
"Transp Res Part F Traf ﬁc Psychol Behav 2007; 10:321-9; http://dx.doi.org/10.1016/j.trf.2006.12.002 [23] Nieuwenhuys A, Oudejans RRD.",Non-OADS,/arxiv_data1/oa_pdf/8a/9e/kcib-09-03-1174799.PMC4951172.pdf
Psychol Res 2012;76:747-59; PMID:22038472; http://dx.doi.org/10.1007/ s00426-011-0384-xCOMMUNICATIVE & INTEGRATIVE BIOLOGY e1174799-3,Non-OADS,/arxiv_data1/oa_pdf/8a/9e/kcib-09-03-1174799.PMC4951172.pdf
"3, e1166320 (14 pages)http://dx.doi.org/10.1080/19420889.2016.1166320",Non-OADS,/arxiv_data1/oa_pdf/cb/d6/kcib-09-03-1166320.PMC4951174.pdf
"J Neurobiol 1970; 2:1 –11; PMID:4333386; http://dx.doi.org/10.1002/neu.480020102 [5] Serway RA, Jewett JW Jr. Principles of Physics, 4th Ed., 2006.",Non-OADS,/arxiv_data1/oa_pdf/cb/d6/kcib-09-03-1166320.PMC4951174.pdf
"CommunIntegr Biol 2012 May1; 5(3):233 –9; http://dx.doi.org/ 10.4161/cib.19480 [8] Eisenstein EM, Eisenstein D, Smith, James C. The evolu- tionary signi ﬁcance of habituation and sensitization across phylogeny: A behavioral homeostasis model.",OADS,/arxiv_data1/oa_pdf/cb/d6/kcib-09-03-1166320.PMC4951174.pdf
Integ Physiol Behav Sci 2001; 36(4):251 –65; http://dx.doi.org/ 10.1007/BF02688794e1166320-12 E. M. EISENSTEIN ET AL.,OADS,/arxiv_data1/oa_pdf/cb/d6/kcib-09-03-1166320.PMC4951174.pdf
J Behav Biol 1974; 12(3):393 –407; http://dx.doi.org/10.1016/ S0091-6773(74)91601-0 [10] Clark KB.,OADS,/arxiv_data1/oa_pdf/cb/d6/kcib-09-03-1166320.PMC4951174.pdf
Biosystems 2010; 99(1):27 –41; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cb/d6/kcib-09-03-1166320.PMC4951174.pdf
"Beh Brain Res 1997; 82: 121 –32; http://dx.doi.org/10.1016/S0166-4328(97) 80982-5 [20] Eisenstein EM, Carlson AD, Harris JT.",OADS,/arxiv_data1/oa_pdf/cb/d6/kcib-09-03-1166320.PMC4951174.pdf
Integr Physiol Behav Sci 1997; 32(3):265 –71; http://dx.doi.org/10.1007/BF02688624 [21] Eisenstein EM.,Non-OADS,/arxiv_data1/oa_pdf/cb/d6/kcib-09-03-1166320.PMC4951174.pdf
Brain Res 1970; 21:143 –7; PMID:5433110; http://dx.doi.org/10.1016/0006-8993(70) 90031-4 [23] Eisenstein EM.,OADS,/arxiv_data1/oa_pdf/cb/d6/kcib-09-03-1166320.PMC4951174.pdf
J Exp Anal Behav 1958; 1(1):69 –72; http://dx.doi.org/ 10.1901/jeab.1958.1-69 [26] Horridge GA. Learning of leg position by the ventral nerve cord in headless insects.,Non-OADS,/arxiv_data1/oa_pdf/cb/d6/kcib-09-03-1166320.PMC4951174.pdf
"Proc Royal Soc B 1962;157: 33 –52; http://dx.doi.org/10.1098/rspb.1962.0061 [27] Eisenstein EM, Cohen MJ.",Non-OADS,/arxiv_data1/oa_pdf/cb/d6/kcib-09-03-1166320.PMC4951174.pdf
"Animal Behaviour 1965; 13(1): 104–8; http://dx.doi.org/10.1016/0003-3472(65)90079-5 [28] Reep RL, Eisenstein EM, Tweedle CD.",OADS,/arxiv_data1/oa_pdf/cb/d6/kcib-09-03-1166320.PMC4951174.pdf
Physiol Behav 1980; 24(3):501 –13; http://dx.doi.org/10.1016/ 0031-9384(80)90244-9 [29] Harris JT.,OADS,/arxiv_data1/oa_pdf/cb/d6/kcib-09-03-1166320.PMC4951174.pdf
"Behav Brain Res 1999; 103: 211 –7; PMID:10513589; http://dx.doi.org/10.1016/S0166-4328(99)00039-X [32] Perkel DH, Bullock TH.",Non-OADS,/arxiv_data1/oa_pdf/cb/d6/kcib-09-03-1166320.PMC4951174.pdf
"Elife 2014; 3:e03896; http://dx.doi.org/ 10.7554/eLife.03896 [34] Eisenstein EM, Kemeny G, Skurnick ID, Harris JT.",OADS,/arxiv_data1/oa_pdf/cb/d6/kcib-09-03-1166320.PMC4951174.pdf
"Brain Res 1970; 21:148 – 50; PMID:5433111; http://dx.doi.org/10.1016/0006-8993 (70)90032-6 [37] Crease RP, Mann CC.",OADS,/arxiv_data1/oa_pdf/cb/d6/kcib-09-03-1166320.PMC4951174.pdf
J Neural Eng 2011; 8(3):036004; http://dx.doi.org/10.1088/1741-2560/8/3/036004 [41] Reardon S. Disabled patients mind-meld with robots.,OADS,/arxiv_data1/oa_pdf/cb/d6/kcib-09-03-1166320.PMC4951174.pdf
"Front Microbiol 2014; 5:270; PMID:24966852;http://dx.doi.org/10 .3389/fmicb.2014.00270 [45] Spang A, Saw JH, Jergensen SL, Zavemba-Niedzwiedzka K, Martijn J, Lind AE, van Eijk R, Schieper C, Guy L,Ettema TJG.",OADS,/arxiv_data1/oa_pdf/cb/d6/kcib-09-03-1166320.PMC4951174.pdf
"Nature 2015; 521 (7551):173 –9; PMID:25945739; http://dx.doi.org/ 10.1038/nature/14447 [46] Baluska F, Mancuso S. Deep evolutionary origins of neurobiology.",Non-OADS,/arxiv_data1/oa_pdf/cb/d6/kcib-09-03-1166320.PMC4951174.pdf
Commun Integr Biol 2009 Jan-Feb; 2(1):60 –5; http://dx.doi.org/10.4161/cib.2.1.,OADS,/arxiv_data1/oa_pdf/cb/d6/kcib-09-03-1166320.PMC4951174.pdf
"3, e1174798 (16 pages)http://dx.doi.org/10.1080/19420889.2016.1174798",Non-OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Proc Natl Acad Sci U S A 2010; 107:20726-20731; PMID:21071675; http://dx.doi.org/ 10.1073/pnas.1007295107 [3] Vieira OV, Botelho RJ, Grinstein S. Phagosome matura- tion: aging gracefully.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Biochem J 2002; 366:689-704; PMID:12061891; http://dx.doi.org/10.1042/bj20020691 [4] Jeschke A, Zehethofer N, Lindner B, Krupp J, Schwudke D, Haneburger I, Jovic M, Backer JM, Balla T, Hilbi H, et al.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Trends Immunol 2012; 33:397-405; PMID:22560866; http://dx.doi.org/ 10.1016/j.it.2012.03.003 [6] Huotari J, Helenius A. Endosome maturation.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"EMBO J 2011; 30:3481-3500; PMID:21878991; http://dx.doi.org/ 10.1038/emboj.2011.286 [7] Kinchen JM, Ravichandran KS.",Non-OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Nature 2010; 464:778-782;PMID:20305638; http://dx.doi.org/10.1038/nature08853 [8] Poteryaev D, Datta S, Ackema K, Zerial M, Spang A. Identi ﬁcation of the switch in early-to-late endosome transition.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Cell 2010; 141:497-508; PMID:20434987;http://dx.doi.org/10.1016/j.cell.2010.03.011 [9] Nordmann M, Cabrera M, Perz A, Br €ocker C, Ostrowicz C, Engelbrecht-Vandr /C19e S, Ungermann C. The Mon1-Ccz1complex is the GEF of the late endosomal Rab7 homolog Ypt7.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Curr Biol 2010; 20:1654-1659; PMID:20797862; http://dx.doi.org/10.1016/j.cub.2010.08.002 [10] Alvarez-Dominguez C, Barbieri AM, Ber /C19on W, Wandinger-Ness A, Stahl PD.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"J Biol Chem 1996; 271:13834-13843; PMID:8662791; http://dx.doi.org/ 10.1074/jbc.271.23.13834 [11] Harrison RE, Bucci C, Vieira OV, Schroer TA, Grinstein S. Phagosomes fuse with late endosomes and/or lysosomes by extension of membrane protrusions along microtubules: role of Rab7 and RILP.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Mol Cell Biol2003; 23:6494-6506; PMID:12944476; http://dx.doi.org/ 10.1128/MCB.23.18.6494-6506.2003 [12] Hackam DJ, Rotstein OD, Zhang WJ, Demaurex N, Wood- side M, Tsai O, Grinstein S. Regulation of phagosomal acid- iﬁcation.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"J Biol Chem 1997; 272:29810-29820; PMID:9368053; http://dx.doi.org/10.1074/jbc.272.47.29810 [13] Flannagan RS, Jaumouill /C19e V, Grinstein S. The cell biol- ogy of phagocytosis.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Annu Rev Pathol 2012; 7:61-98;PMID:21910624; http://dx.doi.org/10.1146/annurev- pathol-011811-132445 [14] Geisow MJ, D ’Arcy Hart P, Young MR. Temporal changes of lysosome and phagosome pH during phago- lysosome formation in macrophages: studies by ﬂuores- cence spectroscopy.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"J Cell Biol 1981; 89:645-652;PMID:6166620; http://dx.doi.org/10.1083/jcb.89.3.645 [15] Vieira OV, Harrison RE, Scott CC, Stenmark H, Alexander D, Liu J, Gruenberg J, Schreiber AD, Grin-stein S. Acquisition of Hrs, an essential component ofphagosomal maturation, is impaired by mycobacteria.",Non-OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Mol Cell Biol 2004; 24:4593-4604; PMID:15121875; http://dx.doi.org/10.1128/MCB.24.10.4593-4604.2004 [16] Lu N, Shen Q, Mahoney TR, Liu X, Zhou Z.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Mol Biol Cell 2011;22:354-374; PMID:21148288; http://dx.doi.org/10.1091/ mbc.E10-09-0756 [17] Marion S, Hoffmann E, Holzer D, Le Clainche C, Martin M, Sachse M, Ganeva I, Mangeat P, Grif ﬁths G. Ezrin promotes actin assembly at the phagosome mem- brane and regulates phago-lysosomal fusion.",Non-OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Traf ﬁc 2011; 12:421-437; PMID:21210911; http://dx.doi.org/10.1111/j.1600-0854.2011.01158.x [18] Jahraus A, Egeberg M, Hinner B, Habermann A, Sackman E, Pralle A, Faulstich H, Rybin V, Defacque H,Grifﬁths G. ATP-dependent membrane assembly of F- actin facilitates membrane fusion.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Mol Biol Cell 2001; 12:155-170; PMID:11160830; http://dx.doi.org/10.1091/mbc.12.1.155 [19] Dayam RM, Saric A, Shilliday RE, Botelho RJ.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
Traf-ﬁc 2015; 16:1010-1026; PMID:26010303; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
J Clin Invest 2008; 118:2002-2011; PMID:18523652; http://dx.doi.org/10.1172/JCI35433e1174798-12 A. JESCHKE AND A. HAAS,Non-OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
Phys- iol Rev 2013; 93:69-106; PMID:23303906; http://dx.doi.org/10.1152/physrev.00002.2012 [22] Balla T. Phosphoinositides: tiny lipids with giant impact on cell regulation.,Non-OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Physiol Rev 2013; 93:1019-1137; PMID:23899561; http://dx.doi.org/10.1152/physrev.00028.2012 [23] Sasaki T, Takasuga S, Sasaki J, Kofuji S, Eguchi S, Yama- zaki M, Suzuki A. Mammalian phosphoinositide kinasesand phosphatases.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
Prog Lipid Res 2009; 48:307-343;PMID:19580826; http://dx.doi.org/10.1016/j.plipres.,OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Nat Chem Biol 2010; 6:507-513; PMID:20559318; http://dx.doi.org/10.1038/nchembio.390 [29] Carlton JG, Cullen PJ.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
Trends Cell Biol 2005; 15:540-547; PMID:16139503; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Exp Mol Med 2010; 42:1-11; PMID:19887898; http://dx.doi.org/10.3858/emm.2010.42.1.001 [31] Furutani M, Itoh T, Ijuin T, Tsujita K, Takenawa T. Thin layer chromatography-blotting, a novel methodfor the detection of phosphoinositides.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"J Biochem 2006;139:663-670; PMID:16672266; http://dx.doi.org/ 10.1093/jb/mvj076 [32] Purdy GE, Owens RM, Bennett L, Russell DG, Butcher BA.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Cell Microbiol 2005; 7:1627-1634; PMID:16207249; http://dx.doi.org/10.1111/j.1462- 5822.2005.00580.x [33] Sarkes D, Rameh LE.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Biochem J 2010;428:375-384; PMID:20370717; http://dx.doi.org/10.1042/BJ20100129 [34] Gillooly DJ, Morrow IC, Lindsay M, Gould R, Bryant NJ, Gaullier JM, Parton RG, Stenmark H. Localization of phos-phatidylinositol 3-phosphate in yeast and mammalian cells.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"J Cell Biol 2014;205:113-126; PMID:24711504; http://dx.doi.org/ 10.1083/jcb.201312072 [36] Kiefer S, Rogger J, Melone A, Mertz AC, Koryakina A, Hamburger M, K €uenzi P. Separation and detection of all phosphoinositide isomers by ESI-MS. J Pharm Biomed Anal 2010; 53:552-558; PMID:20399587; http://dx.doi.org/10.1016/j.jpba.2010.03.029 [37] Di Paolo G, De Camilli P. Phosphoinositides in cell regula- tion and membrane dynamics.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Nature 2006; 443:651-657; PMID:17035995; http://dx.doi.org/10.1038/nature05185 [38] Wenk MR, Lucast L, Paolo GD, Romanelli AJ, Suchy SF, Nussbaum RL, Cline GW, Shulman GI, McMurray W, Camilli PD.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Nat Biotechnol 2003; 21:813-817; PMID:12808461; http://dx.doi.org/10.1038/nbt837 [39] Idevall-Hagren O, De Camilli P. Detection and manipu- lation of phosphoinositides.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Biochim Biophys Acta 2015; 1851:736-745; PMID:25514766; http://dx.doi.org/ 10.1016/j.bbalip.2014.12.008 [40] Levin R, Grinstein S, Schlam D. Phosphoinositides in phagocytosis and macropinocytosis.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Mol Microbiol 2009; 71:1341-1352; PMID:19208094; http://dx.doi.org/10.1111/j.1365-2958.2009.06608.x [42] Pizarro-Cerda J, Kuhbacher A, Cossart P. Phosphoino- sitides and host-pathogen interactions.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"FEBS Lett 2001; 494:201-207; PMID:11311241; http://dx.doi.org/10.1016/S0014-5793 (01)02356-0 [44] Bakowski MA, Braun V, Lam GY, Yeung T, Heo WD, Meyer T, Finlay BB, Grinstein S, Brumell JH.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Cell Host Microbe 2010; 7:453-462; PMID: 20542249; http://dx.doi.org/10.1016/j.chom.2010.05.011 [45] Vergne I, Chua J, Lee HH, Lucas M, Belisle J, Deretic V. Mechanism of phagolysosome biogenesis block by via- ble Mycobacterium tuberculosis.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"PLoS One 2013; 8:e70514; PMID:23923000; http://dx.doi.org/10.1371/journal.pone.0070514 [47] Saikolappan S, Estrella J, Sasindran SJ, Khan A, Armi- tige LY, Jagannath C, Dhandayuthapani S. The fbpA/ sapM double knock out strain of Mycobacterium tuber-culosis is highly attenuated and immunogenic in macro- phages.",Non-OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
PLoS One 2012; 7:e36198; PMID:22574140; http://dx.doi.org/10.1371/journal.pone.0036198COMMUNICATIVE & INTEGRATIVE BIOLOGY e1174798-13,Non-OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Biochem J 2007; 406:13-18; PMID:17584180; http://dx.doi.org/10.1042/BJ20070670 [49] Singh R, Rao V, Shakila H, Gupta R, Khera A, Dhar N, Singh A, Koul A, Singh Y, Naseema M, et al.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Mol Microbiol 2003;50:751-762; PMID:14617138; http://dx.doi.org/10.1046/j.1365-2958.2003.03712.x [50] Toulabi L, Wu X, Cheng Y, Mao Y. Identi ﬁcation and struc- tural characterization of a Legionella phosphoinositidephosphatase.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"J Biol Chem 2013; 288:24518-24527; PMID: 23843460; http://dx.doi.org/10.1074/jbc.M113.474239 [51] Hsu F, Zhu W, Brennan L, Tao L, Luo ZQ, Mao Y.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"PLoS Biol 2012; 10:e1001245; PMID:22272187; http://dx.doi.org/10.1371/journal.pbio.1001245 [54] Chua J, Deretic V. Mycobacterium tuberculosis repro- grams waves of phosphatidylinositol 3-phosphate onphagosomal organelles.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
J Biol Chem 2004; 279:36982-36992; PMID:15210698; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"PLoS One 2015; 10: e0139957; PMID:26460749; http://dx.doi.org/10.1371/journal.pone.0139957 [57] Bohdanowicz M, Cos /C19ıo G, Backer JM, Grinstein S. Class I and class III phosphoinositide 3-kinases are required for actin polymerization that propels phagosomes.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"J Cell Biol 2000; 151:1353-1368; PMID:11134066;http://dx.doi.org/10.1083/jcb.151.7.1353 [59] Vanhaesebroeck B, Guillermet-Guibert J, Graupera M, Bilanges B.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Nat Rev Mol Cell Biol 2010; 11:329-341; PMID:20379207; http://dx.doi.org/10.1038/ nrm2882 [60] Vieira OV, Bucci C, Harrison RE, Trimble WS, Lanzetti L, Gruenberg J, Schreiber AD, Stahl PD, Grinstein S. Modulation of Rab5 and Rab7 recruitment to phago- somes by phosphatidylinositol 3-kinase.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Mol Cell Biol2003; 23:2501-2514; PMID:12640132; http://dx.doi.org/ 10.1128/MCB.23.7.2501-2514.2003 [61] Vieira OV, Botelho RJ, Rameh L, Brachmann SM, Matsuo T, Davidson HW, Schreiber A, Backer JM, Cantley LC, Grinstein S. Distinct roles of class I and class III phosphati- dylinositol 3-kinases in phagosome formation and matura-tion.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"J Cell Biol 2001; 154:631-644; PMID: 11489920; http://dx.doi.org/10.1083/jcb.200106049 [63] Siddhanta U, McIlroy J, Shah A, Zhang Y, Backer JM.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"J Cell Biol 1998; 143:1647-1659; PMID:9852157; http://dx.doi.org/ 10.1083/jcb.143.6.1647 [64] Thi EP, Lambertz U, Reiner NE.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Nat Cell Biol 2014; 16:1069-1079; PMID:25327288; http://dx.doi.org/10.1038/ncb3053 [66] Ronan B, Flamand O, Vescovi L, Dureuil C, Durand L, Fassy F, Bachelot MF, Lamberton A, Mathieu M, Ber- trand T, et al.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Bio- chem J 2014; 463:413-427; PMID:25177796; http://dx.doi.org/10.1042/BJ20140889 [68] Bojjireddy N, Botyanszki J, Hammond G, Creech D, Peterson R, Kemp DC, Snead M, Brown R, Morrison A, Wilson S, et al.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Pharmacological and genetic targetingof the PI4KA enzyme reveals its important role in main- taining plasma membrane phosphatidylinositol 4-phos- phate and phosphatidylinositol 4,5-bisphosphate levels.J Biol Chem 2014; 289:6120-6132; PMID:24415756; http://dx.doi.org/10.1074/jbc.M113.531426 [69] Knight ZA, Gonzalez B, Feldman ME, Zunder ER, Goldenberg DD, Williams O, Loewith R, Stokoe D, Balla A, Toth B, et al.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Cell 2006; 125:733-747; PMID:16647110; http://dx.doi.org/10.1016/j.cell.2006.03.035 [70] Kim GHE, Dayam RM, Prashar A, Terebiznik M, Botelho RJ.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
Traf- ﬁc 2014; 15:1143-1163; PMID:25041080; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
J Biol Chem1999; 274:21589-21597; PMID:10419465; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"J Chem Biol 2010; 3:157-163; PMID:21643420; http://dx.doi.org/10.1007/s12154- 010-0041-7 [75] Pirruccello M, Nandez R, Idevall-Hagren O, Alcazar- Roman A, Abriola L, Berwick SA, Lucast L, Morel D, De Camilli P. Identi ﬁcation of inhibitors of inositol 5- phosphatases through multiple screening strategies.ACS Chem Biol 2014; 9:1359-1368; PMID:24742366; http://dx.doi.org/10.1021/cb500161z [76] Suwa A, Yamamoto T, Sawada A, Minoura K, Hosogai N, Tahara A, Kurama T, Shimokawa T, Aramori I. Dis- covery and functional characterization of a novel small molecule inhibitor of the intracellular phosphatase,SHIP2.",Non-OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Br J Pharmacol 2009; 158:879-887;PMID:19694723; http://dx.doi.org/10.1111/j.1476- 5381.2009.00358.x [77] Hazeki K, Nigorikawa K, Takaba Y, Segawa T, Nukuda A, Masuda A, Ishikawa Y, Kubota K, Takasuga S, Hazeki O.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"FEBS Lett 2012; 586:4010-4015; PMID:23068606; http://dx.doi.org/10.1016/j.febslet.2012.09.043 [78] Bohdanowicz M, Balkin DM, De Camilli P, Grinstein S. Recruitment of OCRL and Inpp5B to phagosomes byRab5 and APPL1 depletes phosphoinositides and attenuates Akt signaling.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Mol Biol Cell 2012; 23:176- 187; PMID:22072788; http://dx.doi.org/10.1091/mbc.E11-06-0489 [79] Endemann GC, Graziani A, Cantley LC.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Biochem J 1991; 273:63-66; PMID:1846531; http://dx.doi.org/10.1042/bj2730063 [80] Kamen LA, Levinsohn J, Cadwallader A, Tridandapani S, Swanson JA.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"J Immunol 2008; 180:7497-7505; PMID:18490750; http://dx.doi.org/10.4049/jimmunol.180.11.7497 [81] Ma J, Becker C, Reyes C, Underhill DM.",Non-OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
J Immunol 2014; 192:1356-1360; PMID:24442442; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Biochim Biophys Acta 2014; 1841:1085-1096; PMID:24713581; http://dx.doi.org/10.1016/j.bbalip.2014.03.012 [83] Ozaki S, DeWald DB, Shope JC, Chen J, Prestwich GD.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Nat Chem Biol 2010; 6:324-326; PMID:20364126; http://dx.doi.org/10.1038/nchembio.348 [85] Raiborg C, Schink KO, Stenmark H. Class III phosphati- dylinositol 3-kinase and its catalytic product PtdIns3Pin regulation of endocytic membrane traf ﬁc.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
FEBS J 2013; 280:2730-2742; PMID:23289851; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Mol Cell 2015; 57:219-234; PMID: 25578879; http://dx.doi.org/10.1016/j.molcel.2014.12.007 [88] Block MR, Glick BS, Wilcox CA, Wieland FT, Rothman JE.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Cell 1996; 85:83-94;PMID:8620540; http://dx.doi.org/10.1016/S0092-8674 (00)81084-3 [90] Weber T, Zemelman BV, McNew JA, Westermann B, Gmachl M, Parlati F, S €ollner TH, Rothman JE.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Cell 1998; 92:759-772; PMID:9529252; http://dx.doi.org/10.1016/S0092-8674(00)81404-X [91] Becken U, Haas A.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
J Cell Biol 2004; 167:1087-1098;PMID:15611334; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
Mol Biol Cell 2000; 11:807-817; PMID:10712501; http://dx.doi.org/ 10.1091/mbc.11.3.807COMMUNICATIVE & INTEGRATIVE BIOLOGY e1174798-15,Non-OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Mol Biol Cell 2011; 22:216-229;http://dx.doi.org/10.1091/mbc.E10-04-0317 [96] Petiot A, Faure J, Stenmark H, Gruenberg J. PI3P signaling regulates receptor sorting but not transport in the endoso-mal pathway.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"J Cell Biol 2003; 162:971-979; PMID:12975344; http://dx.doi.org/10.1083/jcb.200303018 [97] Mills IG, Jones AT, Clague MJ.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"FEBS J 2006;273:4959-4971; PMID:17018057; http://dx.doi.org/ 10.1111/j.1742-4658.2006.05494.x [99] Stroupe C, Collins KM, Fratti RA, Wickner W. Puri ﬁca- tion of active HOPS complex reveals its af ﬁnities for phosphoinositides and the SNARE Vam7p.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"EMBO J 2006; 25:1579-1589; PMID:16601699; http://dx.doi.org/ 10.1038/sj.emboj.7601051 [100] Pankiv S, Alemu EA, Brech A, Bruun JA, Lamark T, Overvatn A, Bjørkøy G, Johansen T. FYCO1 is a Rab7 effector that binds to LC3 and PI3P to mediate microtu-bule plus end-directed vesicle transport.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"J Cell Biol 2010; 188:253-269; PMID:20100911; http://dx.doi.org/ 10.1083/jcb.200907015 [101] Dai S, Zhang Y, Weimbs T, Yaffe MB, Zhou D. Bacteria- generated PtdIns(3)P recruits VAMP8 to facilitate phago- cytosis.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Traf ﬁc 2007; 8:1365-1374; PMID:17645435; http://dx.doi.org/10.1111/j.1600-0854.2007.00613.x [102] Jovic M, Kean MJ, Szentpetery Z, Polevoy G, Gingras AC, Brill JA, Balla T. Two phosphatidylinositol 4-kin- ases control lysosomal delivery of the Gaucher diseaseenzyme, b –glucocerebrosidase.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Mol Biol Cell 2012; 23:1533-1545; PMID:22337770; http://dx.doi.org/ 10.1091/mbc.E11-06-0553 [103] Sridhar S, Patel B, Ap hkhazava D, Macian F, Santambrogio L, Shields D, Cuervo AM.",Non-OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"EMBO J 2013; 32:324-339;PMID:23258225; http://dx.doi.org/10.1038/emboj.2012.341 [104] Defacque H, Bos E, Garvalov B, Barret C, Roy C, Mangeat P, Shin HW, Rybin V, Grif ﬁths G. Phosphoinos itides regulate membrane-dependent actin assembly by latex bead phago-somes.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Mol Biol Cell 2002; 13:1190-1202; PMID:11950931; http://dx.doi.org/10.1091/mbc.01-06-0314 [105] Wickner W. Membrane fusion: ﬁve lipids, four SNAREs, three chaperones, two nucleotides, and a Rab, all dancing in a ring on yeast vacuoles.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Annu Rev Cell Dev Biol 2010; 26:115-136; PMID:20521906; http://dx.doi.org/10.1146/annurev-cellbio-100109-104131[106] Bennett TL, Kraft SM, Reaves BJ, Mima J, O ’Brien KM, Starai VJ.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"PLoS One 2013; 8:e56798; PMID:23437241; http://dx.doi.org/10.1371/ journal.pone.0056798 [107] Sreelatha A, Bennett TL, Carpinone EM, O ’Brien KM, Jordan KD, Burdette DL, Orth K, Starai VJ.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Proc Natl Acad Sci U S A 2015;112:100-105; PMID:25453092; http://dx.doi.org/ 10.1073/pnas.1413764111 [108] Ellson CD, Anderson KE, Morgan G, Chilvers ER, Lipp P, Stephens LR, Hawkins PT.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Curr Biol 2001; 11:1631-1635; PMID:11676926; http://dx.doi.org/10.1016/S0960-9822(01)00447-X [109] Christoforidis S, McBride HM, Burgoyne RD, Zerial M. The Rab5 effector EEA1 is a core component of endo-some docking.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Nature 1999; 397:621-625; PMID:10050856; http://dx.doi.org/10.1038/17618 [110] Lawe DC, Chawla A, Merithew E, Dumas J, Carrington W, Fogarty K, Lifshitz L, Tuft R, Lambright D, CorveraS.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"J Biol Chem 2002;277:8611-8617; PMID:11602609; http://dx.doi.org/ 10.1074/jbc.M109239200 [111] Nielsen E, Christoforidis S, Uttenweiler-Joseph S, Miac- z y n s k aM ,D e w i t t eF ,W i l mM ,H o ﬂack B, Zerial M. Rabenosyn-5, a novel Rab5 effector, is complexed with hVPS45 and recruited to endosomes through a FYVEﬁnger domain.",Non-OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"J Cell Biol 151:601-612; PMID:11062261; http://dx.doi.org/10.1083/jcb.151.3.601 [112] Pizarro-Cerd /C19a J, Payrastre B, Wang YJ, Veiga E, Yin HL, Cossart P. Type II phosphatidylinositol 4-kinases pro- mote Listeria monocytogenes entry into target cells.",Non-OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"Cell Microbiol 2007; 9:2381-2390; http://dx.doi.org/10.1111/ j.1462-5822.2007.00967.x [113] Shin HW, Hayashi M, Christoforidis S, Lacas-Gervais S, Hoepfner S, Wenk MR, Modregger J, Uttenweiler- Joseph S, Wilm M, Nystuen A, et al.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"J Cell Biol 2005; 170:607-618; PMID:16103228; http://dx.doi.org/ 10.1083/jcb.200505128 [114] Segawa T, Hazeki K, Nigorikawa K, Morioka S, Guo Y ,T a k a s u g aS ,A s a n u m aK ,H a z e k iO .I n p p 5 e increases the Rab5 association and phosphatidylino-sitol 3-phosphate accumulation at the phagosome through an interaction with Rab20.",OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
Biochem J 2014; 464:365-375; PMID:252699 36; http://dx.doi.org/ 10.1042/BJ20140916e1174798-16 A. JESCHKE AND A. HAAS,OADS,/arxiv_data1/oa_pdf/ec/9c/kcib-09-03-1174798.PMC4951175.pdf
"3, e1178431 (3 pages)http://dx.doi.org/10.1080/19420889.2016.1178431",Non-OADS,/arxiv_data1/oa_pdf/a1/23/kcib-09-03-1178431.PMC4951176.pdf
Annu Rev Ecol Syst 1977; 8:407-27;http://dx.doi.org/10.1146/annurev.es.08.110177.002203 [2] Koptur S. Extra ﬂoral nectary-mediated interactions between insects and plants.,OADS,/arxiv_data1/oa_pdf/a1/23/kcib-09-03-1178431.PMC4951176.pdf
"Ann Bot 2013; 111:1251-61; PMID:23087129; http://dx.doi.org/10.1093/aob/mcs225 [4] Heil M. Extra ﬂoral nectar at the plant-insect interface: a spotlight on chemical ecology, phenotypic plasticity, andfood webs.",OADS,/arxiv_data1/oa_pdf/a1/23/kcib-09-03-1178431.PMC4951176.pdf
Annu Rev Entomol 2015; 60:213-32; PMID:25564741; http://dx.doi.org/10.1146/annurev-ento- 010814-020753 [5] Heil M. Indirect defence via tritrophic interactions.,Non-OADS,/arxiv_data1/oa_pdf/a1/23/kcib-09-03-1178431.PMC4951176.pdf
New Phytol 2008; 178:41-61; PMID:18086230; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a1/23/kcib-09-03-1178431.PMC4951176.pdf
JTrop Ecol 2004; 20:201-8; http://dx.doi.org/10.1017/ S026646740300110X [8] Bronstein JL.,OADS,/arxiv_data1/oa_pdf/a1/23/kcib-09-03-1178431.PMC4951176.pdf
"J Trop Ecol 2004; 20:201-8; http://dx.doi.org/10.1017/S026646740300110X [11] Gish M, Mescher MC, De Moraes CM.",OADS,/arxiv_data1/oa_pdf/a1/23/kcib-09-03-1178431.PMC4951176.pdf
Proc R Soc London Ser B Biol Sci 2015; 282:20151835; PMID:26446809; http://dx.doi.org/ 10.1098/rspb.2015.1835 [12] Elias TS.,OADS,/arxiv_data1/oa_pdf/a1/23/kcib-09-03-1178431.PMC4951176.pdf
"Can J Bot 1988; 66:1435-48; http://dx.doi.org/10.1139/b88-198 [14] Melo Y, Machado SR, Alves M. Anatomy of extra ﬂoral nectaries in Fabaceae from dry-seasonal forest in Brazil.e1178431-2 M. GISH ET AL.",OADS,/arxiv_data1/oa_pdf/a1/23/kcib-09-03-1178431.PMC4951176.pdf
"Bot J Linn Soc 2010; 163:87-98; http://dx.doi.org/ 10.1111/j.1095-8339.2010.01047.x [15] Turner GW, Lersten NR.",OADS,/arxiv_data1/oa_pdf/a1/23/kcib-09-03-1178431.PMC4951176.pdf
"Am J Bot 1983; 70:475-80; http://dx.doi.org/10.2307/2443158 [16] Hanley ME, Lamont BB, Fairbanks MM, Rafferty CM.",Non-OADS,/arxiv_data1/oa_pdf/a1/23/kcib-09-03-1178431.PMC4951176.pdf
"Perspect Plant Ecol Evol Syst 2007; 8:157-78; http://dx.doi.org/10.1016/j.ppees.2007.01.001 [17] Clissold FJ, Sanson GD, Read J, Simpson SJ.",OADS,/arxiv_data1/oa_pdf/a1/23/kcib-09-03-1178431.PMC4951176.pdf
"Ecology 2009; 90:3393-405; PMID: 20120808; http://dx.doi.org/10.1890/09-0130.1 [18] Elias TS, Gelband H. Morphology, anatomy, and rela- tionship of extra ﬂoral nectaries and hydathodes in two species of Impatiens (Balsaminaceae).",OADS,/arxiv_data1/oa_pdf/a1/23/kcib-09-03-1178431.PMC4951176.pdf
"Bot Gaz 1977;138:206-12; http://dx.doi.org/10.1086/336916 [19] Machado SR, Morellato LPC, Sajo MG, Oliveira PS.",OADS,/arxiv_data1/oa_pdf/a1/23/kcib-09-03-1178431.PMC4951176.pdf
"Plant Biol 2008; 10:660-73; PMID:18761504; http://dx.doi.org/10.1111/ j.1438-8677.2008.00068.x [20] Gon ¸calves-Souza P, Gon ¸calves EG, Paiva EAS.",OADS,/arxiv_data1/oa_pdf/a1/23/kcib-09-03-1178431.PMC4951176.pdf
Bot J Linn Soc 2016; 180:229 –40; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a1/23/kcib-09-03-1178431.PMC4951176.pdf
Flora 2007; 202:455-61; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a1/23/kcib-09-03-1178431.PMC4951176.pdf
"ﬂora.2006.11.001 [22] Elias TS, Rozich WR, Newcombe L. The foliar and ﬂoral nectaries of Turnera ulmifolia L. Am J Bot 1975; 62:570- 6; http://dx.doi.org/10.2307/2441934 [23] Boughton VH.",Non-OADS,/arxiv_data1/oa_pdf/a1/23/kcib-09-03-1178431.PMC4951176.pdf
"Am J Bot 1982; 69:1420-8; http://dx.doi.org/10.2307/2443103[25] Rocha DI, da Silva LC, Valente VMM, Francino DMT, Meira RMSA.",OADS,/arxiv_data1/oa_pdf/a1/23/kcib-09-03-1178431.PMC4951176.pdf
"Annu Rev Plant Biol 2005; 56:41-71; PMID:15862089; http://dx.doi.org/10.1146/annurev.arplant.56.032604.144106 [30] Cot /C19e GG, Gibernau M. Distribution of calcium oxalate crystals in ﬂoral organs of Araceae in relation to pollina- tion strategy.",OADS,/arxiv_data1/oa_pdf/a1/23/kcib-09-03-1178431.PMC4951176.pdf
Am J Bot 2012; 99:1231-42; PMID:22753813;http://dx.doi.org/10.3732/ajb.1100499 [31] Hochuli DF.,OADS,/arxiv_data1/oa_pdf/a1/23/kcib-09-03-1178431.PMC4951176.pdf
Oikos 1996; 75:133-41; http://dx.doi.org/ 10.2307/3546331 [32] Neville AC.,Non-OADS,/arxiv_data1/oa_pdf/a1/23/kcib-09-03-1178431.PMC4951176.pdf
Am J Phys Anthropol 1998; 107:297-304; PMID:9821494; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a1/23/kcib-09-03-1178431.PMC4951176.pdf
"Ann Bot 2008; 102:653-6; PMID:18697757;http://dx.doi.org/10.1093/aob/mcn130 [35] Lambers H, Chapain FS, Thijs PL.",OADS,/arxiv_data1/oa_pdf/a1/23/kcib-09-03-1178431.PMC4951176.pdf
"1, e1187349 (16 pages)http://dx.doi.org/10.1080/19381980.2016.1187349",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
Two ongoing trials (VITAL 74and DO-HEALTH (http://do-health.eu/wordpress/)) test 2000 IU vitaminDERMATO-ENDOCRINOLOGY e1187349-5,Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Mayo Clinic Proc 2013; 88:720-55; PMID:23790560; http://dx.doi.org/10.1016/j.mayocp.2013.05.011 [2] Pludowski P, Holick MF, Pilz S, Wagner CL, Hollis BW, Grant WB, Shoenfeld Y, Lerchbaum E, Llewellyn DJ,Kienreich K, et al.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
12:976-89; PMID:23542507; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Diabetes Care 2013; 36:1422-8;PMID:23613602; http://dx.doi.org/10.2337/dc12-0962 [4] Wang L, Song Y, Manson JE, Pilz S, Marz W, Michaels- son K, Lundqvist A, Jassal SK, Barrett-Connor E, ZhangC, et al.",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Circ Cardiovasc Qual Outcomes 2012; 5:819-29; PMID:23149428; http://dx.doi.org/10.1161/CIRCOUTCOMES.112.967604 [5] Garland CF, Gorham ED, Mohr SB, Garland FC.",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Ann Epidemiol 2009; 19:468-83; PMID:19523595; http://dx.doi.org/10.1016/j.annepidem.2009.03.021 [6] Moukayed M, Grant WB.",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Nutrients 2013; 5:3993-4021;PMID:24084056; http://dx.doi.org/10.3390/nu5103993 [7] Mann EH, Chambers ES, Pfeffer PE, Hawrylowicz CM.",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Ann N Y Acad Sci 2014; 1317:57-69; PMID:24738964; http://dx.doi.org/10.1111/nyas.12410 [8] Littlejohns TJ, Henley WE, Lang IA, Annweiler C, Beauchet O, Chaves PH, Fried L, Kestenbaum BR,Kuller LH, Langa KM, et al.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Neurology 2014;83:920-8; PMID:25098535; http://dx.doi.org/10.1212/ WNL.0000000000000755 [9] Cannell JJ, Grant WB.",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Dermatoendocrinology 2013; 5:199-204;PMID:24494055; http://dx.doi.org/10.4161/derm.24356 [10] Agmon-Levin N, Theodor E, Segal RM, Shoenfeld Y. Vitamin D in systemic and organ-speci ﬁc autoimmune diseases.",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Clin Rev Allergy Immunol 2013; 45:256-66;PMID:23238772; http://dx.doi.org/10.1007/s12016-012- 8342-y [11] Wagner CL, Baggerly C, McDonnell SL, Baggerly L, Hamilton SA, Winkler J, Warner G, Rodriguez C, SharyJR, Smith PG, et al.",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"J Steroid Biochem Mol Biol2015:148:256-60; PMID:25448734; http://dx.doi.org/ 10.1016/j.jsbmb.2014.11.013 [12] Cannell JJ, Hollis BW, Zasloff M, Heaney RP.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
Expert Opin Pharmacother 2008; 9:107-18; PMID:18076342; http://dx.doi.org/10.1517/14656566.9.1.107 [13] Hujoel PP.,Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"NutrRev 2013; 71:88-97; PMID:23356636; http://dx.doi.org/ 10.1111/j.1753-4887.2012.00544.x[14] Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC,Gallo RL, Jones G, et al.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"JClin Endocrinol Metab 2011; 96:53-8; PMID:21118827;http://dx.doi.org/10.1210/jc.2010-2704 [15] Manson JE, Bassuk SS, Lee IM, Cook NR, Albert MA, Gordon D, Zaharris E, Macfadyen JG, Danielson E, Lin J,et al.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Contemp Clin Trials 2012; 33:159-71; PMID:21986389;http://dx.doi.org/10.1016/j.cct.2011.09.009 [16] Stolzenberg-Solomon RZ, Vieth R, Azad A, Pietinen P, Taylor PR, Virtamo J, Albanes D. A prospective nestedcase-control study of vitamin D status and pancreaticcancer risk in male smokers.",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Cancer Res 2006;66:10213-9; PMID:17047087; http://dx.doi.org/10.1158/0008-5472.CAN-06-1876 [17] Stolzenberg-Solomon RZ, Hayes RB, Horst RL, Ander- son KE, Hollis BW, Silverman DT.",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Cancer Res 2009;69:1439-47; PMID:19208842; http://dx.doi.org/10.1158/0008-5472.CAN-08-2694 [18] Bao Y, Ng K, Wolpin BM, Michaud DS, Giovannucci E, Fuchs CS.",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Cancer Epidemiol Biomarkers Prev 2012; 21:82-91; http://dx.doi.org/10.1158/1055-9965.EPI-11-0836 [20] Kroll MH, Bi C, Garber CC, Kaufman HW, Liu D, Caston-Balderrama A, Zhang K, Clarke N, Xie M, Reitz RE, et al.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"PloSone 2015; 10:e0118108; PMID:25738588; http://dx.doi.org/10.1371/journal.pone.0118108 [21] Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G, Stattin P, Harvei S, Hakulinen T,Luostarinen T, et al.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
Int J Cancer 2004; 108:104-8;PMID:14618623; http://dx.doi.org/10.1002/ijc.11375 [22] Grant WB.,Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
Effect of interval between serum draw and follow-up period on relative risk of cancer incidencewith respect to 25-hydroxyvitamin D level: Implicationsfor meta-analyses and setting vitamin D guidelines.Dermatoendocrinol 2011; 3:199-204; PMID:22110780; http://dx.doi.org/10.4161/derm.15364DERMATO-ENDOCRINOLOGY e1187349-11,Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Serum 25-hydroxy vitamin D andprostate cancer risk in a large nested case-control study.Cancer Epidemiol Biomarkers Prev 2011; 20:1850-60;http://dx.doi.org/10.1158/1055-9965.EPI-11-0403 [24] Brandstedt J, Almquist M, Manjer J, Malm J. Vitamin D, PTH, and calcium and the risk of prostate cancer: a prospective nested case-control study.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Cancer Causes Control 2012; 23:1377-85; http://dx.doi.org/10.1007/s10552-012-9948-3 [25] Meyer HE, Robsahm TE, Bjorge T, Brustad M, Blomhoff R. Vitamin D, season, and risk of prostate cancer: a nestedcase-control study within Norwegian health studies.",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Am JClin Nutr 2013; 97:147-54; PMID:23193007; http://dx.doi.org/10.3945/ajcn.112.039222 [26] Kristal AR, Till C, Song X, Tangen CM, Goodman PJ, Neuhauser ML, Schenk JM, Thompson IM, MeyskensFL, Jr., Goodman GE, et al.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Cancer Epidemiol Bio-markers Prev 2014; 23:1494-504; http://dx.doi.org/10.1158/1055-9965.EPI-14-0115 [27] Deschasaux M, Souberbielle JC, Latino-Martel P, Sut- ton A, Charnaux N, Druesne-Pecollo N, Galan P, Hercberg S, Le Clerc S, Kesse-Guyot E, et al.",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Br J Nutr 2016; 115(2):305-14; PMID: 26568368; http://dx.doi.org/10.1017/S0007114515004353 [28] Xu Y, Shao X, Yao Y, Xu L, Chang L, Jiang Z, Lin Z.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"J Cancer Res Clin Oncol2014; 140:1465-77; PMID:24838848; http://dx.doi.org/10.1007/s00432-014-1706-3 [29] Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010.",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"CA Cancer J Clin 2010; 60:277-300; PMID:20610543;http://dx.doi.org/10.3322/caac.20073 [30] Bouchardy C, Fioretta G, Rapiti E, Verkooijen HM, Rapin CH, Schmidlin F, Miralbell R, Zanetti R. Recent trends in prostate cancer mortality show a continuousdecrease in several countries.",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Int J Cancer 2008;123:421-9; PMID:18452171; http://dx.doi.org/10.1002/ijc.23520 [31] Shui IM, Mucci LA, Kraft P, Tamimi RM, Lindstrom S, Penney KL, Nimptsch K, Hollis BW, Dupre N, PlatzEA, et al.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"J Natl Cancer Inst 2012;104:690-9; PMID:22499501; http://dx.doi.org/10.1093/jnci/djs189 [32] Mondul AM, Weinstein SJ, Moy KA, M €annist €oS , Albanes D. Circulating 25-Hydroxyvitamin D and Pros-tate Cancer Survival.",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
Cancer Epidemiol BiomarkersPrev 2016; 25(4); 665-9; PMID: 26809275; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Int J Cancer 2012; 131:1187-96;PMID:22033893; http://dx.doi.org/10.1002/ijc.27327 [35] Murphy AB, Nyame Y, Martin IK, Catalona WJ, Hollowell CM, Nadler RB, Kozlowski JM, Perry KT, Kajdacsy-Balla A, Kittles R. Vitamin D de ﬁciency pre- dicts prostate biopsy outcomes.",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Clin Cancer Res 2014;20:2289-99; PMID:24789033; http://dx.doi.org/10.1158/1078-0432.CCR-13-3085 [36] Gilbert R, Bonilla C, Metcalfe C, Lewis S, Evans DM, Fraser WD, Kemp JP, Donovan JL, Hamdy FC, NealDE, et al.",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Cancer Causes Control 2015; 26:205-18; http://dx.doi.org/10.1007/s10552-014-0500-5 [37] Schenk JM, Till CA, Tangen CM, Goodman PJ, Song X, Torkko KC, Kristal AR, Peters U, Neuhouser ML.",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Cancer Epidemiol Biomarkers Prev 2014; 23:1484- 93; http://dx.doi.org/10.1158/1055-9965.EPI-13-1340 [38] Hill G, Connelly J, Hebert R, Lindsay J, Millar W. Ney- man’s bias re-visited.",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"J Clin Epidemiol 2003; 56:293-6; PMID:12767404; http://dx.doi.org/10.1016/S0895-4356(02)00571-1 [39] Travis RC, Crowe FL, Allen NE, Appleby PN, Roddam AW, Tjonneland A, Olsen A, Linseisen J, Kaaks R, Boe-ing H, et al.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Am J Epidemiol 2009; 169:1223-32;PMID:19359375; http://dx.doi.org/10.1093/aje/kwp022 [40] Michaelsson K, Baron JA, Snellman G, Gedeborg R, Byberg L, Sundstrom J, Berglund L, Arnlov J, HellmanP, Blomhoff R, et al.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Am J Clin Nutr 2010; 92:841-8; PMID:20720256; http://dx.doi.org/10.3945/ajcn.2010.29749 [41] Jorde R, Figenschau Y, Hutchinson M, Emaus N, Grimnes G. High serum 25-hydroxyvitamin D concentrations areassociated with a favorable serum lipid pro ﬁle.",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
Eur J Clin Nutr 2010; 64:1457-64; PMID:20823896; http://dx.doi.org/10.1038/ejcn.2010.176 [42] Grant WB.,Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"J Clin Endocrinol Metab 2013;98:2160-7; PMID:23533239; http://dx.doi.org/10.1210/ jc.2013-1185 [44] Durup D, Jorgensen HL, Christensen J, Tjonneland A, O l s e nA ,H a l k j a e rJ ,L i n dB ,H e e g a a r dA M ,S c h w a r zP .AReverse J-Shaped Association Between Serum 25-Hydroxy-vitamin D and Cardiovascular Disease Mortality: TheCopD Study.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"J Clin Endocrinol Metab 2015; 100:2339-46;PMID:25710567; http://dx.doi.org/10.1210/jc.2014-4551 [45] Zittermann A, Kuhn J, Dreier J, Knabbe C, Gummert JF, Borgermann J. Vitamin D status and the risk of major adverse cardiac and cerebrovascular events in cardiacsurgery.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Eur Heart J 2013; 34:1358-64; PMID:23315905;http://dx.doi.org/10.1093/eurheartj/ehs468 [46] Vimaleswaran KS, Cavadino A, Berry DJ, LifeLines Cohort Study i, Jorde R, Dieffenbach AK, Lu C, AlvesAC, Heerspink HJ, Tikkanen E, et al.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Lancet Diabetes Endocrinol 2014; 2:719-29; PMID:24974252;http://dx.doi.org/10.1016/S2213-8587(14)70113-5 [47] Zittermann A, Kuhn J, Ernst JB, Becker T, Dreier J, Knabbe C, Gummert JF, Borgermann J. Twenty- ﬁve- hydroxyvitamin D, 1,25-dihydroxyvitamin D and post-operative outcome in cardiac surgery.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
J Clin EndocrinolMetab 2015; 100:72-80; PMID:25365313; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"JAMA InternMed 2015; 175:745-54; PMID:25775274; http://dx.doi.org/10.1001/jamainternmed.2015.0237 [49] Ensrud KE, Blackwell TL, Cauley JA, Cummings SR, Barrett-Connor E, Dam TT, Hoffman AR, Shikany JM,Lane NE, Stefanick ML, et al.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"J Am Geriatr Soc 2011; 59:101-6; PMID:21226680; http://dx.doi.org/10.1111/j.1532-5415.2010.03201.x [50] Ensrud KE, Ewing SK, Fredman L, Hochberg MC, Cauley J A ,H i l l i e rT A ,C u m m i n g sS R ,Y a f f eK ,C a w t h o nP M .C i r - culating 25-hydroxyvitamin D levels and frailty status in older women.",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
J Clin Endocrinol Metab 2010; 95:5266-73;PMID:21131545; http://dx.doi.org/10.1210/jc.2010-2317 [51] Bischoff-Ferrari HA.,OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Rev Endocr Metab Disord 2012; 13:71-7; PMID:22020957; http://dx.doi.org/10.1007/s11154-011-9200-6 [52] Janssen HC, Samson MM, Verhaar HJ.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"J BoneMiner Res 2004; 19:265-9; PMID:14969396; http://dx.doi.org/10.1359/jbmr.2004.19.2.265 [54] Bouillon R, Bischoff-Ferrari H, Willett W. Vitamin D and health: perspectives from mice and man.",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
J Mol Histol 2010; 41:137-42;PMID:20549314; http://dx.doi.org/10.1007/s10735-010- 9270-x [56] Freedman LP.,OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Arch Internal Med 2009; 169:551-61; PMID:19307517; http://dx.doi.org/10.1001/archinternmed.2008.600 [58] Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention withvitamin D supplementation: a meta-analysis of randomizedcontrolled trials.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"JAMA 2005; 293:2257-64; http://dx.doi.org/10.1001/jama.293.18.2257 [59] Cameron ID, Murray GR, Gillespie LD, Robertson MC, Hill KD, Cumming RG, Kerse N. Interventions for pre-venting falls in older people in nursing care facilitiesand hospitals.",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Cochrane Database Syst Rev 2010;CD005465; PMID:20091578; http://dx.doi.org/10.1002/14651858.CD005465.pub2 [60] Kalyani RR, Stein B, Valiyil R, Manno R, Maynard JW, Crews DC.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
J Am Geriatr Soc 2010; 58:1299-310; PMID:20579169; http://dx.doi.org/10.1111/j.1532-5415.2010.02949.x [61] Bischoff-Ferrari HA.,OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Rheum Dis Clin North Am 2012; 38:107-13;PMID:22525846; http://dx.doi.org/10.1016/j.rdc.2012.03.010 [62] Bolland MJ, Grey A, Gamble GD, Reid IR.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Lancet DiabetesEndocrinol 2014; 2:307-20; PMID:24703049; http://dx.doi.org/10.1016/S2213-8587(13)70212-2 [63] Boonen S, Bischoff-Ferrari HA, Cooper C, Lips P, Ljunggren O, Meunier PJ, Reginster JY.",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
Arch InternMed 2011; 171:265; author reply -6; PMID:21325121;http://dx.doi.org/10.1001/archinternmed.2010.531 [65] Bischoff-Ferrari HA.,OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Endocrinol Metab Clin North Am 2010; 39:347-53, table of contents; PMID:20511056; http://dx.doi.org/ 10.1016/j.ecl.2010.02.009 [66] Bischoff-Ferrari HA, Dawson-Hughes B, Platz A, Orav EJ, Stahelin HB, Willett WC, Can U, Egli A, Mueller NJ,Looser S, et al.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Arch Intern Med2010; 170:813-20; PMID:20458090; http://dx.doi.org/10.1001/archinternmed.2010.67 [67] Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D, Nicholson GC.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"JAMA 2010;303:1815-22; http://dx.doi.org/10.1001/jama.2010.594 [68] Bischoff-Ferrari HA, Dawson-Hughes B, Orav EJ, Staehelin HB, Meyer OW, Theiler R, Dick W, WillettWC, Egli A.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"JAMA Intern Med 2016;176:175-83; PMID:26747333; http://dx.doi.org/10.1001/jamainternmed.2015.7148 [69] Bischoff-Ferrari HA, Shao A, Dawson-Hughes B, Hath- cock J, Giovannucci E, Willett WC.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Osteoporos Int2010; 21:1121-32; PMID:19957164; http://dx.doi.org/ 10.1007/s00198-009-1119-3 [70] Bischoff-Ferrari HA, Willett WC, Orav EJ, Lips P, Meu- nier PJ, Lyons RA, Flicker L, Wark J, Jackson RD, Cau-ley JA, et al.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"N Engl J Med2012; 367:40-9; PMID:22762317; http://dx.doi.org/10.1056/NEJMoa1109617 [71] Trivedi DP, Doll R, Khaw KT.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Rheuma- tology (Oxford) 2007; 46:1852-7; PMID:17998225; http://dx.doi.org/10.1093/rheumatology/kem240 [73] Bleicher K, Cumming RG, Naganathan V, Blyth FM, Le Couteur DG, Handelsman DJ, Waite LM, Seibel MJ.",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
J Bone Miner Res 2014; 29:2024-31; PMID:24677358; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"J Steroid Biochem Mol Biol2016; 155(Pt B):252-6; PMID: 25864623; http://dx.doi.org/10.1016/j.jsbmb.2015.04.006 [75] Kalueff AV, Tuohimaa P. Neurosteroid hormone vita- min D and its utility in clinical nutrition.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Curr OpinClin Nutr Metab Care 2007; 10:12-9; PMID:17143049; http://dx.doi.org/10.1097/MCO.0b013e328010ca18 [76] Annweiler C, Schott AM, Berrut G, Chauvire V, Le Gall D, Inzitari M, Beauchet O. Vitamin D and ageing: neu-rological issues.",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Neuropsychobiology 2010; 62:139-50;PMID:20628264; http://dx.doi.org/10.1159/000318570 [77] Oudshoorn C, Mattace-Raso FU, van der Velde N, Colin EM, van der Cammen TJ.",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Dement Ger- iatr Cogn Disord 2008; 25:539-43; PMID:18503256;http://dx.doi.org/10.1159/000134382 [78] Etgen T, Sander D, Bickel H, Sander K, Forstl H. Vita- min D de ﬁciency, cognitive impairment and dementia: a systematic review and meta-analysis.",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Dement GeriatrCogn Disord 2012; 33:297-305; PMID:22759681; http://dx.doi.org/10.1159/000339702 [79] Annweiler C, Montero-Odasso M, Llewellyn DJ, Richard-Devantoy S, Duque G, Beauchet O. Meta-anal-ysis of memory and executive dysfunctions in relationto vitamin D. J Alzheimer Dis 2013; 37:147-71;PMID:23948884 [80] McGrath J, Scragg R, Chant D, Eyles D, Burne T, Obra- dovic D. No association between serum 25-hydroxyvita-min D3 level and performance on psychometric tests in NHANES III.",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Neuroepidemiology 2007; 29:49-54; PMID:17898524; http://dx.doi.org/10.1159/000108918 [81] Maddock J, Geoffroy MC, Power C, Hypponen E. Twenty- ﬁve-Hydroxyvitamin D and cognitive performance in mid- life.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Br J Nutr 2014; 111:904-14; PMID:24135155; http://dx.doi.org/10.1017/S0007114513003176 [82] Granic A, Hill TR, Kirkwood TB, Davies K, Collerton J, Martin-Ruiz C, von Zglinicki T, Saxby BK, Wesnes KA, Collerton D, et al.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Eur J Neurol 2015; 22:106-15, e6-7; http://dx.doi.org/10.1111/ene.12539 [83] Annweiler C, Llewellyn DJ, Beauchet O.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Meta-analysis of All-Cause MortalityAccording to Serum 25-Hydroxyvitamin D. Am J PublicHealth 2014; 104:e43-50; PMID:24922127; http://dx.doi.org/10.2105/AJPH.2014.302034 [85] Zittermann A, Iodice S, Pilz S, Grant WB, Bagnardi V, Gandini S. Vitamin D de ﬁciency and mortality risk in the general population: a meta-analysis of prospective cohort studies.",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"95:91-100; PMID:221703 74; http://dx.doi.org/ 10.3945/ajcn.111.014779 [86] Durup D, Jorgensen HL, Christensen J, Schwarz P, Hee- gaard AM, Lind B.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
J Clin EndocrinolMetab 2012; 97:2644-52; PMID:22573406; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"J Clin Endo- crinol Metab 2015; 100:L51; PMID:26047083; http://dx.doi.org/10.1210/jc.2015-1809 [88] Amrein K, Quraishi SA, Litonjua AA, Gi bbons FK, Pieber TR, Camargo CA, Jr., Giovannucci E, Christopher KB.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"J Clin Endocrinol Metab 2014; 99:1461-9; PMID:24423347; http://dx.doi.org/10.1210/jc.2013-3481 [89] Amrein K, Schnedl C, Holl A, Riedl R, Christopher KB, Pachler C, Urbanic Purkart T, Waltensdorfer A, MunchA, Warnkross H, et al.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
JAMA 2014; 312:1520-30; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"J Nutr 2010; 140:999-1006; PMID:20200114;http://dx.doi.org/10.3945/jn.109.119636 [91] Ramon R, Ballester F, Aguinagalde X, Amurrio A, Vioque J, Lacasana M, Rebagliato M, Murcia M, Iniguez C. Fish consumption during pregnancy, prenatal mer-cury exposure, and anthropometric measures at birth ina prospective mother-infant cohort study in Spain.",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"AmJ Clin Nutr 2009; 90:1047-55; PMID:19710189; http://dx.doi.org/10.3945/ajcn.2009.27944 [92] Zhu P, Tong SL, Hu WB, Hao JH, Tao RX, Huang K, Mou Z, Zhou QF, Jiang XM, Tao FB.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Sci Rep 2015; 5:14930;PMID:26450157; http://dx.doi.org/10.1038/srep14930 [93] Hypponen E, Sovio U, Wjst M, Patel S, Pekkanen J, Hartikainen AL, Jarvelinb MR.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Ann N Y Acad Sci 2004;1037:84-95; PMID:15699498; http://dx.doi.org/10.1196/ annals.1337.013 [94] Nehra D, Carlson SJ, Fallon EM, Kalish B, Potemkin AK, Gura KM, Simpser E, Compher C, Puder M, Amer-ican Society for P, et al.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"JPEN J Parenter Enteral Nutr 2013;37:570-98; PMID:23685349; http://dx.doi.org/10.1177/0148607113487216 [95] Kull I, Bergstrom A, Melen E, Lilja G, van Hage M, Pershagen G, Wickman M. Early-life supplementationof vitamins A and D, in water-soluble form or in peanut oil, and allergic diseases during childhood.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"J AllergyClin Immunol 2006; 118:1299-304; PMID:17157660;http://dx.doi.org/10.1016/j.jaci.2006.08.022 [96] Schuster GU, Kenyon NJ, Stephensen CB.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Acta Derm Venereol 2009;89:28-32; PMID:19197538; http://dx.doi.org/10.2340/00015555-0541 [98] Gale CR, Robinson SM, Harvey NC, Javaid MK, Jiang B, Martyn CN, Godfrey KM, Cooper C, Princess Anne Hospital Study G. Maternal vitamin D status duringpregnancy and child outcomes.",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Eur J Clin Nutr 2008;62:68-77; PMID:17311057; http://dx.doi.org/10.1038/sj.ejcn.1602680 [99] Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H. Randomized trial of vitamin D supplementa-tion to prevent seasonal in ﬂuenza A in schoolchildren.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Am J Clin Nutr 2010; 91:1255-60; PMID:20219962; http://dx.doi.org/10.3945/ajcn.2009.29094 [100] Hypponen E, Berry DJ, Wjst M, Power C. Serum 25- hydroxyvitamin D and IgE - a signi ﬁcant but nonlinear relationship.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Allergy 2009; 64:613-20; PMID:19154546;http://dx.doi.org/10.1111/j.1398-9995.2008.01865.x [101] Rothers J, Wright AL, Stern DA, Halonen M, Camargo CA, Jr. Cord blood 25-hydroxyvitamin D levels are associated with aeroallergen sensitization in children from Tucson, Arizona.",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"J Allergy Clin Immunol 2011;128:1093-9 e1-5; PMID:21855975; http://dx.doi.org/10.1016/j.jaci.2011.07.015 [102] Tolppanen AM, Sayers A, Granell R, Fraser WD, Hen- derson J, Lawlor DA.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
Epide- miology 2013; 24:310-9; PMID:23377091; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Eur J Clin Nutr 2014; 68:1334-40;PMID:24986817; http://dx.doi.org/10.1038/ejcn.2014.121 [104] Niruban SJ, Alagiakrishnan K, Beach J, Senthilselvan A.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"J Asthma 2015; 52:653-61; PMID:25563060; http://dx.doi.org/10.3109/02770903.2015.1004339 [105] Maslova E, Hansen S, Thorne-Lyman AL, Jensen CB, Strom M, Cohen A, Nielsen NO, Olsen SF.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Pediatric Allergy Immunol 2014; 25:706-13;PMID:25348236; http://dx.doi.org/10.1111/pai.12295 [106] Hansen S, Maslova E, Strom M, Linneberg A, Halldors- son TI, Granstrom C, Dahl R, Hoffmann HJ, Olsen SF.DERMATO-ENDOCRINOLOGY e1187349-15",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"J Allergy Clin Immunol 2015; 136:169-76e2; PMID:25649083; http://dx.doi.org/10.1016/j.jaci.2014.12.1924 [107] Lerchbaum E, Pilz S, Trummer C, Rabe T, Schenk M, Heijboer AC, Obermayer-Pietsch B. Serum vitamin D levels and hypogonadism in men.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Andrology 2014;2:748-54; PMID:25044703; http://dx.doi.org/10.1111/j.2047-2927.2014.00247.x [108] Karras S, Anagnostis P, Kotsa K, Goulis DG.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Fertil Steril 2011; 95:1000-4;PMID:21122842; http://dx.doi.org/10.1016/j.fertnstert.2010.11.002 [110] Hammoud AO, Meikle AW, Peterson CM, Stanford J, Gibson M, Carrell DT.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Osteoporos Int 2013; 24:1567-77; PMID:23229471; http://dx.doi.org/10.1007/s00198-012-2231-3 [112] Cantorna MT, Mahon BD.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Early pregnancy maternal vitamin D con- centrations and risk of gestational diabetes mellitus.Paediatr Perinat Epidemiol 2015; 29:196-9;PMID:25873289; http://dx.doi.org/10.1111/ppe.12187 [114] Veldurthy V, Wei R, Campbell M, Lupicki K, Dhawan P, Christakos S. Twenty- ﬁve-Hydroxyvitamin D3 24- Hydroxylase: A Key Regulator of 1,25(OH)2D3 Catabo- lism and Calcium Homeostasis.",Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Vitam Horm 2016; 100:137-50; PMID:26827951; http://dx.doi.org/10.1016/bs.vh.2015.10.005 [115] Black LJ, Anderson D, Clarke MW, Ponsonby AL, Lucas RM, Ausimmune Investigator G. Analytical Bias in theMeasurement of Serum 25-Hydroxyvitamin D Concen-trations Impairs Assessment of Vitamin D Status inClinical and Research Settings.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"PloS One 2015; 10: e0135478; PMID:26266807; http://dx.doi.org/10.1371/ journal.pone.0135478 [116] Sempos CT, Durazo-Arvizu RA, Binkley N, Jones J, Merkel JM, Carter GD.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
J Ste-roid Biochem Mol Biol 2015; pii: S0960-0760(15)30059-5; PMID: 26321386; http://dx.doi.org/10.1016/ j.jsbmb.2015.08.027 [117] Carter GD.,OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Clin Chem 2012; 58:486-8; PMID:22238254;http://dx.doi.org/10.1373/clinchem.2011.180562 [118] Hypponen E, Turner S, Cumberland P, Power C, Gibb I. Serum 25-hydroxyvitamin D measurement in a largepopulation survey with statistical harmonization ofassay variation to an international standard.",OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
J Clin Endocrinol Metab 2007; 92:4615-22; PMID:17726070; http://dx.doi.org/10.1210/jc.2007-1279 [119] Boucher BJ.,Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
Curr Drug Targets 2011; 12:61-87; PMID:20795936;http://dx.doi.org/10.2174/138945011793591653e1187349-16 W. B.,Non-OADS,/arxiv_data1/oa_pdf/00/8c/kder-08-01-1187349.PMC4951179.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(3):373-382 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.3.373 Factors Associated With Upper Extremity  Functional Recovery Following   Low-Frequency Repetitive Transcranial  Magnetic Stimulation in Stroke Patients Seo Young Kim, MD1, Sung Bong Shin, MD1, Seong Jae Lee, MD, PhD2,   Tae Uk Kim, MD, PhD1, Jung Keun Hyun, MD, PhD1,3,4 1Department of Rehabilitation Medicine, Dankook University College of Medicine, Cheonan;   2Department of Rehabilitation Medicine, National Rehabilitation Center, Seoul;   3Department of Nanobiomedical Science, BK21 Plus NBM Global Research Center for Regenerative Medicine,   Dankook University, Cheonan; 4Institute of Tissue Regeneration Engineering, Dankook University, Cheonan, Korea Objective  To investigate the factors related to upper extremity functional improvement following inhibitory  repetitive transcranial magnetic stimulation (rTMS) in stroke patients.",Non-OADS,/arxiv_data1/oa_pdf/be/d0/arm-40-373.PMC4951355.pdf
"Tel: +82-41-550-3889, Fax: +82-41-551-7062, E-mail: rhhyun@dankook.ac.krORCID: Seo Young Kim (http://orcid.org/0000-0002-5351-8044); Sung Bong Shin (http://orcid.org/0000-0002-5273-3586); Seong Jae Lee (http://orcid.org/0000-0001-7867-4695); Tae Uk Kim (http://orcid.org/0000-0001-9904-8781); Jung Keun Hyun (http://orcid.org/0000-0001-9254-4424).",Non-OADS,/arxiv_data1/oa_pdf/be/d0/arm-40-373.PMC4951355.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/be/d0/arm-40-373.PMC4951355.pdf
"In addition, walking ability repre-Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(3):383-391 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.3.383 Transcranial Motor Evoked Potentials of   Lower Limbs Can Prognosticate Ambulation   in Hemiplegic Stroke Patients Pyoungsik Hwang, MD, Min Kyun Sohn, MD, PhD, Sungju Jee, MD, Hyunkeun Lee, MD Department of Rehabilitation Medicine, Chungnam National University School of Medicine, Daejeon, Korea Objective  To examine the association between motor evoked potentials (MEPs) in lower limbs and ambulatory  outcomes of hemiplegic stroke patients.",OADS,/arxiv_data1/oa_pdf/19/e0/arm-40-383.PMC4951356.pdf
"Tel: +82-42-338-2460, Fax: +82-42-338-2461, E-mail: mksohn@cnu.ac.krORCID: Pyoungsik Hwang (http://orcid.org/0000-0001-6677-1789); Min Kyun Sohn (http://orcid.org/0000-0002-2548-545X); Sungju Jee (http://orcid.org/0000-0002-9400-9609); Hyunkeun Lee (http://orcid.org/0000-0002-9306-6011).",Non-OADS,/arxiv_data1/oa_pdf/19/e0/arm-40-383.PMC4951356.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/e0/arm-40-383.PMC4951356.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(3):392-400 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.3.392 Association Between a Polymorphism  (rs2071214) in Baculoviral IAP Repeat  Containing 5 Gene ( BIRC5 ) and   Ischemic Stroke in Korean Population Jinmann Chon, MD1, Hee-Sang Kim, MD1, Dong Hwan Yun, MD1, Seung Don Yoo, MD1,   Dong Hwan Kim, MD1, Seung Ah Lee, MD1, Su Kang Kim, MD2, Hae Jeong Park, MD2,   Joo-Ho Chung, MD2, Sungjoon Chung, MD1, Jinah Yeo, MD1 1Department of Physical Medicine and Rehabilitation, Kyung Hee University School of Medicine, Seoul;   2Kohwang Medical Research Institute, Kyung Hee University, Seoul, Korea Objective  To investigate whether baculoviral inhibitor of apoptosis (IAP) repeat containing 5 gene ( BIRC5 )  polymorphisms are associated with the development and clinical phenotypes of ischemic stroke in Korea population.",Non-OADS,/arxiv_data1/oa_pdf/ed/f2/arm-40-392.PMC4951357.pdf
"Tel: +82-2-958-8565, Fax: +82-2-958-8560, E-mail: especially02@hanmail.netORCID: Seung Don Yoo (http://orcid.org/0000-0003-4513-2560); Seung Ah Lee (http://orcid.org/0000-0002-3426-6259); Jinah Yeo (http://orcid.org/0000-0003-2796-0805).",Non-OADS,/arxiv_data1/oa_pdf/ed/f2/arm-40-392.PMC4951357.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/f2/arm-40-392.PMC4951357.pdf
"After searching the dbSNP data - base (http://www.ncbi.nlm.nih.gov/SNP/), we selected",OADS,/arxiv_data1/oa_pdf/ed/f2/arm-40-392.PMC4951357.pdf
The required sample size for statistical power was estimated using a genetic power calculator (http://pngu.mgh.harvard.edu/~purcell/gpc/cc2.html).,OADS,/arxiv_data1/oa_pdf/ed/f2/arm-40-392.PMC4951357.pdf
http://dx.doi.org/10.1007/s12035-015-9332-x.,Non-OADS,/arxiv_data1/oa_pdf/ed/f2/arm-40-392.PMC4951357.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(3):401-411 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.3.401 Effects of Adjuvant Mental Practice on Affected  Upper Limb Function Following a Stroke:  Results of Three-Dimensional Motion   Analysis, Fugl-Meyer Assessment of the   Upper Extremity and Motor Activity Logs Hyun Seung Oh, MD1, Eun Joo Kim, MD1, Doo Young Kim, MD2, Soo Jeong Kim, MD1 1Department of Rehabilitation Medicine, National Rehabilitation Center, Seoul;   2Goseong Community Health Center, Gyeongsangnam-do, Korea Objective  To investigate the effects of adjuvant mental practice (MP) on affected upper limb function following a  stroke using three-dimensional (3D) motion analysis.",OADS,/arxiv_data1/oa_pdf/8d/06/arm-40-401.PMC4951358.pdf
"Tel: +82-2-901-1633, Fax: +82-2-901-3835, E-mail: silverzookim@gmail.comORCID: Hyun Seung Oh (http://orcid.org/0000-0002-9765-0397); Eun Joo Kim (http://orcid.org/0000-0001-6166-7886); Doo Young Kim (http://orcid.org/0000-0003-1327-5348); Soo Jeong Kim (http://orcid.org/0000-0003-3951-6947).",Non-OADS,/arxiv_data1/oa_pdf/8d/06/arm-40-401.PMC4951358.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8d/06/arm-40-401.PMC4951358.pdf
"As PSDM has been found to significantly affect functional outcome, resump-Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(3):412-419 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.3.412 Predictors of Depressive Mood in Patients   With Isolated Cerebellar Stroke:   A Retrospective Study Dong Jin Koh, MD, Na Young Kim, MD, Yong Wook Kim, MD, PhD Department of Rehabilitation Medicine and Research Institute of Rehabilitation Medicine,   Yonsei University College of Medicine & Severance Hospital, Seoul, Korea Objective  To identify predictive factors of depressive mood in patients with isolated cerebellar stroke.",Non-OADS,/arxiv_data1/oa_pdf/65/3b/arm-40-412.PMC4951359.pdf
"Tel: +82-2-2228-3716, Fax: +82-2-363-2795, E-mail: ywkim1@yuhs.acORCID: Dong Jin Koh (http://orcid.org/0000-0001-5673-3068); Na Young Kim (http://orcid.org/0000-0001-9888-3953); Yong Wook Kim (http://orcid.org/0000-0002-5234-2454).",Non-OADS,/arxiv_data1/oa_pdf/65/3b/arm-40-412.PMC4951359.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/65/3b/arm-40-412.PMC4951359.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(3):420-431 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.3.420 Virtual Reality-Guided Motor Imagery   Increases Corticomotor Excitability in   Healthy Volunteers and Stroke Patients Hyungjun Im, MD1, Jeunghun Ku, PhD2, Hyun Jung Kim, MD1, Youn Joo Kang, MD1 1Department of Rehabilitation Medicine, Eulji Hospital, Eulji University School of Medicine, Seoul;   2Department of Biomedical Engineering, Keimyung University, Daegu, Korea Objective  To investigate the effects of using motor imagery (MI) in combination with a virtual reality (VR)  program on healthy volunteers and stroke patients.",Non-OADS,/arxiv_data1/oa_pdf/a0/47/arm-40-420.PMC4951360.pdf
"Tel: +82-2-970-8315, Fax: +82-2-979-8268, E-mail: md52516@hanmail.netORCID: Hyungjun Im (http://orcid.org/0000-0002-2360-7775); Jeunghun Ku (http://orcid.org/0000-0002-9610-0078); Hyun Jung Kim (http://orcid.org/0000-0002-2198-5668); Youn Joo Kang (http://orcid.org/0000-0002-9938-5435).",Non-OADS,/arxiv_data1/oa_pdf/a0/47/arm-40-420.PMC4951360.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/47/arm-40-420.PMC4951360.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(3):432-439 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.3.432 Characteristics of Dysphagia in Severe  Traumatic Brain Injury Patients:   A Comparison With Stroke Patients  Won Kyung Lee, MD1, Jiwoon Yeom, MD1, Woo Hyung Lee, MD1, Han Gil Seo, MD, MS1,   Byung-Mo Oh, MD, PhD1, Tai Ryoon Han, MD, PhD2 1Department of Rehabilitation Medicine, Seoul National University Hospital, Seoul National University College of Medicine,  Seoul; 2Department of Rehabilitation Medicine, Gangwon-Do Rehabilitation Hospital, Chuncheon, Korea Objective  To compare the swallowing characteristics of dysphagic patients with traumatic brain injury (TBI) with  those of dysphagic stroke patients.",OADS,/arxiv_data1/oa_pdf/d3/c7/arm-40-432.PMC4951361.pdf
"Tel: +82-33-248-7702, Fax: +82-33-248-7713, E-mail: tairyoon@snu.ac.kr  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d3/c7/arm-40-432.PMC4951361.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(3):440-446 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.3.440 The Functional Dysphagia Scale Is a Useful   Tool for Predicting Aspiration Pneumonia   in Patients With Parkinson Disease  Jong Hwa Lee, MD1, Kyeong Woo Lee, MD1, Sang Beom Kim, MD1,  Sook Joung Lee, MD1, Sang Myung Chun, MD2, Sung Moon Jung, MD1 Departments of 1Physical Medicine and Rehabilitation, 2Neurology, Dong-A University College of Medicine, Busan, Korea Objective  To describe the correlation between the functional dysphagia scale and aspiration pneumonia and  which characteristics influence the occurrence of aspiration pneumonia in patients with idiopathic Parkinson  disease.",OADS,/arxiv_data1/oa_pdf/14/6f/arm-40-440.PMC4951362.pdf
"Tel: +82-51-240-5690, Fax: +82-51-254-8511, E-mail: zzugul36@naver.comORCID: Jong Hwa Lee (http://orcid.org/0000-0003-2489-358X); Kyeong Woo Lee (http://orcid.org/0000-0001-8785-5535); Sang Beom Kim (http://orcid.org/0000-0002-5622-5933); Sook Joung Lee (http://orcid.org/0000-0002-6894-445X); Sang Myung Chun (http://orcid.org/0000-0001-5905-2188); Sung Moon Jung (http://orcid.org/0000-0003-2674-5337).",Non-OADS,/arxiv_data1/oa_pdf/14/6f/arm-40-440.PMC4951362.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/6f/arm-40-440.PMC4951362.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(3):447-456 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.3.447 EMG Activity of Masseter Muscles in the Elderly  According to Rheological Properties of Solid Food Au Jin Kang, MD1, Don-Kyu Kim, MD1, Si Hyun Kang, MD1,   Kyung Mook Seo, MD1, Hyoung Su Park, PhD2, Ki-Hwan Park, PhD2 1Department of Physical Medicine and Rehabilitation, Chung-Ang University College of Medicine, Seoul;  2Department of Food Science & Technology, Chung-Ang University, Seoul, Korea Objective  To assess the impact of aging on masticatory muscle function according to changes in hardness of solid  food.",OADS,/arxiv_data1/oa_pdf/f9/f4/arm-40-447.PMC4951363.pdf
"Tel: +82-2-6299-1881, Fax: +82-2-6298-1866, E-mail: donkim21@cau.ac.kr  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/f4/arm-40-447.PMC4951363.pdf
"The Univeral Design Foods guidelines for elderly people Stage 1 Stage 2 Stage 3 Stage 4 Classifications Able to chew easily Able to smash with  gumsAble to smash with  tongueAble to swallow without  chewing Standards of  chewingContains hard and big  ingredients, a little  hard to swallowContains hard and big  ingredients not easy to swallowContains soft and small  ingredients, easy to swallowHard to swallow if   contains solid food Standards of  swallowingAble to swallow   commonlyDepends on   ingredients,  hard to swallowHave experience hard  to swallow water or liquid ingredientsHard to swallow water  or liquid ingredients Hardness (N/m 2) 5×1055×1042×1045×103 Cited from the Japan Care Food Conference 2012 (http://www.udf.jp/about_udf/section_01.html).",Non-OADS,/arxiv_data1/oa_pdf/f9/f4/arm-40-447.PMC4951363.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(3):457-462 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.3.457 Optimal Needle Placement for Extensor   Hallucis Longus Muscle: A Cadaveric Study In Yae Cheong, MD1, Do Kyun Kim, MD1, Ye Jeong Oh, B_KIN2, Byung Kyu Park, MD, PhD1,   Ki Hoon Kim, MD, PhD1, Dong Hwee Kim, MD, PhD1 1Department of Physical Medicine and Rehabilitation, Korea University College of Medicine, Seoul;   2School of Kinesiology, University of British Columbia, Vancouver, Canada Objective  To determine the midpoint (MD) of extensor hallucis longus muscle (EHL) and compare the accuracy  of different needle electromyography (EMG) insertion techniques through cadaver dissection.",Non-OADS,/arxiv_data1/oa_pdf/7d/3d/arm-40-457.PMC4951364.pdf
"Tel: +82-31-412-5330, Fax: +82-31-412-5344, E-mail: rmkdh@korea.ac.krORCID: In Yae Cheong (http://orcid.org/0000-0003-3621-6017); Do Kyun Kim (http://orcid.org/0000-0002-3257-6683); Ye Jeong Oh (http://orcid.org/0000-0002-3832-6108); Byung Kyu Park (http://orcid.org/0000-0001-8445-7099); Ki Hoon Kim (http://orcid.org/0000-0002-7257-3858); Dong Hwee Kim (http://orcid.org/0000-0002-8116-0078).",Non-OADS,/arxiv_data1/oa_pdf/7d/3d/arm-40-457.PMC4951364.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7d/3d/arm-40-457.PMC4951364.pdf
"The pathogenesis of rotator cuff lesions is cur - rently under debate; however, several intrinsic and ex - trinsic factors are believed to play important roles in the Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(3):463-469 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.3.463 Influence of Hyperlipidemia   on the Treatment of Supraspinatus  Tendinopathy With or Without Tear Jae-Min Kim, MD, Min-Wook Kim, MD, PhD, Hyun-Jung Do, MD Department of Rehabilitation, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea  Objective  To investigate the influence of hyperlipidemia on the treatment of supraspinatus tendinopathy, with or  without tear.",Non-OADS,/arxiv_data1/oa_pdf/e3/9b/arm-40-463.PMC4951365.pdf
"Tel: +82-32-280-5981, Fax: +82-32-280-5992, E-mail: jung024@hanmail.netORCID: Jae-Min Kim (http://orcid.org/0000-0003-4217-3228); Min-Wook Kim (http://orcid.org/0000-0003-4505-809X); Hyun-Jung Do (http://orcid.org/0000-0001-7972-2548).",Non-OADS,/arxiv_data1/oa_pdf/e3/9b/arm-40-463.PMC4951365.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e3/9b/arm-40-463.PMC4951365.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(3):470-480 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.3.470 Monitoring of Motor and Somatosensory   Evoked Potentials During Spine Surgery:  Intraoperative Changes and   Postoperative Outcomes  Shin Hye Chang, MD1,2, Yoon Ghil Park, MD, PhD1,2, Dae Hyun Kim, MD3, Seo Yeon Yoon, MD1,2 1Department of Rehabilitation Medicine, Gangnam Severance Hospital, Seoul; 2Rehabilitation Institute of Neuromuscular  Disease, Yonsei University College of Medicine, Seoul; 3Veteran Health Service Medical Center, Seoul, Korea  Objective  To evaluate whether the combination of muscle motor evoked potentials (mMEPs) and somatosensory  evoked potentials (SEPs) measured during spinal surgery can predict immediate and permanent postoperative  motor deficits.",OADS,/arxiv_data1/oa_pdf/24/7f/arm-40-470.PMC4951366.pdf
"Tel: +82-2-2019-3493, Fax: +82-2-3463-7585, E-mail: DRTLC@yuhs.acORCID: Shin Hye Chang (http://orcid.org/0000-0003-1749-3940); Yoon Ghil Park (http://orcid.org/0000-0001-9054-5300); Dae Hyun Kim (http://orcid.org/0000-0002-5065-4286); Seo Yeon Yoon (http://orcid.org/0000-0002-0365-2923).",Non-OADS,/arxiv_data1/oa_pdf/24/7f/arm-40-470.PMC4951366.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/24/7f/arm-40-470.PMC4951366.pdf
"Advances in general care facilities and the availability of speciﬁc treatments have improved the outcome for patients with Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(3):481-488 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.3.481 Prediction of Functional Outcome in   Axonal Guillain-Barre Syndrome  Eun Jung Sung, MD, Dae Yul Kim, MD, Min Cheol Chang, MD, Eun Jae Ko, MD Department of Rehabilitation Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Objective  To identify the factors that could predict the functional outcome in patients with the axonal type of  Guillain-Barre syndrome (GBS).",Non-OADS,/arxiv_data1/oa_pdf/2c/33/arm-40-481.PMC4951367.pdf
"Tel: +82-2-3010-3800, Fax: +82-2-3010-6964, E-mail: dykimsmart@gmail.comORCID: Eun Jung Sung (http://orcid.org/0000-0002-3798-8978); Dae Yul Kim (http://orcid.org/0000-0003-1275-1736); Min Cheol Chang (http://orcid.org/0000-0002-7629-7213); Eun Jae Ko (http://orcid.org/0000-0001-7198-5407).",Non-OADS,/arxiv_data1/oa_pdf/2c/33/arm-40-481.PMC4951367.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/33/arm-40-481.PMC4951367.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(3):489-495 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.3.489 Clinical Findings of Asymptomatic   Carpal Tunnel Syndrome in Patients   With Diabetes Mellitus Hye Young Han, MD1, Ha Min Kim, MD2, So Young Park, MD1,    Min-Wook Kim, MD, PhD1, Jae Min Kim, MD, PhD1, Dae-Hyun Jang, MD, PhD1 1Department of Rehabilitation Medicine, Incheon St. Mary's Hospital, College of Medicine,   The Catholic University of Korea, Incheon; 2GwangGyo Charm and Good Hospital, Yongin, Korea Objective  To evaluate the clinical differences between patients with diabetes mellitus (DM) who have asym- ptomatic carpal tunnel syndrome (CTS) and those who have symptomatic CTS.",Non-OADS,/arxiv_data1/oa_pdf/4c/e6/arm-40-489.PMC4951368.pdf
"Tel: +82-32-280-5207, Fax: +82-32-280-5040, E-mail: dhjangmd@naver.comORCID: Hye Young Han (http://orcid.org/0000-0003-2252-3884; Ha Min Kim (http://orcid.org/0000-0002-6211-6485); So Young Park (http://orcid.org/0000-0002-3547-9547); Min-Wook Kim (http://orcid.org/0000-0003-4505-809X); Jae Min Kim (http://orcid.org/0000-0003-4217-3228); Dae-HyunJang (http://orcid.org/0000-0001-8293-084X).",Non-OADS,/arxiv_data1/oa_pdf/4c/e6/arm-40-489.PMC4951368.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4c/e6/arm-40-489.PMC4951368.pdf
"The PQ muscle receives the final Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(3):496-501 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.3.496 Anatomic Characteristics of Pronator   Quadratus Muscle: A Cadaver Study  Phil Woo Choung, MD1, Min Young Kim, MD1, Hyung Soon Im, MD1, Ki Hoon Kim, MD, PhD1,   Im Joo Rhyu, MD, PhD2,3, Byung Kyu Park, MD, PhD1, Dong Hwee Kim, MD, PhD1,3 Departments of 1Physical Medicine and Rehabilitation, 2Anatomy, Korea University College of Medicine, Seoul;   3Practical Anatomy Center, Korea University College of Medicine, Seoul, Korea Objective  To identify the anatomic characteristics of the pronator quadratus (PQ) muscle and the entry zone (EZ)  of the anterior interosseous nerve (AIN) to this muscle by means of cadaver dissection.",Non-OADS,/arxiv_data1/oa_pdf/26/fa/arm-40-496.PMC4951369.pdf
"Tel: +82-31-412-5330, Fax: +82-31-412-5344, E-mail: rmkdh@korea.ac.krORCID: Phil Woo Choung (http://orcid.org/0000-0003-0252-226X); Min Young Kim (http://orcid.org/0000-0003-4188-8213); Hyung Soon Im (http://orcid.org/0000-0003-0732-7690); Ki Hoon Kim (http://orcid.org/0000-0002-7257-3858); Im Joo Rhyu (http://orcid.org/0000-0002-5558-6278); Byung Kyu Park (http://orcid.org/0000-0001-8445-7099); Dong Hwee Kim (http://orcid.org/0000-0002-8116-0078).",Non-OADS,/arxiv_data1/oa_pdf/26/fa/arm-40-496.PMC4951369.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/fa/arm-40-496.PMC4951369.pdf
"Although the exact pathogenesis of FS is still unclear, temporal evolution Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(3):502-508 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.3.502 Ultrasonographic Measurement of the Thickness  of Axillary Recess Capsule in Healthy Volunteers Kyoung Tae Kim, MD1, Dong Gyu Lee, MD1,   Soyoung Lee, MD, PhD1, Du Hwan Kim, MD1,2,3 1Department of Rehabilitation Medicine, 2Pain Research Center, and   3Institute for Medical Science, Keimyung University School of Medicine, Daegu, Korea Objective  To evaluate the inter-rater and intra-rater reliability of ultrasonographic measurements of axillary  recess (AR) thickness in healthy individuals, and to analyze the factors affecting the thickness of the AR capsule.",OADS,/arxiv_data1/oa_pdf/7c/7c/arm-40-502.PMC4951370.pdf
"Tel: +82-53-250-7477, Fax: +82-53-250-7205, E-mail: ri-pheonix@hanmail.netORCID: Kyoung Tae Kim (http://orcid.org/0000-0001-9355-8326); Dong Gyu Lee (http://orcid.org/0000-0002-4787-4448); Soyoung Lee (http://orcid.org/0000-0002-4713-0713); Du Hwan Kim (http://orcid.org/0000-0002-9980-8549).",Non-OADS,/arxiv_data1/oa_pdf/7c/7c/arm-40-502.PMC4951370.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/7c/arm-40-502.PMC4951370.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(3):509-519 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.3.509 Effect of Radial Extracorporeal Shock Wave  Therapy on Hemiplegic Shoulder Pain Syndrome Sung Hwan Kim, MD, Kang Wook Ha, MD, Yun Hee Kim, MD, Pyong-Hwa Seol, MD,  Ho-Jun Kwak, MD, Seung-Wan Park, MD, Byung-Ju Ryu, MD Department of Physical Medicine and Rehabilitation, Sahmyook Medical Center, Seoul, Korea Objective  To investigate the effect of radial extracorporeal shock wave therapy (rESWT) on hemiplegic shoulder  pain (HSP) syndrome.",OADS,/arxiv_data1/oa_pdf/73/f4/arm-40-509.PMC4951371.pdf
"Tel: +82-2-2210-3136, Fax: +82-2-2210-3133, E-mail: btjrbj@gmail.comORCID: Sung Hwan Kim (http://orcid.org/0000-0003-2795-945X); Kang Wook Ha (http://orcid.org/0000-0002-0216-0871); Yun Hee Kim (http://orcid.org/0000-0003-1629-9310); Pyong-Hwa Seol (http://orcid.org/0000-0001-8778-8184); Ho-Jun Kwak (http://orcid.org/0000-0001-7667-8051); Seung-Wan Park (http://orcid.org/0000-0002-5996-3544); Byung-Ju Ryu (http://orcid.org/0000-0003-0109-9885).",Non-OADS,/arxiv_data1/oa_pdf/73/f4/arm-40-509.PMC4951371.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/73/f4/arm-40-509.PMC4951371.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(3):520-527 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.3.520 Usefulness of a Hanging Position With Internal  Rotation of Shoulder in Ultrasonography- Guided Intra-articular Steroid Injection   for Adhesive Capsulitis  Chang Han Lee, MD1, Hyung Seok Nam, MD2,3, Shi-Uk Lee, MD, PhD3 1Department of Rehabilitation Medicine, Gyeongsang National University Hospital,   Gyeongsang National University Graduate School of Medicine, Jinju;   2Department of Biomedical Engineering, Seoul National University College of Medicine, Seoul;   3Department of Rehabilitation Medicine, Seoul National University Boramae Medical Center, Seoul, Korea Received February 22, 2016; Accepted April 6, 2016Corresponding author: Shi-Uk LeeDepartment of Rehabilitation Medicine, Seoul National University Boramae Medical Center, 20 Boramae-ro 5-gil, Dongjak-gu, Seoul 07061, Korea.",Non-OADS,/arxiv_data1/oa_pdf/88/da/arm-40-520.PMC4951372.pdf
"Tel: +82-2-870-2671, Fax: +82-2-870-3866, E-mail: ShiUk.Lee@gmail.comORCID: Chang Han Lee (http://orcid.org/0000-0001-8351-5226); Hyung Seok Nam (http://orcid.org/0000-0002-2210-7170); Shi-Uk Lee (http://orcid.org/0000-0003-0850-5217).",Non-OADS,/arxiv_data1/oa_pdf/88/da/arm-40-520.PMC4951372.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/88/da/arm-40-520.PMC4951372.pdf
"Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2016;40(3):528-533 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.3.528 Anorectal Manometric and Urodynamic  Parameters According to the Spinal Cord   Injury Lesion  Bon Il Koo, MD1,2, Tae Sik Bang, MD1,2, Soo-Yeon Kim, MD, PhD1,2,  Sung Hwa Ko, MD1,2, Wan Kim, MD1,2, Hyun-Yoon Ko, MD, PhD1,2 1Department of Rehabilitation Medicine, Pusan National University School of Medicine, Yangsan;  2Research Institute for Convergence of Biomedical Science and Technology,   Pusan National University Yangsan Hospital, Yangsan, Korea Objective  To assess the correlation between the anorectal function and bladder detrusor function in patients with  complete spinal cord injury (SCI) according to the type of lesion.",OADS,/arxiv_data1/oa_pdf/a6/a1/arm-40-528.PMC4951373.pdf
"Tel: +82-55-360-4250, Fax: +82-55-360-4251, E-mail: drkohy@gmail.comORCID: Bon Il Koo (http://orcid.org/0000-0002-5142-2743); Tae Sik Bang (http://orcid.org/0000-0001-7847-0561); Soo-Yeon Kim (http://orcid.org/0000-0001-5679-0126); Sung Hwa Ko (http://orcid.org/0000-0003-4900-5972); Wan Kim (http://orcid.org/0000-0003-0372-2407); Hyun-Yoon Ko (http://orcid.org/0000-0001-5506-7219).",Non-OADS,/arxiv_data1/oa_pdf/a6/a1/arm-40-528.PMC4951373.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a6/a1/arm-40-528.PMC4951373.pdf
"Annals of Rehabilitation MedicineCase Report Ann Rehabil Med 2016;40(3):534-539 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.3.534 Thoracic Radiculopathy due to Rare Causes Hee Eun Choi, MD1, Min Ha Shin, MD1, Geun Yeol Jo, MD, PhD1, Ji Yeon Kim, MD, PhD2 Departments of 1Physical Medicine and Rehabilitation, 2Pathology,   Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea Thoracic radiculopathy represents an uncommon spinal disorder that is frequently overlooked in the evaluation  of thoracic, or abdominal pain syndrome.",Non-OADS,/arxiv_data1/oa_pdf/c0/30/arm-40-534.PMC4951374.pdf
"Keywords  Radiculoapthy, Abdominal pain, Ewing sarcoma Received April 2, 2015; Accepted July 21, 2015 Corresponding author: Min Ha Shin Department of Physical Medicine and Rehabilitation, Inje University Haeundae Paik Hospital, Inje University College of Medicine, 875 Haeun-daero, Haeundae-gu, Busan 48108, Korea, Tel: +82-51-797-3250, Fax: +82-51-797-0298, E-mail: rehab8520@gmail.comORCID: Hee Eun Choi (http://orcid.org/0000-0002-8753-929X); Min Ha Shin (http://orcid.org/0000-0003-3752-2163); Geun Yeol Jo (http://orcid.org/0000-0002-5726-060X); Ji Yeon Kim (http://orcid.org/0000-0002-4612-4434).",Non-OADS,/arxiv_data1/oa_pdf/c0/30/arm-40-534.PMC4951374.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c0/30/arm-40-534.PMC4951374.pdf
"Bilateral anterior opercular syndrome and partial Klu- ver–Bucy syndrome are associated with bilateral middle Annals of Rehabilitation MedicineCase Report Ann Rehabil Med 2016;40(3):540-544 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.3.540 Bilateral Anterior Opercular Syndrome   With Partial Kluver–Bucy Syndrome   in a Stroke Patient: A Case Report Ah-Ra Cho, MD1, Young-Ho Lim, MD1, Sae-Hoon Chung, MD1,   Eun-Hi Choi, MD, PhD1, Jong Youb Lim, MD1,2 1Department of Rehabilitation Medicine, Hallym University Chuncheon Sacred Heart Hospital, Hallym University   College of Medicine, Chuncheon; 2Department of Rehabilitation Medicine, Eulji University Hospital, Daejeon, Korea Bilateral anterior opercular syndrome and partial Kluver–Bucy syndrome are associated with bilateral middle  cerebral artery lesions.",Non-OADS,/arxiv_data1/oa_pdf/57/3c/arm-40-540.PMC4951375.pdf
"Tel: +82-42-611-3631, Fax: +82-42-611-3633, E-mail: jylimmd@eulji.ac.krORCID: Ah-Ra Cho (http://orcid.org/0000-0003-3533-2243); Young-Ho Lim (http://orcid.org/0000-0002-4446-3854); Sae-Hoon Chung (http://orcid.org/0000-0002-7861-9503); Eun-Hi Choi (http://orcid.org/0000-0002-7345-6952); Jong Youb Lim (http://orcid.org/0000-0001-9100-4864).",Non-OADS,/arxiv_data1/oa_pdf/57/3c/arm-40-540.PMC4951375.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/57/3c/arm-40-540.PMC4951375.pdf
"We report the first case of neurovascular com-Annals of Rehabilitation MedicineCase Report Ann Rehabil Med 2016;40(3):545-550 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.3.545 Neurovascular Compression Caused by  Popliteus Muscle Enlargement   Without Discrete Trauma Kyoung Jin Cho, MD1, Sangkuk Kang, MD, PhD1, Sanghyung Ko, MD1,  Junghyun Baek, MD1, Yeongkyun Kim, MD2, Noh Kyoung Park, MD1 Departments of 1Physical Medicine and Rehabilitation, 2Vascular Surgery, Sun General Hospital, Daejeon, Korea Popliteal entrapment syndrome caused by isolated popliteus muscle enlargement is very rare, although its  occurrence has been reported after discrete trauma.",Non-OADS,/arxiv_data1/oa_pdf/07/ae/arm-40-545.PMC4951376.pdf
"Tel: +82-42-220-8468, Fax: +82-303-3130-8468, E-mail: nkpark@sunhospital.co.krORCID: Kyoung Jin Cho (http://orcid.org/0000-0001-7690-9067); Sangkuk Kang (http://orcid.org/0000-0003-0563-3280); Sanghyung Ko (http://orcid.org/0000-0001-6651-2533); Junghyun Baek (http://orcid.org/0000-0002-7296-0153); Yeongkyun Kim (http://orcid.org/0000-0001-6333-8568); Noh Kyoung Park (http://orcid.org/0000-0002-6950-5387).",Non-OADS,/arxiv_data1/oa_pdf/07/ae/arm-40-545.PMC4951376.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/ae/arm-40-545.PMC4951376.pdf
"Among the various treatment methods, botulinum tox - in type A (BTX-A) injection has been introduced recently, but it is difficult to identify the dystonic muscles, and its Annals of Rehabilitation MedicineCase Report Ann Rehabil Med 2016;40(3):551-555 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.3.551 Precise Muscle Selection Using Dynamic  Polyelectromyography for Treatment of   Post-stroke Dystonia: A Case Report Tae Min Jung, MD1, Ae Ryoung Kim, MD1, Yoonju Lee, MD2,   Dae-Hyun Kim, MD3, Deog Young Kim, MD, PhD1 1Department of Rehabilitation Medicine and Research Institute of Rehabilitation Medicine, Yonsei University   College of Medicine, Seoul; 2Department of Neurology, Yonsei University College of Medicine, Seoul;   3Department of Physical Medicine and Rehabilitation, Veterans Health Service Medical Center, Seoul, Korea Dystonia has a wide range of causes, but treatment of dystonia is limited to minimizing the symptoms as there is  yet no successful treatment for its cause.",Non-OADS,/arxiv_data1/oa_pdf/80/49/arm-40-551.PMC4951377.pdf
"Tel: +82-2-2228-3714, Fax: +82-2-3463-7585, E-mail: kimdy@yuhs.acORCID: Tae Min Jung (http://orcid.org/0000-0003-1391-7873); Ae Ryoung Kim (http://orcid.org/0000-0003-3765-3024); Yoonju Lee (http://orcid.org/0000-0002-3609-0285); Dae-Hyun Kim (http://orcid.org/0000-0002-5065-4286); Deog Young Kim (http://orcid.org/0000-0001-7622-6311).",Non-OADS,/arxiv_data1/oa_pdf/80/49/arm-40-551.PMC4951377.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/80/49/arm-40-551.PMC4951377.pdf
"Phadke, PhD4,5,6,   Farooq Ismail, MD4,5, Sun Im, MD, PhD1 1Department of Rehabilitation Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea;   2Department of Rehabilitation Medicine, Pusan National University School of Medicine, Busan, Korea; 3Research Institute for  Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Korea;   4Spasticity Research Program, West Park Healthcare Centre, Toronto, Canada; 5Division of Physiatry, Department of Medicine,  University of Toronto, Toronto, Canada; 6Faculty of Health, York University, Toronto, Canada http://dx.doi.org/10.5535/arm.2016.40.2.279 Ann Rehabil Med 2016;40(2):279-287 To the Editor, After publication of our article, we found that an error in wording in the abstract should be corrected.The correct sentence is as follows, with changes in bold font: “ About 69% of the respondents replied that they did not have any standardized protocols for performing botulinum  toxin injection in patients using anticoagulants.",Non-OADS,/arxiv_data1/oa_pdf/c4/f6/arm-40-556.PMC4951378.pdf
"” We apologize for any inconvenience this may have caused.Yours sincerely, Yongjun JangCorrigendum Corresponding author: Sun Im Department of Rehabilitation Medicine, Bucheon St Mary’s Hospital, College of Medicine, The Catholic University of Korea, 327 Sosa-ro, Wonmi-gu, Bucheon 14647, KoreaTel: +82-32-340-2182, Fax: +82-32-340-2173, E-mail: lafolia@catholic.ac.kr  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/f6/arm-40-556.PMC4951378.pdf
Copyright © 2016 by Korean Academy of Rehabilitation MedicineAnn Rehabil Med 2016;40(3):556pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.3.556 Annals of Rehabilitation Medicine,Non-OADS,/arxiv_data1/oa_pdf/c4/f6/arm-40-556.PMC4951378.pdf
"Correction: Comparison of Therapeutic Effect  of Extracorporeal Shock Wave in Calcific Versus  Noncalcific Lateral Epicondylopathy Jong Wook Park, MD, Ji Hye Hwang, MD, PhD, Yoo Seong Choi, MD, Sang Jun Kim, MD, PhD Department of Physical and Rehabilitation Medicine, Samsung Medical Center,   Sungkyunkwan University School of Medicine, Seoul, Korea http://dx.doi.org/10.5535/arm.2016.40.2.294  Ann Rehabil Med 2016;40(2):294-300 To the Editor, We found the funding acknowledgment in this article was omitted as published.",Non-OADS,/arxiv_data1/oa_pdf/ae/67/arm-40-557.PMC4951379.pdf
"We apologize for any inconvenience this may have caused.Yours sincerely, Sang Jun Kim Corrigendum Corresponding author: Sang Jun Kim Department of Physical and Rehabilitation Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, KoreaTel: +82-2-3410-6069, Fax: +82-2-3410-0052, E-mail: guitarren.kim@samsung.com  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ae/67/arm-40-557.PMC4951379.pdf
Copyright © 2016 by Korean Academy of Rehabilitation MedicineAnn Rehabil Med 2016;40(3):557pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2016.40.3.557 Annals of Rehabilitation Medicine,Non-OADS,/arxiv_data1/oa_pdf/ae/67/arm-40-557.PMC4951379.pdf
"2, 2016G&I    Genomics & InformaticseISSN 2234-0742 Genomics Inform  2016;14(2):41 http://dx.doi.org/10.5808/GI.2016.14.2.41 EDITORIAL *Corresponding author:  Tel: +82-2-2258-7343, Fax: +82-2-537-0572, E-mail: yejun@catholic.ac.kr Copyright © 2016 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).Editor’s Introduction to This Issue Yeun-Jun Chung*  IRCGP , College of Medicine, The Catholic University of Korea, Seoul 06591, Korea Next generation sequencing (NGS) has been facilitating  the discovery and functional validation of causal variants in  diverse rare diseases.",Non-OADS,/arxiv_data1/oa_pdf/ea/21/gni-14-41.PMC4951398.pdf
"G&I    Genomics & InformaticseISSN 2234-0742 Genomics Inform  2016;14(2):42-45 http://dx.doi.org/10.5808/GI.2016.14.2.42 REVIEW ARTICLE Received July 31, 2015; Revised May 10, 2016; Accepted May 26, 2016 *Corresponding author:  Tel: +82-2-740-8912, Fax: +82-2-3673-2167, E-mail: murimchoi@snu.ac.kr Copyright © 2016 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).Ultra-rare Disease and Genomics-Driven  Precision Medicine Sangmoon Lee, Murim Choi* Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea Since next-generation sequencing (NGS) technique was adopted into  clinical practices, revolutionary advances in diagnosing  rare genetic diseases have been achieved through translating genomic medicine into precision or personalized management.",Non-OADS,/arxiv_data1/oa_pdf/92/46/gni-14-42.PMC4951399.pdf
"Chest  2011;139:1480-1490 [16], with permission of Elsevier (License Number: 3892970032119).a potentiator of CFTR, and lumacaftor (Orkambi, Vertex  Pharmaceuticals; combination drug with ivacaftor), a cor- rector of CFTR, were approved by the FDA for the treatment of cystic fibrosis patients with nonsynonymous mutations  (http://www.kalydeco.com) and the F508del mutation  (http://www.orkambi.com), respectively [15].",Non-OADS,/arxiv_data1/oa_pdf/92/46/gni-14-42.PMC4951399.pdf
"G&I    Genomics & InformaticseISSN 2234-0742 Genomics Inform  2016;14(2):46-52 http://dx.doi.org/10.5808/GI.2016.14.2.46 ORIGINAL ARTICLE Received November 25, 2015; Revised April 25, 2016; Accepted April 25, 2016 *Corresponding author:  Tel: +82-2-2123-3683, Fax: +82-2-364-8660, E-mail: yjkim@yonsei.ac.kr †These two authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/0d/33/gni-14-46.PMC4951400.pdf
"Copyright © 2016 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).Classification of Colon Cancer Patients Based  on the Methylation Patterns of Promoters Wonyoung Choi1†, Jungwoo Lee1†, Jin-Young Lee2, Sun-Min Lee2,  Da-Won Kim1, Young-Joon Kim1,2* 1Department of Integrated OMICS for Biomedical Science, Graduate School, Yonsei University, Seoul 03722, Korea 2Department of Biochemistry, College of Life Science & Biotechnology, Yonsei University, Seoul 03722, Korea Diverse somatic mutations have been reported to serve as cancer drivers.",Non-OADS,/arxiv_data1/oa_pdf/0d/33/gni-14-46.PMC4951400.pdf
Methods TCGA COAD DNA methylation datasets and  expression datasets Both methylation and gene expression data were obtained  from the TCGA Data Portal (https://tcga-data.nci.nih.gov/,OADS,/arxiv_data1/oa_pdf/0d/33/gni-14-46.PMC4951400.pdf
Supplementary materials Supplementary data including two tables can be found  with this article online at http://www.genominfo.org/src/  sm/gni-14-46-s001.pdf.Acknowledgments This research was supported by the Global Research  Laboratory Program of the National Research Foundation  (NRF; grant No.,OADS,/arxiv_data1/oa_pdf/0d/33/gni-14-46.PMC4951400.pdf
"SUPPLEMENTARY INFORMATION Classification of Colon Cancer  Patients Based on the Methylation Patterns of Promoters Wonyoung Choi1†, Jungwoo Lee1†, Jin-Young Lee2, Sun-Min Lee2,  Da-Won Kim1, Young-Joon Kim1,2* 1Department of Integrated OMICS for Biomedical Science, Graduate School,  Yonsei University, Seoul 03722, Korea 2Department of Biochemistry, College  of Life Science & Biotechnology,  Yonsei University, Seoul 03722, Korea http://www.genominfo.org/src/sm/gni-14-46-s001.pdf",Non-OADS,/arxiv_data1/oa_pdf/0d/33/gni-14-46.PMC4951400.pdf
"G&I    Genomics & InformaticseISSN 2234-0742 Genomics Inform  2016;14(2):53-61 http://dx.doi.org/10.5808/GI.2016.14.2.53 ORIGINAL ARTICLE Received March 21, 2016; Revised April 6, 2016; Accepted April 8, 2016 *Corresponding author:  Tel: +919840054575, Fax: +91-44-28254180, E-mail: vumashankar@gmail.com †These two authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/4f/50/gni-14-53.PMC4951401.pdf
"Copyright © 2016 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).Multilevel Precision-Based Rational Design of Chemical Inhibitors Targeting the Hydrophobic Cleft  of Toxoplasma gondii  Apical Membrane  Antigen 1 (AMA1) Umashankar Vetrivel1*†, Shalini Muralikumar1†, Mahalakshmi B2, Lily Therese K2,  Madhavan HN2, Mohamed Alameen1, Indhuja Thirumudi1 1Centre for Bioinformatics, Kamalnayan Bajaj Institute for Research in Vision and Ophthalmology, Vision Research Foundation,  Sankara Nethralaya, Chennai 600-006, India, 2L&T Microbiology Research Centre, Kamalnayan Bajaj Institute for Research in Vision and Ophthalmology, Vision Research  Foundation, Sankara Nethralaya, Chennai 600-006, India Toxoplasma gondii  is an intracellular Apicomplexan parasite and a ca usative agent of toxoplasmosis in human.",Non-OADS,/arxiv_data1/oa_pdf/4f/50/gni-14-53.PMC4951401.pdf
Supplementary materials Supplementary data including one figure can be found  with this article online at http://www.genominfo.org/src/  sm/gni-14-53-s001.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4f/50/gni-14-53.PMC4951401.pdf
"SUPPLEMENTARY INFORMATION Multilevel Precision-Based Ration al Design of Chemical Inhibi tors Targeting the Hydrophobic  Cleft of Toxoplasma gondii  Apical Membrane Antigen 1 (AMA1) Umashankar Vetrivel1*†, Shalini Muralikumar1†, Mahalakshmi B2, Lily Therese K2,  Madhavan HN2, Mohamed Alameen1, Indhuja Thirumudi1 1Centre for Bioinformatics, Kamalnayan Bajaj Institute for Research in Vision and Ophthalmology, Vision  Research Foundation, Sankara Neth ralaya, Chennai 600-006, India, 2L&T Microbiology Research Centre, Kamalnayan Bajaj In stitute for Research in Vision and Ophthalmology,  Vision Research Foundation, Sankar a Nethralaya, Chennai 600-006, India http://www.genominfo.org/src/sm/gni-14-53-s001.pdf.",Non-OADS,/arxiv_data1/oa_pdf/4f/50/gni-14-53.PMC4951401.pdf
"G&I    Genomics & InformaticseISSN 2234-0742 Genomics Inform  2016;14(2):62-68 http://dx.doi.org/10.5808/GI.2016.14.2.62 ORIGINAL ARTICLE Received April 14, 2016; Revised May 6, 2016; Accepted May 8, 2016 *Corresponding author:  Tel: +82-2-2072-4012, Fax: +82-2-766-3276, E-mail: jaemoon2@gmail.com **Corresponding author: Tel: +82-2-740-8129, Fax: +82-2-742-5947, E-mail: jongil@snu.ac.kr †These two authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/ca/ab/gni-14-62.PMC4951402.pdf
"Copyright © 2016 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).Genome-Wide Association Study of  Bone Mineral Density in Korean Men Ye Seul Bae1†, Sun-Wha Im2†, Mi So Kang1, Jin Hee Kim1, Soon Hang Lee1, Be Long Cho1,  Jin Ho Park1, You-Seon Nam1, Ho-Young Son3, San Deok Yang3, Joohon Sung4,  Kwang Ho Oh1, Jae Moon Yun1*, Jong Il Kim3** 1Department of Family Medicine, Seoul National University Hospital, Seoul National University College of Medicine,  Seoul 03080, Korea, 2Neuro-Immune Information Storage Network Research Center, Seoul National University College of Medicine,  Seoul 03080, Korea, 3Department of Biochemistry and Molecular Biology, Seoul Na tional University College of Medicine, Seoul 03080, Korea, 4Department of Epidemiology, Seoul National University School of Public Health/Institute of Health and Environment,  Seoul National University, Seoul 08826, Korea Osteoporosis is a medical condition of glob al concern, with increasing incidence in both sexes.",Non-OADS,/arxiv_data1/oa_pdf/ca/ab/gni-14-62.PMC4951402.pdf
Supplementary materials Supplementary data including two figures can be found  with this article online at http://www.genominfo.org/src/  sm/gni-14-62-s001.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ca/ab/gni-14-62.PMC4951402.pdf
"SUPPLEMENTARY INFORMATION Genome-Wide Association Study of Bone Mineral Density in Korean Men Ye Seul Bae1†, Sun-Wha Im2†, Mi So Kang1, Jin Hee Kim1, Soon Hang Lee1,  Be Long Cho1, Jin Ho Park1, You-Seon Nam1, Ho-Young Son3, San Deok Yang3,  Joohon Sung4, Kwang Ho Oh1, Jae Moon Yun1*, Jong Il Kim3** 1Department of Family Medicine, Seoul National Univer sity Hospital, Seoul National University College of  Medicine, Seoul 03080, Korea, 2Neuro-Immune Information Storage Network Research  Center, Seoul National University College of  Medicine, Seoul 03080, Korea, 3Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine,  Seoul 03080, Korea, 4Department of Epidemiology, Seoul National University  School of Public Health/Institute of Health and  Environment, Seoul National University 08826, Seoul, Korea http://www.genominfo.org/src/sm/gni-14-62-s001.pdf.",Non-OADS,/arxiv_data1/oa_pdf/ca/ab/gni-14-62.PMC4951402.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Jul;57(4):1006-1015 http://dx.doi.org/10.3349/ymj.2016.57.4.1006",Non-OADS,/arxiv_data1/oa_pdf/00/db/ymj-57-1006.PMC4951443.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.1006both cell therapies have yielded satisfactory results.11-15 How - ever, bone marrow collection is restricted by the patient’s con - dition and age,13 and the invasive procedure may result in in - fection.",Non-OADS,/arxiv_data1/oa_pdf/00/db/ymj-57-1006.PMC4951443.pdf
"1008Cell Therapy for ONFH with Allogenic PBMSCs http://dx.doi.org/10.3349/ymj.2016.57.4.1006quently stained with Diaminobenzidine (Gene Tech, Shanghai,  China) for 5 min, and washed with tap water.",Non-OADS,/arxiv_data1/oa_pdf/00/db/ymj-57-1006.PMC4951443.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.1006the FH through the bone tunnel.,Non-OADS,/arxiv_data1/oa_pdf/00/db/ymj-57-1006.PMC4951443.pdf
"1010Cell Therapy for ONFH with Allogenic PBMSCs http://dx.doi.org/10.3349/ymj.2016.57.4.1006(equivalent to 5 ng total RNA), and 9.5 µL of RNase Free dH 2O.",Non-OADS,/arxiv_data1/oa_pdf/00/db/ymj-57-1006.PMC4951443.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.1006RESULTS Mobilized rPBMSCs owned the growth characteristics  of MSCs Spindle adherent cells were observed after 24 h of primary cul - ture of mobilized rabbit peripheral blood mononuclear cells  (PBMNCs).,OADS,/arxiv_data1/oa_pdf/00/db/ymj-57-1006.PMC4951443.pdf
"1012Cell Therapy for ONFH with Allogenic PBMSCs http://dx.doi.org/10.3349/ymj.2016.57.4.1006phied, some of which even fused into vesicles and hemato - poietic tissues obviously decreased.",Non-OADS,/arxiv_data1/oa_pdf/00/db/ymj-57-1006.PMC4951443.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.1006in the PBMSCT and CD groups.,OADS,/arxiv_data1/oa_pdf/00/db/ymj-57-1006.PMC4951443.pdf
"1014Cell Therapy for ONFH with Allogenic PBMSCs http://dx.doi.org/10.3349/ymj.2016.57.4.1006DISCUSSION Analysis of CFE of PBMNCs, according to the adherent culture  method,22 indicated that the frequency of adult human PBM - SCs ranged from 0.5 to 5 per million mononuclear cells, which  is 1/20 to 1/5 of human BMMSCs.",OADS,/arxiv_data1/oa_pdf/00/db/ymj-57-1006.PMC4951443.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.1006inhibition of angiogenesis?,Non-OADS,/arxiv_data1/oa_pdf/00/db/ymj-57-1006.PMC4951443.pdf
"Key Words:  Expenditures, prescription drugs, price changesYonsei Med J 2016 Jul;57(4):1016-1021 http://dx.doi.org/10.3349/ymj.2016.57.4.1016Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received: October 19, 2015   Revised: December 4, 2015 Accepted: December 14, 2015Co-corresponding authors: Dr. Kihong Chun, Department of Preventive Medi- cine and Public Health, Ajou University School of Medicine, 164 World cup-ro, Yeongtong-gu, Suwon 16499, Korea.Tel: 82-31-219-5303, Fax: 82-31-219-5084, E-mail: ajoujkh@ajou.ac.kr andDr.",Non-OADS,/arxiv_data1/oa_pdf/8b/84/ymj-57-1016.PMC4951444.pdf
"© Copyright: Yonsei University College of Medicine 2016This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro-duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8b/84/ymj-57-1016.PMC4951444.pdf
"1017 http://dx.doi.org/10.3349/ymj.2016.57.4.1016Jeong-Sook Jo, et al.",OADS,/arxiv_data1/oa_pdf/8b/84/ymj-57-1016.PMC4951444.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.1016 1018Factors Contributing to Drug Expenditures RESULTS Rate of change in drug expenditure by factor The Laspeyres and Paasche indexes were used to adjust and  identify the rate of change in drug expenditure according to original use, drug-mix, and therapeutic choice (Table 1).",OADS,/arxiv_data1/oa_pdf/8b/84/ymj-57-1016.PMC4951444.pdf
"1019 http://dx.doi.org/10.3349/ymj.2016.57.4.1016Jeong-Sook Jo, et al.",OADS,/arxiv_data1/oa_pdf/8b/84/ymj-57-1016.PMC4951444.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.1016 1020Factors Contributing to Drug Expenditures are a global trend, the difference is striking in Korea, compared  to other OECD countries.",OADS,/arxiv_data1/oa_pdf/8b/84/ymj-57-1016.PMC4951444.pdf
"1021 http://dx.doi.org/10.3349/ymj.2016.57.4.1016Jeong-Sook Jo, et al.",OADS,/arxiv_data1/oa_pdf/8b/84/ymj-57-1016.PMC4951444.pdf
"Key Words:   Meningiomas, venous infarction, operations, craniotomyYonsei Med J 2016 Jul;57(4):1022-1028 http://dx.doi.org/10.3349/ymj.2016.57.4.1022Technical Report pISSN: 0513-5796 · eISSN: 1976-2437 Received:  May 11, 2015   Revised:  October 8, 2015 Accepted:  November 24, 2015 Corresponding author:  Dr. Seoung Woo Park, Department of Neurosurgery,  Kangwon National University Hospital, 156 Baengnyeong-ro, Chuncheon 24289,  Korea.",Non-OADS,/arxiv_data1/oa_pdf/a8/a3/ymj-57-1022.PMC4951445.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a8/a3/ymj-57-1022.PMC4951445.pdf
"1023 http://dx.doi.org/10.3349/ymj.2016.57.4.1022Chang Ki Hong, et al.",OADS,/arxiv_data1/oa_pdf/a8/a3/ymj-57-1022.PMC4951445.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.1022 1024Falcotentorial Meningioma preoperative phase and at last follow-up were 84.5 (range, 70 to  90) and 91.8 (60 to 100), respectively.",Non-OADS,/arxiv_data1/oa_pdf/a8/a3/ymj-57-1022.PMC4951445.pdf
"1025 http://dx.doi.org/10.3349/ymj.2016.57.4.1022Chang Ki Hong, et al.",OADS,/arxiv_data1/oa_pdf/a8/a3/ymj-57-1022.PMC4951445.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.1022 1026Falcotentorial Meningioma this is likely due to prolonged retraction of the occipital lobe.,Non-OADS,/arxiv_data1/oa_pdf/a8/a3/ymj-57-1022.PMC4951445.pdf
"1027 http://dx.doi.org/10.3349/ymj.2016.57.4.1022Chang Ki Hong, et al.",OADS,/arxiv_data1/oa_pdf/a8/a3/ymj-57-1022.PMC4951445.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.1022 1028Falcotentorial Meningioma ligate the vein of Galen when the straight sinus was occluded.,Non-OADS,/arxiv_data1/oa_pdf/a8/a3/ymj-57-1022.PMC4951445.pdf
"Key Words:  Laparoscopy, pelvic organ prolapse, robotic surgical procedures, sacrumYonsei Med J 2016 Jul;57(4):1029-1033 http://dx.doi.org/10.3349/ymj.2016.57.4.1029Technical Report pISSN: 0513-5796 · eISSN: 1976-2437 Received: October 16, 2015   Revised: November 10, 2015 Accepted: November 10, 2015Corresponding author: Dr. Sa Ra Lee, Department of Obstetrics and Gynecology, Ewha Womans University School of Medicine, 1071 Anyangcheon-ro, Yangcheon-gu, Seoul 07985, Korea.Tel: 82-2-2650-6011, Fax: 82-2-2647-9860, E-mail: sarahmd@ewha.ac.kr •The author has no financial conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/08/5a/ymj-57-1029.PMC4951446.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro-duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/08/5a/ymj-57-1029.PMC4951446.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.1029 1030Robotic Single Site Sacrocolpopexy for Advanced Pelvic Organ Prolapse sacrocolpopexy.,Non-OADS,/arxiv_data1/oa_pdf/08/5a/ymj-57-1029.PMC4951446.pdf
"1031 http://dx.doi.org/10.3349/ymj.2016.57.4.1029Sa Ra Lee traperitoneal fat of the anterior abdominal wall obscuring the  operation field was temporarily sutured and tied to the anterior abdominal wall with 2-0 PDS TM sutures (Ethicon, Johnson &  Johnson, New Brunswick, NJ, USA).",Non-OADS,/arxiv_data1/oa_pdf/08/5a/ymj-57-1029.PMC4951446.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.1029 1032Robotic Single Site Sacrocolpopexy for Advanced Pelvic Organ Prolapse RSS operation, the silicon port partially blocked the path for  the removal of the curved needles, whereas the silicon port did not block the path when I inserted the curved needles as shown in the schematic drawing in Fig.",Non-OADS,/arxiv_data1/oa_pdf/08/5a/ymj-57-1029.PMC4951446.pdf
"1033 http://dx.doi.org/10.3349/ymj.2016.57.4.1029Sa Ra Lee lenging in terms of single-port laparoscopic surgery.8,9 LSC for  POP is a good example of this type of technically difficult sur - gery.",Non-OADS,/arxiv_data1/oa_pdf/08/5a/ymj-57-1029.PMC4951446.pdf
"Key Words:   Orientia tsutsugamushi , scrub typhus, tigecycline, IC 50Yonsei Med J 2016 Jul;57(4):1034-1037 http://dx.doi.org/10.3349/ymj.2016.57.4.1034Brief Communication pISSN: 0513-5796 · eISSN: 1976-2437 Received:  March 6, 2015   Revised:  September 10, 2015 Accepted:  September 14, 2015 Corresponding author:  Dr. Jin-Soo Lee, Division of Infectious Diseases, Depart - ment of Internal Medicine, Inha University School of Medicine, 27 Inhang-ro, Jung- gu, Incheon 22332, Korea.",Non-OADS,/arxiv_data1/oa_pdf/7f/a7/ymj-57-1034.PMC4951447.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7f/a7/ymj-57-1034.PMC4951447.pdf
"1035 http://dx.doi.org/10.3349/ymj.2016.57.4.1034Sun-Myoung Lee, et al.",OADS,/arxiv_data1/oa_pdf/7f/a7/ymj-57-1034.PMC4951447.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.1034 1036Tigecycline on O. tsutsugamushi for the treatment of complicated skin and soft tissue infections  and intra-abdominal infection in 2005.16 It has a broad antibac - terial activity.,Non-OADS,/arxiv_data1/oa_pdf/7f/a7/ymj-57-1034.PMC4951447.pdf
"1037 http://dx.doi.org/10.3349/ymj.2016.57.4.1034Sun-Myoung Lee, et al.",OADS,/arxiv_data1/oa_pdf/7f/a7/ymj-57-1034.PMC4951447.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Jul;57(4):1038-1041 http://dx.doi.org/10.3349/ymj.2016.57.4.1038",Non-OADS,/arxiv_data1/oa_pdf/b7/b3/ymj-57-1038.PMC4951448.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.1038proved the study (AJIRB-MED-FOD-14-196).,Non-OADS,/arxiv_data1/oa_pdf/b7/b3/ymj-57-1038.PMC4951448.pdf
"1040Xanthigen and Brown Adipose Tissue http://dx.doi.org/10.3349/ymj.2016.57.4.1038that all human BAT abundantly expressed beige cell-selective  genes, but the expression of classical brown fat-selective genes  were nearly undetectable.6 There seems to be an important  physiological cross-talk between the constitutive (BAT) and re - cruitable (beige) brown fat cells.7  The sympathetic nervous system is currently seen as the main  effector for brown fat function8 and white adipocytes of pure  white fat that are subject to adrenergic stimulation are able to  undergo a process of direct transformation into brown adipo - cytes.9 Under cold exposure, the sympathetic nerve system is  activated via the expression of cold receptor TRPM8 in human  adipocytes inducing their “browning” .",Non-OADS,/arxiv_data1/oa_pdf/b7/b3/ymj-57-1038.PMC4951448.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.1038es compensatory browning of white fat.,Non-OADS,/arxiv_data1/oa_pdf/b7/b3/ymj-57-1038.PMC4951448.pdf
"Key Words:  Pneumocystis pneumonia, HIV infections, immune reconstitution inflammatory syndromeYonsei Med J 2016 Jul;57(4):1042-1046 http://dx.doi.org/10.3349/ymj.2016.57.4.1042Case Report pISSN: 0513-5796 · eISSN: 1976-2437 Received: May 18, 2015   Revised: July 16, 2015 Accepted: July 20, 2015Corresponding author: Dr. Jung Yeon Heo, Division of Infectious Diseases, De-partment of Internal Medicine, Chungbuk National University Hospital, 776 1sun-hwan-ro, Seowon-gu, Cheongju 28644, Korea.Tel: 82-43-269-7364, Fax: 82-43-273-3252, E-mail: jyeon78@naver.com •The authors have no financial conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/90/7e/ymj-57-1042.PMC4951449.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro-duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/7e/ymj-57-1042.PMC4951449.pdf
"1043 http://dx.doi.org/10.3349/ymj.2016.57.4.1042Hyung-Woo Kim, et al.",OADS,/arxiv_data1/oa_pdf/90/7e/ymj-57-1042.PMC4951449.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.1042 1044Granulomatous PJP in an HIV-Infected Patient Table 1.,Non-OADS,/arxiv_data1/oa_pdf/90/7e/ymj-57-1042.PMC4951449.pdf
"1045 http://dx.doi.org/10.3349/ymj.2016.57.4.1042Hyung-Woo Kim, et al.",OADS,/arxiv_data1/oa_pdf/90/7e/ymj-57-1042.PMC4951449.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.1042 1046Granulomatous PJP in an HIV-Infected Patient infection: a systematic review and meta-analysis.,Non-OADS,/arxiv_data1/oa_pdf/90/7e/ymj-57-1042.PMC4951449.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Jul;57(4):1047-1048 http://dx.doi.org/10.3349/ymj.2016.57.4.1047 Arbekacin as an Alternative Drug to Teicoplanin   for the Treatment of MRSA Infection Ji-Hee Hwang1, Ju-Hyung Lee2, Ju-Sin Kim1, Jeong-Hwan Hwang3,4,5, and Chang-Seop Lee3,4,5 1Department of Pharmacy, Chonbuk National University Hospital, Jeonju; Departments of 2Preventive Medicine, 3Internal Medicine, and 4Research Institute of Clinical Medicine, Chonbuk National University, Jeonju; 5Biomedical Research Institute of Chonbuk National University Hospital, Jeonju, Korea.Letter to the Editor",Non-OADS,/arxiv_data1/oa_pdf/9d/4b/ymj-57-1047.PMC4951450.pdf
"1048Arbekacin as an Alternative Drug to Teicoplanin http://dx.doi.org/10.3349/ymj.2016.57.4.1047BER of the arbekacin and teicoplanin groups were 72.9% (51/  70) and 70.3% (45/64), respectively: The BER of the arbekacin  group was 2.6% higher than that of the teicoplanin group, but  this difference was not significant ( p=0.835).",OADS,/arxiv_data1/oa_pdf/9d/4b/ymj-57-1047.PMC4951450.pdf
")Yonsei Med J 2016 Jul;57(4):1049-1049 http://dx.doi.org/10.3349/ymj.2016.57.4.1049Erratum pISSN: 0513-5796 · eISSN: 1976-2437 © Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.The year of death of Hun Jae Lee was incorrectly written as 1983, when in fact the correct year was 1981.",Non-OADS,/arxiv_data1/oa_pdf/04/b9/ymj-57-1049.PMC4951451.pdf
")Yonsei Med J 2016 Jul;57(4):1050-1050 http://dx.doi.org/10.3349/ymj.2016.57.4.1050Erratum pISSN: 0513-5796 · eISSN: 1976-2437 © Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.We would like to change the order of authors such that the first author is SM Kwon.",Non-OADS,/arxiv_data1/oa_pdf/a4/16/ymj-57-1050.PMC4951452.pdf
"1051 www.eymj.orgYonsei Med J 2016 July;57(4):1051-1051 http://dx.doi.org/10.3349/ymj.2016.57.4.1051Erratum pISSN: 0513-5796 · eISSN: 1976-2437 © Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.ACKNOWLEDGEMENTS This study was supported by a grant from Dong-A Pharm.",Non-OADS,/arxiv_data1/oa_pdf/ae/16/ymj-57-1051.PMC4951453.pdf
"Key Words:  Immunity, respiratory syncytial viruses, vaccine, vaccine-enhanced diseasesYonsei Med J 2016 Jul;57(4):809-816 http://dx.doi.org/10.3349/ymj.2016.57.4.809Review Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  March 22, 2016    Corresponding author:  Dr. Jun Chang, Graduate School of Pharmaceutical Sci - ences, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul 03760,  Korea.",Non-OADS,/arxiv_data1/oa_pdf/11/2f/ymj-57-809.PMC4951454.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/11/2f/ymj-57-809.PMC4951454.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.809 810Immunity and Vaccines for Respiratory Syncytial Virus Infection immunity against RSV by recognizing certain conserved viral  motifs.5,6 For instance, the fusion (F) protein of RSV has been  observed to activate TLR4.7 Moreover, RSV induces produc - tion of inflammatory cytokines and chemokines through  TLR2 and TLR6, which activate innate immunity by promot - ing TNF-α, interleukin (IL)-6, MCP-1, and RANTES produc - tion.8 The early inflammatory signals generated by RSV-TLR  interactions during RSV infection are likely to recruit neutro - phils and natural killer (NK) cells into the lung, which are im - portant for clearing RSV-infected cells.",Non-OADS,/arxiv_data1/oa_pdf/11/2f/ymj-57-809.PMC4951454.pdf
"811 http://dx.doi.org/10.3349/ymj.2016.57.4.809Joo Young Kim and Jun Chang ing between CX3C and CX3CRl and reduced viral replication  in both prophylaxis and treatment mouse models of RSV chal - lenge.23 A non-neutralizing monoclonal antibody against a G  protein epitope (amino acid positions 174 –187) was reported  to provide passive protection via both ADCC and comple - ment-mediated cytolysis.24 Previous works suggested that a re - combinant G protein core fragment of amino acids 131 to 230  (Gcf) induced strong immunoglobulin responses (RSV-spe - cific IgG and IgA) in mice as well as potent chemotactic activi - ty in a cell migration assay.25 An excellent vector-based muco - sal vaccine comprising a recombinant replication-deficient  adenovirus expressing the tandem repeats of Gcf also induced  strong RSV-specific B-cell responses and showed protective  efficacy against human RSV A and B.26,27 As prophylactic vaccine candidates or therapeutics, con - served RSV antigens and neutralizing and/or non-neutralizing  antibodies to these target antigens could play a role in provid - ing protection against RSV infection.",Non-OADS,/arxiv_data1/oa_pdf/11/2f/ymj-57-809.PMC4951454.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.809 812Immunity and Vaccines for Respiratory Syncytial Virus Infection Despite their importance in RSV clearance, T cells are also  associated with RSV disease severity.",Non-OADS,/arxiv_data1/oa_pdf/11/2f/ymj-57-809.PMC4951454.pdf
813 http://dx.doi.org/10.3349/ymj.2016.57.4.809Joo Young Kim and Jun Chang Table 1.,OADS,/arxiv_data1/oa_pdf/11/2f/ymj-57-809.PMC4951454.pdf
"Clinical Trials of Vaccines for RSV Infection VaccineAge (yrs) Developer Phase ReferenceType Antigen Live-attenuatedRSV-PIV3 chimeric virus (MEDI-534) 0.2–9 MedImmune 1, 2 Gomez, et al.57; Bernstein, et al.58; Yang, et al.59 rA2cp248/404/1030ΔSH (MEDI-559) 0.4–2 MedImmune 1, 2 Schickli, et al.60; Malkin, et al.61 RSV MEDI ΔM2-2 0.5–49 NIAID 1 Bermingham and Collins62; Karron, et al.63 RSV ΔNS2 Δ1313 I1314L 0.5–5 NIAID 1 Luongo, et al.64 rA2cp248/404/1030ΔSH containing five independent     attenuating elements0.5–2 NIAID 1 Luongo, et al.65 RSV LID ΔM2-2 0.5–2 NIAID 1 M2-2 deleted RSV (D46cpΔM2-2) 0.5–5 NIAID 1 Karron, et al.63 SubunitRSV-F 2–6, 18–49, >60 Novavax 1, 2, 3Calder, et al.66; Collins and Mottet67;     López, et al.68; Glenn, et al.69 RSV-sF/GLA (MEDI-7510) >60 MedImmune 1, 2 RSV F 18–45 Novartis 1 RSV-SHe/DepoVaxTM and alum 50–64Dalhousie University,     ImmunoVaccine Technologies1 https://www.imvaccine.com/infectvac.php VectoredChimpanzee Adenovirus and Modified Vaccinia Ankara     encoding the F, N, and M2-1 proteins of RSV     (PanAd3-RSV, MVA-RSV)18–75 ReiThera Srl 1 Pierantoni, et al.70 Adenovirus encoding full length RSV F protein     (Ad26.RSV.FA2 & Ad35.RSV.FA2)18–50 Crucell Holland BV 1 Widjojoatmodjo, et al.71 Chimpanzee Adenovirus encoding RSV protein     (ChAd155-RSV; GSK3389245A)18–45 GSK 1 http://www.gsk-clinicalstudyregister.com/study/201974#ps Modified Vaccinia Ankara encoding two surface     proteins of RSV (MVA-mBN294B)18–65 Bavarian Nordic 1 http://www.bavarian-nordic.com/ Immuno-stimulant GSK3003891A 18–45 GSK 1, 2http://www.gsk-clinicalstudyregister.com/compounds/     gsk3003891a#ps RSV, respiratory syncytial virus; PIV3, parainfluenza virus type 3; cp, cold-passaged; NIAID, National Institute of Allergy and Infectious Diseases; GSK, GlaxoSmithKline.",Non-OADS,/arxiv_data1/oa_pdf/11/2f/ymj-57-809.PMC4951454.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.809 814Immunity and Vaccines for Respiratory Syncytial Virus Infection nity, viral immune evasion, and immunopathology of RSV in - fection, the closer we move towards the first licensed RSV vac - cine.",Non-OADS,/arxiv_data1/oa_pdf/11/2f/ymj-57-809.PMC4951454.pdf
"815 http://dx.doi.org/10.3349/ymj.2016.57.4.809Joo Young Kim and Jun Chang PL, et al.",OADS,/arxiv_data1/oa_pdf/11/2f/ymj-57-809.PMC4951454.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.809 816Immunity and Vaccines for Respiratory Syncytial Virus Infection tory syncytial virus fusion protein and complexes that it forms  with monoclonal antibodies.,Non-OADS,/arxiv_data1/oa_pdf/11/2f/ymj-57-809.PMC4951454.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Jul;57(4):817-823 http://dx.doi.org/10.3349/ymj.2016.57.4.817",Non-OADS,/arxiv_data1/oa_pdf/01/69/ymj-57-817.PMC4951455.pdf
"818Hearing Restoration in Neurofibromatosis Type II Patients http://dx.doi.org/10.3349/ymj.2016.57.4.817However, this hypothesis cannot explain hearing loss when  tumors are small, progressive hearing loss in the presence of  non-growing tumors, or unpredictable onset of hearing loss.4,5  In 2012, Roosli, et al.6 reviewed the histopathology of cochle - ae in patients with VSs and observed loss of inner and outer  hair cells, atrophy of the stria vascularis, loss of cochlear neu - rons, and the presence of endolymphatic hydrops.",Non-OADS,/arxiv_data1/oa_pdf/01/69/ymj-57-817.PMC4951455.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.817chored Solutions AB, Molnlycke, Sweden), and BonebridgeTM  (MED-EL, Innsbruck, Austria).",OADS,/arxiv_data1/oa_pdf/01/69/ymj-57-817.PMC4951455.pdf
820Hearing Restoration in Neurofibromatosis Type II Patients http://dx.doi.org/10.3349/ymj.2016.57.4.817tifacts.,Non-OADS,/arxiv_data1/oa_pdf/01/69/ymj-57-817.PMC4951455.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.817AUDITORY BRAINSTEM IMPLANT After the first successful implantation in 1979, ABIs were origi - nally the only way to restore hearing in patients with NF-II.",Non-OADS,/arxiv_data1/oa_pdf/01/69/ymj-57-817.PMC4951455.pdf
"822Hearing Restoration in Neurofibromatosis Type II Patients http://dx.doi.org/10.3349/ymj.2016.57.4.817of cases of NF-II have bilateral VSs.2 If a contralateral VS is too  large, cerebellar retraction is hardly feasible; thus, RSA would  not be able to provide the proper surgical views.",Non-OADS,/arxiv_data1/oa_pdf/01/69/ymj-57-817.PMC4951455.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.817ing with a new implant technology: a comparative study with a  new nonskin penetrating Baha system.,Non-OADS,/arxiv_data1/oa_pdf/01/69/ymj-57-817.PMC4951455.pdf
http://dx.doi.org/10.1227/neu.0000000000001125.,Non-OADS,/arxiv_data1/oa_pdf/01/69/ymj-57-817.PMC4951455.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Jul;57(4):824-830 http://dx.doi.org/10.3349/ymj.2016.57.4.824",Non-OADS,/arxiv_data1/oa_pdf/07/66/ymj-57-824.PMC4951456.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.824used the World Health Organization (WHO) grading system  of primary brain tumors.,Non-OADS,/arxiv_data1/oa_pdf/07/66/ymj-57-824.PMC4951456.pdf
"826Re-Irradiation for Recurrent Gliomas http://dx.doi.org/10.3349/ymj.2016.57.4.824tions and 195.8 Gy (range, 157.3–239.7 Gy) for median cumu - lative BED ( α/β=2 Gy).",Non-OADS,/arxiv_data1/oa_pdf/07/66/ymj-57-824.PMC4951456.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.824tient characteristics and survival outcome.,OADS,/arxiv_data1/oa_pdf/07/66/ymj-57-824.PMC4951456.pdf
"828Re-Irradiation for Recurrent Gliomas http://dx.doi.org/10.3349/ymj.2016.57.4.824Gy (range, 181.3–232.5 Gy), and the median time between prior  RT and re-irradiation was 32 months (range, 19–173 months).",OADS,/arxiv_data1/oa_pdf/07/66/ymj-57-824.PMC4951456.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.824vs.,OADS,/arxiv_data1/oa_pdf/07/66/ymj-57-824.PMC4951456.pdf
830Re-Irradiation for Recurrent Gliomas http://dx.doi.org/10.3349/ymj.2016.57.4.824therapy and chemotherapy.,Non-OADS,/arxiv_data1/oa_pdf/07/66/ymj-57-824.PMC4951456.pdf
"Key Words:   Urinary bladder neoplasms, receptor tyrosine kinases, prognosis, cystectomyYonsei Med J 2016 Jul;57(4):831-839 http://dx.doi.org/10.3349/ymj.2016.57.4.831Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  June 9, 2015   Revised:  October 22, 2015 Accepted:  October 23, 2015 Corresponding author:  Dr. Sun Young Rha, Division of Medical Oncology, De - partment of Internal Medicine, Yonsei University College of Medicine, 50-1 Yon - sei-ro, Seodaemun-gu, Seoul 03722, Korea.",Non-OADS,/arxiv_data1/oa_pdf/00/15/ymj-57-831.PMC4951457.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/00/15/ymj-57-831.PMC4951457.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.831 832FGFR1, a Prognostic Factor in Muscle Invasive Urothelial Carcinoma experience one or more recurrences, and 25% will eventually  develop muscle invasive disease.",Non-OADS,/arxiv_data1/oa_pdf/00/15/ymj-57-831.PMC4951457.pdf
"833 http://dx.doi.org/10.3349/ymj.2016.57.4.831Seungtaek Lim, et al.",OADS,/arxiv_data1/oa_pdf/00/15/ymj-57-831.PMC4951457.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.831 834FGFR1, a Prognostic Factor in Muscle Invasive Urothelial Carcinoma in 36 patients (36.7%).",Non-OADS,/arxiv_data1/oa_pdf/00/15/ymj-57-831.PMC4951457.pdf
"835 http://dx.doi.org/10.3349/ymj.2016.57.4.831Seungtaek Lim, et al.",OADS,/arxiv_data1/oa_pdf/00/15/ymj-57-831.PMC4951457.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.831 836FGFR1, a Prognostic Factor in Muscle Invasive Urothelial Carcinoma DISCUSSION We investigated the prognostic role of three different RTKs in  the survival of the patients who underwent radical cystectomy  for muscle invasive UC, and found that FGFR1 was a strong  prognostic factor, whereas HER2 and FGFR3 did not show any  prognostic impact.",OADS,/arxiv_data1/oa_pdf/00/15/ymj-57-831.PMC4951457.pdf
"837 http://dx.doi.org/10.3349/ymj.2016.57.4.831Seungtaek Lim, et al.",OADS,/arxiv_data1/oa_pdf/00/15/ymj-57-831.PMC4951457.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.831 838FGFR1, a Prognostic Factor in Muscle Invasive Urothelial Carcinoma ever, one should be cautious to accept this hypothesis until it  is validated in subsequent trials.",Non-OADS,/arxiv_data1/oa_pdf/00/15/ymj-57-831.PMC4951457.pdf
"839 http://dx.doi.org/10.3349/ymj.2016.57.4.831Seungtaek Lim, et al.",OADS,/arxiv_data1/oa_pdf/00/15/ymj-57-831.PMC4951457.pdf
"Key Words:  Nasopharyngeal neoplasm, neoplasm metastasis, prognosisYonsei Med J 2016 Jul;57(4):840-845 http://dx.doi.org/10.3349/ymj.2016.57.4.840Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received: July 20, 2015   Revised: December 4, 2015 Accepted: December 9, 2015Corresponding author: Dr. Jianji Pan, Provincial Clinical College of Fujian Medical University, Department of Radiation Oncology, Fujian Provincial Cancer Hospital, No.",Non-OADS,/arxiv_data1/oa_pdf/d9/7c/ymj-57-840.PMC4951458.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro-duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d9/7c/ymj-57-840.PMC4951458.pdf
"841 http://dx.doi.org/10.3349/ymj.2016.57.4.840Tianzhu Lu, et al.",OADS,/arxiv_data1/oa_pdf/d9/7c/ymj-57-840.PMC4951458.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.840 842Prognostic Evaluation for NPC with Bone-Only Metastasis ceived platinum plus gemcitabine, and the other 15 patients  used platinum plus paclitaxel.",Non-OADS,/arxiv_data1/oa_pdf/d9/7c/ymj-57-840.PMC4951458.pdf
"843 http://dx.doi.org/10.3349/ymj.2016.57.4.840Tianzhu Lu, et al.",OADS,/arxiv_data1/oa_pdf/d9/7c/ymj-57-840.PMC4951458.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.840 844Prognostic Evaluation for NPC with Bone-Only Metastasis show different prognoses.8 Bone metastasis is one of the pre- dominant failure sites of NPC, the treatment outcome of which  is far from satisfactory.8,11-13 Our series indicated a median OMS  time of 26.5 months, with a 2-year OMS rate of 52%.",Non-OADS,/arxiv_data1/oa_pdf/d9/7c/ymj-57-840.PMC4951458.pdf
"845 http://dx.doi.org/10.3349/ymj.2016.57.4.840Tianzhu Lu, et al.",OADS,/arxiv_data1/oa_pdf/d9/7c/ymj-57-840.PMC4951458.pdf
"Key Words:   Lymphoma, radiotherapy, recurrenceYonsei Med J 2016 Jul;57(4):846-854 http://dx.doi.org/10.3349/ymj.2016.57.4.846Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  August 27, 2015   Revised:  November 10, 2015 Accepted:  November 23, 2015 Corresponding author:  Dr. Chang-Ok Suh, Department of Radiation Oncology,  Yonsei Cancer Center, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seo - daemun-gu, Seoul 03722, Korea.",Non-OADS,/arxiv_data1/oa_pdf/9c/00/ymj-57-846.PMC4951459.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/00/ymj-57-846.PMC4951459.pdf
"847 http://dx.doi.org/10.3349/ymj.2016.57.4.846Tae Hyung Kim, et al.",OADS,/arxiv_data1/oa_pdf/9c/00/ymj-57-846.PMC4951459.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.846 848Radiotherapy for Early-Stage ENKTL doxorubicin, and prednisone; and four were administered ifos - famide, methotrexate, and VP-16 (IMVP-16).",Non-OADS,/arxiv_data1/oa_pdf/9c/00/ymj-57-846.PMC4951459.pdf
"849 http://dx.doi.org/10.3349/ymj.2016.57.4.846Tae Hyung Kim, et al.",OADS,/arxiv_data1/oa_pdf/9c/00/ymj-57-846.PMC4951459.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.846 850Radiotherapy for Early-Stage ENKTL tion experienced untreated regional node failure.,OADS,/arxiv_data1/oa_pdf/9c/00/ymj-57-846.PMC4951459.pdf
"851 http://dx.doi.org/10.3349/ymj.2016.57.4.846Tae Hyung Kim, et al.",OADS,/arxiv_data1/oa_pdf/9c/00/ymj-57-846.PMC4951459.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.846 852Radiotherapy for Early-Stage ENKTL with that in Patient 6 (7 months).,Non-OADS,/arxiv_data1/oa_pdf/9c/00/ymj-57-846.PMC4951459.pdf
"853 http://dx.doi.org/10.3349/ymj.2016.57.4.846Tae Hyung Kim, et al.",OADS,/arxiv_data1/oa_pdf/9c/00/ymj-57-846.PMC4951459.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.846 854Radiotherapy for Early-Stage ENKTL ed for patients who might benefit from the administration of CT.,Non-OADS,/arxiv_data1/oa_pdf/9c/00/ymj-57-846.PMC4951459.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Jul;57(4):855-864 http://dx.doi.org/10.3349/ymj.2016.57.4.855",Non-OADS,/arxiv_data1/oa_pdf/0c/7b/ymj-57-855.PMC4951460.pdf
"856Prognostic Factors in Korean Non-Muscle-Invasive Bladder Cancer http://dx.doi.org/10.3349/ymj.2016.57.4.855INTRODUCTION Bladder cancer is the second most common malignancy of the  genitourinary tract and shows a male predominance.1,2 In the  United States, bladder cancer was ranked fourth, considering  the incidence among all newly diagnosed cancers in men in  2014.1 It is also estimated that in Korea, a total of 4173 cases  were newly diagnosed in 2014, giving bladder cancer a rank of  seventh, considering the incidence in men.2 Urothelial carcino - ma of the bladder (UCB) is the most common histologic type,  accounting for 80–90% of all bladder cancer.",Non-OADS,/arxiv_data1/oa_pdf/0c/7b/ymj-57-855.PMC4951460.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.855were categorized into low-, intermediate-, and high-risk groups  (Supplementary Table 1, only online).",Non-OADS,/arxiv_data1/oa_pdf/0c/7b/ymj-57-855.PMC4951460.pdf
"858Prognostic Factors in Korean Non-Muscle-Invasive Bladder Cancer http://dx.doi.org/10.3349/ymj.2016.57.4.8552.48; p=0.001) was significantly associated with worse RFS (Sup- plementary Table 3, only online), while there were no relevant  factors with a risk of progression on univariable analysis, ex - cept for advanced age (HR 5.81; 95% CI 1.55–20.02; p=0.008)  (Supplementary Table 4, only online).",Non-OADS,/arxiv_data1/oa_pdf/0c/7b/ymj-57-855.PMC4951460.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.855DISCUSSION Although NMIBC may be treated by TURBT alone, high recur - rence (50–70%) and progression (10–20%) rates can be prob - lematic in the management of most NMIBC cases.3,4 Therefore,  it is necessary to consider adjuvant therapy in most patients to  prevent disease recurrence and progression.",Non-OADS,/arxiv_data1/oa_pdf/0c/7b/ymj-57-855.PMC4951460.pdf
"860Prognostic Factors in Korean Non-Muscle-Invasive Bladder Cancer http://dx.doi.org/10.3349/ymj.2016.57.4.855current CIS, and tumor grade, were developed by the Europe - an Organization for Research and Treatment of Cancer (EO- RTC) and validated by several investigators.14-16 The Spanish  Urological Club for Oncological Treatment (CUETO) scoring  model was also developed to stratify the risk of recurrence and  progression in NMIBC treated with BCG.17 Incorporated vari - ables for the model were sex, age, tumor grade, tumor status (primary, recurrent), multiplicity, and associated Tis for recur - rence, and age, grade, tumor status, T category, multiplicity,  and associated Tis for progression.",OADS,/arxiv_data1/oa_pdf/0c/7b/ymj-57-855.PMC4951460.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.855comitant CIS showed a close association with a high risk of  progression in patients with T1G3 tumors who received BCG.13  In high-risk NMIBC (Ta, T1) patients treated with BCG, tumor  size (<3 cm, ≥3 cm) and T stage (Ta, T1) correlated with recur -rence and progression, respectively.12 Female sex was related  to worse RFS, PFS, and cancer-specific survival (CSS) in pa - tients with T1HG disease.8,9 Other prognostic factors were also  evaluated in several studies.",OADS,/arxiv_data1/oa_pdf/0c/7b/ymj-57-855.PMC4951460.pdf
"862Prognostic Factors in Korean Non-Muscle-Invasive Bladder Cancer http://dx.doi.org/10.3349/ymj.2016.57.4.855intravesical instillation were reported as significant predictors  of recurrence in all NMIBC cases.7,18 In T1HG tumors, papil - lary tumor architecture (vs. sessile), no LVI, non-trigonal tumor  location, intravesical BCG therapy, and presence of muscle  layer in TURBT specimen were suggested as factors associat - ed with improved PFS.5,11 In the present study, the prognostic factors mentioned above  showed various clinical implications in association with prog - nosis after TURBT.",Non-OADS,/arxiv_data1/oa_pdf/0c/7b/ymj-57-855.PMC4951460.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.855vention of disease recurrence and progression.,Non-OADS,/arxiv_data1/oa_pdf/0c/7b/ymj-57-855.PMC4951460.pdf
864Prognostic Factors in Korean Non-Muscle-Invasive Bladder Cancer http://dx.doi.org/10.3349/ymj.2016.57.4.855tional cell carcinoma of the bladder: results of a meta-analysis.,OADS,/arxiv_data1/oa_pdf/0c/7b/ymj-57-855.PMC4951460.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Jul;57(4):865-871 http://dx.doi.org/10.3349/ymj.2016.57.4.865",Non-OADS,/arxiv_data1/oa_pdf/4b/de/ymj-57-865.PMC4951461.pdf
866Metabolic Pathways in Bladder Cancer http://dx.doi.org/10.3349/ymj.2016.57.4.865nological and data analysis have enabled the characterization  of metabolites in biofluids.,OADS,/arxiv_data1/oa_pdf/4b/de/ymj-57-865.PMC4951461.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.865ing system.18  Extraction of RNA, synthesis of cDNA, and real-time  PCR Extraction of RNA and synthesis of cDNA, and real-time PCR  were performed, as described previously.19 The primers used  for gene amplification are shown in Table 1.",OADS,/arxiv_data1/oa_pdf/4b/de/ymj-57-865.PMC4951461.pdf
The metabolic pathways associated  with the selected urinary metabolites were identified using  KEGG pathways (http://www.genome.jp/kegg).,OADS,/arxiv_data1/oa_pdf/4b/de/ymj-57-865.PMC4951461.pdf
"868Metabolic Pathways in Bladder Cancer http://dx.doi.org/10.3349/ymj.2016.57.4.865Comparison of gene expression levels between MIBC  patients and controls  Among the carnitine-acylcarnitine metabolic pathway-asso - ciated genes, the expression levels of CPT1B , CPT1C , and CRAT   were significantly lower in MIBC tissues than those of controls  (p<0.05) (Table 4, Fig.",Non-OADS,/arxiv_data1/oa_pdf/4b/de/ymj-57-865.PMC4951461.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.865DISCUSSION Our previous study identified twelve urinary metabolites, in - cluding carnitine, and their derivatives and melatonin, as po - tential diagnostic biomarkers for BCA.13 The following bioinfor - matics analysis showed that these metabolites were enriched  in the carnitine-acylcarnitine or tryptophan metabolic path - ways.",OADS,/arxiv_data1/oa_pdf/4b/de/ymj-57-865.PMC4951461.pdf
870Metabolic Pathways in Bladder Cancer http://dx.doi.org/10.3349/ymj.2016.57.4.865protein.,Non-OADS,/arxiv_data1/oa_pdf/4b/de/ymj-57-865.PMC4951461.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.865rence using a liquid chromatography-mass spectrometry and cap - illary electrophoresis-mass spectrometry metabolomics approach.,OADS,/arxiv_data1/oa_pdf/4b/de/ymj-57-865.PMC4951461.pdf
"Key Words:  Gene expression, microarray analysis, ovarian cancer, prognosisYonsei Med J 2016 Jul;57(4):872-878 http://dx.doi.org/10.3349/ymj.2016.57.4.872Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received: August 3, 2015   Revised: September 3, 2015 Accepted: October 8, 2015Corresponding author: Dr. Jong-Il Kim, Department of Biomedical Sciences, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080, Korea.Tel: 82-2-740-8251, Fax: 82-2-747-8250, E-mail: jongil@snu.ac.kr •The authors have no financial conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/c5/f8/ymj-57-872.PMC4951462.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro-duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c5/f8/ymj-57-872.PMC4951462.pdf
"873 http://dx.doi.org/10.3349/ymj.2016.57.4.872San-Duk Yang, et al.",OADS,/arxiv_data1/oa_pdf/c5/f8/ymj-57-872.PMC4951462.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.872 874Prognostic Marker Genes in Ovarian Cancer Fig.,Non-OADS,/arxiv_data1/oa_pdf/c5/f8/ymj-57-872.PMC4951462.pdf
"875 http://dx.doi.org/10.3349/ymj.2016.57.4.872San-Duk Yang, et al.",OADS,/arxiv_data1/oa_pdf/c5/f8/ymj-57-872.PMC4951462.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.872 876Prognostic Marker Genes in Ovarian Cancer The clustering of survival and nonsurvival groups from all pa- tients with OC using DEGs was not as clear as the subgroups with or without LI, suggesting that the cancers from each sub-group might have had a different pathophysiology that influ-enced the survival of the patients.",Non-OADS,/arxiv_data1/oa_pdf/c5/f8/ymj-57-872.PMC4951462.pdf
"877 http://dx.doi.org/10.3349/ymj.2016.57.4.872San-Duk Yang, et al.",OADS,/arxiv_data1/oa_pdf/c5/f8/ymj-57-872.PMC4951462.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.872 878Prognostic Marker Genes in Ovarian Cancer worthy of future studies, and that our results would be helpful  for researchers as well as clinicians in the OC field.",Non-OADS,/arxiv_data1/oa_pdf/c5/f8/ymj-57-872.PMC4951462.pdf
Available at: http://www.cdc.gov/uscs.,OADS,/arxiv_data1/oa_pdf/c5/f8/ymj-57-872.PMC4951462.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Jul;57(4):879-884 http://dx.doi.org/10.3349/ymj.2016.57.4.879",Non-OADS,/arxiv_data1/oa_pdf/31/96/ymj-57-879.PMC4951463.pdf
"880ALDH2 Polymorphism and Alcoholic Liver Cirrhosis Risk http://dx.doi.org/10.3349/ymj.2016.57.4.879MATERIALS AND METHODS Search strategy We searched the electronic literature PubMed, Web of Science,  CNKI, Wanfang and Veipu databases for all relevant articles.",OADS,/arxiv_data1/oa_pdf/31/96/ymj-57-879.PMC4951463.pdf
Statistical analysis HWE was evaluated for each study using an internet-based  HWE calculator (http://ihg.gsf.de/cgi-bin/hw/hwa1.pl).,OADS,/arxiv_data1/oa_pdf/31/96/ymj-57-879.PMC4951463.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.879ORs, and the estimated pooled ORs were not materially al - tered.",OADS,/arxiv_data1/oa_pdf/31/96/ymj-57-879.PMC4951463.pdf
"882ALDH2 Polymorphism and Alcoholic Liver Cirrhosis Risk http://dx.doi.org/10.3349/ymj.2016.57.4.879DISCUSSION The metabolism of alcohol consists of two steps, it is first cata - lytically oxidized into acetaldehyde, and then acetaldehyde is  metabolized into harmless acetate by ALDH.31 ALDH2 is the  major enzyme for acetaldehyde elimination, and its polymor - phism determines blood acetaldehyde concentrations after  alcohol consumption.",Non-OADS,/arxiv_data1/oa_pdf/31/96/ymj-57-879.PMC4951463.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.879cise risk estimation.,Non-OADS,/arxiv_data1/oa_pdf/31/96/ymj-57-879.PMC4951463.pdf
884ALDH2 Polymorphism and Alcoholic Liver Cirrhosis Risk http://dx.doi.org/10.3349/ymj.2016.57.4.8796.,Non-OADS,/arxiv_data1/oa_pdf/31/96/ymj-57-879.PMC4951463.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Jul;57(4):885-892 http://dx.doi.org/10.3349/ymj.2016.57.4.885",Non-OADS,/arxiv_data1/oa_pdf/6c/28/ymj-57-885.PMC4951464.pdf
"886Relationship between T2DM and NAFLD Using CAP http://dx.doi.org/10.3349/ymj.2016.57.4.885NAFLD and insulin resistance and/or T2DM.10,11 In addition,  several recent studies have shown that NAFLD per se can pre - dict future development of T2DM.12-14 However, all of these  studies investigated the presence of NAFLD through ultraso - nography, a crude method for detecting hepatic steatosis that  requires more than 30% hepatic lipid for detection and is high - ly subjective with respect to operator’s skill.15 Controlled attenuation parameter (CAP) is a non-invasive  diagnostic method that digitizes the amount of hepatic fat,  based on the properties of ultrasonic attenuation by hepatic fat,  using the central frequency of the Fibroscan® M probe.16 In sev - eral previous studies on various chronic liver diseases, CAP  showed significant correlation with hepatic steatosis and con - siderable diagnostic performance for grading the degree of  steatosis.17-20 Therefore, this novel parameter enabled research - ers to investigate the prevalence and severity of NAFLD through  quantitative measurement of hepatic steatosis with high sen - sitivity.",Non-OADS,/arxiv_data1/oa_pdf/6c/28/ymj-57-885.PMC4951464.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.885maximal abduction by one experienced technician who was  blind to the subjects’ clinical data.,Non-OADS,/arxiv_data1/oa_pdf/6c/28/ymj-57-885.PMC4951464.pdf
"888Relationship between T2DM and NAFLD Using CAP http://dx.doi.org/10.3349/ymj.2016.57.4.885Mcap and IQR/M, respectively) was calculated.",OADS,/arxiv_data1/oa_pdf/6c/28/ymj-57-885.PMC4951464.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.885ing to the glucose tolerance status (6.9% in NGT, 8.4% in pre- diabetes, 22.7% in T2DM; NGT vs. pre-diabetes, p=0.406; NGT  vs. T2DM, p=0.031; pre-diabetes vs. T2DM, p=0.044) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/6c/28/ymj-57-885.PMC4951464.pdf
890Relationship between T2DM and NAFLD Using CAP http://dx.doi.org/10.3349/ymj.2016.57.4.885value (Table 3).,OADS,/arxiv_data1/oa_pdf/6c/28/ymj-57-885.PMC4951464.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.885cepted as a hepatic manifestation of metabolic syndrome, the  CAP value would likely be used as a unique metabolic parame - ter that specifically targets the liver.",Non-OADS,/arxiv_data1/oa_pdf/6c/28/ymj-57-885.PMC4951464.pdf
892Relationship between T2DM and NAFLD Using CAP http://dx.doi.org/10.3349/ymj.2016.57.4.885cose on the development of type 2 diabetes: a 4-year retrospective  longitudinal study.,OADS,/arxiv_data1/oa_pdf/6c/28/ymj-57-885.PMC4951464.pdf
"Key Words:   Cyclooxygenase-2 inhibitors, liver stiffness score, hepatic fibrosis, cholestatic liver disease, biliary atresiaYonsei Med J 2016 Jul;57(4):893-899 http://dx.doi.org/10.3349/ymj.2016.57.4.893Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  June 1, 2015   Revised:  August 24, 2015 Accepted:  September 25, 2015 Corresponding author:  Dr. Seok Joo Han, Department of Pediatric Surgery, Sev - erance Children’s Hospital, Department of Surgery, Yonsei University College of  Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.",Non-OADS,/arxiv_data1/oa_pdf/9c/08/ymj-57-893.PMC4951465.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/08/ymj-57-893.PMC4951465.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.893 894Cyclooxygenase-2 Inhibitor Reduces Liver Stiffness MATERIALS AND METHODS Patient selection The study protocol was explained to all patients (and their par - ents) who were older than 2 years of age and who reported to  our outpatient clinic for management of their BA after Kasai  procedures.,Non-OADS,/arxiv_data1/oa_pdf/9c/08/ymj-57-893.PMC4951465.pdf
"895 http://dx.doi.org/10.3349/ymj.2016.57.4.893Hye Kyung Chang, et al.",OADS,/arxiv_data1/oa_pdf/9c/08/ymj-57-893.PMC4951465.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.893 896Cyclooxygenase-2 Inhibitor Reduces Liver Stiffness ety, change in appetite, skin rash, irritability, abnormal sensa - tion, changes in vision, confusion, or loss of consciousness.",Non-OADS,/arxiv_data1/oa_pdf/9c/08/ymj-57-893.PMC4951465.pdf
"897 http://dx.doi.org/10.3349/ymj.2016.57.4.893Hye Kyung Chang, et al.",OADS,/arxiv_data1/oa_pdf/9c/08/ymj-57-893.PMC4951465.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.893 898Cyclooxygenase-2 Inhibitor Reduces Liver Stiffness three patients may not be significant.,Non-OADS,/arxiv_data1/oa_pdf/9c/08/ymj-57-893.PMC4951465.pdf
"899 http://dx.doi.org/10.3349/ymj.2016.57.4.893Hye Kyung Chang, et al.",OADS,/arxiv_data1/oa_pdf/9c/08/ymj-57-893.PMC4951465.pdf
Av ailable  at: http://www.drugs.com/meloxicam.html.,Non-OADS,/arxiv_data1/oa_pdf/9c/08/ymj-57-893.PMC4951465.pdf
"Key Words:  Duchenne muscular dystrophy, children, myocardial strain, cardiomyopathiesYonsei Med J 2016 Jul;57(4):900-904 http://dx.doi.org/10.3349/ymj.2016.57.4.900Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received: August 3, 2015   Revised: October 13, 2015 Accepted: October 29, 2015Corresponding author: Lucy Youngmin Eun, MD, PhD, Division of Pediatric Cardi-ology, Department of Pediatrics, Yonsei University College of Medicine, Gangnam Severance Hospital, 211 Eonju-ro, Gangnam-gu, Seoul 06273, Korea.Tel: 82-2-2019-3350, Fax: 82-2-3461-9473, E-mail: lucyeun@yuhs.ac •The authors have no financial conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/e9/28/ymj-57-900.PMC4951466.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro-duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e9/28/ymj-57-900.PMC4951466.pdf
"901 http://dx.doi.org/10.3349/ymj.2016.57.4.900Won Ha Jo, et al.",OADS,/arxiv_data1/oa_pdf/e9/28/ymj-57-900.PMC4951466.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.900 902Myocardial Strain in DMD -9.3±3.8%; control: -12.3±4.3%; p =0.012).,Non-OADS,/arxiv_data1/oa_pdf/e9/28/ymj-57-900.PMC4951466.pdf
"903 http://dx.doi.org/10.3349/ymj.2016.57.4.900Won Ha Jo, et al.",OADS,/arxiv_data1/oa_pdf/e9/28/ymj-57-900.PMC4951466.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.900 904Myocardial Strain in DMD Duchenne muscular dystrophy.,Non-OADS,/arxiv_data1/oa_pdf/e9/28/ymj-57-900.PMC4951466.pdf
"Key Words:    Denosumab, postmenopausal osteoporosis, Korea, bone mineral density, biochemical markers of bone turnover Yonsei Med J 2016 Jul;57(4):905-914 http://dx.doi.org/10.3349/ymj.2016.57.4.905Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  March 23, 2015   Revised:  August 28, 2015   Accepted:  September 25, 2015 Corresponding author:  Barbara Kravitz, MS, GlaxoSmithKline Research & Development, 1250 S. Collegeville Road, Collegeville, PA 19426, USA.",Non-OADS,/arxiv_data1/oa_pdf/f8/ba/ymj-57-905.PMC4951467.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f8/ba/ymj-57-905.PMC4951467.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.905 906Denosumab Treatment for Osteoporosis in Korean Postmenopausal Women INTRODUCTION Osteoporosis, a metabolic bone disease characterized by low  bone mineral density (BMD), is a global concern.",Non-OADS,/arxiv_data1/oa_pdf/f8/ba/ymj-57-905.PMC4951467.pdf
"907 http://dx.doi.org/10.3349/ymj.2016.57.4.905Jung-Min Koh, et al.",OADS,/arxiv_data1/oa_pdf/f8/ba/ymj-57-905.PMC4951467.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.905 908Denosumab Treatment for Osteoporosis in Korean Postmenopausal Women label phase, but only within the time frame of Month 6 to Month  12.",Non-OADS,/arxiv_data1/oa_pdf/f8/ba/ymj-57-905.PMC4951467.pdf
"909 http://dx.doi.org/10.3349/ymj.2016.57.4.905Jung-Min Koh, et al.",OADS,/arxiv_data1/oa_pdf/f8/ba/ymj-57-905.PMC4951467.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.905 910Denosumab Treatment for Osteoporosis in Korean Postmenopausal Women AEs (≥5%) were constipation, myalgia, nasopharyngitis, dys - pepsia, and arthralgia (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/f8/ba/ymj-57-905.PMC4951467.pdf
"911 http://dx.doi.org/10.3349/ymj.2016.57.4.905Jung-Min Koh, et al.",OADS,/arxiv_data1/oa_pdf/f8/ba/ymj-57-905.PMC4951467.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.905 912Denosumab Treatment for Osteoporosis in Korean Postmenopausal Women were consistent with prior studies in non-Korean subjects,  with no significant differences seen between denosumab and  placebo.5 None of the reported SAEs were attributed to the study  drug by investigators.",Non-OADS,/arxiv_data1/oa_pdf/f8/ba/ymj-57-905.PMC4951467.pdf
"913 http://dx.doi.org/10.3349/ymj.2016.57.4.905Jung-Min Koh, et al.",OADS,/arxiv_data1/oa_pdf/f8/ba/ymj-57-905.PMC4951467.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.905 914Denosumab Treatment for Osteoporosis in Korean Postmenopausal Women Kravitz, Brian Waterhouse, Antonio Nino, and Lorraine A.  Fitzpatrick are employees of GlaxoSmithKline and receive  stock/stock options in the company.",Non-OADS,/arxiv_data1/oa_pdf/f8/ba/ymj-57-905.PMC4951467.pdf
Avail - able at: http://www.iofbonehealth.org/sites/default/files/media/ PDFs/Regional%20Audits/2013-Asia_Pacific_Audit_0_0.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f8/ba/ymj-57-905.PMC4951467.pdf
Available at: http://www.who.int/chp/topics/ Osteoporosis.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f8/ba/ymj-57-905.PMC4951467.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Jul;57(4):915-922 http://dx.doi.org/10.3349/ymj.2016.57.4.915",Non-OADS,/arxiv_data1/oa_pdf/bb/55/ymj-57-915.PMC4951468.pdf
916Subclinical Hypothyroidism in Cancer Survivors http://dx.doi.org/10.3349/ymj.2016.57.4.915circulating TSH.,Non-OADS,/arxiv_data1/oa_pdf/bb/55/ymj-57-915.PMC4951468.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.915alysis and regression analysis, diagnosis groups were categoriz- ed into three groups: brain/naso, lymphoma, and other tumors.",OADS,/arxiv_data1/oa_pdf/bb/55/ymj-57-915.PMC4951468.pdf
"918Subclinical Hypothyroidism in Cancer Survivors http://dx.doi.org/10.3349/ymj.2016.57.4.915malized group), whereas 30 did not (the persistent group).",Non-OADS,/arxiv_data1/oa_pdf/bb/55/ymj-57-915.PMC4951468.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.915not exceed 10 mU/L throughout the follow-up period.,OADS,/arxiv_data1/oa_pdf/bb/55/ymj-57-915.PMC4951468.pdf
"920Subclinical Hypothyroidism in Cancer Survivors http://dx.doi.org/10.3349/ymj.2016.57.4.915ratio, 15.35; p=0.039) were significant risk factors for persistent  SCH when compared to other tumors as a reference (Table 6).",Non-OADS,/arxiv_data1/oa_pdf/bb/55/ymj-57-915.PMC4951468.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.915large-scale retrospective study conducted in Israel; however,  most of its subjects had autoimmune thyroiditis.11 The rate of  recovery in the meta-analysis was 21.9–50%, and progression  to overt hypothyroidism was 0–28.8%.6 In the Israeli study, SCH  prevalence was 3.3% (n=3938), and 70.1% of patients with SCH  had normal TSH levels in subsequent tests.11 Thyroid dysfunction in childhood cancer survivors is a well- known late effect.3,7,26 Primary hypothyroidism is the most com - mon abnormal thyroid-related response to thyroid irradiation.4  Risk factors for hypothyroidism include neck, craniospinal, and  total body irradiation3,4 yet apparently not chemotherapy.4,13  Compared with primary overt hypothyroidism, SCH in child - hood cancer survivors is less understood.",Non-OADS,/arxiv_data1/oa_pdf/bb/55/ymj-57-915.PMC4951468.pdf
922Subclinical Hypothyroidism in Cancer Survivors http://dx.doi.org/10.3349/ymj.2016.57.4.915improving care and quality of life.,Non-OADS,/arxiv_data1/oa_pdf/bb/55/ymj-57-915.PMC4951468.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Jul;57(4):923-927 http://dx.doi.org/10.3349/ymj.2016.57.4.923",Non-OADS,/arxiv_data1/oa_pdf/ec/6e/ymj-57-923.PMC4951469.pdf
"924Vitamin D Repletion in Korean Women with Osteoporosis http://dx.doi.org/10.3349/ymj.2016.57.4.923fracture [hazard ratio, 0.62; 95% confidence interval (CI), 0.38– 1.00] than those receiving placebo.2 Similarly, a meta-analysis  reported that vitamin D supplementation (≥800 IU daily) com - pared with placebo or calcium alone in patients ages 65 years  or older reduces hip fracture risk by 30% (hazard ratio, 0.70;  95% CI, 0.58–0.86) and nonvertebral fracture risk by 14% (haz - ard ratio, 0.86; 95% CI, 0.76–0.96).3  Data from the 2008–2009 Korea National Health and Nutri - tion Examination Survey (KNHANES) demonstrated that os - teoporosis risk decreases with increased serum levels of 25-hy - droxyvitamin D [25(OH)D].4 An evaluation of multinational  postmenopausal women (n=2606) with osteoporosis revealed  that South Korea had the lowest mean serum 25(OH)D level  (44 nmol/L) out of 18 countries studied (from Europe, the Mid - dle East, Asia, Latin America, and Australia).5 The prevalence  of vitamin D inadequacy, defined as a serum 25(OH)D level  of <75 nmol/L, in South Korean postmenopausal women was  92%.",Non-OADS,/arxiv_data1/oa_pdf/ec/6e/ymj-57-923.PMC4951469.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.923and 9.1–15.4% for 25(OH)D 3.,Non-OADS,/arxiv_data1/oa_pdf/ec/6e/ymj-57-923.PMC4951469.pdf
"926Vitamin D Repletion in Korean Women with Osteoporosis http://dx.doi.org/10.3349/ymj.2016.57.4.923therapy must be accompanied by appropriate lifestyle changes,  including ensuring vitamin D adequacy.1 Vitamin D levels,  along with many other factors such as general nutrition, exer - cise, and smoking, affect the rate of bone loss and fracture risk.",Non-OADS,/arxiv_data1/oa_pdf/ec/6e/ymj-57-923.PMC4951469.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.923ance.,Non-OADS,/arxiv_data1/oa_pdf/ec/6e/ymj-57-923.PMC4951469.pdf
Available at: http://www.asbmr.org/as - bmr-2013-abstract-detail?aid=f2f88d4e-888b-4ef4-b170- 4244d1d6d02c.,Non-OADS,/arxiv_data1/oa_pdf/ec/6e/ymj-57-923.PMC4951469.pdf
"Key Words:   Chronic obstructive pulmonary disease, Korea, roflumilast, treatment efficacy, safetyYonsei Med J 2016 Jul;57(4):928-935 http://dx.doi.org/10.3349/ymj.2016.57.4.928Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  June 24, 2015   Revised:  November 3, 2015 Accepted:  November 17, 2015 Corresponding author:  Dr. Sang-Do Lee, Department of Pulmonary and Critical  Care Medicine and Clinical Research Center for Chronic Obstructive Airway Dis - eases, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic- ro 43-gil, Songpa-gu, Seoul 05505, Korea.",Non-OADS,/arxiv_data1/oa_pdf/59/33/ymj-57-928.PMC4951470.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/59/33/ymj-57-928.PMC4951470.pdf
"929 http://dx.doi.org/10.3349/ymj.2016.57.4.928Jae Seung Lee, et al.",OADS,/arxiv_data1/oa_pdf/59/33/ymj-57-928.PMC4951470.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.928 930Roflumilast in Korean Patients with COPD ing anticholinergics during the treatment period, although sal - butamol was allowed as a rescue medication.",Non-OADS,/arxiv_data1/oa_pdf/59/33/ymj-57-928.PMC4951470.pdf
"931 http://dx.doi.org/10.3349/ymj.2016.57.4.928Jae Seung Lee, et al.",OADS,/arxiv_data1/oa_pdf/59/33/ymj-57-928.PMC4951470.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.928 932Roflumilast in Korean Patients with COPD DISCUSSION The major findings in this study were that roflumilast improved  lung function in moderate to very severe Korean COPD patients,  and the AE profile was comparable to those reported in other  Asian and Western populations.",Non-OADS,/arxiv_data1/oa_pdf/59/33/ymj-57-928.PMC4951470.pdf
"933 http://dx.doi.org/10.3349/ymj.2016.57.4.928Jae Seung Lee, et al.",OADS,/arxiv_data1/oa_pdf/59/33/ymj-57-928.PMC4951470.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.928 934Roflumilast in Korean Patients with COPD majority of our patients had moderate rather than severe COPD.,Non-OADS,/arxiv_data1/oa_pdf/59/33/ymj-57-928.PMC4951470.pdf
Available at: http://www.goldcopd.org/uploads/users/les/ GOLD_Report2014_Feb07.pdf.,Non-OADS,/arxiv_data1/oa_pdf/59/33/ymj-57-928.PMC4951470.pdf
"935 http://dx.doi.org/10.3349/ymj.2016.57.4.928Jae Seung Lee, et al.",OADS,/arxiv_data1/oa_pdf/59/33/ymj-57-928.PMC4951470.pdf
"Key Words:   Helmets, continuous positive airway pressure, respiratory failure, meta-analysis, endotracheal intubation, mortalityYonsei Med J 2016 Jul;57(4):936-941 http://dx.doi.org/10.3349/ymj.2016.57.4.936Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  June 16, 2015   Revised:  October 2, 2015 Accepted:  October 5, 2015 Corresponding author:  Dr. Xin Chen, Department of Respiratory Medicine, Zhuji - ang Hospital, Southern Medical University, 253 Gongye Road, Guangzhou 510282,  China.",Non-OADS,/arxiv_data1/oa_pdf/aa/9c/ymj-57-936.PMC4951471.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/aa/9c/ymj-57-936.PMC4951471.pdf
"937 http://dx.doi.org/10.3349/ymj.2016.57.4.936Yuwen Luo, et al.",OADS,/arxiv_data1/oa_pdf/aa/9c/ymj-57-936.PMC4951471.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.936 938Helmet CPAP vs.,Non-OADS,/arxiv_data1/oa_pdf/aa/9c/ymj-57-936.PMC4951471.pdf
"939 http://dx.doi.org/10.3349/ymj.2016.57.4.936Yuwen Luo, et al.",OADS,/arxiv_data1/oa_pdf/aa/9c/ymj-57-936.PMC4951471.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.936 940Helmet CPAP vs.,Non-OADS,/arxiv_data1/oa_pdf/aa/9c/ymj-57-936.PMC4951471.pdf
"941 http://dx.doi.org/10.3349/ymj.2016.57.4.936Yuwen Luo, et al.",OADS,/arxiv_data1/oa_pdf/aa/9c/ymj-57-936.PMC4951471.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 Jul;57(4):942-949 http://dx.doi.org/10.3349/ymj.2016.57.4.942",Non-OADS,/arxiv_data1/oa_pdf/bc/ad/ymj-57-942.PMC4951472.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.942uate macrovascular ED.,Non-OADS,/arxiv_data1/oa_pdf/bc/ad/ymj-57-942.PMC4951472.pdf
"944AST-120 and Endothelial Dysfunction http://dx.doi.org/10.3349/ymj.2016.57.4.942pendent responses, respectively.18 The laser Doppler probe con - nected to the LDF (Periflux PF4001, standard probe PF408,  Perimed) was fixed within the drug chamber to explore the  same small area of the skin.",Non-OADS,/arxiv_data1/oa_pdf/bc/ad/ymj-57-942.PMC4951472.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.942Indoxyl sulfate  The baseline IS level in the AST-120 group was slightly less  than that of the control group, although the difference was not  statistically significant.",OADS,/arxiv_data1/oa_pdf/bc/ad/ymj-57-942.PMC4951472.pdf
946AST-120 and Endothelial Dysfunction http://dx.doi.org/10.3349/ymj.2016.57.4.942no significant correlation between microvascular (Ach-in - duced iontophoresis) and macrovascular endothelium-de - pendent responses (EDV).,OADS,/arxiv_data1/oa_pdf/bc/ad/ymj-57-942.PMC4951472.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.942of AST-120 treatment.,Non-OADS,/arxiv_data1/oa_pdf/bc/ad/ymj-57-942.PMC4951472.pdf
948AST-120 and Endothelial Dysfunction http://dx.doi.org/10.3349/ymj.2016.57.4.942per se increases oxidative stress and decreases the function of  NO such that EDHFs may be upregulated in early staged CKD  patients.,Non-OADS,/arxiv_data1/oa_pdf/bc/ad/ymj-57-942.PMC4951472.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.94216.,Non-OADS,/arxiv_data1/oa_pdf/bc/ad/ymj-57-942.PMC4951472.pdf
"Key Words:  Transcranial Doppler, lacunar stroke, small vessel disease, diffusion MRIYonsei Med J 2016 Jul;57(4):950-955 http://dx.doi.org/10.3349/ymj.2016.57.4.950Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received: June 26, 2015   Revised: October 12, 2015 Accepted: November 17, 2015Corresponding author: Dr. Jinkwon Kim, Department of Neurology, CHA Bundang Medical Center, CHA University, 59 Yatap-ro, Bundang-gu, Seongnam 13496, Korea.Tel: 82-31-780-3465, Fax: 82-31-780-5269, E-mail: antithrombus@gmail.com •The authors have no financial conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/cf/29/ymj-57-950.PMC4951473.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro-duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cf/29/ymj-57-950.PMC4951473.pdf
"951 http://dx.doi.org/10.3349/ymj.2016.57.4.950Yoon Kim, et al.",OADS,/arxiv_data1/oa_pdf/cf/29/ymj-57-950.PMC4951473.pdf
"3.1.2 for Windows, Research Imaging Institute, San Antonio, TX, USA; http://ric.uthscsa.edu/mango/).",OADS,/arxiv_data1/oa_pdf/cf/29/ymj-57-950.PMC4951473.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.950 952PI and Infarct Volume in Lacunar Stroke ume measured by the two investigators was used.,OADS,/arxiv_data1/oa_pdf/cf/29/ymj-57-950.PMC4951473.pdf
"953 http://dx.doi.org/10.3349/ymj.2016.57.4.950Yoon Kim, et al.",OADS,/arxiv_data1/oa_pdf/cf/29/ymj-57-950.PMC4951473.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.950 954PI and Infarct Volume in Lacunar Stroke functional deterioration of cerebral vasculature and impair ce- rebral perfusion, resulting in brain injury.",Non-OADS,/arxiv_data1/oa_pdf/cf/29/ymj-57-950.PMC4951473.pdf
"955 http://dx.doi.org/10.3349/ymj.2016.57.4.950Yoon Kim, et al.",OADS,/arxiv_data1/oa_pdf/cf/29/ymj-57-950.PMC4951473.pdf
"Key Words:   Morbid obesity, bariatric surgery, outcomes, comparative study, KoreansYonsei Med J 2016 Jul;57(4):956-962 http://dx.doi.org/10.3349/ymj.2016.57.4.956Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  August 20, 2015   Revised:  December 7, 2015 Accepted:  December 7, 2015 Co-corresponding authors:  Dr. Yoonseok Heo, Department of Surgery, Inha University Hospital, Inha University School of Medicine, 27 Inhang-ro, Jung-gu, Incheon  22332, Korea.",Non-OADS,/arxiv_data1/oa_pdf/03/3a/ymj-57-956.PMC4951474.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/3a/ymj-57-956.PMC4951474.pdf
"957 http://dx.doi.org/10.3349/ymj.2016.57.4.956Sang Kuon Lee, et al.",OADS,/arxiv_data1/oa_pdf/03/3a/ymj-57-956.PMC4951474.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.956 958Comparison of Bariatric Procedures in Korea EBMIL was calculated by dividing BMI change from baseline  by excess BMI, which was obtained by subtracting the ideal  BMI (25 kg/m2) from the actual BMI.",OADS,/arxiv_data1/oa_pdf/03/3a/ymj-57-956.PMC4951474.pdf
"959 http://dx.doi.org/10.3349/ymj.2016.57.4.956Sang Kuon Lee, et al.",OADS,/arxiv_data1/oa_pdf/03/3a/ymj-57-956.PMC4951474.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.956 960Comparison of Bariatric Procedures in Korea of band erosion, access port infection, or band leakage.",Non-OADS,/arxiv_data1/oa_pdf/03/3a/ymj-57-956.PMC4951474.pdf
"961 http://dx.doi.org/10.3349/ymj.2016.57.4.956Sang Kuon Lee, et al.",OADS,/arxiv_data1/oa_pdf/03/3a/ymj-57-956.PMC4951474.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.956 962Comparison of Bariatric Procedures in Korea 0.05%, 0.11%, and 0.14%, respectively, suggesting that the surgi - cal risk of bariatric procedures is highest for RYGB, followed by  SG and LAGB.5 This study had several limitations that should be taken into  consideration.",Non-OADS,/arxiv_data1/oa_pdf/03/3a/ymj-57-956.PMC4951474.pdf
"Key Words:  Lung transplantation, pulmonary function test, donor selectionYonsei Med J 2016 Jul;57(4):963-967 http://dx.doi.org/10.3349/ymj.2016.57.4.963Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  September 17, 2015   Revised:  November 10, 2015 Accepted:  November 25, 2015 Corresponding author:  Seokjin Haam, MD, PhD, Department of Thoracic and  Cardiovascular Surgery, Ajou University School of Medicine, 164 World cup-ro,  Yeongtong-gu, Suwon 16499, Korea.",Non-OADS,/arxiv_data1/oa_pdf/6a/c3/ymj-57-963.PMC4951475.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/c3/ymj-57-963.PMC4951475.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.963 964Total Lung Capacity in Lung Transplantation when using formulas to perform lung size matching.,Non-OADS,/arxiv_data1/oa_pdf/6a/c3/ymj-57-963.PMC4951475.pdf
"965 http://dx.doi.org/10.3349/ymj.2016.57.4.963Sung Ho Hwang, et al.",OADS,/arxiv_data1/oa_pdf/6a/c3/ymj-57-963.PMC4951475.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.963 966Total Lung Capacity in Lung Transplantation has several problems: for example, in patients with obstruc - tive lung diseases, such as COPD or emphysema, the thoracic  cavity size increases, compared with the normal thoracic cavi - ty size, by diaphragmatic flattening and widening of the rib  spaces,24 whereas in patients with restrictive lung disease, such  as IPF , thoracic cavity size decreases due to chest wall shrinkage  and contraction of the intercostal spaces.12 However, studies on  degrees of size mismatch by lung diseases patterns are rare.",Non-OADS,/arxiv_data1/oa_pdf/6a/c3/ymj-57-963.PMC4951475.pdf
"967 http://dx.doi.org/10.3349/ymj.2016.57.4.963Sung Ho Hwang, et al.",OADS,/arxiv_data1/oa_pdf/6a/c3/ymj-57-963.PMC4951475.pdf
"Key Words:   Cervical spine, longus colli muscle, uncinate process, surgeryYonsei Med J 2016 Jul;57(4):968-972 http://dx.doi.org/10.3349/ymj.2016.57.4.968Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  October 16, 2015   Revised:  December 16, 2015 Accepted:  December 16, 2015 Corresponding author:  Dr.",Non-OADS,/arxiv_data1/oa_pdf/3d/6b/ymj-57-968.PMC4951476.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3d/6b/ymj-57-968.PMC4951476.pdf
"969 http://dx.doi.org/10.3349/ymj.2016.57.4.968Moon Soo Park, et al.",OADS,/arxiv_data1/oa_pdf/3d/6b/ymj-57-968.PMC4951476.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.968 970Longus Colli Muscle mm for the right longus colli distance, 5.4±1.0 mm for the left  uncinate distance, 17.0±2.3 mm for the inter-uncinate distance,  and 5.4±1.1 mm for the right uncinate distance (Table 1).",OADS,/arxiv_data1/oa_pdf/3d/6b/ymj-57-968.PMC4951476.pdf
"971 http://dx.doi.org/10.3349/ymj.2016.57.4.968Moon Soo Park, et al.",OADS,/arxiv_data1/oa_pdf/3d/6b/ymj-57-968.PMC4951476.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.968 972Longus Colli Muscle tients with chronic neck pain and 20 healthy matched con - trols, the lateral dimensions of the longus colli were not differ - ent between the two groups.9 The lateral dimension of the  longus colli in the patient group was 10.89±2.07 mm on the  dominant side and 10.86±1.87 mm on the nondominant side  versus 10.95±2.08 mm on the dominant side and 10.76±1.48  mm on the nondominant side in the controls.9 These values  are higher than the ones we found.",Non-OADS,/arxiv_data1/oa_pdf/3d/6b/ymj-57-968.PMC4951476.pdf
"Key Words:    Liver cirrhosis, portal hypertension, gastric varix, BRTO, PARTOYonsei Med J 2016 Jul;57(4):973-979 http://dx.doi.org/10.3349/ymj.2016.57.4.973Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  October 13, 2015   Revised:  November 23, 2015 Accepted:  December 9, 2015 Corresponding author:  Dr. Taehwan Kim, Department of Vascular and Interven - tional Radiology, NHIS Ilsan Hospital, 100 Ilsan-ro, Ilsandong-gu, Goyang 10444,  Korea.",Non-OADS,/arxiv_data1/oa_pdf/d5/42/ymj-57-973.PMC4951477.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/42/ymj-57-973.PMC4951477.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.973 974PARTO for Gastric Varix Bleeding Thus, this study was carried out to evaluate the feasibility and  safety of PARTO that was performed on GV bleeding patients  under an emergent clinical setting and analyze the mid-term  clinical results.",Non-OADS,/arxiv_data1/oa_pdf/d5/42/ymj-57-973.PMC4951477.pdf
"975 http://dx.doi.org/10.3349/ymj.2016.57.4.973Taehwan Kim, et al.",OADS,/arxiv_data1/oa_pdf/d5/42/ymj-57-973.PMC4951477.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.973 976PARTO for Gastric Varix Bleeding glue-lipiodol mixture and two microcoils for enhancing shunt  occlusion and prevention of significant complication such as  retroperitoneal hemorrhage (Fig.,Non-OADS,/arxiv_data1/oa_pdf/d5/42/ymj-57-973.PMC4951477.pdf
"977 http://dx.doi.org/10.3349/ymj.2016.57.4.973Taehwan Kim, et al.",OADS,/arxiv_data1/oa_pdf/d5/42/ymj-57-973.PMC4951477.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.973 978PARTO for Gastric Varix Bleeding 1–2 months after the BRTO procedure.,Non-OADS,/arxiv_data1/oa_pdf/d5/42/ymj-57-973.PMC4951477.pdf
"979 http://dx.doi.org/10.3349/ymj.2016.57.4.973Taehwan Kim, et al.",OADS,/arxiv_data1/oa_pdf/d5/42/ymj-57-973.PMC4951477.pdf
"Key Words:   Anesthesia recovery period, craniotomy, dexmedetomidine, remifentanil Yonsei Med J 2016 Jul;57(4):980-986 http://dx.doi.org/10.3349/ymj.2016.57.4.980Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  April 27, 2015   Revised:  October 27, 2015 Accepted:  October 28, 2015 Corresponding author:  Dr. Seung Ho Choi, Department of Anesthesiology and  Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College  of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.",Non-OADS,/arxiv_data1/oa_pdf/8b/ca/ymj-57-980.PMC4951478.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8b/ca/ymj-57-980.PMC4951478.pdf
"981 http://dx.doi.org/10.3349/ymj.2016.57.4.980Hyunzu Kim, et al.",OADS,/arxiv_data1/oa_pdf/8b/ca/ymj-57-980.PMC4951478.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.980 982Dexmedetomidine for Smooth Recovery on Craniotomy end of the surgery to eyes opening) and time to extubation  (from the end of the surgery to extubation) were also recorded  and compared.,OADS,/arxiv_data1/oa_pdf/8b/ca/ymj-57-980.PMC4951478.pdf
"983 http://dx.doi.org/10.3349/ymj.2016.57.4.980Hyunzu Kim, et al.",OADS,/arxiv_data1/oa_pdf/8b/ca/ymj-57-980.PMC4951478.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.980 984Dexmedetomidine for Smooth Recovery on Craniotomy midine that describe the distinctive qualities of sedation, which  is similar to normal sleep.",Non-OADS,/arxiv_data1/oa_pdf/8b/ca/ymj-57-980.PMC4951478.pdf
"985 http://dx.doi.org/10.3349/ymj.2016.57.4.980Hyunzu Kim, et al.",OADS,/arxiv_data1/oa_pdf/8b/ca/ymj-57-980.PMC4951478.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.980 986Dexmedetomidine for Smooth Recovery on Craniotomy mans.,Non-OADS,/arxiv_data1/oa_pdf/8b/ca/ymj-57-980.PMC4951478.pdf
"Key Words:   Airway management, complications, laryngeal masks, supraglottic airwaysYonsei Med J 2016 Jul;57(4):987-997 http://dx.doi.org/10.3349/ymj.2016.57.4.987Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  July 29, 2015   Revised:  October 27, 2015 Accepted:  October 28, 2015 Corresponding author:  Dr. Min-Soo Kim, Department of Anesthesiology and  Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College  of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.",Non-OADS,/arxiv_data1/oa_pdf/06/71/ymj-57-987.PMC4951479.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/06/71/ymj-57-987.PMC4951479.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.987 988Insertion Technique for Supraglottic Airways device with a 90- or 180-degree rotation and then rotating it to  the final position as it enters the hypopharynx.,Non-OADS,/arxiv_data1/oa_pdf/06/71/ymj-57-987.PMC4951479.pdf
"989 http://dx.doi.org/10.3349/ymj.2016.57.4.987Jin Ha Park, et al.",OADS,/arxiv_data1/oa_pdf/06/71/ymj-57-987.PMC4951479.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.987 990Insertion Technique for Supraglottic Airways Table 1.,Non-OADS,/arxiv_data1/oa_pdf/06/71/ymj-57-987.PMC4951479.pdf
"991 http://dx.doi.org/10.3349/ymj.2016.57.4.987Jin Ha Park, et al.",OADS,/arxiv_data1/oa_pdf/06/71/ymj-57-987.PMC4951479.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.987 992Insertion Technique for Supraglottic Airways The incidence of postoperative sore throat on the day of sur - gery and the next day were assessed in four5,6,10,21 and three  studies,5,14,16 respectively.",Non-OADS,/arxiv_data1/oa_pdf/06/71/ymj-57-987.PMC4951479.pdf
"993 http://dx.doi.org/10.3349/ymj.2016.57.4.987Jin Ha Park, et al.",OADS,/arxiv_data1/oa_pdf/06/71/ymj-57-987.PMC4951479.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.987 994Insertion Technique for Supraglottic Airways combe and Keller26 involving the triple airway maneuver (head  extension, mouth opening, and jaw thrust).",Non-OADS,/arxiv_data1/oa_pdf/06/71/ymj-57-987.PMC4951479.pdf
"995 http://dx.doi.org/10.3349/ymj.2016.57.4.987Jin Ha Park, et al.",OADS,/arxiv_data1/oa_pdf/06/71/ymj-57-987.PMC4951479.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.987 996Insertion Technique for Supraglottic Airways There are several limitations that should be considered in our  systematic review and meta-analysis.,Non-OADS,/arxiv_data1/oa_pdf/06/71/ymj-57-987.PMC4951479.pdf
"997 http://dx.doi.org/10.3349/ymj.2016.57.4.987Jin Ha Park, et al.",OADS,/arxiv_data1/oa_pdf/06/71/ymj-57-987.PMC4951479.pdf
"Key Words:   Dexmedetomidine; administration, intranasal; anesthetics, intravenousYonsei Med J 2016 Jul;57(4):998-1005 http://dx.doi.org/10.3349/ymj.2016.57.4.998Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  September 17, 2015   Revised:  December 8, 2015 Accepted:  December 14, 2015 Corresponding author:  Dr. Zheng Chen, Department of Anesthesiology, The Af - filiated People’s Hospital of Jiangsu University, No.8 Dianli Road, Zhenjiang, Ji - angsu 212000, China.",Non-OADS,/arxiv_data1/oa_pdf/b2/86/ymj-57-998.PMC4951480.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/86/ymj-57-998.PMC4951480.pdf
"999 http://dx.doi.org/10.3349/ymj.2016.57.4.998Xiang Wu, et al.",OADS,/arxiv_data1/oa_pdf/b2/86/ymj-57-998.PMC4951480.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.998 1000Intranasal DEX in General Anesthesia solution was infused at 8 mL/kg/h.,Non-OADS,/arxiv_data1/oa_pdf/b2/86/ymj-57-998.PMC4951480.pdf
"1001 http://dx.doi.org/10.3349/ymj.2016.57.4.998Xiang Wu, et al.",OADS,/arxiv_data1/oa_pdf/b2/86/ymj-57-998.PMC4951480.pdf
http://dx.doi.org/10.3349/ymj.2016.57.4.998 1002Intranasal DEX in General Anesthesia Dexmedetomidine significantly decreased BIS values and  OAA/S scores at 40 min after intranasal administration.,Non-OADS,/arxiv_data1/oa_pdf/b2/86/ymj-57-998.PMC4951480.pdf
"1003 http://dx.doi.org/10.3349/ymj.2016.57.4.998Xiang Wu, et al.",OADS,/arxiv_data1/oa_pdf/b2/86/ymj-57-998.PMC4951480.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.4.998 1004Intranasal DEX in General Anesthesia traoperative BIS monitoring, providing a better reflection of the  different sedation effects induced by intravenous and intrana - sal administrations of dexmedetomidine.",Non-OADS,/arxiv_data1/oa_pdf/b2/86/ymj-57-998.PMC4951480.pdf
"1005 http://dx.doi.org/10.3349/ymj.2016.57.4.998Xiang Wu, et al.",OADS,/arxiv_data1/oa_pdf/b2/86/ymj-57-998.PMC4951480.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/b2/52/40261_2016_Article_405.PMC4951511.pdf
http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/b2/52/40261_2016_Article_405.PMC4951511.pdf
http://www.hra.nhs.uk/documents/2013/08/safety- reporting-ctimps-procedural-table.pdf .,Non-OADS,/arxiv_data1/oa_pdf/b2/52/40261_2016_Article_405.PMC4951511.pdf
http://www.drugbank.ca/drugs/DB00847 .,Non-OADS,/arxiv_data1/oa_pdf/b2/52/40261_2016_Article_405.PMC4951511.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/f1/39/40261_2016_Article_412.PMC4951513.pdf
"Osteoarthritis: Care and management in adults, https://www.nice.org.uk/ guidance/CG177;2014 .",Non-OADS,/arxiv_data1/oa_pdf/f1/39/40261_2016_Article_412.PMC4951513.pdf
2010.http://www.ema.europa.eu/ema .,Non-OADS,/arxiv_data1/oa_pdf/f1/39/40261_2016_Article_412.PMC4951513.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Anomalous Middle Cardiac Vein Draining into the Left Atrium Jihyun Sohn,1 Young Soo Lee,2 Seung Pyo Hong,2 and Sung Hee Mun3 1Department of Cardiology, Kyungpook National University Hospital, Daegu, Korea; 2Department of Cardiology, Catholic University of Daegu, Daegu, Korea; 3Department  of Radiology, Catholic University of Daegu, Daegu, Koreahttp://dx.doi.org/10.3346/jkms.2016.31.8.1179  • J Korean Med Sci 2016; 31: 1179-1180 A 67-year-old woman was admitted for radiofrequency catheter  ablation (RFCA) of paroxysmal atrial fibrillation.",Non-OADS,/arxiv_data1/oa_pdf/c4/f7/jkms-31-1179.PMC4951544.pdf
• Anomalous Middle Cardiac Vein Draining into the Left Atrium 1180  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1179cardiac vein into the left atrium (Fig.,Non-OADS,/arxiv_data1/oa_pdf/c4/f7/jkms-31-1179.PMC4951544.pdf
ORCID Jihyun Sohn http://orcid.org/0000-0001-5543-9633 Young Soo Lee http://orcid.org/0000-0002-8229-8300Seung Pyo Hong http://orcid.org/0000-0002-0028-9647 Sung Hee Mun http://orcid.org/0000-0002-8700-2513 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/c4/f7/jkms-31-1179.PMC4951544.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Forecasting Cause-Specific Mortality in Korea up to Year 2032 Forecasting cause-specific mortality can help estimate the future burden of diseases and  provide a clue for preventing diseases.",Non-OADS,/arxiv_data1/oa_pdf/53/7c/jkms-31-1181.PMC4951545.pdf
520150340).http://dx.doi.org/10.3346/jkms.2016.31.8.1181  • J Korean Med Sci 2016; 31: 1181-1189 INTRODUCTION Forecasting cause-specific mortality can help estimate the fu - ture burden of diseases and can be used as fundamental data  for developing public health policies.,Non-OADS,/arxiv_data1/oa_pdf/53/7c/jkms-31-1181.PMC4951545.pdf
• Forecasting Cause-Specific Mortality 1182  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1181pleteness and the ill-defined codes (completeness was defined  as the proportion of all deaths covered by the vital registration  system).,Non-OADS,/arxiv_data1/oa_pdf/53/7c/jkms-31-1181.PMC4951545.pdf
• Forecasting Cause-Specific Mortality http://jkms.org   1183 http://dx.doi.org/10.3346/jkms.2016.31.8.1181 Table 1.,Non-OADS,/arxiv_data1/oa_pdf/53/7c/jkms-31-1181.PMC4951545.pdf
"• Forecasting Cause-Specific Mortality 1184  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1181from 2008-2012 to 2028-2032 (males: 570.7 to 834.7 [46.3%], fe - males: 458.3 to 611.2 [33.4%] per 100,000 person-years).",Non-OADS,/arxiv_data1/oa_pdf/53/7c/jkms-31-1181.PMC4951545.pdf
• Forecasting Cause-Specific Mortality http://jkms.org   1185 http://dx.doi.org/10.3346/jkms.2016.31.8.1181riod 2013-2032.,Non-OADS,/arxiv_data1/oa_pdf/53/7c/jkms-31-1181.PMC4951545.pdf
• Forecasting Cause-Specific Mortality 1186  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1181deaths is projected to increase because of population aging in  Korea.,Non-OADS,/arxiv_data1/oa_pdf/53/7c/jkms-31-1181.PMC4951545.pdf
"• Forecasting Cause-Specific Mortality http://jkms.org   1187 http://dx.doi.org/10.3346/jkms.2016.31.8.1181Therefore, female deaths due to Alzheimer’s disease will be more  than male deaths because Alzheimer’s disease is frequently di - agnosed among the aged people (31).",Non-OADS,/arxiv_data1/oa_pdf/53/7c/jkms-31-1181.PMC4951545.pdf
ORCID Jae-Won Yun http://orcid.org/0000-0001-8020-7316 Mia Son http://orcid.org/0000-0001-7943-532X REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/53/7c/jkms-31-1181.PMC4951545.pdf
"• Forecasting Cause-Specific Mortality 1188  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1181ham J, Adair T, Aggarwal R, Ahn SY, et al.",Non-OADS,/arxiv_data1/oa_pdf/53/7c/jkms-31-1181.PMC4951545.pdf
• Forecasting Cause-Specific Mortality http://jkms.org   1189 http://dx.doi.org/10.3346/jkms.2016.31.8.1181Appendix 1.,Non-OADS,/arxiv_data1/oa_pdf/53/7c/jkms-31-1181.PMC4951545.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Clinical Evaluation of Rapid Diagnostic Test Kit for Scrub Typhus  with Improved Performance Diagnosis of scrub typhus is challenging due to its more than twenty serotypes and the  similar clinical symptoms with other acute febrile illnesses including leptospirosis, murine  typhus and hemorrhagic fever with renal syndrome.",Non-OADS,/arxiv_data1/oa_pdf/e9/70/jkms-31-1190.PMC4951546.pdf
"Received: 2 May 2016 Accepted: 29 May 2016 Address for Correspondence: Yoon-Won Kim, MD  Department of Microbiology, College of Medicine, Hallym  University, 39 Hallymdaehak-gil, Chuncheon 24252, Korea  E-mail: ywkim@hallym.ac.kr Funding:  This research was supported by the Agency for  Defense Development Institute of Civil-Military Technology  Cooperation, Dual Use Technology Program, 2014 (14-SF- EB-11).http://dx.doi.org/10.3346/jkms.2016.31.8.1190  • J Korean Med Sci 2016; 31: 1190-1196 INTRODUCTION Scrub typhus, also called tsutsugamushi disease, scrub fever, Japanese river fever and  trombidiasis, is a disease that causes high fever, headache, and conjunctival hyperemia  by proliferation of Orientia tsutsugamushi  when larvae of Trombiculidae as a vector in - fected with O. tsutsugamushi  bites in the skin of a person and eats the body fluid.",Non-OADS,/arxiv_data1/oa_pdf/e9/70/jkms-31-1190.PMC4951546.pdf
"• Evaluation of a Rapid Diagnostic Kit for Scrub Typhus http://jkms.org   1191 http://dx.doi.org/10.3346/jkms.2016.31.8.1190lated in Korea (13,14).",Non-OADS,/arxiv_data1/oa_pdf/e9/70/jkms-31-1190.PMC4951546.pdf
"• Evaluation of a Rapid Diagnostic Kit for Scrub Typhus 1192  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1190serum diluted two-fold serially (1:10 to 1:1,280 in phosphate  buffered saline [PBS]) to the antigen-coated spot of the slide for  30 minutes, fluorescein isothiocyanate (FITC)-conjugated anti - body, antihuman IgM or IgG (Cappel Laboratories, Cochranville,  PA, USA) was applied to determine the positive signal.",Non-OADS,/arxiv_data1/oa_pdf/e9/70/jkms-31-1190.PMC4951546.pdf
• Evaluation of a Rapid Diagnostic Kit for Scrub Typhus http://jkms.org   1193 http://dx.doi.org/10.3346/jkms.2016.31.8.1190pretation (Fig.,Non-OADS,/arxiv_data1/oa_pdf/e9/70/jkms-31-1190.PMC4951546.pdf
• Evaluation of a Rapid Diagnostic Kit for Scrub Typhus 1194  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1190ificity.,Non-OADS,/arxiv_data1/oa_pdf/e9/70/jkms-31-1190.PMC4951546.pdf
• Evaluation of a Rapid Diagnostic Kit for Scrub Typhus http://jkms.org   1195 http://dx.doi.org/10.3346/jkms.2016.31.8.1190for SD biolines.,Non-OADS,/arxiv_data1/oa_pdf/e9/70/jkms-31-1190.PMC4951546.pdf
ORCID Young-Jin Kim http://orcid.org/0000-0003-1996-9367  Sungman Park http://orcid.org/0000-0002-6105-7129  Ranjan Premaratna http://orcid.org/0000-0002-6588-9467  Stephen Selvaraj http://orcid.org/0000-0003-0103-4061  Sang-Jin Park http://orcid.org/0000-0002-4838-2664  Sora Kim http://orcid.org/0000-0002-5314-2569  Donghwan Kim http://orcid.org/0000-0001-5881-9105  Min Soo Kim http://orcid.org/0000-0001-7489-3532  Dong Hoon Shin http://orcid.org/0000-0002-3513-6333  Kyung-Chan Choi http://orcid.org/0000-0001-6134-8631  Soon-Hwan Kwon http://orcid.org/0000-0002-1582-303X  Wonjun Seo http://orcid.org/0000-0002-7109-3799  Nam Taek Lee http://orcid.org/0000-0002-8352-4760  Seung-Han Kim http://orcid.org/0000-0003-1310-8136  Heui Keun Kang http://orcid.org/0000-0002-3216-4961 Yoon-Won Kim http://orcid.org/0000-0002-2242-2664   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e9/70/jkms-31-1190.PMC4951546.pdf
• Evaluation of a Rapid Diagnostic Kit for Scrub Typhus 1196  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1190Korean J Parasitol 1997; 35: 171-9.,Non-OADS,/arxiv_data1/oa_pdf/e9/70/jkms-31-1190.PMC4951546.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357IgE Sensitization Patterns to Commonly Consumed Foods  Determined by Skin Prick Test in Korean Adults  Offending food allergens can vary with regional preferences in food consumption.",Non-OADS,/arxiv_data1/oa_pdf/3d/43/jkms-31-1197.PMC4951547.pdf
"Keywords:  Food Allergy; Allergen; Eating Habits; Korean; Skin Test; SensitizationSung Ryeol Kim,1 Hye Jung Park,1,2   Kyung Hee Park,1,2 Jae-Hyun Lee,1,2   and Jung-Won Park1,2  1Division of Allergy and Immunology, Department of  Internal Medicine, Yonsei University College of  Medicine, Seoul, Korea; 2Institute of Allergy, Yonsei  University College of Medicine, Seoul, Korea Received: 24 July 2015 Accepted: 10 April 2016 Address for Correspondence: Jung-Won Park, MD Division of Allergy and Immunology, Department of Internal  Medicine, Yonsei University College of Medicine, 50 Yonsei-ro,  Seodaemun-gu, Seoul 03722, Korea E-mail: PARKJW@yuhs.ac Funding:  This study was supported by a grant of the Korean  Health Technology R &D Project, Ministry of Health and Welfare,  Republic of Korea (HI13C0010).http://dx.doi.org/10.3346/jkms.2016.31.8.1197  • J Korean Med Sci 2016; 31: 1197-1201 INTRODUCTION Although less common in adults than in children, food allergy  is prevalent in 3%-5% of all adults (1-3).",Non-OADS,/arxiv_data1/oa_pdf/3d/43/jkms-31-1197.PMC4951547.pdf
• IgE Sensitization Patterns to Food Allergens in Korean Adults 1198  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.119737.7 ± 13.0 years (mean ± SD).,Non-OADS,/arxiv_data1/oa_pdf/3d/43/jkms-31-1197.PMC4951547.pdf
• IgE Sensitization Patterns to Food Allergens in Korean Adults http://jkms.org   1199 http://dx.doi.org/10.3346/jkms.2016.31.8.1197Table 3.,Non-OADS,/arxiv_data1/oa_pdf/3d/43/jkms-31-1197.PMC4951547.pdf
• IgE Sensitization Patterns to Food Allergens in Korean Adults 1200  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1197(0%).,Non-OADS,/arxiv_data1/oa_pdf/3d/43/jkms-31-1197.PMC4951547.pdf
"• IgE Sensitization Patterns to Food Allergens in Korean Adults http://jkms.org   1201 http://dx.doi.org/10.3346/jkms.2016.31.8.1197 In conclusion, this study sought to identify sensitization pat - terns to commonly consumed foods in Korean adults.",Non-OADS,/arxiv_data1/oa_pdf/3d/43/jkms-31-1197.PMC4951547.pdf
ORCID Sung Ryeol Kim http://orcid.org/0000-0001-7418-0049 Hye Jung Park http://orcid.org/0000-0002-1862-1003 Kyung Hee Park http://orcid.org/0000-0003-3605-5364 Jae-Hyun Lee http://orcid.org/0000-0002-0760-0071  Jung-Won Park http://orcid.org/0000-0003-0249-8749   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/3d/43/jkms-31-1197.PMC4951547.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Cross-Reactivity between Oak and Birch Pollens in Korean Tree  Pollinosis Oak and birch trees belong to Fagales order.",Non-OADS,/arxiv_data1/oa_pdf/0a/e0/jkms-31-1202.PMC4951548.pdf
"Keywords:  Cross-Reactivity; Oak Pollen; Tree Pollinosis; IgE; KoreaKyoung Yong Jeong,1 Mina Son,1   Jin Hee Park,2 Kyung Hee Park,1   Hye Jung Park,1 Jae-Hyun Lee,1   Chein-Soo Hong,1 and Jung-Won Park1 1Department of Internal Medicine, Institute of  Allergy, Yonsei University College of Medicine,  Seoul, Korea; 2Department of Biology Education,  Faculty of Education, Seowon University, Cheongju,  Korea Received: 5 January 2016 Accepted: 10 April 2016 Address for Correspondence: Jung-Won Park, MD Department of Internal Medicine, Institute of Allergy, Yonsei  University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu,  Seoul 03722, Korea E-mail: parkjw@yuhs.ac Funding:  This study was supported by a grant from the Korea  Healthcare Technology R &D Project, Ministry of Health, Welfare  and Family Affairs, Republic of Korea (A092076).http://dx.doi.org/10.3346/jkms.2016.31.8.1202  • J Korean Med Sci 2016; 31: 1202-1207 INTRODUCTION In Korea, 4.1% to 22.9% of respiratory allergic subjects with pe - rennial or seasonal symptoms were reported to be sensitized to  oak and/or birch pollen as measured by skin prick test (1-4).",Non-OADS,/arxiv_data1/oa_pdf/0a/e0/jkms-31-1202.PMC4951548.pdf
• Sawtooth and Mongolian Oak Allergens http://jkms.org   1203 http://dx.doi.org/10.3346/jkms.2016.31.8.1202and skin prick testing.,Non-OADS,/arxiv_data1/oa_pdf/0a/e0/jkms-31-1202.PMC4951548.pdf
• Sawtooth and Mongolian Oak Allergens 1204  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1202Fig.,Non-OADS,/arxiv_data1/oa_pdf/0a/e0/jkms-31-1202.PMC4951548.pdf
"• Sawtooth and Mongolian Oak Allergens http://jkms.org   1205 http://dx.doi.org/10.3346/jkms.2016.31.8.1202sawtooth oak, Mongolian oak, and white oak, and profoundly  by common silver birch (Fig.",Non-OADS,/arxiv_data1/oa_pdf/0a/e0/jkms-31-1202.PMC4951548.pdf
• Sawtooth and Mongolian Oak Allergens 1206  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1202 IgE reactivity to Bet v 1 was also competitively inhibited by  the various oak pollen extracts.,Non-OADS,/arxiv_data1/oa_pdf/0a/e0/jkms-31-1202.PMC4951548.pdf
ORCID Kyoung Yong Jeong http://orcid.org/0000-0001-9887-1426 Kyung Hee Park http://orcid.org/0000-0003-3605-5364 Jae-Hyun Lee http://orcid.org/0000-0002-0760-0071 Jung-Won Park http://orcid.org/0000-0003-0249-8749REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/0a/e0/jkms-31-1202.PMC4951548.pdf
• Sawtooth and Mongolian Oak Allergens http://jkms.org   1207 http://dx.doi.org/10.3346/jkms.2016.31.8.1202Immunol 2007; 142: 99-115.,Non-OADS,/arxiv_data1/oa_pdf/0a/e0/jkms-31-1202.PMC4951548.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Immunohistochemical Analysis of ATRX, IDH1 and p53 in  Glioblastoma and Their Correlations with Patient Survival Glioblastoma (GBM) can be classified into molecular subgroups, on the basis of biomarker  expression.",Non-OADS,/arxiv_data1/oa_pdf/93/d0/jkms-31-1208.PMC4951549.pdf
2010-0028631).http://dx.doi.org/10.3346/jkms.2016.31.8.1208  • J Korean Med Sci 2016; 31: 1208-1214 INTRODUCTION Glioblastoma (GBM) is the most aggressive diffuse glioma of  the astrocytic lineage and corresponds to grade IV according to  the WHO classification (1).,Non-OADS,/arxiv_data1/oa_pdf/93/d0/jkms-31-1208.PMC4951549.pdf
"• ATRX, P53, IDH1 Expression and Survival in Glioblastoma http://jkms.org   1209 http://dx.doi.org/10.3346/jkms.2016.31.8.1208to establish prognostically distinct molecular subgroups of GBM  irrespective of the histopathological diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/93/d0/jkms-31-1208.PMC4951549.pdf
"• ATRX, P53, IDH1 Expression and Survival in Glioblastoma 1210  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1208Table 2.",Non-OADS,/arxiv_data1/oa_pdf/93/d0/jkms-31-1208.PMC4951549.pdf
"• ATRX, P53, IDH1 Expression and Survival in Glioblastoma http://jkms.org   1211 http://dx.doi.org/10.3346/jkms.2016.31.8.1208was correlated with the highest median OS and PFS (33.4 and  30.3 months, respectively), while IDH1-/p53+ group have the  lowest median OS and PFS (18.0 and 14.7 months, respective - ly).",Non-OADS,/arxiv_data1/oa_pdf/93/d0/jkms-31-1208.PMC4951549.pdf
"• ATRX, P53, IDH1 Expression and Survival in Glioblastoma 1212  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1208 Cummulative overall survival FU OS (month) 0 50 100 150 2001.0 0.8 0.6 0.4 0.2 0Kaplan meier survival analysis IDH1 negative IDH1 positive Censored Censored P = 0.045 Cummulative overall survival FU PFS (month) 0 20 40 60 80 100 1201.0 0.8 0.6 0.4 0.2 0Kaplan meier survival analysis IDH1 negative IDH1 positive Censored Censored P = 0.040 Cummulative overall survival FU OS (month) 0 50 100 150 2001.0 0.8 0.6 0.4 0.2 0Kaplan meier survival analysis ATRX+ ATRX- Censored Censored P = 0.010 A B C Cummulative overall survival FU PFS (month) 0 20 40 60 80 100 1201.0 0.8 0.6 0.4 0.2 0Kaplan meier survival analysis ATRX positive 1ATRX negative Censored Censored P = 0.012 Cummulative overall survival FU OS (month) 0 50 100 150 2001.0 0.8 0.6 0.4 0.2 0Kaplan meier survival analysis p53 negative p53 positive Censored Censored P = 0.056 Cummulative overall survival FU PFS (month) 0 20 40 60 80 100 1201.0 0.8 0.6 0.4 0.2 0Kaplan meier survival analysis p53 positive p53 negative Censored Censored P = 0.034 D E F Cummulative overall survival FU OS (month) 0 50 100 150 2001.0 0.8 0.6 0.4 0.2 0Kaplan meier survival analysis Age > 45 Age < 45 Censored Censored P = 0.011 G Cummulative overall survival FU PFS (month) 0 20 40 60 80 100 1201.0 0.8 0.6 0.4 0.2 0Kaplan meier survival analysis Age >45 Age < 45 Censored Censored P = 0.113 H Fig.",Non-OADS,/arxiv_data1/oa_pdf/93/d0/jkms-31-1208.PMC4951549.pdf
"• ATRX, P53, IDH1 Expression and Survival in Glioblastoma http://jkms.org   1213 http://dx.doi.org/10.3346/jkms.2016.31.8.1208Fig.",Non-OADS,/arxiv_data1/oa_pdf/93/d0/jkms-31-1208.PMC4951549.pdf
"• ATRX, P53, IDH1 Expression and Survival in Glioblastoma 1214  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1208ORCID Ajay Chaurasia http://orcid.org/0000-0003-0479-3442  Sung-Hye Park http://orcid.org/0000-0002-8681-1597 Jeong-Wook Seo http://orcid.org/0000-0003-0242-1805  Chul-Kee Park http://orcid.org/0000-0002-2350-9876 REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/93/d0/jkms-31-1208.PMC4951549.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357OTX1 Contributes to Hepatocellular Carcinoma Progression by  Regulation of ERK/MAPK Pathway Orthodenticlehomeobox 1 (OTX1) overexpression had previously been associated with the  progression of several tumors.",Non-OADS,/arxiv_data1/oa_pdf/cf/0a/jkms-31-1215.PMC4951550.pdf
"Received: 23 November 2015 Accepted: 12 April 2016 Address for Correspondence: Mei-juan Wu, MD Department of Pathology, Zhejiang Cancer Hospital, No.38  Guangji Road, Gongshu District, Hangzhou, Zhejiang 310022,  China E-mail: wmj1999@126.comhttp://dx.doi.org/10.3346/jkms.2016.31.8.1215  • J Korean Med Sci 2016; 31: 1215-1223 INTRODUCTION Hepatocellular carcinoma (HCC) is one of the most common  malignancies worldwide and is globally the third leading cause  of cancer-related deaths (1,2).",Non-OADS,/arxiv_data1/oa_pdf/cf/0a/jkms-31-1215.PMC4951550.pdf
"• OTX1 Contributes to Hepatocellular Carcinoma Progression 1216  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1215in neural tumors, such as medulloblastomas (14), especially  the specific nodular⁄desmoplasmic subtype (15).",Non-OADS,/arxiv_data1/oa_pdf/cf/0a/jkms-31-1215.PMC4951550.pdf
• OTX1 Contributes to Hepatocellular Carcinoma Progression http://jkms.org   1217 http://dx.doi.org/10.3346/jkms.2016.31.8.1215the negative control shRNA (NC group) or without any trans - fection (control group) with lipofectamine 2000.,Non-OADS,/arxiv_data1/oa_pdf/cf/0a/jkms-31-1215.PMC4951550.pdf
• OTX1 Contributes to Hepatocellular Carcinoma Progression 1218  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1215results showed that the protein level of OTX1 was markedly  higher in the tumor tissues than the non-cancerous tissues (Fig.,OADS,/arxiv_data1/oa_pdf/cf/0a/jkms-31-1215.PMC4951550.pdf
• OTX1 Contributes to Hepatocellular Carcinoma Progression http://jkms.org   1219 http://dx.doi.org/10.3346/jkms.2016.31.8.1215in a consecutive of 5 days.,Non-OADS,/arxiv_data1/oa_pdf/cf/0a/jkms-31-1215.PMC4951550.pdf
• OTX1 Contributes to Hepatocellular Carcinoma Progression 1220  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1215Fig.,Non-OADS,/arxiv_data1/oa_pdf/cf/0a/jkms-31-1215.PMC4951550.pdf
• OTX1 Contributes to Hepatocellular Carcinoma Progression http://jkms.org   1221 http://dx.doi.org/10.3346/jkms.2016.31.8.1215by shOTX1 by up to 78% after 12 hours culture in both Hep G2  and SMMC-7221 cells (Fig.,Non-OADS,/arxiv_data1/oa_pdf/cf/0a/jkms-31-1215.PMC4951550.pdf
• OTX1 Contributes to Hepatocellular Carcinoma Progression 1222  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1215growth and survival and regulates cell differentiation.,Non-OADS,/arxiv_data1/oa_pdf/cf/0a/jkms-31-1215.PMC4951550.pdf
ORCID Hua Li http://orcid.org/0000-0003-1728-1622 Qian Miao http://orcid.org/0000-0002-1864-5697 Chun-wei Xu http://orcid.org/0000-0002-9021-6731 Jian-hui Huang http://orcid.org/0000-0002-2854-112XYue-fen Zhou http://orcid.org/0000-0002-0872-9782 Mei-juan Wu http://orcid.org/0000-0001-7893-2287   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/cf/0a/jkms-31-1215.PMC4951550.pdf
• OTX1 Contributes to Hepatocellular Carcinoma Progression http://jkms.org   1223 http://dx.doi.org/10.3346/jkms.2016.31.8.121517.,Non-OADS,/arxiv_data1/oa_pdf/cf/0a/jkms-31-1215.PMC4951550.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Detection of EGFR  and KRAS  Mutation by Pyrosequencing  Analysis in Cytologic Samples of Non-Small Cell Lung Cancer  EGFR and KRAS  mutations are two of the most common mutations that are present in lung  cancer.",Non-OADS,/arxiv_data1/oa_pdf/f6/ce/jkms-31-1224.PMC4951551.pdf
"Keywords:  EGFR; KRAS ; Pyrosequencing; Cytology Specimen; Mutation Test; Lung  Cancer Seung Eun Lee,1 So-Young Lee,1   Hyung-Kyu Park,1 Seo-Young Oh,1   Hee-Joung Kim,2 Kye-Young Lee,2   and Wan-Seop Kim1 1Department of Pathology, Konkuk University  Medical Center, Konkuk University School of  Medicine, Seoul, Korea; 2Department of Internal  Medicine, Konkuk University Medical Center, Konkuk  University School of Medicine, Seoul, Korea Received: 23 November 2015 Accepted: 10 April 2016 Address for Correspondence: Wan-Seop Kim, MD Department of Pathology, Konkuk University School of Medicine,  Konkuk University Medical Center, 120-1 Neungdong-ro,  Gwangjin-gu, Seoul 05030, Korea E-mail: wskim@kuh.ac.kr Funding:  This study was supported by Konkuk University in  2016.http://dx.doi.org/10.3346/jkms.2016.31.8.1224  • J Korean Med Sci 2016; 31: 1224-1230 INTRODUCTION Lung cancer is one of the most common cause of cancer-relat - ed death worldwide (1).",Non-OADS,/arxiv_data1/oa_pdf/f6/ce/jkms-31-1224.PMC4951551.pdf
• EGFR and KRAS Mutation in Cytologic Samples http://jkms.org   1225 http://dx.doi.org/10.3346/jkms.2016.31.8.1224for mutational sequence analysis due to sparse cellularity (12).,OADS,/arxiv_data1/oa_pdf/f6/ce/jkms-31-1224.PMC4951551.pdf
"• EGFR and KRAS Mutation in Cytologic Samples 1226  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1224 Of them, 119 patients were positive for EGFR  mutation (29.8%),  and among them, 72 patients were female (60.5%, n = 72).",OADS,/arxiv_data1/oa_pdf/f6/ce/jkms-31-1224.PMC4951551.pdf
• EGFR and KRAS Mutation in Cytologic Samples http://jkms.org   1227 http://dx.doi.org/10.3346/jkms.2016.31.8.1224specimens.,OADS,/arxiv_data1/oa_pdf/f6/ce/jkms-31-1224.PMC4951551.pdf
"• EGFR and KRAS Mutation in Cytologic Samples 1228  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1224 The most common histologic subtype was adenocarcinoma  (74.0%, 211 of 289 cases), followed by squamous cell carcinoma  (22.1%, 64 cases), large cell carcinoma (4.5%, 13 cases), and small  cell carcinoma (4.15%, 12 cases).",Non-OADS,/arxiv_data1/oa_pdf/f6/ce/jkms-31-1224.PMC4951551.pdf
"• EGFR and KRAS Mutation in Cytologic Samples http://jkms.org   1229 http://dx.doi.org/10.3346/jkms.2016.31.8.1224advanced lung cancer patients, when it is difficult to obtain tis - sue samples.",Non-OADS,/arxiv_data1/oa_pdf/f6/ce/jkms-31-1224.PMC4951551.pdf
ORCID Seung Eun Lee http://orcid.org/0000-0002-7459-0061 So-Young Lee http://orcid.org/0000-0002-3488-898X Hyung-Kyu Park http://orcid.org/0000-0002-5972-3516 Seo-Young Oh http://orcid.org/0000-0002-2466-0068 Hee-Joung Kim http://orcid.org/0000-0002-2516-5085 Kye-Young Lee http://orcid.org/0000-0003-4687-5593 Wan-Seop Kim http://orcid.org/0000-0001-7704-5942   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f6/ce/jkms-31-1224.PMC4951551.pdf
• EGFR and KRAS Mutation in Cytologic Samples 1230  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.122413.,OADS,/arxiv_data1/oa_pdf/f6/ce/jkms-31-1224.PMC4951551.pdf
• EGFR and KRAS Mutation in Cytologic Samples http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1224Supplementary Table 1.,OADS,/arxiv_data1/oa_pdf/f6/ce/jkms-31-1224.PMC4951551.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357News Portrayal of Cancer: Content Analysis of Threat and Efficacy  by Cancer Type and Comparison with Incidence and Mortality in  Korea How the news media cover cancer may have profound significance for cancer prevention  and control; however, little is known about the actual content of cancer news coverage in  Korea.",Non-OADS,/arxiv_data1/oa_pdf/32/30/jkms-31-1231.PMC4951552.pdf
1310260).http://dx.doi.org/10.3346/jkms.2016.31.8.1231  • J Korean Med Sci 2016; 31: 1231-1238 INTRODUCTION How the news media cover cancer may bear significant impli - cations for cancer prevention and control.,Non-OADS,/arxiv_data1/oa_pdf/32/30/jkms-31-1231.PMC4951552.pdf
"• News Portrayal of Cancer 1232  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1231consequences including fatalistic beliefs about cancer preven - tion (12), depending on the actual content of cancer news sto - ries (13).",Non-OADS,/arxiv_data1/oa_pdf/32/30/jkms-31-1231.PMC4951552.pdf
"• News Portrayal of Cancer http://jkms.org   1233 http://dx.doi.org/10.3346/jkms.2016.31.8.1231 As for the cancer type, coders first read the title and the lead  of each news article to identify whether any specific cancer types  were mentioned.",Non-OADS,/arxiv_data1/oa_pdf/32/30/jkms-31-1231.PMC4951552.pdf
"• News Portrayal of Cancer 1234  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1231threat” and “News efficacy, ” report the mean scores of threat  and efficacy contained in news articles by each cancer, and the  corresponding rank.",OADS,/arxiv_data1/oa_pdf/32/30/jkms-31-1231.PMC4951552.pdf
• News Portrayal of Cancer http://jkms.org   1235 http://dx.doi.org/10.3346/jkms.2016.31.8.1231it was not so compared to the APC (-3).,Non-OADS,/arxiv_data1/oa_pdf/32/30/jkms-31-1231.PMC4951552.pdf
"• News Portrayal of Cancer 1236  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1231threat information (either general or specific), less than 50%  contained efficacy information, and those containing specific  details on efficacy accounted for only one third of news stories.",Non-OADS,/arxiv_data1/oa_pdf/32/30/jkms-31-1231.PMC4951552.pdf
"• News Portrayal of Cancer http://jkms.org   1237 http://dx.doi.org/10.3346/jkms.2016.31.8.1231unt of news coverage by cancer type (3-6,24,25).",Non-OADS,/arxiv_data1/oa_pdf/32/30/jkms-31-1231.PMC4951552.pdf
ORCID Minsun Shim http://orcid.org/0000-0003-4248-7120 Yong-Chan Kim http://orcid.org/0000-0003-4045-1028 Su Yeon Kye http://orcid.org/0000-0003-2535-3518 Keeho Park http://orcid.org/0000-0002-0186-4172 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/32/30/jkms-31-1231.PMC4951552.pdf
• News Portrayal of Cancer 1238  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1231Health Commun  2006; 11 Suppl 1: 157-72.,Non-OADS,/arxiv_data1/oa_pdf/32/30/jkms-31-1231.PMC4951552.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Impact of Hemodialysis and Arteriovenous Access Flow on  Extracranial Hemodynamic Changes in End-Stage Renal Disease  Patients In this study, we characterized cerebral blood flow changes by assessment of blood flow  parameters in neck arteries using carotid duplex ultrasonography and predictive factors for  these hemodynamic changes.",Non-OADS,/arxiv_data1/oa_pdf/e4/22/jkms-31-1239.PMC4951553.pdf
"Keywords:  Arteriovenous Access; Carotid Duplex Ultrasonography; Cerebral Blood Flow;  HemodialysisSarah Chung,1 Hye Seon Jeong,2,3   Dae Eun Choi,1 Hee-Jung Song,2,3   Young Gi Lim,2 Joo Yeon Ham,2   Ki Ryang Na,1 and Kang Wook Lee1 1Renal Division, Department of Internal Medicine,  Chungnam National University Hospital, Daejeon,  Korea; 2Department of Neurology, Chungnam  National University Hospital, Daejeon, Korea;  3Daejeon-Chungnam Regional Cerebrovascular  Center, Chungnam National University Hospital,  Daejeon, Korea Received: 29 October 2015 Accepted: 28 April 2016 Address for Correspondence: Hye Seon Jeong, MD  Department of Neurology, Chungnam National University  Hospital, 282 Munwha-ro, Jung-gu, Daejeon 35015, Korea E-mail: hyuuu28@cnuh.co.krhttp://dx.doi.org/10.3346/jkms.2016.31.8.1239  • J Korean Med Sci 2016; 31: 1239-1245 INTRODUCTION Intermittent hemodialysis influences cerebral hemodynamics  through several mechanisms in patients with end-stage renal  disease (ESRD).",Non-OADS,/arxiv_data1/oa_pdf/e4/22/jkms-31-1239.PMC4951553.pdf
• Hemodialysis and Extracranial Hemodynamic Changes 1240  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1239March 2014.,Non-OADS,/arxiv_data1/oa_pdf/e4/22/jkms-31-1239.PMC4951553.pdf
• Hemodialysis and Extracranial Hemodynamic Changes http://jkms.org   1241 http://dx.doi.org/10.3346/jkms.2016.31.8.1239Table 1.,Non-OADS,/arxiv_data1/oa_pdf/e4/22/jkms-31-1239.PMC4951553.pdf
"• Hemodialysis and Extracranial Hemodynamic Changes 1242  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1239the CCA ( P= 0.007) and changes of -11.9 ± 23.1 and -1.3 ± 23.1,  respectively, in the VA ( P= 0.002).",Non-OADS,/arxiv_data1/oa_pdf/e4/22/jkms-31-1239.PMC4951553.pdf
"• Hemodialysis and Extracranial Hemodynamic Changes http://jkms.org   1243 http://dx.doi.org/10.3346/jkms.2016.31.8.1239compared to 35% for patients in the highest quartile ( P= 0.028,  Table 4).",Non-OADS,/arxiv_data1/oa_pdf/e4/22/jkms-31-1239.PMC4951553.pdf
"• Hemodialysis and Extracranial Hemodynamic Changes 1244  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1239DM, 58.0 ± 13.6; P= 0.028).",Non-OADS,/arxiv_data1/oa_pdf/e4/22/jkms-31-1239.PMC4951553.pdf
ORCID  Sarah Chung http://orcid.org/0000-0002-8184-8905  Hye Seon Jeong http://orcid.org/0000-0002-2031-5662 Dae Eun Choi http://orcid.org/0000-0003-2870-3958 Hee-Jung Song http://orcid.org/0000-0001-9572-4105 Young Gi Lim http://orcid.org/0000-0003-1194-507X Joo Yeon Ham http://orcid.org/0000-0001-6999-1701  Ki Ryang Na http://orcid.org/0000-0002-0136-176X Kang Wook Lee http://orcid.org/0000-0003-3407-1205   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e4/22/jkms-31-1239.PMC4951553.pdf
• Hemodialysis and Extracranial Hemodynamic Changes http://jkms.org   1245 http://dx.doi.org/10.3346/jkms.2016.31.8.1239Doppler ultrasonography.,Non-OADS,/arxiv_data1/oa_pdf/e4/22/jkms-31-1239.PMC4951553.pdf
• Hemodialysis and Extracranial Hemodynamic Changes http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1239Supplementary Table 1.,Non-OADS,/arxiv_data1/oa_pdf/e4/22/jkms-31-1239.PMC4951553.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Online Registry for Nationwide Database of Current Trend of  Helicobacter pylori  Eradication in Korea: Interim Analysis Eradication of Helicobacter pylori  using first-line therapy is becoming less effective.",Non-OADS,/arxiv_data1/oa_pdf/9c/b8/jkms-31-1246.PMC4951554.pdf
"Received: 4 November 2015 Accepted: 9 April 2016 Address for Correspondence: Jae G. Kim, MD Department of Internal Medicine, Chung-Ang University College of  Medicine, 102 Heukseok-ro, Dongjak-gu, Seoul 06973, Korea E-mail: jgkimd@cau.ac.kr Funding:  This work was supported by the Korean Research  Foundation of Internal Medicine Grant 2010.http://dx.doi.org/10.3346/jkms.2016.31.8.1246  • J Korean Med Sci 2016; 31: 1246-1253 INTRODUCTION  Helicobacter pylori  infection affects 20%-50% of the population in the Western world  and up to 80% of those in developing countries (1).",Non-OADS,/arxiv_data1/oa_pdf/9c/b8/jkms-31-1246.PMC4951554.pdf
• Online Registry of Current Helicobacter pylori Eradication in Korea  http://jkms.org   1247 http://dx.doi.org/10.3346/jkms.2016.31.8.1246clinical practice to gauge H. pylori  eradication in Korea.,Non-OADS,/arxiv_data1/oa_pdf/9c/b8/jkms-31-1246.PMC4951554.pdf
"• Online Registry of Current Helicobacter pylori  Eradication in Korea  1248  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1246RESULTS Baseline demographics Thirty four tertiary and academic hospitals, which were repre - sentative of Korean hospitals, prospectively enrolled 5,331 pa - tients.",Non-OADS,/arxiv_data1/oa_pdf/9c/b8/jkms-31-1246.PMC4951554.pdf
"• Online Registry of Current Helicobacter pylori Eradication in Korea  http://jkms.org   1249 http://dx.doi.org/10.3346/jkms.2016.31.8.1246of H. pylori  eradication treatment (73.8% vs. 58.5%, P< 0.001).",Non-OADS,/arxiv_data1/oa_pdf/9c/b8/jkms-31-1246.PMC4951554.pdf
• Online Registry of Current Helicobacter pylori  Eradication in Korea  1250  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1246Table 3.,Non-OADS,/arxiv_data1/oa_pdf/9c/b8/jkms-31-1246.PMC4951554.pdf
"• Online Registry of Current Helicobacter pylori Eradication in Korea  http://jkms.org   1251 http://dx.doi.org/10.3346/jkms.2016.31.8.1246ous gastrointestinal disorder, comorbidity, previous H. pylori   eradication, PPI, duration of treatment, and compliance to treat - ment were related to the success of eradication (Table 4).",OADS,/arxiv_data1/oa_pdf/9c/b8/jkms-31-1246.PMC4951554.pdf
• Online Registry of Current Helicobacter pylori  Eradication in Korea  1252  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1246 Most of recently recommended therapy regimens for H. py ­ lori eradication are 7 days in duration.,Non-OADS,/arxiv_data1/oa_pdf/9c/b8/jkms-31-1246.PMC4951554.pdf
ORCID Beom Jin Kim http://orcid.org/0000-0002-0938-6697 Hyun-Soo Kim http://orcid.org/0000-0003-4834-0496 Hyun Joo Song http://orcid.org/0000-0002-4107-9590 Il-Kwun Chung http://orcid.org/0000-0001-6732-9714 Gwang Ha Kim http://orcid.org/0000-0001-9721-5734 Byung-Wook Kim http://orcid.org/0000-0002-2290-4954 Ki-Nam Shim http://orcid.org/0000-0003-4004-6292 Seong Woo Jeon http://orcid.org/0000-0002-9539-9389 Yun Jin Jung http://orcid.org/0000-0002-3622-9216 Chang-Hun Yang http://orcid.org/0000-0003-4036-2981 Ji Hyun Kim http://orcid.org/0000-0003-0861-2792 Tae Ho Kim http://orcid.org/0000-0003-2015-5176 Sang Gyun Kim http://orcid.org/0000-0003-1799-9028 Woon Geon Shin http://orcid.org/0000-0002-9851-5576 Sun Moon Kim http://orcid.org/0000-0002-0436-3381 Sok Won Han http://orcid.org/0000-0003-2705-778X Jun Haeng Lee http://orcid.org/0000-0002-5272-1841 Kyung Ho Kim http://orcid.org/0000-0002-9607-6258 Sue K. Park http://orcid.org/0000-0001-5002-9707 Byung-Joo Park http://orcid.org/0000-0003-4630-4942 Joongyub Lee http://orcid.org/0000-0003-2784-3772 Jae G. Kim http://orcid.org/0000-0002-4841-9404 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/9c/b8/jkms-31-1246.PMC4951554.pdf
• Online Registry of Current Helicobacter pylori Eradication in Korea  http://jkms.org   1253 http://dx.doi.org/10.3346/jkms.2016.31.8.1246pylori  infection in Korea.,Non-OADS,/arxiv_data1/oa_pdf/9c/b8/jkms-31-1246.PMC4951554.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Characteristics and Outcomes of Second Malignant Neoplasms  after Childhood Cancer Treatment: Multi-Center Retrospective  Survey This retrospective study investigated the clinical characteristics and outcomes of second  malignant neoplasms (SMNs) in survivors of childhood cancer from multiple institutions in  Korea.",Non-OADS,/arxiv_data1/oa_pdf/21/7c/jkms-31-1254.PMC4951555.pdf
"Received: 25 October 2015 Accepted: 20 April 2016 Address for Correspondence: Jong Jin Seo, MD Division of Pediatric Hematology/Oncology, Department of  Pediatrics, Asan Medical Center Children’s Hospital, University  of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu,  Seoul 05505, Korea E-mail: jjseo@amc.seoul.kr Funding:  This study was supported by grants from the young  investigator’s research fund of the Korean Society of Pediatric  Hematology & Oncology and from the National R &D Program  for Cancer Control, Ministry of Health and Welfare, Republic of  Korea (1420250).http://dx.doi.org/10.3346/jkms.2016.31.8.1254  • J Korean Med Sci 2016; 31: 1254-1261 INTRODUCTION The outcomes of childhood cancer have improved in recent decades, and the number  of long-term survivors of childhood cancer is expected to increase significantly in the  future.",Non-OADS,/arxiv_data1/oa_pdf/21/7c/jkms-31-1254.PMC4951555.pdf
"• Second Malignant Neoplasms after Childhood Cancer http://jkms.org   1255 http://dx.doi.org/10.3346/jkms.2016.31.8.1254tions in Korea between 1981 and 1997, only a small number of  patients with a limited spectrum of disease were enrolled for  that analysis (7).",Non-OADS,/arxiv_data1/oa_pdf/21/7c/jkms-31-1254.PMC4951555.pdf
"• Second Malignant Neoplasms after Childhood Cancer 1256  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1254cumulative carboplatin dose of 4,125 mg/m2 (range, 1,252-10,411  mg/m2).",Non-OADS,/arxiv_data1/oa_pdf/21/7c/jkms-31-1254.PMC4951555.pdf
"• Second Malignant Neoplasms after Childhood Cancer http://jkms.org   1257 http://dx.doi.org/10.3346/jkms.2016.31.8.125414.0 years), while that of solid tumors not associated with radia - tion was 8.0 years (range, 1.1-18.5 years; P= 0.134).",Non-OADS,/arxiv_data1/oa_pdf/21/7c/jkms-31-1254.PMC4951555.pdf
"• Second Malignant Neoplasms after Childhood Cancer 1258  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1254The 5-year OS rates of patients with common types of SMN, in - cluding AML, MDS, CNS tumors, osteosarcoma, and thyroid  carcinoma, were 18%, 33%, 32%, 64%, and 100%, respectively  (Fig.",Non-OADS,/arxiv_data1/oa_pdf/21/7c/jkms-31-1254.PMC4951555.pdf
"• Second Malignant Neoplasms after Childhood Cancer http://jkms.org   1259 http://dx.doi.org/10.3346/jkms.2016.31.8.1254follow-up time of the study, and the limitation of our question - naire survey to pediatric hemato-oncologists.",Non-OADS,/arxiv_data1/oa_pdf/21/7c/jkms-31-1254.PMC4951555.pdf
• Second Malignant Neoplasms after Childhood Cancer 1260  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1254vide baseline data for future multi-center trials of childhood  SMNs.,Non-OADS,/arxiv_data1/oa_pdf/21/7c/jkms-31-1254.PMC4951555.pdf
ORCID Kyung-Nam Koh http://orcid.org/0000-0002-6376-672X Keon Hee Yoo http://orcid.org/0000-0002-5980-7912  Ho Joon Im http://orcid.org/0000-0001-8799-4068 Ki Woong Sung http://orcid.org/0000-0001-5989-4772  Hong Hoe Koo http://orcid.org/0000-0001-8082-1412  Hyo Sun Kim http://orcid.org/0000-0003-1260-7814  Jung Woo Han http://orcid.org/0000-0001-8936-1205  Jong Hyung Yoon http://orcid.org/0000-0001-7871-1548  Hyeon Jin Park http://orcid.org/0000-0002-9557-3412  Byung-Kiu Park http://orcid.org/0000-0001-9743-0610  Hee Jo Baek http://orcid.org/0000-0003-2301-9823  Hoon Kook http://orcid.org/0000-0002-9135-5821  Jun Ah Lee http://orcid.org/0000-0003-3310-9566  Jae Min Lee http://orcid.org/0000-0001-6822-1051  Kwang Chul Lee http://orcid.org/0000-0003-3552-8721  Soon Ki Kim http://orcid.org/0000-0002-4785-1705  Meerim Park http://orcid.org/0000-0002-6847-9447  Young-Ho Lee http://orcid.org/0000-0003-1498-2773  Chuhl Joo Lyu http://orcid.org/0000-0001-7124-7818  Jong Jin Seo http://orcid.org/0000-0002-0191-7836 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/21/7c/jkms-31-1254.PMC4951555.pdf
• Second Malignant Neoplasms after Childhood Cancer http://jkms.org   1261 http://dx.doi.org/10.3346/jkms.2016.31.8.1254single institution experience.,Non-OADS,/arxiv_data1/oa_pdf/21/7c/jkms-31-1254.PMC4951555.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Risk Factors for Functional Constipation in Young Children  Attending Daycare Centers Our objective was to determine the risk factors associated with the development of  functional constipation (FC) in young children attending daycare centers.",Non-OADS,/arxiv_data1/oa_pdf/9c/f8/jkms-31-1262.PMC4951556.pdf
"Keywords:  Constipation; Child; Daycare Centers; QuestionnaireMinkyu Park,1 Yun Gyu Bang,1   and Ky Young Cho2 1Department of Pediatrics, KEPCO Medical Center,  Seoul, Korea; 2Department of Pediatrics, Kangnam  Sacred Heart Hospital, Hallym University College of  Medicine, Seoul, Korea Received: 10 May 2016 Accepted: 13 May 2016 Address for Correspondence: Ky Young Cho, MD Department of Pediatrics, Kangnam Sacred Heart Hospital,  Hallym University College of Medicine, 1 Singil-ro,  Yeongdeungpo-gu, Seoul 07440, Korea E-mail: choky96@daum.net Funding:  This work was supported by a grant from the Ewha  Womans University Department of Pediatrics Research Fund  (2015EUPR0804).http://dx.doi.org/10.3346/jkms.2016.31.8.1262  • J Korean Med Sci 2016; 31: 1262-1265 INTRODUCTION Functional constipation (FC) is common in children with an  estimated prevalence of 3% worldwide (1).",Non-OADS,/arxiv_data1/oa_pdf/9c/f8/jkms-31-1262.PMC4951556.pdf
• Constipation in Young Children Attending Daycare Centers http://jkms.org   1263 http://dx.doi.org/10.3346/jkms.2016.31.8.1262Table 1.,Non-OADS,/arxiv_data1/oa_pdf/9c/f8/jkms-31-1262.PMC4951556.pdf
"• Constipation in Young Children Attending Daycare Centers 1264  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1262DISCUSSION This study showed that maternal history of constipation, early  experience of painful defecation, no or difficult defecation at  the daycare center, drinking 500 mL or less of water per day, and  no meat consumption were risk factors for FC in early child - hood, opposed to external factors such as the age of toilet train - ing, the birth of siblings or environmental change (7).",Non-OADS,/arxiv_data1/oa_pdf/9c/f8/jkms-31-1262.PMC4951556.pdf
• Constipation in Young Children Attending Daycare Centers http://jkms.org   1265 http://dx.doi.org/10.3346/jkms.2016.31.8.1262apy to prevent FC and to modify precipitating factors in early  childhood.,Non-OADS,/arxiv_data1/oa_pdf/9c/f8/jkms-31-1262.PMC4951556.pdf
ORCID  Minkyu Park http://orcid.org/0000-0002-0570-6059  Yun Gyu Bang http://orcid.org/0000-0002-5851-2995 Ky Young Cho http://orcid.org/0000-0002-0565-8077REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/9c/f8/jkms-31-1262.PMC4951556.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Clinical Outcomes of Cryopreserved Arterial Allograft Used as a  Vascular Conduit for Hemodialysis This single center cohort study aimed to test the hypothesis that use of a cryopreserved  arterial allograft could avoid the maturation or healing process of a new vascular access  and to evaluate the patency of this technique compared with that of vascular access using  a prosthetic graft.",Non-OADS,/arxiv_data1/oa_pdf/ec/0e/jkms-31-1266.PMC4951557.pdf
"Keywords:  Allografts; Cryopreservation; Renal Insufficiency; Vascular Access DevicesTae-Yong Ha,1 Young Hoon Kim,1   Jai Won Chang,2 Yangsoon Park,3  Youngjin Han,1 Hyunwook Kwon,1   Tae-Won Kwon,1 Duck Jong Han,1   Yong-Pil Cho,1 and Sung-Gyu Lee1 1Department of Surgery, University of Ulsan College  of Medicine and Asan Medical Center, Seoul, Korea;  2Department of Internal Medicine University of  Ulsan College of Medicine and Asan Medical Center,  Seoul, Korea; 3Department of Pathology, University  of Ulsan College of Medicine and Asan Medical  Center, Seoul, Korea Received: 17 August 2015 Accepted: 12 April 2016 Address for Correspondence: Yong-Pil Cho, MD  Department of Surgery, University of Ulsan College of Medicine,  Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu,   Seoul 05505, Korea  E-mail: ypcho@amc.seoul.kr Funding:  This study was supported by a grant (grant number  2012-0557) from the Asan Institute for Life Sciences, Asan  Medical Center, Seoul, Korea.http://dx.doi.org/10.3346/jkms.2016.31.8.1266  • J Korean Med Sci 2016; 31: 1266-1272 INTRODUCTION Morbidity and mortality in end-stage renal disease (ESRD) pa - tients undergoing hemodialysis have been associated with di - alysis efficiency (1).",Non-OADS,/arxiv_data1/oa_pdf/ec/0e/jkms-31-1266.PMC4951557.pdf
• A Cryopreserved Allograft for Hemodialysis http://jkms.org   1267 http://dx.doi.org/10.3346/jkms.2016.31.8.1266created to enable hemodialysis at our institution.,Non-OADS,/arxiv_data1/oa_pdf/ec/0e/jkms-31-1266.PMC4951557.pdf
"• A Cryopreserved Allograft for Hemodialysis 1268  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1266formed using SPSS software (version 18.0; SPSS, Chicago, IL,  USA), with P values ≤ 0.05 considered statistically significant.",Non-OADS,/arxiv_data1/oa_pdf/ec/0e/jkms-31-1266.PMC4951557.pdf
"• A Cryopreserved Allograft for Hemodialysis http://jkms.org   1269 http://dx.doi.org/10.3346/jkms.2016.31.8.1266 At the time of access placement, there was no definite steno - sis or occlusion of the central vein and use of an ipsilateral cen -tral venous catheter for hemodialysis did not differ in the two  groups ( P= 0.665) (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/ec/0e/jkms-31-1266.PMC4951557.pdf
"• A Cryopreserved Allograft for Hemodialysis 1270  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1266fragmentation and calcification of internal elastic lamella, and  widening of interlamellar spaces.",Non-OADS,/arxiv_data1/oa_pdf/ec/0e/jkms-31-1266.PMC4951557.pdf
• A Cryopreserved Allograft for Hemodialysis http://jkms.org   1271 http://dx.doi.org/10.3346/jkms.2016.31.8.1266sisted) and cumulative (assisted) access survival.,Non-OADS,/arxiv_data1/oa_pdf/ec/0e/jkms-31-1266.PMC4951557.pdf
ORCID  Tae-Yong Ha http://orcid.org/0000-0001-9932-0212 Young Hoon Kim http://orcid.org/0000-0003-3840-8426 Jai Won Chang http://orcid.org/0000-0003-0296-5992 Yangsoon Park http://orcid.org/0000-0003-2832-3525 Youngjin Han http://orcid.org/0000-0002-5315-0155  Hyunwook Kwon http://orcid.org/0000-0001-5018-5304 Tae-Won Kwon http://orcid.org/0000-0003-3803-0013 Duck Jong Han http://orcid.org/0000-0002-0990-6824 Yong- Pil Cho http://orcid.org/0000-0002-0639-451X Sung-Gyu Lee http://orcid.org/0000-0001-9161-3491    REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ec/0e/jkms-31-1266.PMC4951557.pdf
• A Cryopreserved Allograft for Hemodialysis 1272  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.126613.,Non-OADS,/arxiv_data1/oa_pdf/ec/0e/jkms-31-1266.PMC4951557.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Simvastatin Reduces Capsular Fibrosis around Silicone Implants Capsular fibrosis and contracture occurs in most breast reconstruction patients who  undergo radiotherapy, and there is no definitive solution for its prevention.",Non-OADS,/arxiv_data1/oa_pdf/d9/b9/jkms-31-1273.PMC4951558.pdf
"Keywords:  Simvastatin; Fibrosis; Implant Capsular ContractureKyu Jin Chung,1 Ki Rin Park,2   Jun Ho Lee,1 Tae Gon Kim,1   and Yong-Ha Kim1 1Department of Plastic and Reconstructive Surgery,  College of Medicine, Yeungnam University, Daegu,  Korea; 2RED Plastic Surgery, Changwon, Korea Received: 17 December 2015 Accepted: 10 April 2016 Address for Correspondence: Yong-Ha Kim, MD Department of Plastic and Reconstructive Surgery, College of  Medicine, Yeungnam University, 170 Hyeonchung-ro, Nam-gu,  Daegu 42415, Korea E-mail: kimyon@ynu.ac.kr Funding:  This research was supported by a grant of Yeungnam  University Medical Center (2013).http://dx.doi.org/10.3346/jkms.2016.31.8.1273  • J Korean Med Sci 2016; 31: 1273-1278 INTRODUCTION Implant-based immediate breast reconstruction after skin spar - ing mastectomy has recently become an accepted approach for  management of patients with breast cancer (1).",Non-OADS,/arxiv_data1/oa_pdf/d9/b9/jkms-31-1273.PMC4951558.pdf
• Simvastatin and Fibrosis 1274  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1273had free access to standard rat chow and were housed in indi - vidual cages and maintained at 21 ± 2°C and a 12-hour light/  12-hour dark cycle (light on 7 AM to 7 PM).,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/jkms-31-1273.PMC4951558.pdf
• Simvastatin and Fibrosis http://jkms.org   1275 http://dx.doi.org/10.3346/jkms.2016.31.8.1273capsular fibrosis.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/jkms-31-1273.PMC4951558.pdf
"• Simvastatin and Fibrosis 1276  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1273renchymal thickness, and it is possible that capsular fibrosis ra - tio is changed.",Non-OADS,/arxiv_data1/oa_pdf/d9/b9/jkms-31-1273.PMC4951558.pdf
• Simvastatin and Fibrosis http://jkms.org   1277 http://dx.doi.org/10.3346/jkms.2016.31.8.1273questions remain unanswered.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/jkms-31-1273.PMC4951558.pdf
ORCID  Kyu Jin Chung http://orcid.org/0000-0001-6335-1818Ki Rin Park http://orcid.org/0000-0001-5582-5083 Jun Ho Lee http://orcid.org/0000-0002-0062-6420 Tae Gon Kim http://orcid.org/0000-0002-6738-4630 Yong-Ha Kim http://orcid.org/0000-0002-1804-9086   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/jkms-31-1273.PMC4951558.pdf
• Simvastatin and Fibrosis 1278  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.127365.,Non-OADS,/arxiv_data1/oa_pdf/d9/b9/jkms-31-1273.PMC4951558.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Effects of High-Intensity-Focused Ultrasound Treatment on  Benign Uterine Tumor In this study, the effects of high-intensity-focused ultrasound (HIFU) treatment on benign  uterine tumor patients were examined.",Non-OADS,/arxiv_data1/oa_pdf/95/42/jkms-31-1279.PMC4951559.pdf
"Keywords:  High-Intensity-Focused Ultrasound; Benign Uterine Tumor; Treatment EffectsJaeyoon Park,1,4 Jae Seong Lee,2   Jae-Hwan Cho,3 and Sungchul Kim4 1Department of Radiology, Incheon Christian  Hospital, Incheon, Korea; 2Department of Obstetrics  and Gynaecology, Aegis Womanmed Clinic, Seoul,  Korea; 3Department of Radiological Technology,  Ansan College, Ansan, Korea; 4Department of  Radiological Science, Gachon University Medical  Campus, Incheon, Korea Received: 18 January 2016 Accepted: 11 May 2016 Address for Correspondence: Sungchul Kim, PhD Department of Radiological Science, Gachon University Medical  Campus, 191 Hambangmoe-ro, Yeonsu-gu, Incheon 21936,  Korea E-mail: ksc@gachon.ac.krhttp://dx.doi.org/10.3346/jkms.2016.31.8.1279  • J Korean Med Sci 2016; 31: 1279-1283 INTRODUCTION The uterus, which is associated with sex and childbirth, has been  socioculturally recognized as a symbolic organ of mature wom - en (1).",Non-OADS,/arxiv_data1/oa_pdf/95/42/jkms-31-1279.PMC4951559.pdf
• Ultrasound Treatment on Benign Uterine Tumor 1280  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1279300 W to 400 W considering the subject’s pain level and the trans - mutation level of the fibroid and adenomyosis shown in the ul - trasound.,Non-OADS,/arxiv_data1/oa_pdf/95/42/jkms-31-1279.PMC4951559.pdf
• Ultrasound Treatment on Benign Uterine Tumor http://jkms.org   1281 http://dx.doi.org/10.3346/jkms.2016.31.8.1279Treatment effects according to the subject’s fertility The reduction of the benign uterine tumor volume was statisti - cally significant up to six months after treatment in all fertilities.,Non-OADS,/arxiv_data1/oa_pdf/95/42/jkms-31-1279.PMC4951559.pdf
"• Ultrasound Treatment on Benign Uterine Tumor 1282  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1279-were investigated (8,9).",Non-OADS,/arxiv_data1/oa_pdf/95/42/jkms-31-1279.PMC4951559.pdf
"• Ultrasound Treatment on Benign Uterine Tumor http://jkms.org   1283 http://dx.doi.org/10.3346/jkms.2016.31.8.1279ma, the follow-up observation of 7 pregnant women who expe - rienced unplanned pregnancies showed that all women had a  full term delivery and did not have any specific complications  related to the pregnancy within 1 year (range: 5-32 weeks, aver - age: 20 ± 8.85 weeks) after receiving HIFU treatment.",Non-OADS,/arxiv_data1/oa_pdf/95/42/jkms-31-1279.PMC4951559.pdf
ORCID Jaeyoon Park http://orcid.org/0000-0001-7212-7391 Jae Seong Lee http://orcid.org/0000-0002-3988-1496  Jae-Hwan Cho http://orcid.org/0000-0001-7112-3866 Sungchul Kim http://orcid.org/0000-0002-4195-1297 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/95/42/jkms-31-1279.PMC4951559.pdf
Available at  http://www.nhis.or.kr/bbs7/boards/B0039/13321 [accessed on 1 May  2015].,Non-OADS,/arxiv_data1/oa_pdf/95/42/jkms-31-1279.PMC4951559.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Differences in Utilization Patterns among Medications in  Children and Adolescents with Attention-Deficit/Hyperactivity  Disorder: a 36-Month Retrospective Study Using the Korean  Health Insurance Review and Assessment Claims Database We evaluated the differences in utilization patterns including persistence and adherence  among medications in children and adolescents with attention deficit hyperactivity disorder  (ADHD).",Non-OADS,/arxiv_data1/oa_pdf/be/d3/jkms-31-1284.PMC4951560.pdf
http://dx.doi.org/10.3346/jkms.2016.31.8.1284  • J Korean Med Sci 2016; 31: 1284-1291 INTRODUCTION Attention-deficit/hyperactivity disorder (ADHD) is the most common childhood dis - order in psychiatric outpatient clinics and affects 3%-8% of the pediatric population  worldwide (1).,Non-OADS,/arxiv_data1/oa_pdf/be/d3/jkms-31-1284.PMC4951560.pdf
• Utilization Patterns among Medications in ADHD http://jkms.org   1285 http://dx.doi.org/10.3346/jkms.2016.31.8.1284and better adherence to treatment seem to be important throu- ghout treatment period.,Non-OADS,/arxiv_data1/oa_pdf/be/d3/jkms-31-1284.PMC4951560.pdf
• Utilization Patterns among Medications in ADHD 1286  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1284tence and adherence were measured for 36 months or more.,Non-OADS,/arxiv_data1/oa_pdf/be/d3/jkms-31-1284.PMC4951560.pdf
"• Utilization Patterns among Medications in ADHD http://jkms.org   1287 http://dx.doi.org/10.3346/jkms.2016.31.8.1284group, 405.2 ± 274.0 in ATX group, respectively (F = 3.418, P=  0.017, IR-MPH < OROS-MPH < ER-MPH, ATX in post hoc Tukey  test) (Table 2).",OADS,/arxiv_data1/oa_pdf/be/d3/jkms-31-1284.PMC4951560.pdf
• Utilization Patterns among Medications in ADHD 1288  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1284spectively.,Non-OADS,/arxiv_data1/oa_pdf/be/d3/jkms-31-1284.PMC4951560.pdf
"• Utilization Patterns among Medications in ADHD http://jkms.org   1289 http://dx.doi.org/10.3346/jkms.2016.31.8.1284tions, covariates including girls and general hospitals were as - sociated with increased adherence.",Non-OADS,/arxiv_data1/oa_pdf/be/d3/jkms-31-1284.PMC4951560.pdf
• Utilization Patterns among Medications in ADHD 1290  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1284ORCID Soo-Young Bhang http://orcid.org/0000-0001-5254-0314 Jun-Won Hwang http://orcid.org/0000-0001-5407-8514  Young-Sook Kwack http://orcid.org/0000-0002-6071-238X Yoo Sook Joung http://orcid.org/0000-0002-9225-4643 Soyoung Lee http://orcid.org/0000-0003-2473-2954 Bongseog Kim http://orcid.org/0000-0002-2534-6986  Seok Han Sohn http://orcid.org/0000-0001-6130-9317 Un Sun Chung http://orcid.org/0000-0003-3871-1425 Jaewon Yang http://orcid.org/0000-0001-5064-5948 Minha Hong http://orcid.org/0000-0003-4924-1107 Geon Ho Bahn http://orcid.org/0000-0002-3550-0422 Hyung Yun Choi http://orcid.org/0000-0002-6134-3504 In-Hwan Oh http://orcid.org/0000-0002-5450-9887 Yeon Jung Lee http://orcid.org/0000-0002-5624-0447 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/be/d3/jkms-31-1284.PMC4951560.pdf
• Utilization Patterns among Medications in ADHD http://jkms.org   1291 http://dx.doi.org/10.3346/jkms.2016.31.8.1284among young people with newly diagnosed attention-deficit/hyperactiv - ity disorder.,Non-OADS,/arxiv_data1/oa_pdf/be/d3/jkms-31-1284.PMC4951560.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Degree of Diabetic Retinopathy in Patients with Type 2  Diabetes Correlates with the Presence and Severity of Coronary  Heart Disease Both diabetic retinopathy (DR) and coronary heart disease (CHD) are clinically significant in  diabetic patients.",Non-OADS,/arxiv_data1/oa_pdf/05/cc/jkms-31-1292.PMC4951561.pdf
"Keywords:  Coronary Heart Disease; Diabetic Retinopathy; Type 2 DiabetesTaewoong Um,1 Dong Hoon Lee,2   Joon-Won Kang,4 Eun Young Kim,5   and Young Hee Yoon3 1Department of Ophthalmology, 38th Fighter Group  Medical Station, Gunsan, Korea; 2Department of  Ophthalmology, Yonsei Eagle Eye Hospital,  Seongnam, Korea; 3Department of Ophthalmology,  Asan Medical Center, University of Ulsan, College of  Medicine, Seoul, Korea; 4Department of Radiology,  Asan Medical Center, University of Ulsan, College of  Medicine, Seoul, Korea; 5Department of Radiology,  Chonbuk National University Medical School and  Hospital, Research Institute of Clinical Medicine,  Jeonju, Korea Received: 10 November 2015 Accepted: 11 May 2016 Address for Correspondence: Young Hee Yoon, MD Department of Ophthalmology, Asan Medical Center, University  of Ulsan, College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu,  Seoul 05505, Korea E-mail: yhyoon@amc.seoul.kr Funding:  This work was supported by Asan Institute for Life  Science (08-084).http://dx.doi.org/10.3346/jkms.2016.31.8.1292  • J Korean Med Sci 2016; 31: 1292-1299 INTRODUCTION Coronary heart disease (CHD) is a leading cause of death in pa - tients with diabetes mellitus (1,2), and is one of the well-known  macrovascular complications of diabetes.",Non-OADS,/arxiv_data1/oa_pdf/05/cc/jkms-31-1292.PMC4951561.pdf
• The Relationship between Diabetic Retinopathy and Coronary Heart Disease http://jkms.org   1293 http://dx.doi.org/10.3346/jkms.2016.31.8.1292any history of cardiac symptoms were obtained from the pa - tients’ medical records.,OADS,/arxiv_data1/oa_pdf/05/cc/jkms-31-1292.PMC4951561.pdf
"• The Relationship between Diabetic Retinopathy and Coronary Heart Disease 1294  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1292tional review board of the Asan Medical Center, Seoul, Korea  (IRB No.",Non-OADS,/arxiv_data1/oa_pdf/05/cc/jkms-31-1292.PMC4951561.pdf
• The Relationship between Diabetic Retinopathy and Coronary Heart Disease http://jkms.org   1295 http://dx.doi.org/10.3346/jkms.2016.31.8.1292Fig.,Non-OADS,/arxiv_data1/oa_pdf/05/cc/jkms-31-1292.PMC4951561.pdf
• The Relationship between Diabetic Retinopathy and Coronary Heart Disease 1296  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1292Table 3.,Non-OADS,/arxiv_data1/oa_pdf/05/cc/jkms-31-1292.PMC4951561.pdf
• The Relationship between Diabetic Retinopathy and Coronary Heart Disease http://jkms.org   1297 http://dx.doi.org/10.3346/jkms.2016.31.8.1292DISCUSSION It has been speculated that the pathologic processes that occur  at the microvascular level may contribute to the pathogenesis  of macrovascular complications such as CHD.,Non-OADS,/arxiv_data1/oa_pdf/05/cc/jkms-31-1292.PMC4951561.pdf
"• The Relationship between Diabetic Retinopathy and Coronary Heart Disease 1298  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1292values of our patients into five groups (ACS ≥ 400, 100 ≤ ACS <   400, 10 ≤ ACS < 100, 1 ≤ ACS < 10, or 0 ≤ ACS < 1) in accordance  with a previous study (15).",Non-OADS,/arxiv_data1/oa_pdf/05/cc/jkms-31-1292.PMC4951561.pdf
"• The Relationship between Diabetic Retinopathy and Coronary Heart Disease http://jkms.org   1299 http://dx.doi.org/10.3346/jkms.2016.31.8.1292data: Um T. Analysis and interpretation of data: Um T, Lee DH,  Kang JW, Kim EY, Yoon YH.",OADS,/arxiv_data1/oa_pdf/05/cc/jkms-31-1292.PMC4951561.pdf
ORCID  Taewoong Um http://orcid.org/0000-0001-9059-4751 Dong Hoon Lee http://orcid.org/0000-0002-7571-7749 Joon-Won Kang http://orcid.org/0000-0001-6478-0390 Eun Young Kim http://orcid.org/0000-0002-7280-8856 Young Hee Yoon http://orcid.org/0000-0002-2849-7528 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/05/cc/jkms-31-1292.PMC4951561.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Is There Any Age Cutoff to Treat Elderly Patients with Head and  Neck Cancer?",Non-OADS,/arxiv_data1/oa_pdf/c9/71/jkms-31-1300.PMC4951562.pdf
"Keywords:  Head and Neck Neoplasms; Geriatric Assessment; Surgical Procedures,  Operative; Radiation OncologyHeejin Kim,1 Seong Dong Kim,2   Ye Ji Shim,2 Sang Yeon Lee,2   Myung-Whun Sung,2,3 Kwang Hyun Kim,2  and J. Hun Hah2,3 1Department of Otorhinolaryngology-Head and  Neck Surgery, Hallym University, Dongtan Sacred  Heart Hospital, Hwaseong, Korea; 2Department of  Otorhinolaryngology-Head and Neck Surgery, Seoul  National University College of Medicine, Seoul,  Korea; 3Cancer Research Institute, Seoul National  University College of Medicine, Seoul, Korea Received: 15 September 2015 Accepted: 20 April 2016 Address for Correspondence: J. Hun Hah, MD Department of Otorhinolaryngology-Head and Neck Surgery  and Cancer Research Institute, Seoul National University College  of Medicine, 101 Daehak-ro Jongno-gu, Seoul 03080, Korea E-mail: jhunhah@snu.ac.krhttp://dx.doi.org/10.3346/jkms.2016.31.8.1300  • J Korean Med Sci 2016; 31: 1300-1306 INTRODUCTION Due to lower birth rates and better healthcare, the average age  of the world’s population has increased.",Non-OADS,/arxiv_data1/oa_pdf/c9/71/jkms-31-1300.PMC4951562.pdf
• Management of Elderly Patients with Head and Neck Cancer http://jkms.org   1301 http://dx.doi.org/10.3346/jkms.2016.31.8.1300have severe comorbidities; these findings have led to a number  of debates (6-8).,Non-OADS,/arxiv_data1/oa_pdf/c9/71/jkms-31-1300.PMC4951562.pdf
A complete ACE-27 data form is available on http://oto.wustl.,OADS,/arxiv_data1/oa_pdf/c9/71/jkms-31-1300.PMC4951562.pdf
"• Management of Elderly Patients with Head and Neck Cancer 1302  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1300on Cancer, 7th edition (16).",Non-OADS,/arxiv_data1/oa_pdf/c9/71/jkms-31-1300.PMC4951562.pdf
• Management of Elderly Patients with Head and Neck Cancer http://jkms.org   1303 http://dx.doi.org/10.3346/jkms.2016.31.8.1300Table 3.,Non-OADS,/arxiv_data1/oa_pdf/c9/71/jkms-31-1300.PMC4951562.pdf
• Management of Elderly Patients with Head and Neck Cancer 1304  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1300tomically complex and plays vital physiological roles.,Non-OADS,/arxiv_data1/oa_pdf/c9/71/jkms-31-1300.PMC4951562.pdf
• Management of Elderly Patients with Head and Neck Cancer http://jkms.org   1305 http://dx.doi.org/10.3346/jkms.2016.31.8.1300cantly more comorbidities than septuagenarians.,Non-OADS,/arxiv_data1/oa_pdf/c9/71/jkms-31-1300.PMC4951562.pdf
ORCID Heejin Kim http://orcid.org/0000-0001-6157-3636 Seong Dong Kim http://orcid.org/0000-0001-8768-3462 Ye Ji Shim http://orcid.org/0000-0002-0597-9962 Sang Yeon Lee http://orcid.org/0000-0002-4671-2615 Myung-Whun Sung http://orcid.org/0000-0003-3513-9996 Kwang Hyun Kim http://orcid.org/0000-0002-7184-3887 J. Hun Hah http://orcid.org/0000-0002-5110-012X REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/c9/71/jkms-31-1300.PMC4951562.pdf
Available at http://stats.oecd.org/index.aspx?DataSetCode  =HEALTH_STAT# [accessed on 29 July 2015].,OADS,/arxiv_data1/oa_pdf/c9/71/jkms-31-1300.PMC4951562.pdf
• Management of Elderly Patients with Head and Neck Cancer 1306  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1300patients.,Non-OADS,/arxiv_data1/oa_pdf/c9/71/jkms-31-1300.PMC4951562.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Skin Barrier Function Is Not Impaired and Kallikrein  7 Gene  Polymorphism Is Frequently Observed in Korean X-linked  Ichthyosis Patients Diagnosed by Fluorescence in Situ  Hybridization and Array Comparative Genomic Hybridization X-linked ichthyosis (XLI) is a recessively inherited ichthyosis.",Non-OADS,/arxiv_data1/oa_pdf/d7/89/jkms-31-1307.PMC4951563.pdf
": HI14C2687).http://dx.doi.org/10.3346/jkms.2016.31.8.1307  • J Korean Med Sci 2016; 31: 1307-1318 INTRODUCTION X-linked ichthyosis (XLI, OMIM#308100) is a relatively rare he - reditary keratinization disorder that affects between 1 in 2,000  and 1 in 6,000 males worldwide (1).",Non-OADS,/arxiv_data1/oa_pdf/d7/89/jkms-31-1307.PMC4951563.pdf
• Novel Features of Korean X-linked Ichthyosis Patients 1308  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1307factor is that point mutations cannot be detected.,Non-OADS,/arxiv_data1/oa_pdf/d7/89/jkms-31-1307.PMC4951563.pdf
"• Novel Features of Korean X-linked Ichthyosis Patients http://jkms.org   1309 http://dx.doi.org/10.3346/jkms.2016.31.8.1307for each sample, and the normalized G/R ratio represented the  relative average number of copies of the sequence for those  spots that were selected as controls.",OADS,/arxiv_data1/oa_pdf/d7/89/jkms-31-1307.PMC4951563.pdf
• Novel Features of Korean X-linked Ichthyosis Patients 1310  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1307Table 2.,Non-OADS,/arxiv_data1/oa_pdf/d7/89/jkms-31-1307.PMC4951563.pdf
"• Novel Features of Korean X-linked Ichthyosis Patients http://jkms.org   1311 http://dx.doi.org/10.3346/jkms.2016.31.8.1307Statistical analysis To compare the TEWL, SC hydration, skin surface pH and SC  cytokine expression levels between the patient and control groups,  we performed the nonparametric Mann-Whitney statistical  analysis.",Non-OADS,/arxiv_data1/oa_pdf/d7/89/jkms-31-1307.PMC4951563.pdf
"• Novel Features of Korean X-linked Ichthyosis Patients 1312  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1307of the patient or control groups showed mutations in FLG  gene,  whether 3321delA or K4022X, which are the most frequent FLG   mutation (over 95%) found in Korean atopic dermatitis (AD)  patients.",Non-OADS,/arxiv_data1/oa_pdf/d7/89/jkms-31-1307.PMC4951563.pdf
• Novel Features of Korean X-linked Ichthyosis Patients http://jkms.org   1313 http://dx.doi.org/10.3346/jkms.2016.31.8.1307and B).,Non-OADS,/arxiv_data1/oa_pdf/d7/89/jkms-31-1307.PMC4951563.pdf
"• Novel Features of Korean X-linked Ichthyosis Patients 1314  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1307DISCUSSION In the epidermis, SSase hydrolyzes 3 β-sulfate esters from CSO 4.",Non-OADS,/arxiv_data1/oa_pdf/d7/89/jkms-31-1307.PMC4951563.pdf
• Novel Features of Korean X-linked Ichthyosis Patients http://jkms.org   1315 http://dx.doi.org/10.3346/jkms.2016.31.8.1307Fig.,Non-OADS,/arxiv_data1/oa_pdf/d7/89/jkms-31-1307.PMC4951563.pdf
• Novel Features of Korean X-linked Ichthyosis Patients 1316  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1307SC (28).,Non-OADS,/arxiv_data1/oa_pdf/d7/89/jkms-31-1307.PMC4951563.pdf
"• Novel Features of Korean X-linked Ichthyosis Patients http://jkms.org   1317 http://dx.doi.org/10.3346/jkms.2016.31.8.1307 In summary, Korean XLI patients showed different features  as compared with previously known characteristics of Western  XLI patients.",Non-OADS,/arxiv_data1/oa_pdf/d7/89/jkms-31-1307.PMC4951563.pdf
Approval of final manuscript: all authors ORCID  Noo Ri Lee http://orcid.org/0000-0002-0933-4416 Na Young Yoon http://orcid.org/0000-0002-4137-4071 Minyoung Jung http://orcid.org/0000-0001-5131-1069 Ji-Yun Kim http://orcid.org/0000-0002-2097-6874 Seong Jun Seo http://orcid.org/0000-0003-2915-839X Hye-young Wang http://orcid.org/0000-0001-8404-2248 Hyeyoung Lee http://orcid.org/0000-0003-1572-5250 Young Bae Sohn http://orcid.org/0000-0002-4664-1941 Eung Ho Choi http://orcid.org/0000-0002-0148-5594  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d7/89/jkms-31-1307.PMC4951563.pdf
• Novel Features of Korean X-linked Ichthyosis Patients 1318  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1307limited gene responses before and after moisturizing treatments.,Non-OADS,/arxiv_data1/oa_pdf/d7/89/jkms-31-1307.PMC4951563.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Preventing Venous Thromboembolism with Use of Intermittent  Pneumatic Compression after Total Hip Arthroplasty in Korean  Patients Intermittent Pneumatic Compression (IPC) device has been used to prevent venous  thromboembolism (VTE).",Non-OADS,/arxiv_data1/oa_pdf/53/b4/jkms-31-1319.PMC4951564.pdf
"Keywords:  Intermittent Pneumatic Compression; Venous Thromboembolism; Deep Vein  Thrombosis; Pulmonary Embolism; Total Hip ArthroplastyWoo-Lam Jo,1 Young-Kyun Lee,2   Yong-Chan Ha,3 Kyung-Min Lee,2   Bun-Jung Kang,4 and Kyung-Hoi Koo2 1Department of Orthopaedic Surgery, Seoul Saint  Mary’s Hospital, Seoul, Korea; 2Department of  Orthopaedic Surgery, Seoul National University  Bundang Hospital, Seongnam, Korea; 3Department  of Orthopaedic Surgery, Chung-Ang University  Hospital, Seoul, Korea; 4Department of Orthopaedic  Surgery, Gyeongsang National University Hospital,  Jinju, Korea Received: 13 October 2015 Accepted: 12 April 2016 Address for Correspondence: Young-Kyun Lee, MD Department of Orthopaedic Surgery, Seoul National University  Bundang Hospital, 166 Gumi-ro, Seongnam 13620, Korea E-mail: ykleemd@gmail.comhttp://dx.doi.org/10.3346/jkms.2016.31.8.1319  • J Korean Med Sci 2016; 31: 1319-1323 INTRODUCTION Deep vein thrombosis (DVT) and pulmonary embolism (PE)  are well known complications after total hip arthroplasty (THA).",Non-OADS,/arxiv_data1/oa_pdf/53/b4/jkms-31-1319.PMC4951564.pdf
"• Intermittent Pneumatic Compression after Total Hip Arthroplasty 1320  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1319MATERIALS AND METHODS Inclusion of patients From January 2010 to December 2013, 876 primary THAs (746  patients) were done at our department.",Non-OADS,/arxiv_data1/oa_pdf/53/b4/jkms-31-1319.PMC4951564.pdf
"• Intermittent Pneumatic Compression after Total Hip Arthroplasty http://jkms.org   1321 http://dx.doi.org/10.3346/jkms.2016.31.8.1319tomatic DVT was 0%, 0.1% (1/992), and 0.8% (8/992), respec - tively, in that study.",Non-OADS,/arxiv_data1/oa_pdf/53/b4/jkms-31-1319.PMC4951564.pdf
• Intermittent Pneumatic Compression after Total Hip Arthroplasty 1322  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1319symptomatic DVTs.,Non-OADS,/arxiv_data1/oa_pdf/53/b4/jkms-31-1319.PMC4951564.pdf
ORCID Woo-Lam Jo http://orcid.org/0000-0001-7021-9348 Young-Kyun Lee http://orcid.org/0000-0001-6564-4294 Yong-Chan Ha http://orcid.org/0000-0002-6249-0581 Kyung-Min Lee http://orcid.org/0000-0002-3819-4002 Bun-Jung Kang http://orcid.org/0000-0002-4155-6772 Kyung-Hoi Koo http://orcid.org/0000-0001-5251-2911REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/53/b4/jkms-31-1319.PMC4951564.pdf
• Intermittent Pneumatic Compression after Total Hip Arthroplasty http://jkms.org   1323 http://dx.doi.org/10.3346/jkms.2016.31.8.131920.,Non-OADS,/arxiv_data1/oa_pdf/53/b4/jkms-31-1319.PMC4951564.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Comparative Effectivenesses of Pulsed Radiofrequency and  Transforaminal Steroid Injection for Radicular Pain due to Disc  Herniation: A Prospective Randomized Trial Transforaminal Epidural steroid injections (TFESI) have been widely adopted to alleviate and  control radicular pain in accord with current guidelines.",Non-OADS,/arxiv_data1/oa_pdf/13/1e/jkms-31-1324.PMC4951565.pdf
"Keywords:  Pulsed Radiofrequency Treatment; Transforaminal Epidural Steroid Injection;  Radicular PainDong Gyu Lee,1 Sang-Ho Ahn,2   and Jungwon Lee2 1Department of Physical Medicine & Rehabilitation,  Dongsan Medical Center, Keimyung University  School of Medicine, Daegu, Korea; 2Department of  Physical Medicine & Rehabilitation, Yeungnam  University School of Medicine, Daegu, Korea Received: 21 April 2016 Accepted: 23 June 2016 Address for Correspondence: Sang-Ho Ahn, MD Department of Rehabilitation Medicine and Spine Center,  Yeungnam University, College of Medicine, 170 Hyunchung-ro,  Nam-gu, Daegu 42415, Korea E-mail: spineahn@ynu.ac.kr Funding:  This work was supported by the 2015 Yeungnam  University Research Grant.http://dx.doi.org/10.3346/jkms.2016.31.8.1324  • J Korean Med Sci 2016; 31: 1324-1330 INTRODUCTION Steroids are powerful anti-inflammatory agents, and effectively  reduce nerve root inflammation produced by disc herniation  or a disc pathology near the epidural space.",Non-OADS,/arxiv_data1/oa_pdf/13/1e/jkms-31-1324.PMC4951565.pdf
"• Effectiveness of Pulsed Radiofrequency for Radicular Pain http://jkms.org   1325 http://dx.doi.org/10.3346/jkms.2016.31.8.1324MATERIALS AND METHODS Materials During the period from March 2013 to February 2015, 193 pa - tients were underwent TFESI for the treatment of spinal radicu - lar pain.",Non-OADS,/arxiv_data1/oa_pdf/13/1e/jkms-31-1324.PMC4951565.pdf
• Effectiveness of Pulsed Radiofrequency for Radicular Pain 1326  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1324Table 1.,Non-OADS,/arxiv_data1/oa_pdf/13/1e/jkms-31-1324.PMC4951565.pdf
• Effectiveness of Pulsed Radiofrequency for Radicular Pain http://jkms.org   1327 http://dx.doi.org/10.3346/jkms.2016.31.8.1324Table 3.,Non-OADS,/arxiv_data1/oa_pdf/13/1e/jkms-31-1324.PMC4951565.pdf
"• Effectiveness of Pulsed Radiofrequency for Radicular Pain 1328  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1324when TFESI is conducted by well trained physicians, the injec - tion of particulate steroid into an artery around the spinal canal  can occlude capillaries and arterioles and cause spinal cord and  cerebellar infarction resulting in permanent motor and sensory  deficits (31).",Non-OADS,/arxiv_data1/oa_pdf/13/1e/jkms-31-1324.PMC4951565.pdf
• Effectiveness of Pulsed Radiofrequency for Radicular Pain http://jkms.org   1329 http://dx.doi.org/10.3346/jkms.2016.31.8.1324the above-mentioned studies did not include comparable con - trols or validate the benefits of DRG stimulation by PRF in sub - acute radicular limb pain.,Non-OADS,/arxiv_data1/oa_pdf/13/1e/jkms-31-1324.PMC4951565.pdf
ORCID Dong Gyu Lee http://orcid.org/0000-0002-4787-4448 Sang-Ho Ahn http://orcid.org/0000-0003-2921-7820 Jungwon Lee http://orcid.org/0000-0001-9230-3583 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/13/1e/jkms-31-1324.PMC4951565.pdf
• Effectiveness of Pulsed Radiofrequency for Radicular Pain 1330  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1324neck disability index.,Non-OADS,/arxiv_data1/oa_pdf/13/1e/jkms-31-1324.PMC4951565.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Emergency Department Crowding Disparity: A Nationwide  Cross-Sectional Study In this study, we evaluated national differences in emergency department (ED) crowding to  identify factors significantly associated with crowding in institutes and communities across  Korea.",Non-OADS,/arxiv_data1/oa_pdf/61/34/jkms-31-1331.PMC4951566.pdf
http://dx.doi.org/10.3346/jkms.2016.31.8.1331  • J Korean Med Sci 2016; 31: 1331-1336 INTRODUCTION Emergency Department (ED) crowding has become a major  public health concern (1-3).,Non-OADS,/arxiv_data1/oa_pdf/61/34/jkms-31-1331.PMC4951566.pdf
• Emergency Department Crowding 1332  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1331NEDIS data had been collected for less than 12 months.,OADS,/arxiv_data1/oa_pdf/61/34/jkms-31-1331.PMC4951566.pdf
• Emergency Department Crowding http://jkms.org   1333 http://dx.doi.org/10.3346/jkms.2016.31.8.1331RESULTS Characteristics of study subjects A total of 120 EDs were included in the final analysis.,OADS,/arxiv_data1/oa_pdf/61/34/jkms-31-1331.PMC4951566.pdf
• Emergency Department Crowding 1334  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1331Table 3.,Non-OADS,/arxiv_data1/oa_pdf/61/34/jkms-31-1331.PMC4951566.pdf
"• Emergency Department Crowding http://jkms.org   1335 http://dx.doi.org/10.3346/jkms.2016.31.8.1331DISCUSSION In our study, we gathered data from 120 officially designated  EDs and found significant differences in crowding state.",OADS,/arxiv_data1/oa_pdf/61/34/jkms-31-1331.PMC4951566.pdf
ORCID Won Chul Cha http://orcid.org/0000-0002-2778-2992 Ki Ok Ahn http://orcid.org/0000-0002-8446-3269 Sang Do Shin http://orcid.org/0000-0003-4953-2916 Jeong Ho Park http://orcid.org/0000-0001-6330-9820 Jin Sung Cho http://orcid.org/0000-0001-6762-4692 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/61/34/jkms-31-1331.PMC4951566.pdf
• Emergency Department Crowding 1336  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1331United States Health System (US).,Non-OADS,/arxiv_data1/oa_pdf/61/34/jkms-31-1331.PMC4951566.pdf
Available at http://www.acep.org/work - area/DownloadAsset.aspx?id=8872 [accessed on 24 Feburary 2016].,OADS,/arxiv_data1/oa_pdf/61/34/jkms-31-1331.PMC4951566.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Influence of Daily Fluid Balance prior to Continuous Renal  Replacement Therapy on Outcomes in Critically Ill Patients Positive fluid balance is a risk factor for mortality in critically ill patients, especially those  requiring continuous renal replacement therapy (CRRT).",Non-OADS,/arxiv_data1/oa_pdf/d1/15/jkms-31-1337.PMC4951567.pdf
"Keywords:  Continuous Renal Replacement Therapy; Critically Ill Patients; Daily Fluid  Balance; Organ FailureMin Jee Han, Ki Hyun Park,   Jung-ho Shin, and Su Hyun Kim Department of Internal Medicine, Chung-Ang  University Hospital, Seoul, Korea Received: 19 January 2016 Accepted: 12 April 2016 Address for Correspondence: Jung-ho Shin, MD Department of Internal Medicine, Chung-Ang University  Hospital, 102 Heukseok-ro, Dongjak-gu, Seoul 06973, Korea  E-mail: junghoshin1982@gmail.comhttp://dx.doi.org/10.3346/jkms.2016.31.8.1337  • J Korean Med Sci 2016; 31: 1337-1344 INTRODUCTION Fluid therapy is essential for treating critically ill patients.",Non-OADS,/arxiv_data1/oa_pdf/d1/15/jkms-31-1337.PMC4951567.pdf
• Fluid Balance before Continuous Renal Replacement Therapy 1338  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1337ma admissions; 12 were postoperative admissions; and 16 had  preexisting end-stage renal disease requiring dialysis.,Non-OADS,/arxiv_data1/oa_pdf/d1/15/jkms-31-1337.PMC4951567.pdf
"• Fluid Balance before Continuous Renal Replacement Therapy http://jkms.org   1339 http://dx.doi.org/10.3346/jkms.2016.31.8.1337CRRT initiation, there were 37 patients (37.0%) in group 1, 31  (31.0%) in group 2, and 32 (32.0%) in group 3.",Non-OADS,/arxiv_data1/oa_pdf/d1/15/jkms-31-1337.PMC4951567.pdf
• Fluid Balance before Continuous Renal Replacement Therapy 1340  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1337Fig.,Non-OADS,/arxiv_data1/oa_pdf/d1/15/jkms-31-1337.PMC4951567.pdf
• Fluid Balance before Continuous Renal Replacement Therapy http://jkms.org   1341 http://dx.doi.org/10.3346/jkms.2016.31.8.1337 The HR for organ failure depending on daily fluid balance  was determined (Table 3).,Non-OADS,/arxiv_data1/oa_pdf/d1/15/jkms-31-1337.PMC4951567.pdf
• Fluid Balance before Continuous Renal Replacement Therapy 1342  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1337DISCUSSION We retrospectively investigated the outcomes affected by fluid  accumulation in critically ill patients receiving CRRT.,Non-OADS,/arxiv_data1/oa_pdf/d1/15/jkms-31-1337.PMC4951567.pdf
• Fluid Balance before Continuous Renal Replacement Therapy http://jkms.org   1343 http://dx.doi.org/10.3346/jkms.2016.31.8.1337fluid.,Non-OADS,/arxiv_data1/oa_pdf/d1/15/jkms-31-1337.PMC4951567.pdf
ORCID Min Jee Han http://orcid.org/0000-0002-8712-6292 Ki Hyun Park http://orcid.org/0000-0003-0142-027X  Jung-ho Shin http://orcid.org/0000-0001-9755-3100 Su Hyun Kim http://orcid.org/0000-0003-3382-528X REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d1/15/jkms-31-1337.PMC4951567.pdf
• Fluid Balance before Continuous Renal Replacement Therapy 1344  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1337domized evaluation of normal vs. augmented level of replacement thera - py trial.,Non-OADS,/arxiv_data1/oa_pdf/d1/15/jkms-31-1337.PMC4951567.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Hypopituitarism Presenting as Adrenal Insufficiency and  Hypothyroidism in a Patient with Wilson’s Disease: A Case Report  Wilson’s disease typically presents symptoms associated with liver damage or  neuropsychiatric disturbances, while endocrinologic abnormalities are rare.",Non-OADS,/arxiv_data1/oa_pdf/5e/42/jkms-31-1345.PMC4951568.pdf
"Keywords:  Hepatolenticular Degeneration; Hypopituitarism; Hypothyroidism; Adrenal  InsufficiencyHae Won Lee,1 Jin Du Kang,1   Chang Woo Yeo,1 Sung Woon Yoon,1  Kwang Jae Lee,1 and Mun Ki Choi2 1Department of Internal Medicine, Daedong  Hospital, Busan, Korea; 2Department of Internal  Medicine, New Tong Yeong Hospital, Tongyeong,  Korea Received: 17 February 2015 Accepted: 22 June 2015 Address for Correspondence: Mun Ki Choi, MD Department of Internal Medicine, New Tong Yeong Hospital,  192 Mujeon 7-gil, Tongyeong 53034, Korea E-mail: cutegor@naver.comhttp://dx.doi.org/10.3346/jkms.2016.31.8.1345  • J Korean Med Sci 2016; 31: 1345-1348 INTRODUCTION Wilson’s disease is a rare autosomal recessive inherited disor - der of copper metabolism causing excessive copper accumula - tion in the liver, brain, cornea and several other organs in the  body, requiring specific treatment to remove or detoxify tissue  copper and to prevent reaccumulation (1).",Non-OADS,/arxiv_data1/oa_pdf/5e/42/jkms-31-1345.PMC4951568.pdf
• Adrenal Insufficiency and Hypothyroidism in Wilson’s Disease 1346  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1345Table 1.,Non-OADS,/arxiv_data1/oa_pdf/5e/42/jkms-31-1345.PMC4951568.pdf
• Adrenal Insufficiency and Hypothyroidism in Wilson’s Disease http://jkms.org   1347 http://dx.doi.org/10.3346/jkms.2016.31.8.1345lin-induced hypoglycemia.,Non-OADS,/arxiv_data1/oa_pdf/5e/42/jkms-31-1345.PMC4951568.pdf
• Adrenal Insufficiency and Hypothyroidism in Wilson’s Disease 1348  http://jkms.org http://dx.doi.org/10.3346/jkms.2016.31.8.1345potential conditions (13).,Non-OADS,/arxiv_data1/oa_pdf/5e/42/jkms-31-1345.PMC4951568.pdf
ORCID Hae Won Lee http://orcid.org/0000-0002-7744-2187 Jin Du Kang http://orcid.org/0000-0003-2191-7718 Chang Woo Yeo http://orcid.org/0000-0001-5753-4191 Sung Oon Yoon http://orcid.org/0000-0001-7073-020X Kwang Jae Lee http://orcid.org/0000-0001-5468-6499 Mun Ki Choi http://orcid.org/0000-0002-5725-7128REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/5e/42/jkms-31-1345.PMC4951568.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2016.02.001 2211-3835 &2016 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/c5/51/main.PMC4951582.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: ALIX, ALG-2 interacting protein X; ATPase, adenosine triphosphatase; BBB, blood –brain barrier; CCK-8, cell counting kit-8; CD, cluster of differentiation; DIL, 1,10-dioctadecyl-3,3,30,30-tetramethylindocarbocyanine perchlorate; DNA, deoxyribonucleic acid; EGF, epidermal growth factor; EGFR, epidermal growth factor receptor; EpCAM, epithelial cell adhesion molecule; ESCRT, endosomal sorting complexes required for transport; EV, extracellular vesicle; HEK293, human embryonic kidney cell line 293; HeLa, Henrietta Lacks cells; HIV, human immunode ﬁciency virus; HMGA2, high- mobility group AT-hook protein; Hsp, heat shock proteins; IL-6, interleukin-6; ILVs, intraluminal vesicles; kRAS, Kirsten rat sarcoma; LPS,lipopolysaccharides; MAPK-1, mitogen-activated protein kinase 1; MHC, major histocompatibility complex; miRNA, micro RNA; MPS, mononuclear phagocyte system; mRNA, messenger RNA; MVB, multi-vesicular body biogenesis; PBMC, peripheral blood mononuclear cells; PD, Parkinson ’s disease; PEG, polyethylene glycol; RNA, ribonucleic acid; ROS, reactive oxygen species; RPE1, retinal pigment epithelial cells 1; siRNA, small interferenc e RNA; TNF- α, tumor necrosis factor α; TSG101, tumor susceptibility gene 101; VPS4, vacuolar protein sorting-associated protein 4 nCorresponding author.",Non-OADS,/arxiv_data1/oa_pdf/c5/51/main.PMC4951582.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2016.01.007 2211-3835 &2016 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/58/c9/main.PMC4951583.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/58/c9/main.PMC4951583.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bb/8a/main.PMC4951585.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2016.05.004 2211-3835 &2016 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/c6/dd/main.PMC4951586.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: LA, leuprolide acetate; LHRH, luteinizing hormone release hormone; MCT, medium chain triglyceride; NMP, N-methyl-2-pyrrolidone; SPC, soya phosphatidyl choline; SPME, the injectable gel system (soya phosphatidyl choline, medium chain triglyceride and ethanol); SPME-LA, LA- loaded SPME; VPGs, vesicular phospholipid gels.",Non-OADS,/arxiv_data1/oa_pdf/c6/dd/main.PMC4951586.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/51/main.PMC4951587.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2016.05.011 2211-3835 &2016 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/d9/a4/main.PMC4951588.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: Abs, integrin aVb3 mAbs; B-PDEAEA, poly[(2-acryloyl) ethyl ( p-boronic acid benzyl) diethylammonium bromide]; BPS, bridged polysilsesquioxanexerogel; BSA, bovine serum albumin; CA4, combretastatin A4; CAPL, charge reversible pullulan-based; CHPNH2, cationic choles teryl group –bearing pullulans; Cit, citraconic anhydride; CMC, carboxymethyl cellulose; CPLAs, cationic polylactides; Cya, cysteamine hydrochloride; DAP, 2,3-diamino-propionate; DCL, dimethyl maleamidic acid- ε-caprolactone; DDS, drug delivery system; DM, dimyristeroyl; DMA, 2,3-dimethylmaleic anhydride; DMPA, dimethylol propionic acid; DOX, doxorubicin; FITC, ﬂuorescein isothiocyanate; Glu, glutamic acid; GO, graphene oxide; GSH, glutathione; HCC, hepatocellular carcinoma; HEP, 1,4-bis(2-hydroxyethyl) piperazine; His, histidine; HMP, p-hydroxylmethylenephenol; MG, microgels; MMPs, matrix metalloproteinases; MNP, magnetic nanoparticles; NPs, nanoparticles; PAEP, poly(allyl ethylene phosphate); pA-F, ﬂuorescein-labeled polyanion; PAH, poly(allylamine) hydrochloride; PBAE, poly( β-amino ester); PCL, poly( ε-caprolactone); PDADMAC, poly(diallyldimethylammonium chloride); PEG, polyethylene glycol; PEI, polyethylenimine; PEO, poly(ethylene oxide); PK, protein kinase; PLA, ploylactic acid; PLGA, poly(lac tic-co- glycolic acid); PLL, poly( L-lysine); PMA, poly(methacrylic acid); PS, pH sensitive; PSS, poly(sodium 4-styrenesulfonate); PSSS, poly(styrene- co-4-styrene- sulfonate); PTX, paclitaxel; PU, polyurethane; PVPON, poly( N-vinylpyrrolidone); ROS, reactive oxygen species; SOD, superoxide dismutase; TMA, 2- (mercaptoethyl) trimethylammonium chloride; TUNA, thioundecyl-tetraethyleneglycolester- o-nitrobenzy-lethyldimethyl ammonium bromide nCorresponding author at: Key Laboratory of Smart Drug Delivery, Ministry of Education, Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai 201203, China.",Non-OADS,/arxiv_data1/oa_pdf/d9/a4/main.PMC4951588.pdf
Available from: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d9/a4/main.PMC4951588.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2016.03.010 2211-3835 &2016 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/6a/f4/main.PMC4951589.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6a/f4/main.PMC4951589.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2016.04.001 2211-3835 &2016 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/e3/c6/main.PMC4951590.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e3/c6/main.PMC4951590.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2016.03.011 2211-3835 &2016 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/d3/a7/main.PMC4951591.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: API, active pharmaceutical ingredient; CLF, coarse lactose ﬁnes; dae, aerodynamic diameter; DPI, dry powder inhaler; ED, emission dose; ER, elongation ratio; FLF, ﬁne lactose ﬁnes; FPF, ﬁne particle fraction; FR, ﬂatness ratio; Fshape, shape factor; Fsurface , surface factor; MFV, minimum ﬂuidization velocity; PDD, pulmonary drug delivery; pMDI, pressurized metered-dose inhaler; RO, roundness nCorresponding authors at: School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China.",Non-OADS,/arxiv_data1/oa_pdf/d3/a7/main.PMC4951591.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2016.05.010 2211-3835 &2016 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/7e/e0/main.PMC4951592.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7e/e0/main.PMC4951592.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2016.03.003 2211-3835 &2016 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/7b/11/main.PMC4951593.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/11/main.PMC4951593.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org /licenses/by-nc-nd/4.0/ ).Chinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences www.elsevier.com/locate/apsb www.sciencedirect.comActa Pharmaceutica Sinica B http://dx.doi.org/10.1016/j.apsb.2016.05.013 2211-3835 &2016 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/40/0e/main.PMC4951594.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/40/0e/main.PMC4951594.pdf
"A list of the putative Mycobacterium  tuberculosis  adhesins identified by computational analyses a    Annot ation  Putative adhesin -encoding genes   ESAT -6-like proteins  Rv1037c  and Rv3890c   Hypothetical proteins    Rv0538 , Rv0584 , Rv0679c , Rv0988 , Rv1115 , Rv1116A , Rv1269c , Rv2190c ,  Rv2730 , Rv3036 c, Rv3067 , Rv3207c , Rv3337 , Rv3491 , Rv3705c , Rv3811 ,  and Rv3822   Immunogenic protein Mpt64  Rv1980c   Low -molecular -weight antigen CFP2  Rv2376c   Major secreted immunogenic protein  Mpt70  Rv2875   Mce -family protein  Rv0590   PE family proteins  Rv1089  and Rv1788   PE-PGRS family proteins    Rv0578c , Rv0872c , Rv0977 , Rv0980c , Rv1450c , Rv1803c , Rv2126c ,  Rv2487c , Rv2853 , Rv3345c , Rv3507 , and Rv3514   Periplasmic phosphate -binding  lipoprotein  Rv0932c   Possible chitinase  Rv1987   Possible conserved lipoproteins  Rv1881c  and Rv3576   PPE family proteins  Rv0304c , Rv0354c , Rv0755c , Rv1548c , Rv2353c , Rv2356c , and Rv3159c   Probable cutinase precursor  Rv1984c   Probable lipoprotein aminopeptidase  Rv0418   Probable penicillin -binding protein  Rv0050   Soluble secreted antigen Mpt53  precu rsor  Rv2878c   Superoxide dismutase  Rv3846       a Putative adhesins identified from Kumar et al  (18) and the MycobacRV web server (http://mycobacteriarv.igib.res.in )",Non-OADS,/arxiv_data1/oa_pdf/a9/db/IJBMS-19-579.PMC4951595.pdf
"Using the MycobacRV web server   (http://mycobacteriarv.igib.res.in ), 37 novel  prospec - tive adhesins were identified in M. tuberculosis   H37Rv (Table 2).",OADS,/arxiv_data1/oa_pdf/a9/db/IJBMS-19-579.PMC4951595.pdf
Available from:  http://apps.who.int/iris/bitstream/10665/137094/ 1/97892415 64809_eng.pdf?ua=1 .,OADS,/arxiv_data1/oa_pdf/a9/db/IJBMS-19-579.PMC4951595.pdf
"Key Words :Anesthesia, Competency-based educat ion, Medical education, Residency Received: December 3, 2015 •Revised: January 20, 2016 •Accepted: March 4, 2016 Corresponding Author:  Sylvain Boet (http://orcid.org/0000-0002-1679-818X) Department of Anesthesiology & Department of Innovation in Medi cal Education, The Ottawa  Hospital, 501 Smyth Rd, Critical Care Wing 1401, Ottawa K1H 8L6 , ON, Canada Tel: +1.613.737.8187  Fax: +1.613.737.8189  email: sboet@toh.on .",Non-OADS,/arxiv_data1/oa_pdf/53/d2/kjme-2016-20.PMC4951736.pdf
c a                 Korean J Med Educ 2016 Jun; 28(2): 157-168. http://dx.doi.org/10.3946/kjme.2016.20 eISSN: 2005-7288 Ⓒ The Korean Society of Medical Education.,Non-OADS,/arxiv_data1/oa_pdf/53/d2/kjme-2016-20.PMC4951736.pdf
ORCID:  Sylvain Boet: http://orcid.org/0000-0002-1679-818X;  Ashlee-Ann E. Pigford: http://orcid.org/0000-0001-5028-8792;  Viren N. Naik: http://orcid.org/0000-0002-2387-7329 Acknowledgements:  T h e  a u t h o r s  t h a n k  t h e  p r o g r a m   directors and residents who agreed to participate in this  study.,Non-OADS,/arxiv_data1/oa_pdf/53/d2/kjme-2016-20.PMC4951736.pdf
Available from: https://www.afmc.ca/future-of-medical- education-in-canada/postgraduate-project/pdf/FMEC_PG_Final-Report_EN.pdf.,Non-OADS,/arxiv_data1/oa_pdf/53/d2/kjme-2016-20.PMC4951736.pdf
Available from: https://www.afmc.ca/pdf/fmec/19_Glover %20Takahashi_Competency-based%20Education.pdf.,Non-OADS,/arxiv_data1/oa_pdf/53/d2/kjme-2016-20.PMC4951736.pdf
Available from: http://www.royalcollege.ca/common/documents/ educational_initiatives/rc_competency-by-design_ebook_e.pdf.,Non-OADS,/arxiv_data1/oa_pdf/53/d2/kjme-2016-20.PMC4951736.pdf
"  243 TEACHING TIPS Assessing effective physic ian-patient communication  skills: “Are you listening to me, doc?” Anthony C. Berman1,2 and Darryl S. Chutka2 1School of Education, Hamline Un iversity, Saint Paul, MN, and 2Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, USA Received: December 17, 2015 •Revised: January 12, 2016 •Accepted: January 18, 2016 Corresponding Author:  Anthony C. Berman (http://orcid.org/0000-0002-4385-1097) Mayo Clinic College of Medicine, 200 First Street SW, Rochester  55905, MN, USA Tel: +1.507.288.4939  Fax: +1.507.538.7234  email: brmns@msn.co m                 Korean J Med Educ 2016 Jun; 28(2): 243-249. http://dx.doi.org/10.3946/kjme.2016.21 eISSN: 2005-7288 Ⓒ The Korean Society of Medical Education.",Non-OADS,/arxiv_data1/oa_pdf/5f/ee/kjme-2016-21.PMC4951737.pdf
ORCID:  Anthony C. Berman: http://orcid.org/0000-0002-4385-1097;,Non-OADS,/arxiv_data1/oa_pdf/5f/ee/kjme-2016-21.PMC4951737.pdf
"Anthony C. Berman and Darryl S. Chutka : Physician-patient commu nication skills   248 Korean J Med Educ 2016 Jun; 28(2): 243-249.Darryl S. Chutka: http://orcid.org/0000-0001-9299-7490 Acknowledgements:  Anthony C. Berman, Ed.D.",Non-OADS,/arxiv_data1/oa_pdf/5f/ee/kjme-2016-21.PMC4951737.pdf
"Key Words :Clinical competence, Cross-sectional studies, Ir an, Self-assessment, Surveys and questionnaires Received: January 18, 2016 •Revised: February 23, 2016 •Accepted: February 23, 2016 Corresponding Author:  Marzeyeh Loripoor (http://orcid.org/0000-0002-9290-8993) Midwifery and Reproductive Health Department, School of Nursing  and Midwifery, Rafsanjan  University of Medical Sciences, Jomhori St., Rafsanjan 77187967 55, Iran Tel: +98.3434255900  Fax: +98.3434258497  email: marzeyehloripo o r @ y a h o o .",Non-OADS,/arxiv_data1/oa_pdf/25/a0/kjme-2016-22.PMC4951738.pdf
c o m       Korean J Med Educ 2016 Jun; 28(2): 195-200. http://dx.doi.org/10.3946/kjme.2016.22 eISSN: 2005-7288 Ⓒ The Korean Society of Medical Education.,Non-OADS,/arxiv_data1/oa_pdf/25/a0/kjme-2016-22.PMC4951738.pdf
ORCID:  Tabandeh sadeghi: http://orcid.org/0000-0002-8850-3432; Marzeyeh Loripoor: http://orcid.org/0000-0002-9290-8993 Acknowledgements:  This study was a research project  approved in Rafsanjan University of Medical Sciences  and was financially sponsored by this university.,Non-OADS,/arxiv_data1/oa_pdf/25/a0/kjme-2016-22.PMC4951738.pdf
"  219Received: January 27, 2016 •Revised: February 25, 2016 •Accepted: February 29, 2016 Corresponding Author:  Anbarasi K (http://orcid.org/0000-0002-7667-8112) Sri Ramachandra University, Porur, Chennai, IndiaTel: +91.09500012995  Fax: +91.04445928643  email: anbarasi815@ g m a i l .",Non-OADS,/arxiv_data1/oa_pdf/bf/7c/kjme-2016-23.PMC4951739.pdf
c o m         Korean J Med Educ 2016 Jun; 28(2): 219-229. http://dx.doi.org/10.3946/kjme.2016.23 eISSN: 2005-7288 Ⓒ The Korean Society of Medical Education.,Non-OADS,/arxiv_data1/oa_pdf/bf/7c/kjme-2016-23.PMC4951739.pdf
ORCID:  Kandaswamy Deivanayagam:  http://orcid.org/0000-0001-9228-4781; Anbarasi K: http://orcid.org/0000-0002-7667-8112 Acknowledgements:  We sincerely thank our team members  who consistently contributed their time and showed their  commitment throughout the program series and our chancellor for his generous support.,Non-OADS,/arxiv_data1/oa_pdf/bf/7c/kjme-2016-23.PMC4951739.pdf
"Key Words :Standardized patients, Problem-based lear ning, Problem representation, Video case Received: December 7, 2015 •Revised: February 27, 2016 •Accepted: February 29, 2016 Corresponding Author:  Jong-Tae Lee (http://orcid.org/0000-0002-6132-897X) Department of Preventive Medicine, Inje University College of M edicine, 75 Bokji-ro, Busanjin-gu,  Busan 47392, Korea Tel: +82.51.890.6742  Fax: +82.51.895.1864  email: pmljt742@inj e .",Non-OADS,/arxiv_data1/oa_pdf/25/30/kjme-2016-24.PMC4951740.pdf
k r                 Korean J Med Educ 2016 Jun; 28(2): 169-178. http://dx.doi.org/10.3946/kjme.2016.24 eISSN: 2005-7288 Ⓒ The Korean Society of Medical Education.,Non-OADS,/arxiv_data1/oa_pdf/25/30/kjme-2016-24.PMC4951740.pdf
ORCID:  Bo Young Yoon: http://orcid.org/0000-0002-9635-4799; Ikseon Choi: http://orcid.org/0000-0001-8005-1649;  Seokjin Choi: http://orcid.org/0000-0002-2688-4006; Tae-Hee Kim: http://orcid.org/0000-0002-3001-234X; Hyerin Roh: http://orcid.org/0000-0002-3879-709X; Byoung Doo Rhee: http://orcid.org/0000-0002-9459-3227;Jong-Tae Lee: http://orcid.org/0000-0002-6132-897X Acknowledgements:  None.,Non-OADS,/arxiv_data1/oa_pdf/25/30/kjme-2016-24.PMC4951740.pdf
"Key Words :Extracurricular activity, Medical school, Admission Received: December 16, 2015 •Revised: February 14, 2016 •Accepted: March 3, 2016 Corresponding Author:  Sang Hyun Kim (http://orcid.org/0000-0002-5543-6878) Department of Microbiology and Immunology, Kangwon National Uni versity School of Medicine,  1 Gangwondaehak-gil, Chuncheon 24341, Korea  Tel: +82.33.250.8863  Fax: +82.33.250.8808  email: sanghyun@kan g w o n .",Non-OADS,/arxiv_data1/oa_pdf/af/d2/kjme-2016-25.PMC4951741.pdf
k r           Korean J Med Educ 2016 Jun; 28(2): 201-207. http://dx.doi.org/10.3946/kjme.2016.25 eISSN: 2005-7288 Ⓒ The Korean Society of Medical Education.,Non-OADS,/arxiv_data1/oa_pdf/af/d2/kjme-2016-25.PMC4951741.pdf
"ORCID:  Sang Hyun Kim: http://orcid.org/0000-0002-5543-6878 Acknowledgements:  I appreciate the support by members  of the Department of Microbiology and Immunology,  Kangwon National University School of Medicine, Chuncheon, Korea.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/kjme-2016-25.PMC4951741.pdf
"  237Received: December 4, 2015 •Revised: January 6, 2016 •Accepted: March 4, 2016 Corresponding Author:  Hyun-Hee Kong (http://orcid.org/0000-0003-1075-0051) Department of Parasitology, Dong-A University College of Medici ne, 32 Daesingongwon-ro, Seo-gu,  Busan 49201, Korea Tel: +82.51.240.2645  Fax: +82.51.240.2866  email: hhkong@dau.a c .",Non-OADS,/arxiv_data1/oa_pdf/f1/a7/kjme-2016-26.PMC4951742.pdf
k r                 Korean J Med Educ 2016 Jun; 28(2): 237-241. http://dx.doi.org/10.3946/kjme.2016.26 eISSN: 2005-7288 Ⓒ The Korean Society of Medical Education.,Non-OADS,/arxiv_data1/oa_pdf/f1/a7/kjme-2016-26.PMC4951742.pdf
ORCID:  Ji-Hyun Seo: http://orcid.org/0000-0002-0691-3957;  Hyun-Hee Kong: http://orcid.org/0000-0003-1075-0051;  Sun-Ju Im: http://orcid.org/0000-0002-3038-3570; HyeRin Roh: http://orcid.org/0000-0002-3879-709x; Do-Kyong Kim: http://orcid.org/0000-0001-8639-1951;  Hwa-ok Bae: http://orcid.org/0000-0002-3962-6911; Young-Rim Oh: http://orcid.org/0000-0002-0376-1345 Acknowledgements:  None.,Non-OADS,/arxiv_data1/oa_pdf/f1/a7/kjme-2016-26.PMC4951742.pdf
Available from: http://www.gmc-uk.org/guidance/good_medical_practice/ record_work.asp.,Non-OADS,/arxiv_data1/oa_pdf/f1/a7/kjme-2016-26.PMC4951742.pdf
"  153 OPINION How to improve the continuing  professional development in Korea Myung Jin Lee  Korean Medical Ethics Study Group Received: January 4, 2016 •Revised: February 12, 2016 •Accepted: February 12, 2016 Corresponding Author:  Myung Jin Lee (http://orcid.org/0000-0001-9076-7771) 1384 Nambusunhwan-ro, Geumcheon-gu, Seoul 08547, KoreaTel: +82.10.5259.5795  Fax: +82.2.865.5527  email: papa5795@han m a i l .",Non-OADS,/arxiv_data1/oa_pdf/72/83/kjme-2016-27.PMC4951743.pdf
n e t             Korean J Med Educ 2016 Jun; 28(2): 153-156. http://dx.doi.org/10.3946/kjme.2016.27 eISSN: 2005-7288 Ⓒ The Korean Society of Medical Education.,Non-OADS,/arxiv_data1/oa_pdf/72/83/kjme-2016-27.PMC4951743.pdf
ORCID:  Myung Jin Lee: http://orcid.org/0000-0001-9076-7771 Acknowledgements:  N one.,Non-OADS,/arxiv_data1/oa_pdf/72/83/kjme-2016-27.PMC4951743.pdf
"  179Received: March 2, 2016 •Revised: April 25, 2016 •Accepted: April 25, 2016 Corresponding Author:  Miran Kim (http://orcid.org/0000-0001-5553-5334) Department of Obstetrics & Gynecology, Ajou University School o f Medicine, 206 World cup-ro, Yeongtong-gu, Suwon 16499, Korea Tel: +82.31.219.5300  Fax: +82.31.219.4093  email: kmr5300@ajou .",Non-OADS,/arxiv_data1/oa_pdf/1e/6f/kjme-2016-28.PMC4951744.pdf
k r      Korean J Med Educ 2016 Jun; 28(2): 179-183. http://dx.doi.org/10.3946/kjme.2016.28 eISSN: 2005-7288 Ⓒ The Korean Society of Medical Education.,Non-OADS,/arxiv_data1/oa_pdf/1e/6f/kjme-2016-28.PMC4951744.pdf
More active student participa-tion in future education programs is needed to develop faculty teaching methods.ORCID:  Su Jin Chae: http://orcid.org/0000-0003-3060-8933; Miran Kim: http://orcid.org/0000-0001-5553-5334;  Ki Hong Chang: http://orcid.org/0000-0002-3627-5642 Acknowledgements:  N one.,Non-OADS,/arxiv_data1/oa_pdf/1e/6f/kjme-2016-28.PMC4951744.pdf
"  185Received: February 4, 2016 •Revised: March 13, 2016 •Accepted: March 17, 2016 Corresponding Author:  Mohammad Arab (http://orcid.org/0000-0002-2161-7638) Department of Health Economics and Management, 4th Floor, New B uilding, School of Public  Health, Tehran University of Medical Sciences, Tehran, Iran Tel: +98.21.889.89129  Fax: +98.21.889.89129  email: arabmoha@t u m s .",Non-OADS,/arxiv_data1/oa_pdf/7a/f4/kjme-2016-29.PMC4951745.pdf
i r           Korean J Med Educ 2016 Jun; 28(2): 185-194. http://dx.doi.org/10.3946/kjme.2016.29 eISSN: 2005-7288 Ⓒ The Korean Society of Medical Education.,Non-OADS,/arxiv_data1/oa_pdf/7a/f4/kjme-2016-29.PMC4951745.pdf
"ORCID:  Narges Neyazi: http://orcid.org/0000-0001-8900-1648;  Mohammad Arab: http://orcid.org/0000-0002-2161-7638;  Freshteh Farzianpour: http://orcid.org/0000-0002-7040-1710; Mahmood Mahmoudi: http://orcid.org/0000-0001-7386-9565 Acknowledgements:  The authors would like to appreciate  all faculty members, library staff and all officials in public  health, nursing and midwifery, rehabilitation and allied medical sciences faculties at Tehran University of Medical Sciences w ho participated in this study.",Non-OADS,/arxiv_data1/oa_pdf/7a/f4/kjme-2016-29.PMC4951745.pdf
"Key Words :Middle East respiratory syndrome, Emerging infectious disease, Medical students, Risk assessment Received: March 8, 2016 •Revised: April 15, 2016 •Accepted: April 21, 2016 Corresponding Author:  Hye Won Jang (http://orcid.org/0000-0002-3053-7138) Department of Medical Education, Sungkyunkwan University School  of Medicine, 81 Irwon-ro  Gangnam-gu, Seoul 06351, Korea Tel: +82.2.2148.9906  Fax: +82.2.2148.9926  email: jhw463@skku.",Non-OADS,/arxiv_data1/oa_pdf/c3/1c/kjme-2016-30.PMC4951746.pdf
e d u        Korean J Med Educ 2016 Jun; 28(2): 209-217. http://dx.doi.org/10.3946/kjme.2016.30 eISSN: 2005-7288 Ⓒ The Korean Society of Medical Education.,Non-OADS,/arxiv_data1/oa_pdf/c3/1c/kjme-2016-30.PMC4951746.pdf
ORCID:  Seung Won Park: http://orcid.org/0000-0002-5012-8534; Hye Won Jang: http://orcid.org/0000-0002-3053-7138;,Non-OADS,/arxiv_data1/oa_pdf/c3/1c/kjme-2016-30.PMC4951746.pdf
"Seung Won Park, et al : Avoiding student infection during MERS o utbreak   216 Korean J Med Educ 2016 Jun; 28(2): 209-217.Yon Ho Choe: http://orcid.org/0000-0003-1525-7688; Kyung Soo Lee: http://orcid.org/0000-0002-3660-5728;Yong Chan Ahn: http://orcid.org/0000-0002-1971-8472;Myung Jin Chung: http://orcid.org/0000-0002-6271-3343;Kyu-Sung Lee: http://orcid.org/0000-0003-0891-2488;Kyunghoon Lee: http://orcid.org/0000-0003-0694-2499;Taehee Han: http://orcid.org/0000-0002-7247-3283 Acknowledgements:  N one.",Non-OADS,/arxiv_data1/oa_pdf/c3/1c/kjme-2016-30.PMC4951746.pdf
Available from: http://www.who.int/csr/disease/coronavirus_infections/mers-5-february-2015.pdf?ua=1.,Non-OADS,/arxiv_data1/oa_pdf/c3/1c/kjme-2016-30.PMC4951746.pdf
Available from: http://apps.who.int/iris/ bitstream/10665/156273/1/roadmapsitrep_18Mar2015_eng.pdf?ua=1&ua=1.,OADS,/arxiv_data1/oa_pdf/c3/1c/kjme-2016-30.PMC4951746.pdf
"  231Received: February 16, 2016 •Revised: March 8, 2016 •Accepted: April 15, 2016 Corresponding Author:  Kun Hwang (http://orcid.org/0000-0002-1994-2538) Department of Plastic Surgery, Inha University School of Medici ne, 27 Inhang-ro, Jung-gu, Incheon  22332, Korea  Tel: +82.32.890.3514  Fax: +82.32.890.2918  email: jokerhg@inha .",Non-OADS,/arxiv_data1/oa_pdf/2a/dd/kjme-2016-31.PMC4951747.pdf
k r          Korean J Med Educ 2016 Jun; 28(2): 231-235. http://dx.doi.org/10.3946/kjme.2016.31 eISSN: 2005-7288 Ⓒ The Korean Society of Medical Education.,Non-OADS,/arxiv_data1/oa_pdf/2a/dd/kjme-2016-31.PMC4951747.pdf
ORCID:  Se Won Hwang: http://orcid.org/0000-0003-4365-2060; Hun Kim: http://orcid.org/0000-0002-6296-9584; Ae Yang Kim: http://orcid.org/0000-0002-5704-3875;Kun Hwang: http://orcid.org/0000-0002-1994-2538 Acknowledgements:  None.,Non-OADS,/arxiv_data1/oa_pdf/2a/dd/kjme-2016-31.PMC4951747.pdf
"[http://dx.doi.org/10.1177/2040622315590318 ] [PMID: 26336596 ] [2] Kushida CA, Littner MR, Hirshkowitz M, et al.",OADS,/arxiv_data1/oa_pdf/7d/36/TORMJ-10-46.PMC4951758.pdf
"[http://dx.doi.org/10.1136/thx.2003.007195 ] [PMID: 15618587 ] [4] Banhiran W, Kittiphumwong P, Assanasen P, Chongkolwatana C, Metheetrairut C. Adjustable thermoplastic mandibular advancement device for obstructive sleep apnea: outcomes and practicability.",Non-OADS,/arxiv_data1/oa_pdf/7d/36/TORMJ-10-46.PMC4951758.pdf
"[http://dx.doi.org/10.1002/lary.24607 ] [PMID: 24458949 ] [5] Schönhofer B, Hochban W, Vieregge HJ, Brünig H, Köhler D. Immediate intraoral adaptation of mandibular advancing appliances of thermoplastic material for the treatment of obstructive sleep apnea.",Non-OADS,/arxiv_data1/oa_pdf/7d/36/TORMJ-10-46.PMC4951758.pdf
"[http://dx.doi.org/10.1159/000029468 ] [PMID: 10705268 ] [6] Vanderveken OM, Boudewyns AN, Braem MJ, et al.",OADS,/arxiv_data1/oa_pdf/7d/36/TORMJ-10-46.PMC4951758.pdf
"[http://dx.doi.org/10.1080/00016480310015984 ] [PMID: 15267184 ] [7] Maurer JT, Huber K, Verse T, Hörmann K, Stuck B.",OADS,/arxiv_data1/oa_pdf/7d/36/TORMJ-10-46.PMC4951758.pdf
"[http://dx.doi.org/10.1016/j.otohns.2006.08.008 ] [PMID: 17275545 ] [8] Vanderveken OM, Devolder A, Marklund M, et al.",OADS,/arxiv_data1/oa_pdf/7d/36/TORMJ-10-46.PMC4951758.pdf
[http://dx.doi.org/10.1164/rccm.200701-114OC ] [PMID: 17673699 ],Non-OADS,/arxiv_data1/oa_pdf/7d/36/TORMJ-10-46.PMC4951758.pdf
[http://dx.doi.org/10.1177/0194599812439683 ] [PMID: 22399278 ] [10] American Academy of Sleep Medicine Task Force.,Non-OADS,/arxiv_data1/oa_pdf/7d/36/TORMJ-10-46.PMC4951758.pdf
[http://dx.doi.org/10.1213/ANE.0b013e318248f4f5 ] [PMID: 22366847 ] [12] Johns MW.,Non-OADS,/arxiv_data1/oa_pdf/7d/36/TORMJ-10-46.PMC4951758.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7d/36/TORMJ-10-46.PMC4951758.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0d/61/ijcp-09-02-4086.PMC4951759.pdf
Available from: http://www.vlvbio.com/product/m30-apoptosense-elisa/ .,Non-OADS,/arxiv_data1/oa_pdf/0d/61/ijcp-09-02-4086.PMC4951759.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/1f/ijcp-09-02-4212.PMC4951760.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4f/27/ijcp-09-02-3966.PMC4951761.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/88/ca/ijcp-09-02-3647.PMC4951762.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/9a/ijcp-09-02-6360.PMC4951763.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d2/a7/ijcp-09-02-4755.PMC4951764.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c7/28/ijcp-09-02-4809.PMC4951766.pdf
Available from: http://www.wcrf.org/int/cancer-facts-ﬁgures/data-speciﬁc- cancers/colorectal-cancer-statistics#BOTH .,Non-OADS,/arxiv_data1/oa_pdf/c7/28/ijcp-09-02-4809.PMC4951766.pdf
Available from: http://www.cancer.org/research/ cancerfactsstatistics/colorectal-cancer-facts-ﬁgures .,Non-OADS,/arxiv_data1/oa_pdf/c7/28/ijcp-09-02-4809.PMC4951766.pdf
Available from: http://www.ircancer.ir/ default.aspx?tabid=88&ArticleId=355 .,OADS,/arxiv_data1/oa_pdf/c7/28/ijcp-09-02-4809.PMC4951766.pdf
Available from: http://www.cancer.org/research/cancerfactsﬁgures/ colorectalcancer%20factsﬁgures/colorectal-cancer-facts-ﬁgures- 2011-2013-page%2015 .,Non-OADS,/arxiv_data1/oa_pdf/c7/28/ijcp-09-02-4809.PMC4951766.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/e7/ijcp-09-02-4389.PMC4951767.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f1/72/ijcp-09-02-3910.PMC4951768.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c3/85/ijcp-09-02-3838.PMC4951769.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/50/80/ijcp-09-02-4209.PMC4951770.pdf
"[http://dx.doi.org/10.1016/j.ijcard.2006.12.043 ] [PMID: 17395318 ] [2] Fujiwara K, Naito Y, Higashiue S, et al.",OADS,/arxiv_data1/oa_pdf/27/58/TOCMJ-10-130.PMC4951776.pdf
"[http://dx.doi.org/10.1016/j.amjmed.2003.11.015 ] [PMID: 15006585 ] [4] Kajita LJ, Martinez EE, Ambrose JA, et al.",OADS,/arxiv_data1/oa_pdf/27/58/TOCMJ-10-130.PMC4951776.pdf
"[http://dx.doi.org/10.1002/1522-726X(200101)52:1<49::AID-CCD1012>3.0.CO;2-0 ] [PMID: 11146522 ] [5] Dodd JD, Maree A, Palacios I, et al.",OADS,/arxiv_data1/oa_pdf/27/58/TOCMJ-10-130.PMC4951776.pdf
"[http://dx.doi.org/10.1161/CIRCULATIONAHA.106.645622 ] [PMID: 17200448 ] [6] Caldera AE, Cruz-Gonzalez I, Bezerra HG, et al.",OADS,/arxiv_data1/oa_pdf/27/58/TOCMJ-10-130.PMC4951776.pdf
"[http://dx.doi.org/10.1378/chest.08-2922 ] [PMID: 19497900 ] [7] Piña Y, Exaire JE, Sandoval J.",OADS,/arxiv_data1/oa_pdf/27/58/TOCMJ-10-130.PMC4951776.pdf
"[http://dx.doi.org/10.4187/respcare.02252 ] [PMID: 23271814 ] [9] Żyłkowska J, Kurzyna M, Florczyk M, et al.",OADS,/arxiv_data1/oa_pdf/27/58/TOCMJ-10-130.PMC4951776.pdf
"[http://dx.doi.org/10.1378/chest.11-2794 ] [PMID: 22797193 ] [10] Lee MS, Oyama J, Bhatia R, Kim YH, Park SJ.",OADS,/arxiv_data1/oa_pdf/27/58/TOCMJ-10-130.PMC4951776.pdf
"[http://dx.doi.org/10.1002/ccd.22592 ] [PMID: 20506194 ] [11] Rich S, Dantzker DR, Ayres SM, et al.",OADS,/arxiv_data1/oa_pdf/27/58/TOCMJ-10-130.PMC4951776.pdf
[http://dx.doi.org/10.7326/0003-4819-107-2-216 ] [PMID: 3605900 ] [12] Rich S. Primary pulmonary hypertension.,Non-OADS,/arxiv_data1/oa_pdf/27/58/TOCMJ-10-130.PMC4951776.pdf
"[http://dx.doi.org/10.1016/0033-0620(88)90016-3 ] [PMID: 3055067 ] [13] Lindsey JB, Brilakis ES, Banerjee S. Acute coronary syndrome due to extrinsic compression of the left main coronary artery in a patient with severe pulmonary hypertension: successful treatment with percutaneous coronary intervention.",Non-OADS,/arxiv_data1/oa_pdf/27/58/TOCMJ-10-130.PMC4951776.pdf
"[http://dx.doi.org/10.1016/j.carrev.2007.07.003 ] [PMID: 18206638 ] [14] Tespili M, Saino A, Personeni D, Silvestro A, Scopelliti P, Banfi C. Life-threatening left main stenosis induced by compression from a dilated pulmonary artery.",Non-OADS,/arxiv_data1/oa_pdf/27/58/TOCMJ-10-130.PMC4951776.pdf
"[http://dx.doi.org/10.2459/JCM.0b013e32831e3f9c ] [PMID: 19377383 ] [15] Kothari SS, Bahl VK.",OADS,/arxiv_data1/oa_pdf/27/58/TOCMJ-10-130.PMC4951776.pdf
"[http://dx.doi.org/10.1002/clc.20457 ] [PMID: 19685513 ] [17] Jodocy D, Friedrich GJ, Bonatti JO, et al.",OADS,/arxiv_data1/oa_pdf/27/58/TOCMJ-10-130.PMC4951776.pdf
"[http://dx.doi.org/10.1016/j.jtcvs.2008.02.076 ] [PMID: 19577087 ] [18] Bonderman D, Fleischmann D, Prokop M, Klepetko W, Lang IM.",OADS,/arxiv_data1/oa_pdf/27/58/TOCMJ-10-130.PMC4951776.pdf
"[http://dx.doi.org/10.1161/hc0202.100239 ] [PMID: 11790711 ] [19] Jo Y, Kawamura A, Jinzaki M, et al.",OADS,/arxiv_data1/oa_pdf/27/58/TOCMJ-10-130.PMC4951776.pdf
"[http://dx.doi.org/10.1378/chest.112.3.842 ] [PMID: 9315824 ] [21] Kawut SM, Bagiella E, Lederer DJ, et al.",OADS,/arxiv_data1/oa_pdf/27/58/TOCMJ-10-130.PMC4951776.pdf
[http://dx.doi.org/10.1161/CIRCULATIONAHA.110.015693 ] [PMID: 21593252 ] © Demerouti et al.,Non-OADS,/arxiv_data1/oa_pdf/27/58/TOCMJ-10-130.PMC4951776.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/58/TOCMJ-10-130.PMC4951776.pdf
"[http://dx.doi.org/10.1510/icvts.2009.214551] [PMID: 19815567] [2] Bauer A, Diez C, Schubel J, et al.",OADS,/arxiv_data1/oa_pdf/4c/69/TOCMJ-10-148.PMC4951779.pdf
"[http://dx.doi.org/10.1177/0267659110371705] [PMID: 20581025] [4] Wippermann J, Albes JM, Hartrumpf M, et al.",OADS,/arxiv_data1/oa_pdf/4c/69/TOCMJ-10-148.PMC4951779.pdf
"[http://dx.doi.org/10.1016/j.ejcts.2005.03.032] [PMID: 15939621] [5] Vohra HA, Whistance R, Modi A, Ohri SK.",OADS,/arxiv_data1/oa_pdf/4c/69/TOCMJ-10-148.PMC4951779.pdf
"[http://dx.doi.org/10.1155/2009/707042] [6] Dreizler T, Herbrechtsmeier T, Born F, et al.",OADS,/arxiv_data1/oa_pdf/4c/69/TOCMJ-10-148.PMC4951779.pdf
"[http://dx.doi.org/10.1111/j.1525-1594.2004.00030.x] [PMID: 15554936] [8] Philipp A, Schmid F, Foltan M, et al.",OADS,/arxiv_data1/oa_pdf/4c/69/TOCMJ-10-148.PMC4951779.pdf
"[http://dx.doi.org/10.1016/j.jtcvs.2009.03.042] [PMID: 19660383] [10] El-Essawi A, Hajek T, Skorpil J, et al.",OADS,/arxiv_data1/oa_pdf/4c/69/TOCMJ-10-148.PMC4951779.pdf
"Allogeneic Blood Product Usage in Coronary Artery The Open Cardiovascular Medicine Journal, 2016, Volume 10   157 [http://dx.doi.org/10.1016/j.ejcts.2010.01.035] [PMID: 20206540] [11] Biancari  F,  Rimpiläinen  R.  Meta-analysis  of  randomised  trials  comparing  the  effectiveness  of  miniaturised  versus  conventional cardiopulmonary  bypass  in  adult  cardiac  surgery.",Non-OADS,/arxiv_data1/oa_pdf/4c/69/TOCMJ-10-148.PMC4951779.pdf
"[http://dx.doi.org/10.1136/hrt.2008.158709] [PMID: 19342377] [12] Puehler T, Haneya A, Philipp A, et al.",OADS,/arxiv_data1/oa_pdf/4c/69/TOCMJ-10-148.PMC4951779.pdf
"[http://dx.doi.org/10.1016/j.ejcts.2010.08.006] [PMID: 20851618] [13] Gruenwald CE, McCrindle BW, Crawford-Lean L, et al.",OADS,/arxiv_data1/oa_pdf/4c/69/TOCMJ-10-148.PMC4951779.pdf
"[http://dx.doi.org/10.1016/j.jtcvs.2008.08.044] [PMID: 19114187] [14] Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD.",OADS,/arxiv_data1/oa_pdf/4c/69/TOCMJ-10-148.PMC4951779.pdf
"[http://dx.doi.org/10.1016/S0003-4975(97)01347-7] [PMID: 9485240] [16] Mahoney CB, Lemole GM.",OADS,/arxiv_data1/oa_pdf/4c/69/TOCMJ-10-148.PMC4951779.pdf
"[http://dx.doi.org/10.1016/S1010-7940(99)00157-8] [PMID: 10485422] [17] Ranucci M, Isgrò G. Minimally invasive cardiopulmonary bypass: does it really change the outcome?",Non-OADS,/arxiv_data1/oa_pdf/4c/69/TOCMJ-10-148.PMC4951779.pdf
"[http://dx.doi.org/10.1186/cc5777] [PMID: 17433112] [18] Koivisto SP, Wistbacka JO, Rimpiläinen R, et al.",OADS,/arxiv_data1/oa_pdf/4c/69/TOCMJ-10-148.PMC4951779.pdf
"[http://dx.doi.org/10.1177/0267659110364443] [PMID: 20179173] [19] Remadi JP, Rakotoarivelo Z, Marticho P, Benamar A.",Non-OADS,/arxiv_data1/oa_pdf/4c/69/TOCMJ-10-148.PMC4951779.pdf
[http://dx.doi.org/10.1016/j.ahj.2005.03.067] [PMID: 16368318] [20] Durandy  YD.,OADS,/arxiv_data1/oa_pdf/4c/69/TOCMJ-10-148.PMC4951779.pdf
"[http://dx.doi.org/10.1016/j.jtcvs.2009.06.030] [PMID: 19931674] [21] Murphy GJ, Angelini GD.",OADS,/arxiv_data1/oa_pdf/4c/69/TOCMJ-10-148.PMC4951779.pdf
"[http://dx.doi.org/10.1097/01.CCM.0000217920.48559.D8] [PMID: 16607235] [23] Koch CG, Khandwala F, Li L, Estafanous FG, Loop FD, Blackstone EH.",Non-OADS,/arxiv_data1/oa_pdf/4c/69/TOCMJ-10-148.PMC4951779.pdf
"[http://dx.doi.org/10.4103/0971-9784.38444] [PMID: 18182754] [25] Puehler  T,  Haneya  A,  Philipp  A,  et  al.",OADS,/arxiv_data1/oa_pdf/4c/69/TOCMJ-10-148.PMC4951779.pdf
"[http://dx.doi.org/10.1111/j.1525-1594.2004.00030.x] [PMID: 15554936] [27] Abdel-Rahman U, Ozaslan F, Risteski PS, et al.",OADS,/arxiv_data1/oa_pdf/4c/69/TOCMJ-10-148.PMC4951779.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and",Non-OADS,/arxiv_data1/oa_pdf/4c/69/TOCMJ-10-148.PMC4951779.pdf
"[http://dx.doi.org/10.1023/A:1004630127000] [PMID: 10934747] [2] Cohen JA, Scheeringa MS. Post-traumatic stress disorder diagnosis in children: challenges and promises.",Non-OADS,/arxiv_data1/oa_pdf/7f/dd/TONEUJ-10-31.PMC4951780.pdf
Available from: https://www.recoveryranch.com/articles/trauma-and-ptsd-articles/child-sexual-abuse-as-a-cause-of-ptsd-post-traumatic-stress-disorder/ [4] Adams JA.,Non-OADS,/arxiv_data1/oa_pdf/7f/dd/TONEUJ-10-31.PMC4951780.pdf
"[http://dx.doi.org/10.3389/fnhum.2012.00052] [PMID: 22457645] [6] Tupler LA, De Bellis MD.",OADS,/arxiv_data1/oa_pdf/7f/dd/TONEUJ-10-31.PMC4951780.pdf
[http://dx.doi.org/10.3389/fpsyt.2013.00080] [PMID: 23966957] © Parano et al.,OADS,/arxiv_data1/oa_pdf/7f/dd/TONEUJ-10-31.PMC4951780.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7f/dd/TONEUJ-10-31.PMC4951780.pdf
"[http://dx.doi.org/10.2147/JBM.S19009 ] [PMID: 22287864 ] [2] Ito H, Matsuno T, Minami A.",OADS,/arxiv_data1/oa_pdf/1f/4e/TOORTHJ-10-252.PMC4951781.pdf
"[http://dx.doi.org/10.1097/BLO.0b013e31803b942a ] [PMID: 17308478 ] [3] Ito H, Tanino H, Yamanaka Y, Nakamura T, Minami A, Matsuno T. The Chiari pelvic osteotomy for patients with dysplastic hips and poor joint congruency: long-term follow-up.",Non-OADS,/arxiv_data1/oa_pdf/1f/4e/TOORTHJ-10-252.PMC4951781.pdf
"[http://dx.doi.org/10.1302/0301-620X.93B6.26178 ] [PMID: 21586768 ] [4] Tuy B, Bhate C, Beebe K, Patterson F, Benevenia J. IVC filters may prevent fatal pulmonary embolism in musculoskeletal tumor surgery.",Non-OADS,/arxiv_data1/oa_pdf/1f/4e/TOORTHJ-10-252.PMC4951781.pdf
"[http://dx.doi.org/10.1007/s11999-008-0607-7 ] [PMID: 18989730 ] [5] Ito  H,  Tanino  H,  Sato  T,  Nishida  Y,  Matsuno  T.  Early  weight-bearing  after  periacetabular  osteotomy  leads  to  a  high  incidence  of postoperative pelvic fractures.",Non-OADS,/arxiv_data1/oa_pdf/1f/4e/TOORTHJ-10-252.PMC4951781.pdf
"[http://dx.doi.org/10.1186/1471-2474-15-234 ] [PMID: 25015753 ] [6] Jain V, Dhaon BK, Jaiswal A, Nigam V, Singla J.",Non-OADS,/arxiv_data1/oa_pdf/1f/4e/TOORTHJ-10-252.PMC4951781.pdf
"[http://dx.doi.org/10.1136/pgmj.2003.018127 ] [PMID: 15579615 ] [7] Fujita S, Hirota S, Oda T, Kato Y, Tsukamoto Y, Fuji T. Deep venous thrombosis after total hip or total knee arthroplasty in patients in Japan.",Non-OADS,/arxiv_data1/oa_pdf/1f/4e/TOORTHJ-10-252.PMC4951781.pdf
"[http://dx.doi.org/10.1097/00003086-200006000-00020 ] [PMID: 10853166 ] [8] Kang BJ, Lee YK, Kim HJ, Ha YC, Koo KH.",OADS,/arxiv_data1/oa_pdf/1f/4e/TOORTHJ-10-252.PMC4951781.pdf
"[http://dx.doi.org/10.1007/s11999-011-1979-7 ] [PMID: 21748508 ] [9] Masuda EM, Kistner RL, Musikasinthorn C, Liquido F, Geling O, He Q.",OADS,/arxiv_data1/oa_pdf/1f/4e/TOORTHJ-10-252.PMC4951781.pdf
"[http://dx.doi.org/10.1016/j.jvs.2011.05.092 ] [PMID: 22032881 ] [10] Yun WS, Lee KK, Cho J, Kim HK, Kyung HS, Huh S. Early treatment outcome of isolated calf vein thrombosis after total knee arthroplasty.",OADS,/arxiv_data1/oa_pdf/1f/4e/TOORTHJ-10-252.PMC4951781.pdf
"[http://dx.doi.org/10.4174/jkss.2012.82.6.374 ] [PMID: 22708100 ] [11] Dorr LD, Gendelman V, Maheshwari AV, Boutary M, Wan Z, Long WT.",OADS,/arxiv_data1/oa_pdf/1f/4e/TOORTHJ-10-252.PMC4951781.pdf
"[http://dx.doi.org/10.2106/JBJS.F.00235 ] [PMID: 18056497 ] [12] Zaltz I, Beaulé P, Clohisy J, et al.",OADS,/arxiv_data1/oa_pdf/1f/4e/TOORTHJ-10-252.PMC4951781.pdf
"[http://dx.doi.org/10.2106/JBJS.J.01769 ] [PMID: 21543691 ] [13] Polkowski GG, Duncan ST, Bloemke AD, Schoenecker PL, Clohisy JC.",OADS,/arxiv_data1/oa_pdf/1f/4e/TOORTHJ-10-252.PMC4951781.pdf
"[http://dx.doi.org/10.1007/s11999-014-3614-x ] [PMID: 24733447 ] [14] Byun SS, Kim JH, Kim YJ, Jeon YS, Park CH, Kim WH.",OADS,/arxiv_data1/oa_pdf/1f/4e/TOORTHJ-10-252.PMC4951781.pdf
"[http://dx.doi.org/10.3348/kjr.2008.9.1.59 ] [PMID: 18253077 ] [15] Uehara  M,  Funabashi  N,  Miyagi  J,  et  al.",OADS,/arxiv_data1/oa_pdf/1f/4e/TOORTHJ-10-252.PMC4951781.pdf
[http://dx.doi.org/10.1016/j.ijcard.2009.09.556 ] [PMID: 19900725 ] © Yamanaka and Ito; Licensee Bentham Open.,OADS,/arxiv_data1/oa_pdf/1f/4e/TOORTHJ-10-252.PMC4951781.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/4e/TOORTHJ-10-252.PMC4951781.pdf
"[http://dx.doi.org/10.1111/j.1365-2796.1992.tb00960.x ] [PMID: 1602282 ] [2] Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM.",OADS,/arxiv_data1/oa_pdf/31/fb/TORMJ-10-36.PMC4951783.pdf
"[http://dx.doi.org/10.1164/ajrccm.161.5.9903102 ] [PMID: 10806180 ] [3] Pelaia G, Vatrella A, Busceti MT, et al.",OADS,/arxiv_data1/oa_pdf/31/fb/TORMJ-10-36.PMC4951783.pdf
"[http://dx.doi.org/10.1155/2015/879783 ] [4] Drazen JM, Israel E, O’Byrne PM.",Non-OADS,/arxiv_data1/oa_pdf/31/fb/TORMJ-10-36.PMC4951783.pdf
"[http://dx.doi.org/10.1056/NEJM199901213400306 ] [PMID: 9895400 ] [5] Currie GP, Srivastava P, Dempsey OJ, Lee DK.",OADS,/arxiv_data1/oa_pdf/31/fb/TORMJ-10-36.PMC4951783.pdf
"[http://dx.doi.org/10.1093/qjmed/hci024 ] [PMID: 15728398 ] [6] Löfdahl CG, Reiss TF, Leff JA, et al.",OADS,/arxiv_data1/oa_pdf/31/fb/TORMJ-10-36.PMC4951783.pdf
"[http://dx.doi.org/10.1164/ajrccm.155.4.9105060 ] [PMID: 9105060 ] [8] Virchow JC, Mehta A, Ljungblad L, Mitfessel H. Add-on montelukast in inadequately controlled asthma patients in a 6-month open-label study: the MONtelukast In Chronic Asthma (MONICA) study.",Non-OADS,/arxiv_data1/oa_pdf/31/fb/TORMJ-10-36.PMC4951783.pdf
"[http://dx.doi.org/10.1016/j.rmed.2009.11.022 ] [PMID: 20031382 ] [9] Taniguchi  Y,  Tamura  G,  Honma  M,  et  al.",OADS,/arxiv_data1/oa_pdf/31/fb/TORMJ-10-36.PMC4951783.pdf
"[http://dx.doi.org/10.1016/0091-6749(93)90074-P ] [PMID: 8409112 ] [10] Tomari S, Matsuse H, Hirose H, et al.",OADS,/arxiv_data1/oa_pdf/31/fb/TORMJ-10-36.PMC4951783.pdf
"[http://dx.doi.org/10.1159/000151289 ] [PMID: 18689991 ] [11] Barnes NC, Pujet JC.",Non-OADS,/arxiv_data1/oa_pdf/31/fb/TORMJ-10-36.PMC4951783.pdf
"[http://dx.doi.org/10.1136/thx.52.6.523 ] [PMID: 9227718 ] [12] Keam SJ, Lyseng-Williamson KA, Goa KL.",Non-OADS,/arxiv_data1/oa_pdf/31/fb/TORMJ-10-36.PMC4951783.pdf
"[http://dx.doi.org/10.2165/00003495-200363100-00005 ] [PMID: 12699401 ] [13] Yoo SH, Park SH, Song JS, et al.",OADS,/arxiv_data1/oa_pdf/31/fb/TORMJ-10-36.PMC4951783.pdf
[http://dx.doi.org/10.1046/j.1440-1843.2001.00291.x ] [PMID: 11264758 ] [14] Pranlukast hydrate BE study DDS06-181BE.,OADS,/arxiv_data1/oa_pdf/31/fb/TORMJ-10-36.PMC4951783.pdf
"Available  from: http://www.ginasthma.org/documents/4, [Accessed Jan 03, 2016].",OADS,/arxiv_data1/oa_pdf/31/fb/TORMJ-10-36.PMC4951783.pdf
"[http://dx.doi.org/10.4104/pcrj.2009.00010 ] [PMID: 19240948 ] [17] Jung JY, Son JY, Hong SJ, et al.",OADS,/arxiv_data1/oa_pdf/31/fb/TORMJ-10-36.PMC4951783.pdf
"[http://dx.doi.org/10.1164/rccm.200401-033OC ] [PMID: 15256389 ] [19] Ohbayashi H, Shibata N, Hirose T, Adachi M. Additional effects of pranlukast in salmeterol/fluticasone combination therapy for the asthmatic distal airway in a randomized crossover study.",Non-OADS,/arxiv_data1/oa_pdf/31/fb/TORMJ-10-36.PMC4951783.pdf
[http://dx.doi.org/10.1016/j.pupt.2009.08.002 ] [PMID: 19683591 ] [20] Asthma society of Canada.,Non-OADS,/arxiv_data1/oa_pdf/31/fb/TORMJ-10-36.PMC4951783.pdf
"Available at: http://www.asthma.ca/adults/treatment/leukotriene.php, [Assessed Jan 03, 2016] .",Non-OADS,/arxiv_data1/oa_pdf/31/fb/TORMJ-10-36.PMC4951783.pdf
"[http://dx.doi.org/10.1056/NEJM199807163390302 ] [PMID: 9664090 ] [22] Nathan RA, Sorkness CA, Kosinski M, et al.",OADS,/arxiv_data1/oa_pdf/31/fb/TORMJ-10-36.PMC4951783.pdf
"[http://dx.doi.org/10.1016/j.jaci.2003.09.008 ] [PMID: 14713908 ] [23] Yasui H, Fujisawa T, Inui N, et al.",OADS,/arxiv_data1/oa_pdf/31/fb/TORMJ-10-36.PMC4951783.pdf
"[http://dx.doi.org/10.1016/j.rmed.2011.12.014 ] [PMID: 22265857 ] [24] Laviolette M, Malmstrom K, Lu S, et al.",OADS,/arxiv_data1/oa_pdf/31/fb/TORMJ-10-36.PMC4951783.pdf
"[http://dx.doi.org/10.1164/ajrccm.160.6.9803042 ] [PMID: 10588598 ] [25] Obase Y, Shimoda T, Matsuse H, et al.",OADS,/arxiv_data1/oa_pdf/31/fb/TORMJ-10-36.PMC4951783.pdf
[http://dx.doi.org/10.1159/000077419 ] [PMID: 15133341 ] © Kim et al.,OADS,/arxiv_data1/oa_pdf/31/fb/TORMJ-10-36.PMC4951783.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/31/fb/TORMJ-10-36.PMC4951783.pdf
"[http://dx.doi.org/10.1023/B:NEON.0000013499.74404.81 ] [PMID: 15015791 ] [2] Page R, Doshi B, Sharr MM.",Non-OADS,/arxiv_data1/oa_pdf/c6/63/TONIJ-10-80.PMC4951784.pdf
"[http://dx.doi.org/10.1136/jnnp.49.1.93 ] [PMID: 3754275 ] [3] Kageji T, Nagahiro S, Matsuzaki K, et al.",OADS,/arxiv_data1/oa_pdf/c6/63/TONIJ-10-80.PMC4951784.pdf
"[http://dx.doi.org/10.1007/s11060-006-9311-1 ] [PMID: 17205387 ] [4] Huang CY, Chen CA, Hsieh CY, Cheng WF.",OADS,/arxiv_data1/oa_pdf/c6/63/TONIJ-10-80.PMC4951784.pdf
"[http://dx.doi.org/10.1111/j.1525-1438.2007.00934.x ] [PMID: 17425677 ] [5] Lv XF, Qiu YW, Zhang XL, et al.",OADS,/arxiv_data1/oa_pdf/c6/63/TONIJ-10-80.PMC4951784.pdf
[http://dx.doi.org/10.3174/ajnr.A2194 ] [PMID: 20616180 ],Non-OADS,/arxiv_data1/oa_pdf/c6/63/TONIJ-10-80.PMC4951784.pdf
"[http://dx.doi.org/10.3171/jns.1997.86.3.0446 ] [PMID: 9046301 ] [7] Gao Y, Jiang J, Liu Q. Extragonadal malignant germ cell tumors: a clinicopathological and immunohistochemical analysis of 48 cases at a single Chinese institution.",Non-OADS,/arxiv_data1/oa_pdf/c6/63/TONIJ-10-80.PMC4951784.pdf
"[http://dx.doi.org/10.1007/s11060-009-9951-z ] [PMID: 19588227 ] [9] Guo J, Zhong C, Liu Q, et al.",OADS,/arxiv_data1/oa_pdf/c6/63/TONIJ-10-80.PMC4951784.pdf
"[http://dx.doi.org/10.1016/S0090-3019(00)00213-5 ] [PMID: 10874141 ] [11] Fujii T, Itakura T, Hayashi S, Komai N, Nakamine H, Saito K. Primary pineal choriocarcinoma with hemorrhage monitored by computerized tomography.",OADS,/arxiv_data1/oa_pdf/c6/63/TONIJ-10-80.PMC4951784.pdf
"[http://dx.doi.org/10.3171/jns.1981.55.3.0484 ] [PMID: 7196441 ] [12] Kawakami Y, Yamada O, Tabuchi K, Ohmoto T, Nishimoto A.",OADS,/arxiv_data1/oa_pdf/c6/63/TONIJ-10-80.PMC4951784.pdf
[http://dx.doi.org/10.3171/jns.1980.53.3.0369 ] [PMID: 7191440 ] © Li et al.,OADS,/arxiv_data1/oa_pdf/c6/63/TONIJ-10-80.PMC4951784.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c6/63/TONIJ-10-80.PMC4951784.pdf
[http://dx.doi.org/10.1016/j.arth.2010.04.026 ] [PMID: 20541360 ] [2] Harris WH.,OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.3109/17453679408993734 ] [PMID: 8154274 ] [3] Dean JC, Tisdel CL, Goldberg VM, Parr J, Davy D, Stevenson S. Effects of hydroxyapatite tricalcium phosphate coating and intracancellous placement on bone ingrowth in titanium fibermetal implants.",Non-OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.1016/S0883-5403(05)80083-X ] [PMID: 8749769 ] [4] Gallo J, Raska M, Mrázek F, Petrek M. Bone remodeling, particle disease and individual susceptibility to periprosthetic osteolysis.",OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.1111/j.1365-2842.1996.tb01214.x ] [PMID: 8850057 ] [6] Pedersen AB, Mehnert F, Odgaard A, Schrøder HM.",OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.2147/CLEP.S30050 ] [PMID: 22701092 ] [7] Paxton EW, Furnes O, Namba RS, Inacio MC, Fenstad AM, Havelin LI.",OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.2106/JBJS.K.01045 ] [PMID: 22262419 ] [8] Illingworth KD, Wachter N, Maloney WJ, Paprosky WG, Ries MD, Saleh KJ.",OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.1080/000164701753606644 ] [PMID: 11327409 ] [10] Bitar D, Parvizi J.",OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.5312/wjo.v6.i2.172 ] [PMID: 25793158 ] [11] Rujitanaroj PO, Jao B, Yang J, et al.",OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.1016/j.actbio.2012.09.029 ] [PMID: 23036951 ] [12] Messier  SP,  Gutekunst  DJ,  Davis  C,  DeVita  P.  Weight  loss  reduces  knee-joint  loads  in  overweight  and  obese  older  adults  with  knee osteoarthritis.",Non-OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.1002/art.21139 ] [PMID: 15986358 ] [13] Gallo J, Goodman SB, Konttinen YT, Raska M. Particle disease: biologic mechanisms of periprosthetic osteolysis in total hip arthroplasty.",OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.1177/1753425912451779 ] [PMID: 22751380 ] [14] Davies  AP,  Willert  HG,  Campbell  PA,  Learmonth  ID,  Case  CP.",Non-OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
[http://dx.doi.org/10.2106/JBJS.C.00949 ] [PMID: 15634811 ],Non-OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.1016/S0043-1648(03)00522-2 ] [17] Schramm M, Wirtz DC, Holzwarth U, Pitto RP.",OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.1515/bmte.2000.45.4.105 ] [PMID: 10829545 ] [18] Jauch SY, Huber G, Sellenschloh K, et al.",OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.1002/jor.22354 ] [PMID: 23553890 ] [19] Mistry JB, Chughtai M, Elmallah RK, et al.",OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.1007/s10195-016-0391-1 ] [PMID: 26868420 ] [20] Pastides PS, Dodd M, Sarraf KM, Willis-Owen CA.",OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.5312/wjo.v4.i4.161 ] [21] Morawietz  L,  Classen  RA,  Schröder  JH,  et  al.",OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.1136/jcp.2005.027458 ] [PMID: 16731601 ] [22] Mert M, Oztürkmen Y, Ünkar EA, Erdoğan S, Uzümcügil O. Sciatic nerve compression by an extrapelvic cyst secondary to wear debris after a cementless total hip arthroplasty: A case report and literature review.",Non-OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.1016/j.ijscr.2013.07.008 ] [PMID: 23959404 ] [23] Berend ME, Ritter MA, Hyldahl HC, Meding JB, Redelman R. Implant migration and failure in total knee arthroplasty is related to body mass index and tibial component size.",OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.1016/j.arth.2008.05.020 ] [PMID: 18722310 ] [24] Wong J, Steklov N, Patil S, et al.",OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.1002/jor.21221 ] [PMID: 20882595 ] [25] Aspenberg P, van der Vis H. Fluid pressure may cause periprosthetic osteolysis.",Non-OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.3109/17453679809002344 ] [PMID: 9524506 ] [26] Pap  G,  Machner  A,  Rinnert  T,  et  al.",OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.1002/1529-0131(200104)44:4<956::AID-ANR153>3.0.CO;2-3 ] [PMID: 11315935 ] [27] Goldring SR, Jasty M, Roelke MS, Rourke CM, Bringhurst FR, Harris WH.",OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.1002/art.1780290704 ] [PMID: 3091038 ] [28] Windisch C, Windisch B, Kolb W, Kolb K, Grützner P, Roth A. Osteodensitometry measurements of periprosthetic bone using dual energy X-ray absorptiometry following total knee arthroplasty.",Non-OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.1007/s00402-012-1601-9 ] [PMID: 22886240 ] [29] Banerjee S, Pivec R, Issa K, Kapadia BH, Khanuja HS, Mont MA.",Non-OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.5923/j.ajbe.20110101.02 ] [31] Vermes C, Chandrasekaran R, Jacobs JJ, Galante JO, Roebuck KA, Glant TT.",Non-OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.1007/s11999-008-0472-4 ] [PMID: 18781371 ] [33] Ingram  JH,  Stone  M,  Fisher  J,  Ingham  E.  The  influence  of  molecular  weight,  crosslinking  and  counterface  roughness  on  TNF-alpha production by macrophages in response to ultra high molecular weight polyethylene particles.",Non-OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.1016/j.biomaterials.2003.10.054 ] [PMID: 15020125 ] [34] Willert  HG,  Buchhorn  GH,  Fayyazi  A,  Lohmann  C.  Histopathological  changes  around  metal/metal  joints  indicate  delayed  type hypersensitivity.",Non-OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
[http://dx.doi.org/10.1097/00003086-200112000-00008 ] [PMID: 11764373 ],Non-OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.1016/j.biomaterials.2009.09.017 ] [PMID: 19781765 ] [38] Purdue PE, Koulouvaris P, Nestor BJ, Sculco TP.",OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.1007/s11420-006-9003-6 ] [PMID: 18751821 ] [39] Atkins GJ, Haynes DR, Howie DW, Findlay DM.",Non-OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.5312/wjo.v2.i10.93 ] [PMID: 22474627 ] [40] Witte F, Hort N, Vogt C, et al.",OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.1016/j.cossms.2009.04.001 ] [41] Feyerabend F, Fischer J, Holtz J, et al.",OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.1016/j.actbio.2009.09.024 ] [PMID: 19800429 ] [42] Pichler K, Kraus T, Martinelli E, et al.",OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.1007/s00264-013-2163-3 ] [PMID: 24258151 ] [43] Catelas I, Petit A, Zukor DJ, Antoniou J, Huk OL.",OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.1016/S0142-9612(02)00351-4 ] [PMID: 12423593 ] [44] Tsaousi A, Jones E, Case CP.",OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.1016/j.mrgentox.2010.01.012 ] [PMID: 20139029 ] [45] Vermes C, Roebuck KA, Chandrasekaran R, Dobai JG, Jacobs JJ, Glant TT.",OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.1359/jbmr.2000.15.9.1756 ] [PMID: 10976995 ] [46] Jimbo R, Sawase T, Shibata Y, et al.",OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.1016/j.biomaterials.2007.04.029 ] [PMID: 17512051 ] [47] Pap T, Pap G, Hummel KM, et al.",OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.1016/j.bone.2012.09.011 ] [PMID: 22995462 ] [49] Nalepka JL, Lee MJ, Kraay MJ, et al.",OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.1097/01.blo.0000224050.94248.38 ] [PMID: 16735873 ] [50] Henderson B, Poole S, Wilson M. Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis.",Non-OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.1359/jbmr.2001.16.11.2082 ] [PMID: 11697805 ] [52] Hirayama  T,  Tamaki  Y,  Takakubo  Y,  et  al.",OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.1002/jor.21369 ] [PMID: 21308757 ] [53] Ishimi Y, Miyaura C, Jin CH, et al.",OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"[http://dx.doi.org/10.1002/jbmr.5650060807 ] [PMID: 1785373 ] [55] Ragab AA, Van De Motter R, Lavish SA, et al.",OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
[http://dx.doi.org/10.1002/jor.1100170603 ] [PMID: 10632445 ],Non-OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
[http://dx.doi.org/10.1016/S0022-3913(97)70210-5 ] [PMID: 9029469 ] © Sukur et al.,OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/71/TOORTHJ-10-241.PMC4951796.pdf
"CTTI Recommendations: Quality by Design , http://www.ctti-clinicaltria ls.org/files/QbD_toolkit/ CTTI%20Quality%20by%20D esign%20Recommendations_ FINAL_1JUN15.pdf (2015, accessed 15 June 2015).",Non-OADS,/arxiv_data1/oa_pdf/02/56/10.1177_1740774516643491.PMC4952025.pdf
"Critical to qual- ity factors , http://www.ctti-clinicaltrials.org/files/QbD_ toolkit/Principles%20Document_finaldraft_19MAY15.pdf (2015, accessed 15 June 2015).",Non-OADS,/arxiv_data1/oa_pdf/02/56/10.1177_1740774516643491.PMC4952025.pdf
"Quality by Design Toolkit , http://www.ctti-clinicaltrials.org/qbd (2015, accessed 15 June 2015).20.International conference on harmonisation of technical requirements for registration of pharmaceuticals for humanuse, final concept paper—addendum for ICH E6, Guide- line for Good Clinical Practice, http://www.ich.org/filead-min/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6/E6_R2__Addendum_Step2.pdf (2015, accessed 10August 2015).",Non-OADS,/arxiv_data1/oa_pdf/02/56/10.1177_1740774516643491.PMC4952025.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/f2/1c/10.1177_2325967116655742.PMC4954546.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/f6/e4/10.1177_2325967116657530.PMC4954547.pdf
Colleges and universities offering foot- ball increases to all-time high of 773. http://www.footballfoundation.,Non-OADS,/arxiv_data1/oa_pdf/f6/e4/10.1177_2325967116657530.PMC4954547.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/0a/0c/10.1177_2325967116656328.PMC4954548.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/14/3e/10.1177_2325967116654651.PMC4954549.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/18/53/10.1177_2325967116655158.PMC4954550.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/06/23/10.1177_2325967116655313.PMC4954551.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/4.0/ © A Vega-Crespo et al.",Non-OADS,/arxiv_data1/oa_pdf/28/bf/mtm201650.PMC4954563.pdf
"4, 258 –260 http://dx.doi.org/10.1080/19336950.2016.1155900",Non-OADS,/arxiv_data1/oa_pdf/27/6c/kchl-10-04-1155900.PMC4954575.pdf
"FASEB J 2016; 3:1306-16;PMID:26655382; http://dx.doi.org/10.1096/fj.15-281576 [2] Zakharian E, et al.",OADS,/arxiv_data1/oa_pdf/27/6c/kchl-10-04-1155900.PMC4954575.pdf
"Intracellular ATP supports TRPV6 activ- ity via lipid kinases and the generation of PtdIns(4, 5) P.FASEB J 2011; 25:3915-28; PMID:21810903; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/27/6c/kchl-10-04-1155900.PMC4954575.pdf
"J Biol Chem2005; 280:22540-8; PMID:15824111; http://dx.doi.org/10.1074/jbc.M503092200 [4] Wagner TF, et al.",OADS,/arxiv_data1/oa_pdf/27/6c/kchl-10-04-1155900.PMC4954575.pdf
"J Gen Phys-iol 2015; 146:65-77; PMID:26123195; http://dx.doi.org/10.1085/jgp.201411336 [6] Toth BI, et al.",OADS,/arxiv_data1/oa_pdf/27/6c/kchl-10-04-1155900.PMC4954575.pdf
"J Gen Physiol 2015;146:51-63; PMID:26123194; http://dx.doi.org/10.1085/ jgp.201411339[7] Zakharian E, et al.",OADS,/arxiv_data1/oa_pdf/27/6c/kchl-10-04-1155900.PMC4954575.pdf
"Plos One 2009; 4:e5404; PMID:19404398; http://dx.doi.org/10.1371/journal.pone.0005404 [8] Sun X, Zakharian E. Regulation of the temperature-depen- dent activation of transient receptor potential vanilloid 1(TRPV1) by phospholipids in planar lipid bilayers.",OADS,/arxiv_data1/oa_pdf/27/6c/kchl-10-04-1155900.PMC4954575.pdf
J BiolChem 2015; 290:4741-7; PMID:25561742; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/27/6c/kchl-10-04-1155900.PMC4954575.pdf
Cell Reports 11: 1 –8; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b4/71/kchl-10-04-1161988.PMC4954577.pdf
"4, 313 –319 http://dx.doi.org/10.1080/19336950.2016.1161988",Non-OADS,/arxiv_data1/oa_pdf/b4/71/kchl-10-04-1161988.PMC4954577.pdf
The pro-tein sequence was translated from the single cellRT-PCR DNA product using the web-based transla-tion tool ExPASy (SIB Bioinformatics Resource Por-tal; http://web.expasy.org/translate/).,OADS,/arxiv_data1/oa_pdf/b4/71/kchl-10-04-1161988.PMC4954577.pdf
"The calcium- activated slow AHP: cutting through the Gordian knot.Front Cell Neurosci 2012; 6:47; PMID:23112761; http://dx.doi.org/10.3389/fncel.2012.00047 [2] Turner RW, Kruskic M, Teves M, Scheidl-Yee T, Hameed S, Zamponi GW.",OADS,/arxiv_data1/oa_pdf/b4/71/kchl-10-04-1161988.PMC4954577.pdf
"Eur J Physiol 2015; 467:311-28; http://dx.doi.org/ 10.1007/s00424-014-1523-1 [3] King B, Rizwan AP, Asmara H, Heath NC, Engbers JD, Dykstra S, Bartoletti TM, Hameed S, Zamponi GW,Turner RW.",Non-OADS,/arxiv_data1/oa_pdf/b4/71/kchl-10-04-1161988.PMC4954577.pdf
Cell Rep 2015;11:175-82; PMID:25865881; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b4/71/kchl-10-04-1161988.PMC4954577.pdf
